0001554795-13-000067.txt : 20130201 0001554795-13-000067.hdr.sgml : 20130201 20130201115413 ACCESSION NUMBER: 0001554795-13-000067 CONFORMED SUBMISSION TYPE: 10-K PUBLIC DOCUMENT COUNT: 13 CONFORMED PERIOD OF REPORT: 20120831 FILED AS OF DATE: 20130201 DATE AS OF CHANGE: 20130201 FILER: COMPANY DATA: COMPANY CONFORMED NAME: ENTEST BIOMEDICAL, INC. CENTRAL INDEX KEY: 0001449447 STANDARD INDUSTRIAL CLASSIFICATION: AGRICULTURE SERVICES [0700] IRS NUMBER: 263431263 STATE OF INCORPORATION: NV FISCAL YEAR END: 0831 FILING VALUES: FORM TYPE: 10-K SEC ACT: 1934 Act SEC FILE NUMBER: 333-154989 FILM NUMBER: 13565602 BUSINESS ADDRESS: STREET 1: 4700 SPRING STREET, ST 203 CITY: LA MESA STATE: CA ZIP: 91941 BUSINESS PHONE: (619) 702-1404 MAIL ADDRESS: STREET 1: 4700 SPRING STREET, ST 203 CITY: LA MESA STATE: CA ZIP: 91941 FORMER COMPANY: FORMER CONFORMED NAME: JB Clothing Corp DATE OF NAME CHANGE: 20081104 10-K 1 entb0129form10k.htm FORM 10-K

United States Securities and Exchange Commission

Washington, D.C. 20549

Form 10-K

☑	ANNUAL REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934: For the fiscal year ending August 31, 2012

☐	TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934: For the transition period from ___________ to ___________.

Commission file number: 333-154989

ENTEST BIOMEDICAL, INC.

(Name of small business issuer in its charter)

Nevada		26-3431263
(State or other jurisdiction of incorporation or organization)		(I.R.S. Employer Identification No.)

4700 Spring Street, Suite 304, La Mesa, California, 91942

(Address of Principal executive offices)

Issuer’s telephone number: ( 619) 702-1404

_______________

Securities registered under Section 12(b) of the “Exchange Act” None

Securities registered under Section 12(g) of the Exchange Act: None

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☐ No ☑

Indicate by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation S-K (§ 229.405 of this chapter) is not contained herein, and will not be contained, to the best of registrant’s knowledge, in definitive proxy or information statements incorporated by reference in Part III of this Form 10-K or any amendment to this Form 10-K

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company.

Large accelerated filer ☐	Accelerated filer ☐	Non accelerated filer ☐
Smaller reporting Company ☑

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act). Yes ☐ No ☑

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes ☐ No ☑

State the aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant’s most recently completed second fiscal quarter: $528,715

As of January 25, 2013 Entest BioMedical, Inc. had 446,519,900 common shares outstanding, 3,201,397 Series B Preferred shares outstanding, and 5,000 Series AA preferred shares outstanding and 75,000 Non Voting Convertible Preferred shares outstanding.

In this annual report, the terms “Entest BioMedical, Inc.. ”, “Entest”, “Company”, “we”, or “our”, unless the context otherwise requires, mean Entest BioMedical, Inc., a Nevada corporation, and its subsidiary.

CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING STATEMENTS

This annual report on Form 10-K and other reports that we file with the SEC contain statements that are considered forward-looking statements. Forward-looking statements give the Company’s current expectations, plans, objectives, assumptions or forecasts of future events. All statements other than statements of current or historical fact contained in this annual report, including statements regarding the Company’s future financial position, business strategy, budgets, projected costs and plans and objectives of management for future operations, are forward-looking statements. In some cases, you can identify forward-looking statements by terminology such as “anticipate,” “estimate,” “plans,” “potential,” “projects,” “ongoing,” “expects,” “management believes,” “we believe,” “we intend,” and similar expressions. These statements are based on the Company’s current plans and are subject to risks and uncertainties, and as such the Company’s actual future activities and results of operations may be materially different from those set forth in the forward looking statements. Any or all of the forward-looking statements in this annual report may turn out to be inaccurate and as such, you should not place undue reliance on these forward-looking statements. The Company has based these forward-looking statements largely on its current expectations and projections about future events and financial trends that it believes may affect its financial condition, results of operations, business strategy and financial needs. The forward-looking statements can be affected by inaccurate assumptions or by known or unknown risks, uncertainties and assumptions due to a number of factors, including:

·	dependence on key personnel;
·	competitive factors;
·	degree of success of research and development programs
·	the operation of our business; and
·	general economic conditions

These forward-looking statements speak only as of the date on which they are made, and except to the extent required by federal securities laws, we undertake no obligation to update any forward-looking statements to reflect events or circumstances after the date on which the statement is made or to reflect the occurrence of unanticipated events. In addition, we cannot assess the impact of each factor on our business or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking statements. All subsequent written and oral forward-looking statements attributable to the Company or persons acting on its behalf are expressly qualified in their entirety by the cautionary statements contained in this annual report.

PART I

Item 1. Business

We were incorporated in the State of Nevada on September 24, 2008 as JB Clothing Corporation. Until July 10, 2009, our principal business objective was the offering of active/leisure fashion design clothing.

On July 10, 2009 we abandoned our efforts in the field of active/leisure fashion design clothing when we acquired 100% of the share capital of Entest BioMedical, Inc., a California corporation, (“Entest CA”) from Bio-Matrix Scientific Group, Inc. (“BMSN”) for consideration consisting of 10,000,000 shares of the common stock of the Company and the cancellation of 10,000,000 shares of the Company owned and held by Mr. Rick Plote.

As a result of this transaction, the former stockholder of Entest CA held approximately 70% of the voting capital stock of the Company immediately after the transaction. For financial accounting purposes, this acquisition was a reverse acquisition of the Company by Entest CA under the purchase method of accounting, and was treated as a recapitalization with Entest CA as the acquirer. As of November 1, 2011 the former stockholder of Entest CA held approximately 48% of the outstanding common shares of the Company.

Upon acquisition of Entest CA, we abandoned our efforts in the field of active/leisure fashion design clothing. Our business is currently the business of Entest CA, and we currently intend to develop and commercialize therapies, medical devices and medical testing procedures. On July 12, 2009 we adopted the name of Entest CA when we changed our name to Entest BioMedical, Inc.

The Company’s current strategy is to develop and commercialize therapies, medical devices and medical testing procedures for the veterinary market. It is believed by the Company that any required regulatory approvals can be obtained much more rapidly with regard to products and services developed for the veterinary market and that the achievement of successful clinical trials and commercialization of such products and services may allow the company to enter into collaborations with larger pharmaceutical companies for the purpose of developing and commercializing these products and services for human usage.

The process by which a new drug is approved for use in humans within the United States generally begins prior to submission of the IND (Investigational New Drug Application) with the FDA.

Prior to submission of the IND, the sponsor of the drug compound under development must test the drugs on laboratory animals (preclinical testing) in order that toxicity may be determined and efficacy may be demonstrated. The results of such preclinical testing is crucial in determining whether or not the sponsor may proceed onto clinical trials on human beings and preclinical testing is required to be performed on multiple species.

Drug studies in humans can begin only after an IND is reviewed by the FDA and a local institutional review board (IRB). The board is a panel of scientists and non-scientists in hospitals and research institutions that oversees clinical research.

IRBs approve the clinical trial protocols, which describe the type of people who may participate in the clinical trial, the schedule of tests and procedures, the medications and dosages to be studied, the length of the study, the study's objectives, and other details. IRBs make sure the study is acceptable, that participants have given consent and are fully informed of their risks, and that researchers take appropriate steps to protect patients from harm.

After trial protocols have been approved the sponsor moves on to Phase I clinical trials (to determine safety and toxicity in a small number of volunteers) and, if Phase 1 studies don't reveal unacceptable toxicity, Phase II and Phase III clinical trials to determine effectiveness.

The process by which a new drug is approved for veterinary use within the United States generally begins with the sponsor researching and developing the new compound and conducting initial (“pilot”) studies on it for a specific use in a specific animal species (called the “target animal” species) If the results of the pilot studies are promising and there is a potential market for the drug, the drug sponsor contacts The US Food and Drug Administration’s Center for Veterinary Medicine (CVM) to officially begin the drug approval process by opening an Investigational New Animal Drug (“INAD”) file. Information is submitted regarding Chemistry, Manufacturing, and Controls; Effectiveness; Target Animal Safety; Human Food Safety(if applicable); Environmental Impact (if applicable) and Labeling in support of the NADA (New Animal Drug Application) which is submitted by the sponsor for approval by the FDA.

With the exception of a biologic product which can be classified as a medical device, Biologics developed for human use generally are undergo the same path to FDA approval as for drugs. Biologics classified as medical devices may, in most instance, be subject to premarket approval by the FDA. Medical devices intended for veterinary use are not subject to premarket approval by the FDA.

Veterinary Biologics are regulated by the U.S. Department of Agriculture (USDA) which is authorized, under the 1913 Virus-Serum-Toxin Act as amended by the 1985 Food Security Act, to ensure that all veterinary biologics produced in, or imported into, the United States are not worthless, contaminated, dangerous, or harmful. The Veterinary Biologics Program of the USDA's Animal and Plant Health Inspection Service (APHIS) oversees the veterinary biologics industry in the United States.

Domestic manufacturers of veterinary biologics, for domestic use or for export, are required to possess a valid U.S. Veterinary Biologics Establishment License and an individual U.S. Veterinary Biologics Product License for each product produced for sale. Prior to being granted a U.S. Veterinary Biologic Establishment License, the applicant must submit detailed information regarding the facilities and the qualifications of key personnel and must submit to an inspection of the facilities by the Center for Veterinary Biologics, a division of the USDA . To qualify for an establishment license, an applicant also must qualify for at least one product license.

Prior to being granted a U.S. Veterinary Biologics Product License, the applicant must submit detailed information including test reports and research data sufficient to establish purity, safety, potency and efficacy of the product, an Outline of Production, and information regarding labeling and facilities that are to be used in preparation.

It is the Company’s opinion that factors such as the lack of need for multispecies pre clinical testing, smaller subject size in efficacy testing (subjects generally in the hundreds for veterinary equivalent of Phase III clinical trials as opposed to generally in the thousands for Phase III clinical trials for drug compounds for use in humans), lack of the requirement for premarket approval for medical devices intended for veterinary use should generally lead to a shorter timeframe for approval by the appropriate regulators of drugs, biologics, and medical devices intended for veterinary use as opposed to drugs, biologics, and medical devices intended for human use.

The Company is currently focusing its efforts and allocating its resources towards:

(a) The development and commercialization of ImenVax™, a therapeutic cancer vaccine for use in canines

(b) The acquisition of veterinary clinics

The Company is attempting to acquire currently existing veterinary clinics so that it may benefit from:

(a) Cash flow generated from operations during the development stage of the Company’s products and services,

(b) Utilization of the clinics for clinical testing,

On January 4, 2011, 2010, Entest CA acquired from Pet Pointers, Inc. ( a California corporation doing business as McDonald Animal Hospital) and Dr. Gregory McDonald DVM all the goodwill from Dr. McDonald and assets of Pet Pointers, Inc except cash and accounts receivables used in connection with the operation of a veterinary medical clinic located at 225 S. Milpas Street, Santa Barbara, CA 93103 which conducts business under the name McDonald Animal Hospital.

Consideration for the acquisition consisted of:

I. $70,000 in cash

II. $210,000 of the common shares of the Company valued at the closing price per share as of January 4, 2011

III. Payment of no more than $78,000 to a creditor of the sellers to be paid in monthly installments of $1,500 per month

IV. Payment of no more than $25,000 to additional creditors of the sellers to be paid in monthly installments of $825 per month

V. Payment of $50,000 to Dr. McDonald on the first business day of the fourth month following the closing of the acquisition (“Closing”)

The Company also became obligated to make payment to Dr. McDonald of that number of shares of common stock of the Company’s common stock valued at the closing bid price of the trading day immediately prior to issuance which shall equal $70,000 upon completion of the first calendar year during the Employment Period (as such period is defined in the employment agreement entered into between McDonald and Entest CA dated December 31, 2010 ) in which the business acquired generates gross sales in excess of $700,000.

The payment of $50,000 due to Dr. McDonald was satisfied by the Company through the issuance of 143,000 of our common shares to Dr. Gregory McDonald on August 29, 2011.

Dr. McDonald was terminated from his position as Managing Licensee and Supervising Veterinarian of the McDonald Animal Hospital on March 30, 2012.

On October 10, 2012 a Complaint (“Complaint”) was filed in the Superior Court of the State of California against the Company and David Koos by McDonald, a former employee of the Company, alleging breach of contract and breach of the covenant of good faith and dealing in connection with the assumption of lease obligations by the Company in connection with the acquisition of the assets of Pet Pointers, Inc breach of contract and breach of the covenant of good faith and dealing in connection with an employment agreement enters into with McDonald inc connection with the Acquisition, breach of contract in connection with the Acquisition purchase agreement, breach of the covenant of good faith and dealing in connection with the Acquisition purchase agreement, implied indemnity in connection to amounts owed by McDonald to Anthony and Judi Marinelli, the Internal Revenue Service, and the California Franchise Tax Board, intentional misrepresentation, negligent misrepresentation , failure to pay wages and violations of Sections 2802, 203, and 2806 of the California Labor Code. The Complaint sought judgment for nominal damages, actual damages, compensatory damages, lost wages, compensation, expenses wage benefits and penalties pursuant to California Labor Code Sections 203 et al, 2802 and 2806, indemnification, accrued interest, punitive damages, costs of suit and attorney’s fees.

On November 28, 2012 the “Company executed an agreement (“Agreement”) with Gregory McDonald ("McDonald"), Pet Pointers, Inc. ("Pet Pointer") whereby Mc Donald and Pet Pointer would acquire from the Company all assets ( with the exception of cash and accounts receivable) utilized by the Company in the operation of the McDonald Animal Hospital, a full service veterinary clinic owned and operated by the Company and located in Santa Barbara, California (“McDonald Asset Sale”).

As consideration to the Company for the assets acquired, McDonald and Pet Pointers provided to the Company a General release whereby McDonald and Pet Pointer waive, release and discharge the Company and their respective assignees, officers, directors, shareholders, boards, owners, employees, attorneys, agents, trustors, trustees, beneficiaries, heirs, successors, and representatives from all known and unknown claims, demands, causes of action, attorney's fees, costs, or expenses including:

(1) All claims relating to the Complaint.

(2) Those amounts owed by McDonald to Anthony and Judi Marinelli which the Company became obligated to pay on McDonald’s behalf pursuant to the asset purchase agreement entered into between the Company and Gregory McDonald and Pet Pointers, Inc on January 4, 2011.

(3) Those amounts owed by McDonald to the Internal Revenue Service which the Company became obligated to pay on McDonald’s behalf pursuant to the asset purchase agreement entered into between the Company and Gregory McDonald and Pet Pointers, Inc on January 4, 2011.

(4) Those amounts owed by McDonald to the California Franchise Tax Board which the Company became obligated to pay on McDonald’s behalf pursuant to the asset purchase agreement entered into between the Company and Gregory McDonald and Pet Pointers, Inc on January 4, 2011.

Assets disposed of pursuant to the Agreement include approximately $4,897 of Property Plant and Equipment net of accumulated depreciation as well as all inventory held at the McDonald Animal Hospital.

Assets disposed of pursuant to the Agreement also include

(i) Essentially all intellectual property, including computer software, utilized in connection with the operation of the McDonald Animal Hospital

(ii) All telephone numbers, fax numbers, service marks, trademarks, trade names, fictitious business names, websites, business email addresses, vendor lists, promotional materials, vendor records and any and all business records including, but not limited to, such items stored in computer memories, microfiche, paper record or by any other means relevant to the operation of the McDonald Animal Hospital.

(iii) All customer lists, customer contacts, and any and all customer records that are related to the McDonald Animal Hospital.

As a result of the agreement, the Company anticipates recording a non-cash pre-tax charge for the impairment of goodwill recorded in connection with the acquisition of the McDonald Animal Hospital of approximately $405,000 for the quarter ended November 30, 2012.

Pursuant to the Agreement, the Company became obligated to make payment of $13,000 within five days of the Closing of the Agreement as such term is defined in the Agreement.

Pursuant to the Agreement, the Company agrees to waive, release and discharge McDonald and Pet Pointer from all known and unknown claims, demands, causes of action, attorney's fees, costs, or expenses.

Pursuant to the Agreement, the Company agrees not to engage in a competing business within a 5 mile radius of the property currently housing the McDonald Animal Hospital for three years.

The acquisition of existing veterinary clinics / hospitals remains an integral part of the Company’s business plan. At this time, the company is seeking to identify and acquire veterinary practices existing and operating within the areas of San Diego, California and Orange County, California .The Company believes that these areas are close enough in proximity the Company’s headquarters to allow ease of interaction with the Company's management . In addition, the Company believes owning and operating veterinary clinics within the San Diego, California and Orange County , California areas will provide greater convenience for persons involved with the Company's research and development activities who may be required to utilitize those facilities. The company is currently in discussions with entities it believes can expedite local clinic acquisitions.

The Company has not undertaken any discussions with any pharmaceutical companies regarding the commercialization of any products under development. None of the Company’s products have been approved by any regulatory body for marketing within the United States or anywhere else. No assurance can be given that all or any of the Company’s currently planned products will ever be commercialized. Therapies which are veterinary biologics may be administered to patients of veterinary clinics that may be acquired prior to licensure under the exemption provided by 9 CFR 107.1, which exempts a veterinary biologic from Federal regulation if the product was manufactured by veterinarians AND intended solely for use with their clients' animals under a veterinarian-client-patient (VCP) relationship.

Principal Products and Services

The Company is currently focusing its research and development efforts toward the successful development and commercialization of the ImenVax family of canine cancer vaccines as well as the acquisition of existing veterinary clinics / hospitals to be utilized as potential distribution channels for its ImenVax family of canine cancer vaccines. The Company believes that, in addition to serving as distribution channels for the Company’s immuno-therapeutic cancer vaccine for canines, these clinics will be able to generate revenue for the Company from current operations. It is anticipated by the Company that data collected from canine cancer treatment will provide support for eventual use of this therapy in humans and such therapy may be developed and commercialized by the Company in collaboration with larger and better capitalized pharmaceutical companies.

ImenVax™ I

ImenVax™ I, currently under development by the Company, is a therapeutic for canine cancer which involves isolating tumor cells from the patient and then placing the cells into a cell implant device that is inserted subcutaneously into the patient. The resulting expression of tumor antigens from the device is intended to generate an anti-tumor immune response. The implant chamber device provokes immune responses to the tumor cells isolated from the patient’s own tumor through a process known as indirect presentation. Tumor cells implanted in the device are exposed to conditions that are distinct from the tumor’s environment from which they were isolated. This altered environment allows for anti-tumor responses that are not ordinarily observed in the natural tumor progression.

The cells are :

1) Isolated from the tumor and freed from the natural tumor microenvironment

2) Subjected to an initial ischemic condition of hypoxia that induces increased antigen expression

3) Allowed to repopulate within the device in a context that facilitates extended release of tumor antigens.

The device utilized is comprised of a 0.4 micron inner membrane to retain the implanted cells and an

outer 5 micron membrane that allows blood vessels to form on the surface to enhance biocompatibility. The outer membrane is held in place by a polyester mesh. The membranes are sonically sealed using a polyester mesh insert.

The device contains a surface architecture that promotes vascularization in-vivo. There is an initial ischemic phase that may additionally influence the tumor cell growth characteristics and genetic regulation of the tumor cells.

It is hypothesized that shortly after implantation, the expression of immunosuppressive molecules is down regulated while the release of antigens is maintained, thus allowing immune responses to occur that would normally be suppressed.

The Antigens that are released from the implanted device are taken up by antigen presenting cells (APC).

It is believed that the APCs will be trained to recognize the cancer cells and alert the body’s immune response, activating antibodies and T cells to destroy the tumor cells.

The Company is currently conducting a ten dog safety study to Evaluate ImenVax™ I for the Treatment of Canine Oral Melanoma and determine adverse effects, if any. As of May 17, 2012 three dogs suffering from oral melanoma have been administered the therapy with no dog suffering any material adverse reaction.

Inclusion in the Safety Study is limited to ten dogs with histologically confirmed canine oral melanoma with a Studied Karnofsky performance status of one or less. The subject are required to be over eight kg with measurable tumor lesions by caliper or imaging, either primary or metastatic, that may or may not have had prior non-immunological-based therapy. No concurrent NSAID therapy is allowed and previous use of immune-based therapies is not permitted. Subjects are required to have a two month life expectancy, and, not have any disease or condition (other than the cancer) that would preclude living for 3 to 6 months.

Toxicity is evaluated prior to, and after, treatment and monthly for a period of 3 months. To date, subjects have been recruited solely from patients of the McDonald Animal Hospital in order that the therapy may be administered licensure under the exemption provided by 9 CFR 107.1, which exempts a veterinary biologic from Federal regulation if the product was manufactured by veterinarians AND intended solely for use with their clients' animals under a veterinarian-client-patient (VCP) relationship. To date, 3 dogs have been enrolled in the safety study with none exhibiting any adverse effects. The Company estimates that an additional $100,000 will be required to be expended to complete the safety study.

Subsequent to completion of the safety study and pending favorable results, the Company plans to offer ImenVax™ I to its own patients under the exemption provided by 9 CFR 107.1, which exempts a veterinary biologic from Federal regulation if the product was manufactured by veterinarians AND intended solely for use with their clients' animals under a veterinarian-client-patient (VCP) relationship subject to the successful acquisition of one or more veterinary clinics by the Company.

ImenVax™ II

Also in early stage development by the Company is a version of ImenVax™ called ImenVax™ II which utilizes cell lines for sustained release of immunologically relevant cytokines for maximum anti-tumor immune responses. It is believed by the Company that this controlled release of cytokines will act as an adjuvant to be combined with patient’s tumor cells (antigens) within an implantable membrane encapsulation device.

ImenVax™ II is designed to function in a manner similar to ImenVax™ I. However, In order to further potentiate the tumor antigen specific immune responses, the Company intends to include adjuvant cytokine(s) along with tumor cells into the implantation device. The adjuvants can be added through cytokine expressing cell line. The implantation device to be utilized for administering ImenVax™ II is expected to be substantially similar to that utilized in administering ImenVax™ I.

ImenVax™ III

ImenVax III is intended to function by harnessing the ability of placental extracts to combat canine cancers. ImenVax™III is intended to treat existing tumors through stimulation of immune responses to:

a) kill tumor cells directly;

b) indirectly kill tumor cells by cutting off the tumor blood supply; and

c) block the ability of the tumor to suppress the immune system.

Xenogeneic (from different species) antigen induced immunity has been shown to break self tolerance and capable of engendering immune responses against the endogenous counterpart self-antigen. The use of xenogeneic placental derived agents such as VEGF (vascular endothelial growth factor) has demonstrated regression of soft tissue sarcomas in dogs (Kamstock D, Elmslie R, Thamm D, Dow S. 2007. Evaluation of a xenogeneic VEGF vaccine in dogs with soft tissue sarcoma. 56(8): 1299-309).

ImenVax™ III is intended to be an off the shelf formulation , manufactured under GMP, which shall harness the power of trophoblasts (cells forming the outer layer of a blastocyst, which provide nutrients to the embryo and develop into a large part of the placenta) derived from human placental tissue to combat canine cancers . No tissue processing is required for the administration of the ImenVax™ III therapy as opposed to I and II as no cellular material from the patient is utilized.

ENT-576™

ENT-576™ is a proprietary therapy being developed by the Company for the treatment of Chronic Obstructive Pulmonary Disease (COPD) such therapy comprising of:

a) extracting a therapeutic number of cells from a tissue containing in part a stem cell population;

b) processing said population of cells derived from said tissue so as to concentrate said stem cell population;

c) systemic re-administration of said cell population into the same patient; and

d) exposing the patient lung to a sufficient intensity and frequency of laser irradiation necessary to augment therapeutic activity of said cells in said patient suffering from COPD. The Company has also considered utilizing an FDA approved biochemical drug to produce the desired augmentation of therapeutic activity.

A therapeutic intervention in COPD would require addressing the issues of inflammation and regeneration. Although approaches such as administration of bone marrow stem cells or fat derived cellular components have both regenerative and anti-inflammatory activity in animal models, the Company feels that the need to enhance their potency for clinical applications can be addressed through the usage of low level lasers which studies have demonstrated may induce growth factor production, inhibit inflammation and stimulate angiogenesis.

There can be no assurance that approvals required will be obtained for any of the Company’s current therapies under development, or that if such approvals are obtained that the Company will be able to effectively market its therapies. There can be no assurance given that actual costs and timeframes related to commercialization for any proposed product will not deviate materially from the Company’s estimation. Currently, none of the Company’s products under development may be administered or marketed in the United States or outside of the United states except pursuant to an exemption from relevant regulation. The Company does not anticipate conducting further research and development related to ENT-576™ until completion of the Safety Study due to limited resources available to the Company.

Distribution methods of the products or services:

The Company intends to distribute its products and services through several channels including:

	(a)	utilization of an internal sales force to market directly to veterinary professionals
	(b)	distribution through acquired veterinary clinics if and when such clinics are acquired
	(c)	utilization of contract sales organizations

On October 19, 2011 the Company entered into an agreement with RenovoCyte LLC and Medistem Inc. (“Agreement”) whereby the Company shall provide research services to RenovoCyte LLC in connection with a ten dog pilot study to determine the safety and effectiveness of the utilization of stem cell therapy for the treatment of arthritis in animals (“Pilot Study”). The term of the Agreement is from October 19, 2011 until the earlier of the completion of the Pilot Study or October 19, 2015 unless terminated by RenovoCyte LLC due to an event of force majeure exceeding a period of 4 months. As consideration for providing services pursuant to the Agreement, the Company shall enjoy joint publishing rights with regards to the results of the Pilot Study. Canine mesenchymal multipotent stem cell injections to be utilized during the course of the Pilot Study shall be provided to the Company by RenovoCyte LLC at no cost to the Company.

As of January 26, 2013 there have been 8 canine patients treated through the Pilot Study.

Competitive business conditions and Entest's competitive position in the industry and methods of competition

We are recently formed and have yet to achieve revenues or profits. The animal health pharmaceutical and biologics industries in which we intend to compete are highly competitive and characterized by rapid technological advancement. Many of our competitors have greater resources than we do. Also, The companion animal healthcare industry (e.g. veterinary hospitals and veterinarians) although highly fragmented is also highly competitive.

We intend to be competitive by acquiring veterinary hospitals to serve as distribution channels for the products and services we produce. We also intend to be competitive by utilizing the services and advice of individuals that we believe have expertise in their field in order that we can concentrate our resources on projects in which products and services in which we have the greatest potential to secure a competitive advantage may be developed and commercialized ..

To that effect, we have established a Scientific Advisory Board of (the Advisory Board) comprised of individuals who we believe have a high level of expertise in their professional fields and who have agreed to provide counsel and assistance to us in (a) determining the viability of proposed projects (b) obtaining financing for projects and (c) obtaining the resources required to initiate and complete a project in the most cost effective and rapid manner. The members of the Advisory Board have also agreed to act as consultants on a project by project basis in addition to other services they may provide under any other contractual obligations to us.

Members of the Advisory Board include as follows:

Dr. Brian Koos, MD:

Dr. Brian Koos is Professor and Vice Chair at Obstetrics and Gynecology at the David Geffen School of Medicine at UCLA, Professor at the Brain Research Institute at the UCLA School of Medicine, and Director of the Maternal-Fetal Medicine Fellowship (UCLA). Dr. Koos received his MD from Loma Linda University School of Medicine. Dr. Brian Koos is the brother of David R. Koos, the Company’s Chairman, President and CEO.

Dr. Koos serves as a member of the Advisory Board pursuant to an agreement by and between the Company and Bio-Matrix Scientific Group, Inc. entered into on June 19, 2009 whereby the Bio-Matrix Scientific Group, Inc assigned its rights to the services of Dr. Koos to the Company for consideration to Bio-Matrix Scientific Group of $10,000. Those rights included the services of Dr. Koos as a member of the Company’s Advisory Board for a period ending April 8, 2014.

Dr. Steven Josephs, PhD:

Dr. Josephs is currently serving as Executive Manager and Chief Scientific Officer of TherInject LLC, a company involved in the development of pharmaceuticals to be utilized for the treatment of cancer. Dr. Josephs has 34 years of experience in research and clinical product development and production for biologics, gene therapy and medical devices.

Dr. Josephs has previously served as Director of Research and Development for Therapheresis, Inc, Head of Virology and Senior Research Scientist for Baxter Healthcare Corporation, and Director of Molecular Biology at Universal Biotechnology, Inc where Dr. Josephs directed a group performing contract molecular biology services for government and private industry.

Dr. Josephs has also worked for the National Cancer Institute where his duties included studies of the human T-cell leukemia virus as well as sequence determination and functional analyses of HIV. Dr. Josephs is the co-discoverer of human herpesvirus-6, the etiologic agent of Roseola.

Dr. Josephs holds a B.A. in Chemistry, a Ph.D. in Chemistry and has been granted a Professional Certificate in Drug Development and an ADMET process certificate by the University of California, San Diego. Dr. Josephs has also earned a Master of Science in Science Teaching.

Dr. Josephs serves as a member of the Advisory Board at will and at the pleasure of the Board of Directors of the Company. There is no binding agreement by and between the Company and Dr. Josephs regarding membership on the Advisory Board.

Dr. Ewa Carrier, MD:

Dr. Carrier is Associate Professor of Clinical Medicine and Pediatrics, University of California San Diego

Blood and Marrow Transplant Program.

Dr. Carrier has served as principal investigator for the following clinical protocols:

Protocol For The Use of AMD3100 to Mobilize Peripheral Blood Stem Cells For Collection and Transplantation - Emergency Compassionate Use, Single Patient IND.

Erythropoietic Differentiation of Human ES Cells.

CTLA-4 Blockade with MDX-010 to Induce Graft-Versus-Malignancy Effects Following Allogeneic Hematopoietic Stem Cell Transplantation. (NCI Protocol Number P-6082) (closed to accrual).

Phase 3 Randomized, Open-label Clinical Trial of Tanespimycin (KOS-953) plus Bortezomib Compared to

Bortezomib Alone in Patients with Multiple Myeloma in First Relapse [Protocol KAG-301] [Protocol Version 21-JUL-2007]

Autologous Stem Cell Transplant for Myasthenia Gravis.

Collection of Bone Marrow from Patients with Multiple Myeloma for Study of New Therapies.

A Pilot Study of High-Dose Immunosuppression and Autologous Stem Cell Infusion in Patients with Systemic Lupus

Erythematosus Refractory to Conventional Therapy (closed to accrual).

Autologous Stem Cell Transplant for Myasthenia Gravis – a retrospective analysis.

Dr. Carrier has served as co investigator for the following clinical protocols:

Pilot Study of Allogeneic Peripheral Blood Progenitor Cell Transplantation in Patients with Chemotherapy-Refractory or Poor- Prognosis Metastatic Breast Cancer.

Pilot Study of a Non-Myeloablative Preparative-Regimen for Allogeneic Peripheral Blood Progenitor Cell Transplantation in Patients with Chronic Myeloid and Lymphoid Malignancies.

Phase II Study of a Non-Myeloablative Preparative-Regimen for Allogeneic Hematopoietic Cell Transplantation From Matched Unrelated Donors in Patients with Chronic Myeloid and Lymphoid Malignancies.

A Phase II Study of Tumor-Specific Idiotype (Id) and Soluble GM-CSF Vaccination Following Autologous Peripheral Blood Stem Cell Transplantation in Patients with Low-Grade Non-Hodgkin's Lymphomas.

Phase II Study of FavId (Tumor-Specific Idiotype-KLH) and Soluble GM-CSF Immunotherapy in Patients with Stable or Progressive Grade 1 or 2 Follicular B-Cell Lymphomas [FavId01].

Phase II Trial of Rituxan® plus FavId™ (Tumor-Specific Idiotype-KLH) and GM-CSF Immunotherapy in Patients with Grade 1 or 2 Follicular B-Cell Lymphoma [FavId-04].

Dr. Carrier serves as a member of the Advisory Board at will and at the pleasure of the Board of Directors of the Company. There is no binding agreement by and between the Company and Dr. Carrier regarding membership on the Advisory Board

Dr. Feng Lin, MD:

Dr. Lin is the Director of Research and Development of Entest BioMedical, Inc. and has previously served as Director of Research and Development of Bio-Matrix Scientific Group, Inc., the Company’s largest shareholder.

Previously, Dr. Lin was a Senior Research Scientist, Research & Development with Inovio BC, San Diego and Postdoctoral Fellow in Burnham Institute for Medical Research, La Jolla.

Dr. Lin received his M.D. from Central South University Xiangya School of Medicine, Changsha, China, and received a M.S. Biochemistry & Molecular Biology and a Ph.D. Hematology & Physiology from the same institution.

Dr. Lin serves as a member of the Advisory Board at will and at the pleasure of the Board of Directors of the Company. There is no binding agreement by and between the Company and Dr. Lin regarding membership on the Advisory Board.

Dr. Vladimir I. Bogin, MD, ABIM:

Dr. Bogin is currently the President and CEO of Cromos Pharma, a contract research organization that specializes in biopharmaceutical clinical outsourcing into Russia and Eastern Europe. From 2008 to 2009 he served as Director of Boehringer Ingelheim (a privately held pharmaceutical company) where he was in charge of the phase IV program for Dabigatran Etexilate.

Dr. Bogin studied medicine at the Yale University School of Medicine and the University of Rochester School of Medicine and Dentistry.

Dr. Bogin serves as a member of the Advisory Board at will and at the pleasure of the Board of Directors of the Company. There is no binding agreement by and between the Company and Dr. Bogin regarding membership on the Advisory Board.

Brenda S. Phillips, D.V.M.

Dr. Phillips is a veterinary oncologist and co owner of Veterinary Specialty Hospital of San Diego. She received her Doctor of Veterinary Medicine in 1992 from Michigan State University, College of Veterinary Medicine.

Dr. Phillips agreed on January 6, 2011 to serve as a member of the Advisory Board for a period of 24 months. In connection with that agreement, Dr. Phillips received 10,000 common shares of the Company.

The U.S. market for veterinary services is highly fragmented. According to the American Veterinary Medical Association, there were more than 51,000 veterinarians practicing at the end of 2009. The principal factors in a pet owner’s decision as to which veterinarian to use include convenient location and hours, personal recommendations, reasonable fees and quality of care. In order to be competitive in the animal healthcare industry, we intend to direct our marketing efforts related to clinics , if and when they may be acquired, toward increasing the number of annual visits from existing clients through customer education efforts and toward attracting new clients through local print advertising campaigns.

Sources and availability of raw materials and the names of principal suppliers

The supplies and materials required to conduct our operations are available through a wide variety of sources and may be obtained through a wide variety of sources.

Patents, trademarks, licenses, franchises, concessions, royalty agreements or labor contracts, including duration

Entest has not been granted any patents. Entest is not currently party to any royalty agreements. Entest is not party to any binding labor contracts.

Need for any government approval of principal products or services, effect of existing or probable governmental regulations on the business

ImenVax™ I and ImenVax™ II are Veterinary Biologics. The U.S. Department of Agriculture (USDA) is authorized under the 1913 Virus-Serum-Toxin Act to ensure that all veterinary biologics produced in, or imported into, the United States are not worthless, contaminated, dangerous, or harmful. The Veterinary Biologics Program of the USDA's Animal and Plant Health Inspection Service (“APHIS”) oversees the veterinary biologics industry in the United States.

Prior to being granted a U.S. Veterinary Biologic Establishment License, the applicant must submit detailed information regarding the facilities and the qualifications of key personnel and must submit to an inspection of the facilities by the Center for Veterinary Biologics, a division of the USDA. To qualify for an establishment license, an applicant also must qualify for at least one product license.

In the event that a veterinary clinic or clinics can be acquired, the Company plans to attempt to distribute ImenVax™ I prior to licensure under the exemption provided by 9 CFR 107.1, which exempts a veterinary biologic from Federal regulation if the product was manufactured by veterinarians AND intended solely for use with their clients' animals under a veterinarian-client-patient (VCP) relationship.

ENT-576™ can be considered a “combination product” whose primary mode of action is through animal stem cells (a veterinary biologic) It is intended that the Company will obtain a U.S. Veterinary Biologics Establishment License and a U.S. Veterinary Biologics Product License from the U.S. Department of Agriculture. ENT-576™ can also be administered without license if administered in accordance with the safe harbor provided by 9 CFR 107.1.

ImenVax™ III can be considered a combination product whose primary mode of action is generated through trophoblasts derived from human placental tissue. Entest will be required to obtain approval from the US Food and Drug Administration (FDA) in order to market ImenVax™ III. Entest will apply for an Investigational New Animal Drug exemption (INAD) in order that the product may be shipped for testing and trials and will submit a New Animal Drug Application for ImenVax™ III.

The practice of veterinary medicine is primarily subject to State regulation. The Company will be required to comply with the statutes rules and regulations of the State in which an acquired veterinary clinic is located. Within the State of California, where the Company is focusing its acquisition efforts , the practice of veterinary medicine is primarily governed pursuant to The California Veterinary Medicine Practice Act (CA Bus.& Prof. Code § 4800 et seq.).

Amount spent during the last fiscal year on research and development activities

During the fiscal year ended August 31, 2012 we expended $5,798 on research and development activities.

Costs and effects of compliance with environmental laws (federal, state and local);

Entest has not incurred any unusual or significant costs to remain in compliance with any environmental laws and does not expect to incur any unusual or significant costs to remain in compliance with any environmental laws in the foreseeable future.

Number of total employees and number of full-time employees

As of January 26, 2013, Entest has _____ employees of which _____ are full time.

Item 2. Properties

On November 1, 2011, the Company entered into an agreement to lease approximately 2,320 square feet of office space beginning December 1, 2011 for a period of five years.

Rent to be charged to the Company pursuant to the lease is as follows:

$2,996 per month for the period beginning December 1, 2011 and ending November 30, 2012

$3,116 per month for the period beginning December 1, 2012 and ending November 30, 2013

$3,241 per month for the period beginning December 1, 2013 and ending November 30, 2014

$3,371 per month for the period beginning December 1, 2014 and ending November 30, 2015

$3,506 per month for the period beginning December 1, 2015 and ending November 30, 2016

This property is utilized as office space. The Company believes that the foregoing property is adequate to meet its current needs. While it is anticipated that the Company will require access to laboratory facilities in the future, the Company believes that access to such facilities are available from a variety of sources.

Item 3. Legal Proceedings

On February 3, 2011, a Complaint (“Complaint”) was filed in the U.S. District Court Middle District of the State of Pennsylvania against the Company, the Company’s Chairman and BMSN. by 18KT.TV LLC (“Plaintiffs”) seeking to recover general damages from the Company. in excess of $125,000. The Complaint alleges breach of contract and unjust enrichment relating to an investor relations contract executed by the Company and Craig Fischer (on behalf of 18KT.TV LLC). The Complaint also seeks similar damages from BMSN. The Company believes that the allegations in the complaint are without merit and intends to vigorously defend its interests in this matter. At this time, it is not possible to predict the ultimate outcome of these matters.

On May 24, 2012, a Complaint (“Complaint”) was filed in the U.S. Bankruptcy Court for the District of Oregon against the Company by Titterington Veterinary Services Inc. (“TVS”). The Complaint is an adversary proceeding filed by TVS arising from TVS’s bankruptcy case currently pending in U.S. Bankruptcy Court for the District of Oregon. The Complaint alleges Breach of Contract resulting from the Company’s alleged failure to pay certain expenses the Company was required to pay pursuant to an agreement with TVS, Dr. Ronald Titterington, DVM and Dr. Kathy Snell, DVM (“TVS Agreement”). TVS is seeking a judgment and money award against the Company in an amount to be proven at trial which TVS estimates in the Complaint to be up to $50,000. TVS is also seeking a judgment and order against the Company to provide an accounting of all revenues received by the Company pursuant to the TVS Agreement, all expenses paid, unpaid, and due and owing pursuant to the TVS Agreement as well as a revenue share which TVS claims is due them pursuant to the TVS Agreement. TVS is also seeking a judgment requiring the Company to turn over a sum of money equal to expenses the Company was obligated to pay pursuant to the TVS Agreement. TVS is also seeking attorney’s fees and expenses. The Company believes that the allegations in the complaint are without merit and intends to vigorously defend its interests in this matter. At this time, it is not possible to predict the ultimate outcome of these matters and an outcome unfavorable to the Company may have a material adverse effect on the Company. On September 19, 2012 the Plaintiff’s Claim for Relief for turnover and an accounting under 11 U.S.C. § 542 and the Plaintiff's Claim for Relief for attorney fees were dismissed with prejudice and , as per the claim of breach of contract, the proceeding was transferred to the United States Bankruptcy Court for the District of Southern California for all further proceedings.

On October 10, 2012 a Complaint(“Complaint”) was filed in the Superior Court of the State of California against the Company and David Koos by Dr. Gregory McDonald, a former employee of the Company, alleging breach of contract and breach of the covenant of good faith and dealing in connection with the assumption of lease obligations by the Company in connection with the acquisition of the assets of Pet Pointers, Inc (“Acquisition”) (Note 9) breach of contract and breach of the covenant of good faith and dealing in connection with an employment agreement enters into with Dr. McDonald inc connection with the Acquisition, breach of contract in connection with the Acquisition purchase agreement, breach of the covenant of good faith and dealing in connection with the Acquisition purchase agreement, implied indemnity in connection to amounts owed by Dr. McDonald to Anthony and Judi Marinelli, the Internal Revenue Service, and the California Franchise Tax Board, intentional misrepresentation, negligent misrepresentation , failure to pay wages and violations of Sections 2802, 203, and 2806 of the California Labor Code. The Complaint seeks judgment for nominal damages, actual damages, compensatory damages, lost wages, compensation, expenses wage benefits and penalties pursuant to California Labor Code Sections 203 et al, 2802 and 2806, indemnification, accrued interest, punitive damages, costs of suit and attorney’s fees.

On November 28, 2012, a settlement of the aforementioned Complaint, the “Company executed an agreement (“Agreement”) with Gregory McDonald ("McDonald"), Pet Pointers, Inc. ("Pet Pointer") whereby Mc Donald and Pet Pointer would acquire from the Company all assets ( with the exception of cash and accounts receivable) utilized by the Company in the operation of the McDonald Animal Hospital (“McDonald Asset Sale”).

(1) All claims relating to the Complaint.

(2) Those owed by McDonald to Anthony and Judi Marinelli which the Company became obligated to pay on McDonald’s behalf pursuant to the asset purchase agreement entered into between the Company and Gregory McDonald and Pet Pointers, Inc

Assets disposed of pursuant to the Agreement include all Property Plant and Equipment as well as all inventory held at the McDonald Animal Hospital.

Assets disposed of pursuant to the Agreement also include:

(i) Essentially all intellectual property, including computer software, utilized in connection with the operation of the McDonald Animal Hospital

(iii) All customer lists, customer contacts, and any and all customer records that are related to the McDonald Animal Hospital.

On January 15, 2013 the Company received from Asher Enterprises, Inc.(“Asher”) a written demand for payment of $189,000 ( representing 150% of the outstanding principal balance) plus accrued interest at the Default rate of interest which is 22% per annum. The Demand stems from Asher’s assertion that the Company has defaulted on provisions in two Convertible Notes in the principal amounts of $63,000 per note issued by the Company to Asher as a result of the Company’s failure to comply with the reporting requirements of the Securities and Exchange Act of 1934. Collectively the amount of $189,000 plus accrued interest at the Default rate of interest which is 22% per annum may be referred to as the Default Amount

Pursuant to the terms and conditions of the two notes, in the Event that the Company fails to pay the Default Amount within five business days of written notice that such amount is due and payable, then the Asher shall have the right at any time, so long as the Company remains in default (and so long and to the extent that there are sufficient authorized shares), to require the Company, upon written notice, to immediately issue, in lieu of the Default Amount, the number of shares of Common Stock of the Company equal to the Default Amount divided by the Conversion Price then in effect pursuant to the terms and conditions of the notes.

Item 4. Submission of Matters to a Vote of Security Holders

No matter was submitted during the fourth quarter of the fiscal year covered by this report to a vote of security holders, through the solicitation of proxies or otherwise.

PART II

Item 5. Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities

The Company’s common stock is a "penny stock," as defined in Rule 3a51-1 under the Exchange Act. The penny stock rules require a broker-dealer, prior to a transaction in a penny stock not otherwise exempt from the rules, to deliver a standardized risk disclosure document that provides information about penny stocks and the nature and level of risks in the penny stock market. The broker-dealer also must provide the customer with current bid and offer quotations for the penny stock, the compensation of the broker-dealer and its sales person in the transaction, and monthly account statements showing the market value of each penny stock held in the customer's account. In addition, the penny stock rules require that the broker-dealer, not otherwise exempt from such rules, must make a special written determination that the penny stock is suitable for the purchaser and receive the purchaser's written agreement to the transaction. These disclosure rules have the effect of reducing the level of trading activity in the secondary market for a stock that becomes subject to the penny stock rules. So long as the common stock of the Company is subject to the penny stock rules, it may be more difficult to sell common stock of the Company.

The Company’s authorized capital stock consists of 2,000,000,000 shares of common stock with a par value $0.001, and 5,000,000 shares of preferred stock with a par value $0.001 per share. As of November 1, 2011 there are 20,890,501 shares of common stock issued and outstanding and 5,000 shares of Series AA preferred stock issued and outstanding.

(a) Our common stock is traded on the OTCQB Tier of OTC Markets under the symbol "ENTB”. Prior to August 11, 2009 there was no established trading market for our common stock. From August 11, 2009 to February 23, 2011 our common stock traded primarily on the OTCBB. Below is the range of high and low bid information for our common equity for each quarter within the last two fiscal years. These quotations reflect inter-dealer prices, without retail mark-up, mark-down or commission and may not represent actual transactions.

September 1, 2011 to August 31, 2012	High		Low
First Quarter	$	0.598	$	0.1387
Second Quarter		0.100		0.03
Third Quarter		0.034		0.0017
Fourth Quarter	$	0.0225	$	0.0025
September 1, 2010 to August 31, 2011	High		Low
First Quarter	$	0.30	$	0.52
Second Quarter		4.190		1.250
Third Quarter		2.900		1.180
Fourth Quarter	$	1.1730	$	0.390

Holders

As of August 31, 2012 there were approximately 339 holders of our Common Stock.

Dividends

No cash dividends were paid during the fiscal year ending August 31, 2012. We do not expect to declare cash dividends in the immediate future. On March 6, 2012 a dividend of 3,201,397 shares of Series B Preferred Stock was paid to the Company’s common shareholders of record as of February 21, 2012.

Recent Sales of Unregistered Securities

For the Fiscal Year Ended August 31, 2012:

Shares issued for Services:

On October 7, 2011 the Company issued 50,000 shares of common stock (“Shares”) to a consultant for services rendered.

The Shares were issued pursuant to Section 4(2) of the Securities Act of 1933, as amended. No underwriters were retained to serve as placement agents for the sale. The shares were sold directly through our management. No commission or other consideration was paid in connection with the sale of the shares. There was no advertisement or general solicitation made in connection with this Offer and Sale of Shares. A legend was placed on the certificate that evidences the Shares stating that the Shares have not been registered under the Act and setting forth or referring to the restrictions on transferability and sale of the Shares.

On November 22, 2011 the Company issued 18,333 shares of common stock (“Shares”) to a consultant for services rendered.

On January 10 , 2012 the Company issued 27,499 shares of common stock (“Shares”) to a consultant for services rendered.

On February 26, 2012 the Company issued 174,663 shares of common stock (“Shares”) to a consultant for services rendered.

On March 14, 2012 the Company issued 3,000,000 shares of its common stock (“Shares”) to the order of Capital Path Securities LLC for acting as the Company’s exclusive advisor and placement agent in connection with the Equity Purchase Agreement and Registration Rights Agreement entered into by and between the Company and Southridge Partners II, LP (“Southridge”) on February 27, 2012.

A legend was placed on the certificate that evidences the Shares stating that the Shares have not been registered under the Act and setting forth or referring to the restrictions on transferability and sale of the Shares.

On April 3, 2012 the Company issued 50,000,000 shares of common stock (“Shares”) to David R. Koos as a bonus.

David Koos may not offer to sell, sell, transfer, pledge or otherwise dispose of the Bonus Shares prior to April 2, 2017 (“Restricted Period”).

In the event that, prior to the expiration of the Restricted Period, David Koos voluntarily ceases to be employed at the Company or is terminated for cause the Shares shall be forfeited.

On April 3, 2012 the Company issued 27,000,000 shares of common stock (“Shares”) to seven employees as bonuses.

No employee may offer to sell, sell, transfer, pledge or otherwise dispose of the Bonus Shares prior to April 2, 2017 (“Restricted Period”).

In the event that, prior to the expiration of the Restricted Period, any employee voluntarily ceases to be employed at the Company or is terminated for cause his or her Shares shall be forfeited.

On April 3, 2012 the Company issued 15,000,000 shares of common stock (“Shares”) to Joseph G. Vaini as bonus.

Joseph G. Vaini may not offer to sell, sell, transfer, pledge or otherwise dispose of the Shares prior to April 2, 2017 (“Restricted Period”).

In the event that, prior to the expiration of the Restricted Period, Joseph G. Vaini declines to provide if requested to provide, or is unable to provide if requested to provide, consulting services to the Company of a nature that have been customarily provided by Joseph G. Vaini to the Company the Shares shall be forfeited.

On March 27, 2012 the Company issued 75,000 shares of its nonvoting convertible preferred stock to Southridge in accordance with the terms of the Equity Purchase Agreement entered into by and between the Company and Southridge on February 27, 2012..

Shares issued for Intangible Assets:

On November 11, 2011 the Company issued 2,500,000 shares of common stock (“Shares”) in connection with rights to receive future revenues of a Utah veterinary clinic.

Shares Issued for Debt:

On November 28, 2011 the Company issued 134,983 shares of common stock (“Shares”) in satisfaction of $12,000 principal amount of Convertible Notes Payable.

On December 12, 2011 the Company issued 258,824 shares of common stock (“Shares”) in satisfaction of $11,000 principal amount of Convertible Notes Payable.

On December 19, 2011 the Company issued 338,983 shares of common stock (“Shares”) in satisfaction of $12,000 principal amount of Convertible Notes Payable

On January 27, 2012 the Company issued 227,963 shares of common stock (“Shares”) in satisfaction of $7,500 principal amount of Convertible Notes Payable.

On February 3, 2012 the Company issued 528,821 shares of common stock (“Shares”) in satisfaction of $15,000 principal amount of Convertible Notes Payable.

On February 16, 2012 the Company issued 721,154 shares of common stock (“Shares”) in satisfaction of $15,000 principal amount of Convertible Notes Payable.

On March 7, 2012 the Company issued 2,322,695 shares of common stock (“Shares”) in satisfaction of $32,750 of Convertible Notes Payable.

On March 21, 2012 the Company issued 1,886,195 shares of common stock in satisfaction of $25,200 of Convertible Notes Payable.

On March 26, 2012 the Company issued 3,017,502 shares of common stock (“Shares”) in satisfaction of $24,650 of Convertible Notes Payable.

On April 2, 2012 the Company issued 1,675.111 shares of common stock (“Shares”) in satisfaction of $7,538 of Convertible Notes Payable.

On April 3, 2012 the Company issued 1,590, 909 shares of common stock (“Shares”) in satisfaction of $7,000 of Convertible Notes Payable.

On April 10, 2012 the Company issued 5,555,555 shares of common stock (“Shares”) in satisfaction of $10,000 of Convertible Notes Payable.

On April 12, 2012 the Company issued 4,722,222 shares of common stock (“Shares”) in satisfaction of $8,500 of Convertible Notes Payable.

On April 13, 2012 the Company issued 8,250,000 shares of common stock (“Shares”) in satisfaction of $14,850 of Convertible Notes Payable.

On April 16, 2012 the Company issued 11,250,000 shares of common stock (“Shares”) in satisfaction of $18,000 of Convertible Notes Payable.

On April 18, 2012 the Company issued 1,250,000 shares of common stock (“Shares”) in satisfaction of $2,000 of Convertible Notes Payable

On April 19, 2012 the Company issued 2,724,968 shares of common stock (“Shares”) in satisfaction of $4,300 of Convertible Notes Payable.

On April 24, 2012 the Company issued 4,005,787 shares of common stock (“Shares”) in satisfaction of $6,922 of Convertible Notes Payable.

On May 1, 2012 the Company issued 8,000,000 shares of common stock (“Shares”) in satisfaction of $12,000 of Convertible Notes Payable.

On May 3, 2012 the Company issued 7,142, 857 shares of common stock (“Shares”) in satisfaction of $10,000 of Convertible Notes Payable.

On May 7, 2012 the Company issued 6,250,000 shares of common stock (“Shares”) in satisfaction of $10,000 of Convertible Notes Payable.

On May 9, 2012 the Company issued 5,000,000 shares of common stock (“Shares”) in satisfaction of $500 of principal indebtedness of Convertible Notes Payable.

On June 20, 2012 the company issued 19,054,140 common shares (“Shares”) in satisfaction of $75,842 of Convertible Notes Payable.

On June 25, 2012 the company issued 1,808,172 common shares (“Shares”) in satisfaction of $6,627 of Convertible Notes Payable.

On August 9, 2012 the Company issued 15,976,380 common shares (“Shares”) in satisfaction of $19,880 of Convertible Notes Payable.

On October 17, 2012 the Company issued 23,000,000 common shares (“Shares”) in satisfaction of $19,320 of outstanding convertible indebtedness.

On October 22, 2012 the Company issued 10,810,811 common shares(“Shares”) in satisfaction of $8,000 of outstanding convertible indebtedness.

Shares issued for interest:

On January 27, 2012 the Company issued 51,672 common shares (“Shares”) in satisfaction of $1,700 of interest accrued but unpaid.

On April 10, 2012 the Company issued 833,333 common shares (“Shares”) in satisfaction of $1,500 of interest accrued but unpaid.

On April 18, 2012 the Company issued 875,000 common shares (“Shares”) in satisfaction of $1,400 of interest accrued but unpaid.

On May 9, 2012 the Company issued 1,300,000 common shares (“Shares”) in satisfaction of $1,300 of interest accrued but unpaid.

Shares issued pursuant to Contractual Obligations:

On April 11, 2012 the Company issued 1029679 common shares (“Shares”) pursuant to contractual obligations contained in certain convertible notes outstanding.

On April 11, 2012 the Company issued 2,306,275 common shares (“Shares”) pursuant to contractual obligations contained in certain convertible notes outstanding.

On April 13, 2012 the Company issued 2,430,753 common shares (“Shares”) pursuant to contractual obligations contained in certain convertible notes outstanding.

On August 2, 2012 the Company issued 1,536,948 common shares (“Shares”) pursuant to contractual obligations contained in certain convertible notes outstanding.

Issuance of Convertible Debentures:

The securities were issued pursuant to Section 4(2) of the Securities Act of 1933, as amended. No underwriters were retained to serve as placement agents for the sale. The securities were sold directly through our management. No commission or other consideration was paid in connection with the sale of the securities. There was no advertisement or general solicitation made in connection with this Offer and Sale of securities.

The note contained a provision that until such time as the shares of common stock issuable upon conversion of the Note have been registered under the Act or otherwise may be sold pursuant to Rule 144 without any restriction as to the number of securities as of a particular date that can then be immediately sold, each certificate for shares of common stock issuable upon conversion of the note that has not been so included in an effective registration statement or that has not been sold pursuant to an effective registration statement or an exemption that permits removal of the legend, shall bear a restrictive legend.

On December 20, 2011 the Company amended the terms of $30,000 in existing debt as follows:

(a) Due and payable December 31, 2012

(b) Simple interest of 10% from December 20, 2011 to the date the debt is fully converted or paid in full

(c) Convertible into the common stock of the Company at the option of the holder at a 50% discount from the average of the lowest three Trading Prices for the common stock during the 10 trading day period ending one Trading Day prior to the date the conversion notice is sent by the holder. "Trading Price" means the closing bid price on the applicable trading market as reported by a reliable reporting service.

On February 28, 2012 the Company amended the terms of $85,500 in existing principal indebtedness as well as 3,710 of interest accrued but unpaid to be as follows:

The aggregate indebtedness of $89,210 shall bear simple interest, be payable upon demand of the holder, and be convertible into the common shares of the company at a conversion price per share equal to 60% (the “Discount”) of the lowest closing bid price for the Company’s common stock during the 5 trading days immediately preceding a conversion date, as reported by Bloomberg. provided that if the closing bid price for the common stock on the date in which the conversion shares are deposited into Holder’s brokerage account and confirmation has been received that Holder may execute trades of the conversion shares ( Clearing Date) is lower than the Closing Bid Price, then the purchase price for the conversion shares shall be adjusted such that the Discount shall be taken from the closing bid price on the Clearing Date, and the Company shall issue additional shares to Purchaser to reflect such adjusted Purchase Price (“Bonus Shares”). The company has agreed on a limitation on conversion equal to 9.99% of the Company’s outstanding common stock.

On April 16, 2012 the Company issued a convertible promissory note in the amount of $42,500 which was received April 21, 2012. The note bears an interest rate of eight percent (8%), matures on January 18, 2013. and may be converted after 180 days from execution of this note for shares of the Company’s common stock. The note may be converted at a fifty two percent (52%) discount to the average of the lowest 3 closing bid prices of the common stock during the 10 trading days prior to the conversion date.

On June 15, 2012 the Company amended the terms of $102,349 in existing principal indebtedness as follows:

The Aggregate Indebtedness of $102,349 is convertible at Holder’s option at a conversion price per share equal to 60% (the “Discount”) of the lowest closing bid price for the Company’s common stock during the 5 trading days immediately preceding a conversion date, as reported by Bloomberg (the “Closing Bid Price”); provided that if the closing bid price for the common stock on the date in which the conversion shares are deposited into Holder’s brokerage account and confirmation has been received that Holder may execute trades of the conversion shares ( Clearing Date) is lower than the Closing Bid Price, then the purchase price for the conversion shares shall be adjusted such that the Discount shall be taken from the closing bid price on the Clearing Date, and the Company shall issue additional shares to Purchaser to reflect such adjusted Purchase Price (“Bonus Shares”). The company has agreed on a limitation on conversion equal to 9.99% of the Company’s outstanding common stock.

On July 26, 2012, the Company issued a convertible note in the principal amount of $63,000 to Asher Enterprises, Inc. The Note bears interest at the rate of 8% per annum and matures on April 30, 2013. The Note is convertible any time during the period beginning on the date which is one hundred eighty (180) days following the date of the Note into common stock of the Company, at Asher’s option, at a 39% discount to the average of the three lowest closing bid prices of the common stock during the 10 Trading Day period prior to conversion as Trading Day is defined in the Note.

On August 21, 2012 the Company amended the terms of $59,000 in existing principal indebtedness as follows:

The Aggregate Indebtedness of $59,000 is convertible at Holder’s option at a conversion price per share equal to 60% (the “Discount”) of the lowest closing bid price for the Company’s common stock during the 10 trading days immediately preceding a conversion date, as reported by Bloomberg (the “Closing Bid Price”); provided that if the closing bid price for the common stock on the date in which the conversion shares are deposited into Holder’s brokerage account and confirmation has been received that Holder may execute trades of the conversion shares ( Clearing Date) is lower than the Closing Bid Price, then the purchase price for the conversion shares shall be adjusted such that the Discount shall be taken from the closing bid price on the Clearing Date, and the Company shall issue additional shares to Purchaser to reflect such adjusted Purchase Price (“Bonus Shares”). The company has agreed on a limitation on conversion equal to 9.99% of the Company’s outstanding common stock

On September 20, 2012 the Company issued a convertible promissory note in the amount of $63,000 cash from which was received September 27, 2012. The note bears an interest rate of eight percent (8%), matures on June 25, 2013. and may be converted after 180 days from execution of this note for shares of the Company’s common stock. The note may be converted at a thirty nine percent (39%) discount to the average of the lowest 3 closing bid prices of the common stock during the 10 trading days prior to the conversion date.

Use of Proceeds, Registered Offering

The Company has filed a registration statement on Form S-1 under the Securities Act of 1933 registering for resale up to 37,640,314 shares of our common stock by Southridge which are Put Shares that may be put to Southridge pursuant to an Equity Purchase Agreement dated as of June 1, 2012 by and between Southridge and the Company (“June Purchase Agreement”). The Registration Statement was declared effective by the United States Securities and Exchange Commission on August 27, 2012.

The June Purchase Agreement with Southridge provides that Southridge is committed to purchase up to $10 million of our common stock. We may draw on the facility from time to time, as and when we determine appropriate in accordance with the terms and conditions of the June Purchase Agreement.

We will not receive any proceeds from the sale of the common stock offered through this prospectus by Southridge. However, we will receive proceeds from any sale of the common stock under the Purchase Agreement to Southridge

Between September 4, 2012 and September 17, 2012 the Company sold 26,802,465 common shares to Southridge for the gross amount of $50,000 pursuant to the June Purchase Agreement. The proceeds were utilized as follows:

(1)

$20,000 was utilized to pay debt due to Southridge

(2)

$2,500 was paid to Capital Path Securities who acted as placement agent

(3)

$27,500 was utilized for working capital purposes

On October 2 , 2012 the Company sold 10,837,849 common shares to Southridge for the gross amount of $14,300 pursuant to the June Purchase Agreement. Total gross proceeds of $14,300 were utilized to pay $14,300 of debt due to Southridge by the Company.

Item 6. Selected Financial Data

As we are a “smaller reporting company” as defined by Rule 229.10(f)(1), we are not required to provide the information required by this Item.

Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations

As of August 31, 2012, we had Trade Accounts Receivable of $ 2,268 and as of August 31, 2011 we had Trade Accounts Receivable of $3,135.

The decrease in Trade Accounts Receivable of approximately 27% is attributable to successful collection of $867 of delinquent payments due from a client of the McDonald Animal Hospital.

As of August 31, 2012 we had Due from an Affiliate of $39,140 and as of August 31, 2011 we had Due from an Affiliate of $0.

The increase in Due from an Affiliate is primarily attributable to the reclassification of $59,500 of rental expenses prepaid to a shareholder of the Company to a non interest bearing liability of the shareholder due at the demand of the Company as well as $240 in expenses paid by the Company for the benefit of the shareholder offset by a payment made to the company during the twelve months ended August 31, 2012 of $20,600.

As of August 31, 2012, we had a balance of $13,000 in Current Portion of Prepaid Expenses compared to August 31, 2011 where the balance totaled $62,200.

The decrease in Current Portion of Prepaid Expenses of approximately 79% was primarily attributable to the reclassification of rental expenses prepaid to a shareholder of the Company to a non interest bearing liability of the shareholder due at the demand of the Company.

As of August 31, 2012, the balance in Non-Current Portion of Prepaid Expenses totaled $0 compared to the August 31, 2011 balance of $10,300.

The decrease in the Non-Current Portion of Prepaid Expenses was primarily attributable to the applicable portion of Prepaid Rent being reallocated from a non-current asset to a current asset.

As of August 31, 2012, we had Deposits in the amount of $1,151 and as of August 31, 2011 we had Deposits of $0..

The decrease in Deposits of 100% is attributable to deposits sent by the Company to San Diego Gas and Electric Company to be being applied toward utility charges incurred by the Company.

As of August 31, 2012, we had Accounts Payable of $74,574 and as of August 31, 2011 we had Accounts Payable of $27,564 .

The increase in Accounts Payable of approximately 170 % is primarily attributable to s primarily attributable to increases in outstanding obligations of the Company incurred in the course of business as well as the incurring by the Company of $20,199 in payables pursuant to that agreement entered into by and between the Company and Titterington Veterinary Services, Inc., Dr. Ronald Titterington and Dr. Kathy Snell.

As of August 31, 2012 we had Notes Payable of $225,362 and as of August 31, 2011 we had Notes payable of $159,911.

The increase in Notes Payable of approximately 40% is primarily attributable to a combination of additional borrowings by the Company incurred in order to fund operations and the reclassification of $57,500 of accrued salary to Notes Payable as a result of assignment of the rights to that payment to a third party offset by the reclassification of approximately $280,559 of indebtedness to Convertible Notes payable.

As of August 31, 2012 we had Convertible Notes Payable (net of unamortized discount resulting from a beneficial conversion feature) totaling $121,495 and as of August 31, 2011 we had Convertible Notes Payable (net of unamortized discount resulting from a beneficial conversion feature) totaling $42,430. .

The increase in Convertible Notes Payable (net of unamortized discount resulting from a beneficial conversion feature) of approximately 86% is primarily attributable to:

The issuance of $456,059 in convertible debentures through a combination of initial issuances and modifications of the terms and conditions of existing securities

The recognition of $380,480 of interest expense attributable to amortizations of discounts recognized

Offset by:

$369,059 in principal amount of convertible indebtedness converted into common stock

$37,500 in convertible debt prepaid by the Company

$350,915 of discounts on Convertible Notes recognized

As of August 31, 2012 we had Accrued Expenses of $119,726 and As of August 31, 2011, we had Accrued Expenses of $67, 206

The increase in accrued expenses of approximately 78% is primarily attributable to:

(a) $15,239 in net interest accrued

(b) $44,500 in net additions to salaries accrued but unpaid

offset by $7219 net reductions in accrued tax expenses

Material Changes in Results of Operations

Revenues were $426,252 for the twelve months ended August 31, 2012. Revenues were $349,141 for the twelve months ended August 31, 2011. Net Losses were $1,889,563 for the twelve months ended August 31, 2012 and $951,783 for the same period ended August 31, 2011.

The increase in Net Losses of approximately 98% is primarily attributable to:

(a)

Increase in Cost of Revenue of $29,894

(b)

Increase in rental costs of $18,216

(c)

Increase in Consultant’s Expenses of $268,522

(d)

Loss on early extinguishment of Debt recognized in the amount of $18,647

(e)

Increase in Expenses incurred pursuant to that agreement entered into by and between the Company and Titterington Veterinary Services, Inc., Dr. Ronald Titterington and Dr. Kathy Snell.

(f)

Impairment of intangible Assets recognized in the amount of $683,333

(g)

Increases in Interest Expense attributable to amortization of discount in the amount of $364,052

(h)

Expenses incurred resulting from shares issued pursuant to contractual obligations in the amount of $23,868

(i)

Expenses paid for through the issuance of Preferred shares in the amount of $75,000 such expenses being incurred in connection with that Equity Purchase Agreement entered into by and between the Company and Southridge on February 27, 2012.

Offset by :

A decrease in Research and Development Expenses of $103,265

A decrease in general and Administrative Expenses of $231,185

An increase in other income recognized of $94,850 attributable to cancellation of stock previously issued for services

Recognition of $187,699 in revenue realized as a result of that agreement entered into by and between the Company and Titterington Veterinary Services, Inc., Dr. Ronald Titterington and Dr. Kathy Snell.

All operating revenues realized by the Company re primarily derived through provision of Veterinary Services by the McDonald Animal Hospital. The increases in Total Revenues for the twelve months ended August 31,2012 as compared to the twelve months ended August 31 , 2011 is partially attributable to the fact that the acquisition of the assets of Pet Pointers, Inc. by the Company through which the Company acquired the McDonald Animal Hospital, had not occurred until January 4, 2011.

As of August 31, 2012 we had $42,737 cash on hand and current liabilities of $549,157 (exclusive of convertible debt discount attributable to a beneficial conversion feature) such liabilities consisting of Accounts Payable, Notes Payable, Convertible Notes Payable, Amounts due to Affiliates / Others and Accrued Expenses.

We feel we will not be able to satisfy its cash requirements over the next twelve months and shall be required to seek additional financing.

We currently plan to raise additional funds primarily by offering securities for cash and acquiring existing veterinary clinics with the ability to generate cash flow to fund operations.

There is no guarantee that we will be able to raise any capital through any type of offerings. We can provide no assurance that we can acquire veterinary clinics which can generate sufficient cash flow to neither fund our operations nor can any assurance be made that we can acquire one or more additional veterinary clinics in the near future or at all. We cannot assure that we will be successful in obtaining additional financing necessary to implement our business plan. We have not received any commitment or expression of interest from any financing source that has given us any assurance that we will obtain the amount of additional financing in the future that we currently anticipate. For these and other reasons, we are not able to assure that we will obtain any additional financing or, if we are successful, that we can obtain any such financing on terms that may be reasonable in light of our current circumstances.

As of January 26, 2013 we are not party to any binding agreements which would commit Entest to any material capital expenditures.

Item 7A. Quantitative and Qualitative Disclosures About Market Risk

As we are a smaller reporting company, as defined by Rule 229.10(f)(1), we are not required to provide the information required by this Item.

Item 8. Financial Statements and Supplementary Data

FINANCIAL STATEMENTS

SEALE AND BEERS, CPAs

PCAOB & CPAB REGISTERED AUDITORS

www.sealebeers.com

REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

To the Board of Directors and Stockholders of

Entest BioMedical Inc.

We have audited the accompanying balance sheets of Entest BioMedical, Inc. as of August 31, 2012, and the related statements of income, stockholders’ equity (deficit), and cash flows for the one-year period ended August 31, 2012. Entest BioMedical, Inc.’s management is responsible for these financial statements. Our responsibility is to express an opinion on these financial statements based on our audits.

We conducted our audits in accordance with the standards of the Public Company Accounting Oversight Board (United States). Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement. The company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. Our audit included consideration of internal control over financial reporting as a basis for designing audit procedures that are appropriate in the circumstances, but not for the purpose of expressing an opinion on the effectiveness of the company’s internal control over financial reporting. Accordingly, we express no such opinion. An audit also includes examining, on a test basis, evidence supporting the amounts and disclosures in the financial statements, assessing the accounting principles used and significant estimates made by management, as well as evaluating the overall financial statement presentation. We believe that our audits provide a reasonable basis for our opinion.

In our opinion, the financial statements referred to above present fairly, in all material respects, the financial position of Entest BioMedical, Inc. as of August 31, 2012, and the related statements of income, stockholders’ equity (deficit), and cash flows for the year ended August 31, 2012 in conformity with accounting principles generally accepted in the United States of America.

The accompanying financial statements have been prepared assuming that the Company will continue as a going concern. As discussed in Note 4 to the financial statements, the Company has incurred recurring losses and recurring negative cash flow from operating activities, and has an accumulated deficit which raises substantial doubt about its ability to continue as a going concern. Management’s plans concerning these matters are also described in Note 4. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.

/s/ Seale and Beers, CPAs

Seale and Beers, CPAs

Las Vegas, Nevada

January 25, 2012

50 S. Jones Blvd. Suite 202 Las Vegas, NV 89107 Phone: (888)727-8251 Fax: (888)782-2351

To: The Board of Directors and Stockholders

Entest BioMedical, Inc.

I have audited the accompanying consolidated balance sheet of Entest BioMedical, Inc. as of August 31, 2011 and 2010 and the related statements of operations, stockholders’ equity and cash flows for the years ended August 31, 2011 and 2010, and for the period from inception (August 22, 2008) to August 31, 2011. These financial statements are the responsibility of the Company’s management. My responsibility is to express an opinion on these financial statements based on my audit.

Except as discussed in the following paragraph, I conducted my audits in accordance with the standards of the Public Company Accounting Oversight Board (United States). Those standards require that I plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement. The Company is not required to have, nor was I engaged to perform, an audit of its internal control over financial reporting. My audit included consideration of internal control over financial reporting as a basis for designing audit procedures that are appropriate in the circumstances, but do not for the purpose of expressing an opinion on the effectiveness of the Company’s internal control over financial reporting. Accordingly, I express no such opinion. An audit includes examining, on a test basis, evidence supporting the amounts and disclosures in the financial statements. An audit also includes assessing the accounting principles used and significant estimates made by management, as well as evaluating the overall financial statement presentation. I believe that my audit provides a reasonable basis for my opinion.

In my opinion, the financial statements referred to in the first paragraph present fairly, in all material respects, the financial position of Entest BioMedical, Inc. as of August 31, 2011 and 2010 and the results of its operations and changes in stockholders equity and cash flows for the years ended August 31, 2011 and 2010, and the period from inception (August 22, 2008) to August 31, 2011 in conformity with accounting principles generally accepted in the United States.

The accompanying financial statements have been prepared assuming that the Company is a going concern. As discussed in Note 4 to the financial statements, the Company has not generated income and has accumulated losses. This raises substantive doubt about the Company’s ability to continue as a going concern. Management’s plans in regard to these matters are also described in Note 8. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.

/ s /John Kinross-Kennedy

John Kinross-Kennedy

Certified Public Accountant

Irvine, California

October 31, 2011

ENTEST BIOMEDICAL, INC.
Consolidated Balance Sheet
	As of	As of
	August 31,	August 31,
	2012	2011
ASSETS
Current Assets
Cash	$ 42,737	$ 43,901
Trade accounts receivable, less allowance for uncollectable accounts
of $0 and $0 at February 29, 2012 and August 31, 2011 respectively	2,268	3,135
Inventory	10,298	7,986
Due from Affiliate	39,140	0
Current Portion of Prepaid Expenses	13,000	62,200
Employee Receivable	4,349	4,349
Total Current Assets	111,792	121,571

Property & Equipment (Net of Accumulated Depreciation)	8,832	17,293
Goodwill	405,000	405,000
Intangible Assets (Net of Accumulated Amortization)	1,052	1,828


Non Current Portion of Prepaid Expenses		10,300
Deposits	1,151	0


TOTAL ASSETS	$ 527,827	$ 555,992

LIABILITES AND STOCKHOLDERS' EQUITY
Current Liabilities
Accounts Payable	$ 74,574	$ 27,564
Notes Payable	225,362	159,911
Convertible notes payable, net of discount	121,495	42,430
Due to Other	8,000	8,000
Accrued Expenses	119,726	67,206
Total Current Liabilities	549,157	305,111

Notes Payable	36,469	79,143

TOTAL LIABILITIES	585,626	384,254

STOCKHOLDERS' EQUITY
Common Stock, $0.001 par value, authorized 1,000,000,000 shares;
issued and outstanding 223,492,927 shares
as of August 31, 2012 and August 31, 2011 respectively	223,493	20,838
Preferred Stock , $0.001 par value 5,000,000 shares authorized,
0 shares issued and outstanding as of August 31,2012 and August 31, 2011		0
Series AA Preferred Stock, $0.001 par value 100,000 shares authorized,
5,000 shares issued and outstanding at August 31, 2012 and
as of August 31, 2011	5	5
Series B Preferred
$0.001 par value, 4,400,000 shares authorized, 3,201,397 and 0
issued and outstanding as of August 31, 2012 and August 31, 2011	3,201	0
NonVoting Convertible Preferred
$1 par value, 200,000 shares authorized, 75,000 and 0
issued and outstanding as of August 31, 2012 and August 31, 2011	75,000	0
Additional Paid in Capital	3,030,642	1,619,330
Contributed Capital	274,162	274,162
Accumulated Deficit	(3,664,302)	(1,742,597)

Total Stockholders' Equity	(57,799)	171,738

TOTAL LIABILITIES & STOCKHOLDERS' EQUITY	$ 527,827	$ 555,992

The Accompanying Notes are an integral part of these Financial Statements

ENTEST BIOMEDICAL INC.
Consolidated Statement of Operations
	For the	For the
	Year Ended	Year Ended
	August 31	August 31
	2012	2011
REVENUES
Revenues from Veterinary Services	$ 419,336	$ 349,141
Online Revenues	6,916
TOTAL REVENUE	426,252	349,141

Cost of Revenue	119,299	89,405
GROSS PROFIT	306,953	259,736

COSTS AND EXPENSES
Research and Development	5,798	109,063
Rent Costs	126,812	108,596
General and Administrative	562,424	793,609
Incorporation Costs
Consultant's Expenses	428,040	159,518
Miscellaneous Expenses
Total Costs and Expenses	1,123,074	1,170,786

OPERATING LOSS	(816,121)	(911,050)

OTHER INCOME AND EXPENSE
Other Income	94,949	99
Loss on Early Extinguishment of Debt	(18,647)
Income generated from revenue	187,699
Share Agreement
Expenses incurred from Revenue
Share Agreement	(145,362)
Loss on Impairment of intangible assets	(683,333)
Interest Expense	(29,400)	(24,404)
Interest Expense attributable to
amortization of discount	(380,480)	(16,428)
Expense attributable to issuance
of shares pursuant to contractual obligation	(23,868)
Expense attributable to issuance of
Non Voting Convertible Preferred
Shares in connection with Stock
Purchase Agreement	(75,000)
TOTAL OTHER INCOME AND EXPENSE	(1,073,442)	(40,733)

LOSS BEFORE INCOME TAXES	(1,889,563)	(951,783)
Income Taxes	0	0

NET LOSS	(1,889,563)	(951,783)
Beneficial conversion feature
attributable to issuance of NonVoting
Preferred Stock	(32,142)
NET LOSS available to
common shareholders	(1,921,705)	(951,783)

BASIC AND DILUTED
LOSS PER SHARE	$ (0.02)	$ (0.05)

WEIGHTED AVERAGE	94,990,042	19,895,368
NUMBER OF COMMON
SHARES OUTSTANDING

The Accompanying Notes are an integral part of these Financial Statements

Entest BioMedical, Inc.
Consolidated Statement of Stockholders' Equity
For the Fiscal Years Ended August 31, 2011 and August 31, 2012

							Non Voting				Accumulated
							Convertible				Deficit
			Series AA		Series B		Preferred		Additional	Contrib-	during the
	Common		Preferred		Preferred				Paid-in	uted	Development
	Shares	Amount	Shares	Amount	Shares	Amount	Shares	Amount	Capital	Capital	Stage	Total

Balances, August 31, 2010	17,553,040	$ 17,553							$ 537,415	$ 15,104	$ (790,814)	$ (220,742)
Common Shares issued for Cash	2,217,600	2,217							215,383	-	-	217,600
Common Shares issued for Debt	781,712	780							340,387	-	-	341,167
Common Shares issued to Consultants	74,383	74							121,967	-	-	122,041
Common Stock issued to employees	163,766	164							303,235	-	-	303,399
Restricted Stock Awards issued to employee	50,000	50							(50)	-	-	-
Restricted Stock Award Compensation
expense recognized	-	-							10,000	-	-	10,000
Discount on Convertible Debt recognized	-	-							88,998	-	-	88,998
Increases in Contributed capital	-	-							-	259,058	-	259,058
Preferred Stock issued for Accrued compensation			5,000	5					1,995			2,000
Net Loss Year ended August 31, 2011											(951,783)	(951,783)

Balances, August 31, 2011	20,840,501	$ 20,838	5,000	$ 5					$1,619,330	$274,162	$(1,742,597)	$171,738
Common Shares issued for services	3,272,000	3,269							168,481			171,750
Common Shares issued for intangible assets	2,500,000	2,500							697,500			700,000
Discount on Convertible Note Recognized									350,915			350,915
Common Shares issued for debt	113,695,700	113,695							261,264			374,959
Cancellation of Common Shares Issued	(90,000)	(83)							(86,687)			(86,687)
Restricted Stock Award to employees	77,000,000	77,000							(77,000)			0
Restricted Stock Award to consultant	15,000,000	15,000							(15,000)			0
Restricted Stock Award compensation
Expense Recognized									58,491			58,491
Series B Preferred Dividend paid					3,201,39	3,201			(3,201)			0
Issuance of Non Voting Convertible
Preferred Shares							75,000	75,000				75,000
Recognition of Beneficial Conversion Feature									32,142			32,142
Non Voting Convertible Preferred Shares
Shares issued pursuant to Contractual Obligations	6,274,726	6,274							17,594			23,868
Cancellation of Restricted Stock Award to Employee	(15,000,000)	(15,000)							6,813			(8,187)
Net Loss Year ended August 31, 2012											(1,889,563)	(1,890,259)
Beneficial Conversion Feature Deemed Dividend											(32,142)	(32,142)
Balance August 31, 2012	223,492,927	223,493	5,000	5	3,201,39	3,201	75,000	75,000	3,030,642	274,162	(3,664,302)	(57,799)

The Accompanying Notes are an integral part of these Financial Statements

ENTEST BIOMEDICAL, INC.
Consolidated Statement of Cash Flows
	For the	For the
	Year ended	Year ended
	August 31	August 31
	2012	2011
OPERATING ACTIVITIES
Net (loss)	$ (1,889,563)	$ (951,783)
Adjustments to reconcile net loss to net cash used
by operating activities:
Depreciation Expense	8,461	5,591
Amortization Expense	776	505
Stock issued as Compensation to Employees	48,681	55,399
Stock issued as Compensation to Consultants	181,540	122,007
Change in operating assets and liabilities:
(Increase) Decrease in Trade Accounts Receivable	867	(3,135)
(Increase) Decrease in Inventory	(2,312)	(7,986)
(Increase) Decrease in Employee Receivable		(2,953)
Increase (Decrease) in Accounts Payable	47,010	6,222
(Increase)Decrease in Due to Other
(Increase) Decrease in Prepaid Expenses	59,500	10,100
(Increase) Decrease in Due from Affiliate	(39,140)
(Increase) Decrease in Deposits	(1,151)	1,059
Increase(Decrease) in amortization of intangibles	16,667
Increase (Decrease) in Accrued Expenses	52,520	(60,889)
(Increase)Decrease on gain realized on cancellation
of stock	(94,937)
Increase(Decrease) in Loss on Impairment
of Intangible Assets	683,333

Net Cash Provided Used in Operating Activities	(927,748)	(825,863)

INVESTING ACTIVITIES
Purchase/Sale of Equipment	0	(22,884)
Net cash Provided by (Used in) Investing Activities	0	(22,884)

FINANCING ACTIVITIES
(Increase) Decrease in Goodwill from acquisition		(195,000)
Stock issued in Payment of Debt
Increase (Decrease) in Common stock issued for cash		217,600
(Increase) Decrease in Intangible Assets (net)		(2,299)
Increase (Decrease) in Common stock issued
for expenses	104,768
Increase (Decrease) in Due to Affiliate		8,000
Increase (Decrease) in Due to Shareholder
Increase (Decrease) in Notes Payable	470,901	516,085
Increase (Decrease) in Contributed Capital		259,058
Increase (Decrease) in Additional paid in Capital	350,915	88,998
Net Cash Provided by Financing Activities	926,584	892,442

Net Increase in Cash	(1,164)	43,695

Cash at Beginning of Period	43,901	206


Cash at End of Period	$ 42,737	$ 43,901



Supplemental Disclosure of Noncash investing and financing activities:

	12 Months ended August 31, 2012	12 Months ended August 31, 2011
Stock issued in payment of Debt	$369,059	$391,167
Stock issued in Acquisition of McDonald Animal Hospital		$210,000
Stock issued pursuant to Titterington Agreement	$700,000

The Accompanying Notes are an integral part of these Financial Statements

Entest BioMedical, Inc.

Notes to Consolidated Financial Statements

As of August 31, 2012

NOTE 1. ORGANIZATION AND DESCRIPTION OF BUSINESS

Entest BioMedical Inc. (the “Company”) was incorporated in the State of Nevada on September 24, 2008 as JB Clothing Corporation. Until July 10, 2009, the Company’s principal business objective was the offering of active/leisure fashion design clothing.

On July 10, 2009 the Company abandoned its efforts in the field of active/leisure fashion design clothing when it acquired 100% of the share capital of Entest BioMedical, Inc., a California corporation, (“Entest CA”).

The Company’s current business consists of the development and commercialization of immunotherapeutic therapies for the veterinary market as well as the acquisition and operation of veterinary hospitals.

NOTE 2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

A. BASIS OF ACCOUNTING

The financial statements have been prepared using the basis of accounting generally accepted in the United States of America. Under this basis of accounting, revenues are recorded as earned and expenses are recorded at the time liabilities are incurred. The Company has adopted an August 31 fiscal year-end. The Company recognizes revenue from services and product sales when the following four revenue recognition criteria are met: persuasive evidence of an arrangement exists, delivery has occurred or services have been rendered, the selling price is fixed or determinable, and collectability is reasonably assured. Product sales and service revenues are recorded when the products are delivered and title passes to customers. The customer’s credit card is authorized and charged, or checks/cash are received at the time the services are rendered, thereby providing reasonable assurance of collectability.

B. PRINCIPLES OF CONSOLIDATION

The consolidated financial statements include the accounts of Entest CA, the Company’s wholly owned subsidiary. Significant inter-company transactions have been eliminated.

C. USE OF ESTIMATES

The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.

D. CASH EQUIVALENTS

The Company considers all highly liquid investments with a maturity of three months or less when purchased to be cash equivalents.

E. PROPERTY AND EQUIPMENT

Property and equipment are recorded at cost. Maintenance and repairs are expensed in the year in which they are incurred. Property and equipment consist of Office Equipment, medical Equipment and Computer Equipment. Expenditures that enhance the value of property and equipment are capitalized. All property and equipment is depreciated utilizing the Straight Line Method for a period of thirty months , such period being estimated by the Company to represent the useful life of the assets. For the Fiscal Year ended August 31, 2012 the Company incurred depreciation expense of $8,461 and for the Fiscal Year ended August 31, 2011 the Company incurred depreciation expense of $5,591. No depreciation has been recognized in connection with one piece of computer equipment which has yet to be put into service.

Property Plant and Equipment

Acquisition Cost	Estimated useful Life (Months)		Total
Office Equipment		30	3,235
Medical Equipment		30	17,523
Computer Equipment		30	2,126
Subtotal			22,884
Less Accumulated Depreciation			(14,052)
Total			8,832

F. FAIR VALUE OF FINANCIAL INSTRUMENTS

Fair value is the price that would be received for an asset or the exit price that would be paid to transfer a liability in the principal or most advantageous market in an orderly transaction between market participants on the measurement date. A fair value hierarchy requires an entity to maximize the use of observable inputs, where available. The following summarizes the three levels of inputs required by the standard that the Company uses to measure fair value:

Level 1: Quoted prices in active markets for identical assets or liabilities

Level 2: Observable inputs other than Level 1 prices, such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the related assets or liabilities.

Level 3: Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities.

The Company’s financial instruments as of August 31, 2012 consisted of $261,831, of Notes Payable, $121,495 of Convertible Notes payable (net of discount), $8,000 due to TheraCyte, Inc, $4,349 of Employee Receivables and $39,140 due from an affiliate. The fair value of all of the Company’s financial instruments as of September 30, 2012 were valued according to the Level 3 input. The carrying amount of the financial instruments is equal to the fair value as determined by the Company.

The Company has determined that there are no Level 1 or Level 2 inputs for determining the fair value of the Company’s financial instruments. Fair value was determined by the Company utilizing its own assumptions and estimation. There were no transfers between levels for the period presented.

G. INCOME TAXES

The Company accounts for income taxes using the liability method prescribed by ASC 740, “Income Taxes.” Under this method, deferred tax assets and liabilities are determined based on the difference between the financial reporting and tax bases of assets and liabilities using enacted tax rates that will be in effect in the year in which the differences are expected to reverse. The Company records a valuation allowance to offset deferred tax assets if based on the weight of available evidence, it is more-likely-than-not that some portion, or all, of the deferred tax assets will not be realized. The effect on deferred taxes of a change in tax rates is recognized as income or loss in the period that includes the enactment date.

The Company applied the provisions of ASC 740-10-50, “Accounting For Uncertainty In Income Taxes”, which provides clarification related to the process associated with accounting for uncertain tax positions recognized in our financial statements. Audit periods remain open for review until the statute of limitations has passed. The completion of review or the expiration of the statute of limitations for a given audit period could result in an adjustment to the Company’s liability for income taxes. Any such adjustment could be material to the Company’s results of operations for any given quarterly or annual period based, in part, upon the results of operations for the given period. As of August 31, 2011 and 2010, the Company had no uncertain tax positions, and will continue to evaluate for uncertain positions in the future.

The Company generated a deferred tax credit through net operating loss carry forward. However, a valuation allowance of 100% has been established.

Interest and penalties on tax deficiencies recognized in accordance with ACS accounting standards are classified as income taxes in accordance with ASC Topic 740-10-50-19.

H. BASIC EARNINGS (LOSS) PER SHARE

The Financial Accounting Standards Board (FASB) issued Accounting Standards Codification (ASC) 260, "Earnings Per Share", which specifies the computation, presentation and disclosure requirements for earnings (loss) per share for entities with publicly held common stock. ASC 260 requires the presentation of basic earnings (loss) per share and diluted earnings (loss) per share. The Company has adopted the provisions of ASC 260 effective from inception. Basic net loss per share amounts is computed by dividing the net income by the weighted average number of common shares outstanding. All convertible debt has an anti-dilutive effect on the EPS , therefore Diluted earnings per share are the same as basic earnings per share.

NOTE 3. RECENT ACCOUNTING PRONOUNCEMENTS

On May 2011, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) No. 2011-04, "Amendments to Achieve Common Fair Value Measurement and Disclosure Requirements in U.S. GAAP and IFRSs." The amendments in this update generally represent clarifications of Topic 820, but also include some instances where a particular principle or requirement for measuring fair value or disclosing information about fair value measurements has changed. This update results in common principles and requirements for measuring fair value and for disclosing information about fair value measurements in accordance with U.S. GAAP and IFRS. The amendments in this update are to be applied prospectively. The amendments are effective for interim and annual periods beginning after December 15, 2011. Early application is not permitted. The Company does not expect this guidance to have a significant impact on its consolidated financial position, results of operations or cash flows.

In June 2011, the FASB issued ASU No. 2011-05, "Presentation of Comprehensive Income." This update was amended in December 2011 by ASU No. 2011-12, "Deferral of the Effective Date for Amendments to the Presentation of Reclassifications of Items Out of Accumulated Other Comprehensive Income in Accounting Standards Update No. 2011-05." This update defers only those changes in update 2011-05 that relate to the presentation of reclassification adjustments. All other requirements in update 2011-05 are not affected by this update, including the requirement to report comprehensive income either in a single continuous financial statement or in two separate but consecutive financial statements. ASU No. 2011-05 and 2011-12 are effective for fiscal years (including interim periods) beginning after December 15, 2011. The Company does not expect this guidance to have a significant impact on its consolidated financial position, results of operations or cash flows.

In December 2011, the FASB issued ASU No. 2011-11, "Disclosures about Offsetting Assets and Liabilities." The amendments in this update require enhanced disclosures around financial instruments and derivative instruments that are either (1) offset in accordance with either ASC 210-20-45 or ASC 815-10-45 or (2) subject to an enforceable master netting arrangement or similar agreement, irrespective of whether they are offset in accordance with either ASC 210-20-45 or ASC 815-10-45. An entity should provide the disclosures required by those amendments retrospectively for all comparative periods presented. The amendments are effective during interim and annual periods beginning on or after January 1, 2013. The Company does not expect this guidance to have any impact on its consolidated financial position, results of operations or cash flows.

A variety of proposed or otherwise potential accounting standards are currently under study by standard setting organizations and various regulatory agencies. Due to the tentative and preliminary nature of those proposed standards, the Company’s management has not determined whether implementation of such standards would be material to its financial statements.

NOTE 4. GOING CONCERN

The accompanying financial statements have been prepared assuming that the Company will continue as a going concern. The Company generated net losses of $3,664,302 during the period from August 22, 2008 (inception) through August 31, 2012. This condition raises substantial doubt about the Company's ability to continue as a going concern. The Company's continuation as a going concern is dependent on its ability to meet its obligations, to obtain additional financing as may be required and ultimately to attain profitability. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.

Management plans to raise additional funds primarily by offering securities for cash. Management has raised $197,500 net of legal expenses in the twelve months ended August 31, 2012 through the issuance of convertible notes. The Company has also raised $261,475 from other borrowings during the twelve month ended August 31, 2012.

On June 1, 2012 the Company entered into an Equity Purchase Agreement (the "June Purchase Agreement") with Southridge Partners II, LP, a Delaware limited partnership ("Southridge").

Under the terms of the June Purchase Agreement, Southridge will purchase, at the Company's election, up to $10,000,000 of the Company's registered common stock (the "Shares"). During the term of the Purchase Agreement, the Company may at any time deliver a "put notice" to Southridge thereby requiring Southridge to purchase a certain dollar amount of the Shares. Simultaneous with the delivery of such Shares, Southridge shall deliver payment for the Shares. Subject to certain restrictions, the purchase price for the Shares shall be equal to 91% of the average of the two lowest Closing Prices during the Valuation Period as such capitalized terms are defined in the Agreement.

The number of Shares sold to Southridge shall not exceed the number of such shares that, when aggregated with all other shares of common stock of the Company then beneficially owned by Southridge, would result in Southridge owning more than 9.99% of all of the Company's common stock then outstanding. Additionally, Southridge may not execute any short sales of the Company's common stock.

Any sale of Shares pursuant to the June Agreement is subject to a Registration Statement filed under the Securities Act of 1933 remaining effective for the sale by Southridge of those Shares.

June Agreement shall terminate (i) on the date on which Southridge shall have purchased Shares pursuant to this Agreement for an aggregate Purchase Price of $10,000,000, or (ii) on the date occurring 24 months from the date on which the June Agreement was executed and delivered by the Company and Southridge.

The Company has also agreed to pay the following to Capital Path Securities LLC for acting as the Company’s exclusive advisor and placement agent in connection with the June Purchase Agreement a cash placement fee of 5% of funds received by the Company through the sale of Shares to Southridge as such funds are received by the Company.

On June 12, 2012 a registration statement on form S-1 was filed with the United States Securities and Exchange Commission registering 46,238,705 shares of the Company’s common stock that will be put to Southridge pursuant to the June Agreement which was declared effective by the United States Securities and Exchange Commission on August 27, 2012.

There is no guarantee that the Company will be able to raise additional capital through offerings.

NOTE 5. NOTES PAYABLE

As of August 31, 2012

Current :
Bio Technology Partners Business Trust	13500
Venture Bridge Advisors, Inc.	32508
Southridge Partners II LLP	40000
Sherman Family Trust	79000
Officer Loans (Note 6)	30,180
Current portion of amounts to be paid on
behalf of Gregory McDonald and Pet Pointers, Inc. (Note 10 )	30174
8% Convertible Notes (Note14 )	105,500
10% Convertible Note (Note 14)	59000
Total:	389862

Long Term:
Long Term portion of amounts to be paid on
behalf of Gregory McDonald and
Pet Pointers, Inc. (Note 10 )	36469
Total:	36469

Both of Bio Technology Partners Business Trust and Venture Bridge Advisors have provided lines of credit to the Company in the amount of $200,000 each or so much thereof as may be disbursed to, or for the benefit of the Company by Lender in Lender's sole and absolute discretion. The unpaid principal of these lines of credit bear simple interest at the rate of ten percent per annum. Interest is calculated based on the principal balance as may be adjusted from time to time to reflect additional advances or payments made hereunder. Principal balance and accrued interest shall become due and payable in whole or in part at the demand of the Lender. The Sherman Family Trust has provided a line of credit to the Company in the amount of $____ or so much thereof as may be disbursed to, or for the benefit of the Company by Lender in Lender's sole and absolute discretion. The unpaid principal of this line of credit bears simple interest at the rate of ten percent per annum. Interest is calculated based on the principal balance as may be adjusted from time to time to reflect additional advances or payments made hereunder. Principal balance and accrued interest shall become due and payable in whole or in part at the demand of the Lender. $40,000 loaned to the Company by Southridge Partners II LLP bears no stated interest rate and is payable at the demand of Southridge Partners II LLP.

NOTE 6. RELATED PARTY TRANSACTIONS

During the quarter ended November 30, 2011 David Koos made loans to the Company totaling $8,400. These loans are due and payable at the demand of David Koos and bear simple interest at a rate of 15% per annum.

During the quarter ended February 29, 2012 David Koos made loans to the Company totaling $7,550. These loans are due and payable at the demand of David Koos and bear simple interest at a rate of 15% per annum.

During the quarter ended February 29, 2012 David Koos granted to the Sherman Family Trust, an irrevocable trust for the benefit of Blossom Sherman, all rights to and interest in $25,956 in unpaid indebtedness owed by the Company (bearing simple interest at a rate of 15% per annum and due and payable at the demand of the holder) as well as $3,051 in unpaid interest owed by the Company.

During the quarter ended May 31, 2012 David Koos made loans to the Company in the amount of $13,625. These loans are due and payable at the demand of David Koos and bear simple interest at a rate of 15% per annum

As of August 31, 2012 the Company remains indebted to David R. Koos in the principal amount of $30,180 due and payable at the demand of David Koos and bearing simple interest at a rate of 15% per annum

As of August 31 , 2012 Bio-Matrix Scientific Group, Inc. (“BMSN”) , a major shareholder of the Company, is indebted to the Company in the amount of $39,140. This amount is non interest bearing and is due at the demand of the Company.

NOTE 7. INCOME TAXES


As of August 31, 2012

Deferred tax assets:
Net operating tax carry forwards	$	1,250,503
Other		-0-
Gross deferred tax assets		1,250,503
Valuation allowance		(1,250,503)

Net deferred tax assets	$	-0-

As of August 31 ,2012 the Company has a Deferred Tax Asset of $1,250,503 completely attributable to net operating loss carry forwards of approximately $3,677,949 (which expire 20 years from the date the loss was incurred) consisting of:

(a) $ 13,647 of Net Operating Loss carry forwards acquired in the reverse acquisition of Entest BioMedical, Inc., a California corporation, and

(b) $ 3,664,302 of Net Operating Loss carry forwards attributable to Entest BioMedical, Inc.

Realization of deferred tax assets is dependent upon sufficient future taxable income during the period that deductible temporary differences and carry forwards are expected to be available to reduce taxable income. A valuation allowance is recorded when it is “more likely-than-not” that a deferred tax asset will not be realized. In addition, the reverse acquisition in which Entest BioMedical, Inc. was involved in 2009 has resulted in a change of control. Internal Revenue Code Sec 382 limits the amount of income that may be offset by net operating loss (NOL) carryovers after an ownership change. As a result, the Company has recorded a valuation allowance reducing all deferred tax assets to $ -0-.

Income tax is calculated at the 34% Federal Corporate Rate.

NOTE 8. ACQUISITION OF ENTEST CA

On July 10, 2009 the Company acquired 100% of Entest CA, a California corporation and wholly owned subsidiary of the Company, from BMSN for consideration consisting of (a) the issuance to BMSN of 10,000,000 newly issued common shares of Entest and (b) the return by Mr. Rick Plote of 10,000,000 shares of Entest’s common stock previously issued to him by Entest for cancellation.

NOTE 9. ACQUISITION OF THE ASSETS OF PET POINTERS, INC.

On January 4, 2011Entest CA acquired from Pet Pointers, Inc., a California corporation doing business as McDonald Animal Hospital (“Seller”), and Dr. Gregory McDonald DVM (“McDonald”) all the goodwill from McDonald and assets of Seller except cash and accounts receivables used in connection with the operation of a veterinary medical clinic located at 225 S. Milpas Street, Santa Barbara, CA 93103 (the "Business").

Consideration for the acquisition consisted of:

I. $70,000 in cash

II. $210,000 of the Company’s common shares valued at the closing price per share as of January 4, 2011

III. Payment of no more than $78,000 to a creditor of the Seller to be paid in monthly installments of $1,500 per month

IV. Payment of no more than $25,000 to additional creditors of the Seller to be paid in monthly installments of $825 per month

V. Payment of $50,000 to McDonald on the first business day of the fourth month following the closing of the acquisition (“Closing”)

NOTE 10. COMMITMENTS AND CONTINGECIES

On November 1, 2011, the Company entered into an agreement to lease approximately 2,320 square feet of office space beginning December 1, 2011 for a period of five years.

Rent to be charged to the Company pursuant to the lease is as follows:

$2,996 per month for the period beginning December 1, 2011 and ending November 30, 2012

$3,116 per month for the period beginning December 1, 2012 and ending November 30, 2013

$3,241 per month for the period beginning December 1, 2013 and ending November 30, 2014

$3,371 per month for the period beginning December 1, 2014 and ending November 30, 2015

$3,506 per month for the period beginning December 1, 2015 and ending November 30, 2016

On January 4, 2011, as part of the asset purchase agreement with the Company and Gregory McDonald and Pet Pointers, Inc., the Company pays on behalf of Gregory McDonald and Pet Pointers monthly rent of $7,526 to Anthony Marinelli for the terms indicated in the Gregory McDonald / Pet Pointers lease. These payments are not obligations of the Company but, are payments the Company agreed to make on behalf of Gregory McDonald and Pet Pointers as part of the Asset Purchase Agreement.

On January 4, 2011, as part of the asset purchase agreement with the Company and Gregory McDonald on behalf of Pet Pointers, Inc., the Company pays on behalf of Gregory McDonald and Pet Pointers monthly payments of $1,500 to Anthony and Judi Marinelli towards the extinguishment of a total note of $78,000. These payments are payments the Company agreed to make on behalf of Gregory McDonald and Pet Pointers.

On January 4, 2011, as part of the asset purchase agreement with the Company and Gregory McDonald on behalf of Pet Pointers, Inc., the Company pays on behalf of Gregory McDonald and Pet Pointers an installment agreement due to the Franchise Tax Board in the amount of $11,405 with monthly payments of $400. These payments are payments the Company agreed to make on behalf of Gregory McDonald and Pet Pointers.

On January 4, 2011, as part of the asset purchase agreement with the Company and Gregory McDonald on behalf of Pet Pointers, Inc., the Company pays on behalf of Gregory McDonald and Pet Pointers an installment agreement due to the Internal Revenue Service in the amount of $13,595 with monthly payments of $425. These payments are payments the Company agreed to make on behalf of Gregory McDonald and Pet Pointers.

There were no other legal proceedings against the Company with respect to matters arising in the ordinary course of business. The Company is not involved in any other litigation either as plaintiffs or defendants, and has no knowledge of any threatened or pending litigation against the Company.

On June 1, 2012 the Company entered into an Equity Purchase Agreement (the "June Purchase Agreement") with Southridge Partners II, LP, a Delaware limited partnership ("Southridge").

Any sale of Shares pursuant to the June Agreement is subject to a Registration Statement filed under the Securities Act of 1933 remaining effective for the sale by Southridge of those Shares.

NOTE 11. NON VOTING CONVERTIBLE PREFERRED STOCK

On March 27, 2012 the company issued to Southridge 75,000 shares of its nonvoting convertible preferred stock to Southridge in accordance with the terms of an Equity Purchase Agreement entered into by and between the Company and Southridge which was terminated at the Company’s option on June 1, 2012 (“February Purchase Agreement”).

Non Voting Convertible Preferred Stock is convertible at the option of the holder into shares of the Company’s common stock at a conversion price equal to seventy percent (70%) of the lowest Closing Price for the five (5) trading days immediately preceding written receipt by the Company of the holder’s intent to convert.

“CLOSING PRICE" shall mean the closing bid price for the Company’s common stock on the Principal Market on a Trading Day as reported by Bloomberg Finance L.P.

“PRINCIPAL MARKET" shall mean the principal trading exchange or market for the Company’s common stock.

“TRADING DAY” shall mean a day on which the Principal Market shall be open for business.

The issuance of 75,000 shares of the Company’s nonvoting convertible preferred stock to Southridge resulted in recognition of a beneficial conversion feature in the amount of $32,142.Accordingly, the Company recorded a deemed dividend on the 75,000 shares of the Company’s nonvoting convertible preferred stock of $32,142.

NOTE 12. DIVIDEND OF SERIES B PREFERRED SHARES

On March 6, 2012 a dividend of 3, 201,397 shares of Series B Preferred Stock was paid to the Company’s common shareholders of record as of February 21, 2012.

NOTE 13. STOCKHOLDERS EQUITY

The stockholders' equity section of the Company contains the following classes of capital stock as of August 31, 2012:

Common Stock:

$0.001 par value, 1,000,000,000 shares authorized 222,791,778 shares issued and outstanding as of August 31, 2012.

Preferred Stock:

$0.001 par value 5,000,000 shares authorized of 100,000 shares authorized is authorized as Series AA Preferred Stock , $001 par value of which 5,000 shares are issued and outstanding as of February 29, 2012 and 4,400,000 is authorized as Series B Preferred Stock of which 3, 201,397 shares are issued and outstanding as of August 31, 2012.

Upon any liquidation, dissolution, or winding up of the Company, whether voluntary or involuntary (collectively, a “Liquidation”), before any distribution or payment shall be made to any of the holders of Common Stock or any other series of preferred stock, the holders of Series B Preferred Stock shall be entitled to receive out of the assets of the Company, whether such assets are capital, surplus or earnings, an amount equal to $0.10 per share of Series B Preferred Stock (the “Liquidation Amount”) plus all declared and unpaid dividends thereon, for each share of Series B Preferred Stock held by them.

If, upon any Liquidation, the assets of the Company shall be insufficient to pay the Liquidation Amount, together with declared and unpaid dividends thereon, in full to all holders of Series B Preferred Stock, then the entire net assets of the Company shall be distributed among the holders of the Series B Preferred Stock, ratably in proportion to the full amounts to which they would otherwise be respectively entitled and such distributions may be made in cash or in property taken at its fair value (as determined in good faith by the Board), or both, at the election of the Board..

Non Voting Convertible Preferred Stock having a $1.00 par value:

200,000 shares authorized of which 75, 000 shares are issued and outstanding as of August 31, 2102.

Non Voting Convertible Preferred Stock shall convert at the option of the holder into shares of the corporation’s common stock at a conversion price equal to seventy percent (70%) of the lowest Closing Price for the five (5) trading days immediately preceding written receipt by the corporation of the holder’s intent to convert.

“CLOSING PRICE" shall mean the closing bid price for the corporation’s common stock on the Principal Market on a Trading Day as reported by Bloomberg Finance L.P.

“PRINCIPAL MARKET" shall mean the principal trading exchange or market for the corporation’s common stock.

“TRADING DAY” shall mean a day on which the Principal Market shall be open for business.

NOTE 14. CONVERTIBLE DEBENTURES

On May 20, 2011, the Company issued a convertible promissory note in the amount of $42,500 which was received May 26, 2011. The note bears an interest rate of eight percent (8%), matures on February 23, 2012 and may be converted after 180 days from execution of this note for shares of the Company’s common stock. The note may be converted at a forty two percent (42%) discount to the average of the lowest 3 closing bid prices of the common stock during the 10 trading days prior to the conversion date. The issuance of the note amounted in a beneficial conversion feature of $16,398 which has been amortized under the Interest Method. $42,500 of the principal amount due and $1700 in accrued interest has been converted into 1,012,425 shares of the common stock of the Company.

On July 5, 2011, the Company issued a convertible promissory note (the “Second Note”) in the principal amount of $37,500. The Second Note, which matures April 11, 2012, bears interest at the rate of 8% per annum. At any time after 180 days from the execution of the Second Note, the Second Note is convertible into shares of the Company’s common stock at the election of Asher at a conversion price equal to a 45% discount to the average of the 3 closing bid prices of the common stock during the 10 trading day period prior to conversion. The issuance of the note amounted in a beneficial conversion feature of $37,500 which is amortized under the Interest Method. $37,500 of the principal amount due and $1500 in accrued interest has been converted into 6,193,242 shares of the common stock of the Company.

On August 29, 2011, the Company issued a convertible promissory note (the “Third Note”) in the principal amount of $35,000. The Third Note, which matures May 25, 2012, bears interest at the rate of 8% per annum. At any time after 180 days from the execution of the Third Note, the Third Note is convertible into shares of the Company’s common stock at the election of Asher at a conversion price equal to a 45% discount to the average of the 3 closing bid prices of the common stock during the 10 trading day period prior to conversion. The issuance of the note amounted in a beneficial conversion feature of $35,000 which is amortized under the Interest Method. . $35,000 of the principal amount due and $1400 in accrued interest has been converted into 21,708,333 shares of the common stock of the Company.

On October 25, 2011, the Company issued a convertible promissory note in the amount of $32,500. The note bears an interest rate of eight percent (8%), matures on July 27, 2012 and may be converted after 180 days from execution of this note for shares of the Company’s common stock. The note may be converted at a fifty two percent (52%) discount to the average of the lowest 3 closing bid prices of the common stock during the 10 trading days prior to the conversion date. The issuance of the note amounted in a beneficial conversion feature of $7,634 which is amortized under the Interest Method. $32,500 of the principal amount due and $1300 in accrued interest has been converted into 24,635,165 shares of the common stock of the Company.

On December 19, 2011, the Company issued a convertible promissory note in the amount of $37,500. The note bears an interest rate of eight percent (8%), matures on September 21, 2012 and may be converted after 180 days from execution of this note for shares of the Company’s common stock. The note may be converted at a fifty two percent (52%) discount to the average of the lowest 3 closing bid prices of the common stock during the 10 trading days prior to the conversion date. The issuance of the note amounted in a beneficial conversion feature of $37,500 which is amortized under the Interest Method. The principal balance and $1,500 in accrued interest was satisfied by a payment of $57,647.

On December 20, 2011 the Company amended the terms of $30,000 in existing debt as follows:

(a) Due and payable December 31, 2012

(b) Simple interest of 10% from December 20, 2011 to the date the debt is fully converted or paid in full

The amendment of the note amounted in a beneficial conversion feature of $16,153 which was fully amortized by February 29, 2012. The entire principal balance of the convertible note was converted into 1,249,975 shares of the common stock of the Company prior to February 29, 2012.

On February 28, 2012 the Company amended the terms of $85,500 in existing principal indebtedness as well as 3,710 of interest accrued but unpaid to be as follows:

On June 15, 2012 the Company amended the terms of $102,349 in existing principal indebtedness as follows:

On August 21, 2012 the Company amended the terms of $59,000 in existing principal indebtedness as follows:

NOTE 16. STOCK TRANSACTIONS

During the twelve months ended August 31, 2012 the Company issued 113,695,700 Common Shares in satisfaction of $374,959 in debt and accrued interest.

During the twelve months ended August 31, 2012 the Company issued 3,272,000 Common Shares for services rendered valued at $171,750.

During the twelve months ended August 31, 2012 the Company issued 2,500,000 Common shares for acquisition of intangible assets valued at $700,000.

During the twelve months ended August 31, 2012 the Company issued 6,274,726 Common Shares valued at $23,868 pursuant to contractual obligations contained in certain convertible notes outstanding.

During the twelve months ended August 31, 2012 the Company issued 75,000 shares of its Non Voting Convertible Preferred Stock for services rendered valued at $75,000.

On December 26, 2011 an employee of the Company consented to the cancellation of 15,000 common shares previously issued as compensation.

On December 29, 2011 75,000 common shares previously issued to the company’s former Chief Financial Officer were returned for cancellation by the Company. Of that amount 40,000 were subject to forfeiture and are cancelled pursuant to those forfeiture provisions at the company’s option and the company’s former Chief Financial Officer has consented to cancellation of the remaining 35,000 common shares.

During the Quarter ended May 31, 2012 a dividend of 3, 201,397 shares of Series B Preferred Stock was paid to the Company’s common shareholders of record as of February 21, 2012.

On April 3, 2012 the Company issued 50,000,000 shares of common stock to David R. Koos, the Company’s Chief Executive Officer, as a restricted stock award (“Bonus Shares”).David Koos may not offer to sell, sell, transfer, pledge or otherwise dispose of the Bonus Shares prior to April 2, 2017 (“Restricted Period”). In the event that, prior to the expiration of the Restricted Period, David Koos voluntarily ceases to be employed at the Company or is terminated for cause the Shares shall be forfeited.

On April 3, 2012 the Company issued 27,000,000 shares of common stock to seven employees as a restricted stock award (“Bonus Shares”).No employee may offer to sell, sell, transfer, pledge or otherwise dispose of the Bonus Shares prior to April 2, 2017 (“Restricted Period”).In the event that, prior to the expiration of the Restricted Period, any employee voluntarily ceases to be employed at the Company or is terminated for cause his or her Shares shall be forfeited.

On April 3, 2012 the Company issued 15,000,000 shares of common stock to a consultant as a restricted stock award (“Bonus Shares”).The recipient may not offer to sell, sell, transfer, pledge or otherwise dispose of the Shares prior to April 2, 2017 (“Restricted Period”). In the event that, prior to the expiration of the Restricted Period, the recipient declines to provide if requested to provide, or is unable to provide if requested to provide, consulting services to the Company of a nature that have been customarily provided by the recipient to the Company the Shares shall be forfeited.

On August 2, 2012 an employee of the Company consented to the cancelation of 15,000,000 common shares issued to her as a Restricted Stock Award.

NOTE 17. SUBSEQUENT EVENTS

Between September 4, 2012 and September 17, 2012 the Company sold 26,802,465 common shares to Southridge for the gross amount of $50,000 pursuant to the June Purchase Agreement.

On September 21 , 2012 the Company paid $20,000 of indebtedness due to Southridge.

On October 17, 2012 the Company issued 23,000,000 common shares in satisfaction of $19,320 of outstanding convertible indebtedness.

On October 17, 2012 the Company amended its certificate of incorporation in order to authorize 2,000,000,000 shares of Common Stock

On October 22, 2012 the Company issued 10,810,811 common shares in satisfaction of $8,000 of outstanding convertible indebtedness.

(1) All claims relating to the Complaint.

Assets disposed of pursuant to the Agreement also include

(i) Essentially all intellectual property, including computer software, utilized in connection with the operation of the McDonald Animal Hospital.

(iii) All customer lists, customer contacts, and any and all customer records that are related to the McDonald Animal Hospital.

Pursuant to the Agreement, the Company is obligated to make payment of $13,000 within five days of the Closing of the Agreement as such term is defined in the Agreement.

Item 9. Changes in and Disagreements with Accountants on Accounting and Financial Disclosure

(a) On September 27, 2012 the Board of Directors of . (the “Registrant” or the “Company”) approved of the dismissal of John Kinross-Kennedy, CPA (“Kennedy”) as the Registrant’s independent registered public accounting firm.

Kennedy’s report of the Company’s financial statements for the fiscal years ended August 31, 2011 and August 31, 2010 did not contain any adverse opinion or disclaimer of opinion, nor was modified as to uncertainty, audit scope, or accounting principles. The audit reports prepared by Kennedy for the fiscal years ending August 31, 2011 and August 31, 2010 contained a paragraph with respect to the Company's ability to continue as a going concern.

During the Registrant's two most recent fiscal years and the subsequent interim periods thereto there were no disagreements with Kennedy, whether or not resolved, on any matter of accounting principles or practices, financial statement disclosure, or auditing scope or procedure, which, if not resolved to Kennedy’s satisfaction, would have caused it to make reference to the subject matter of the disagreement in connection with its report on the Registrant's financial statements.

On September 27, 2012, the Board of Directors of the Registrant, acting as the Registrant's Audit Committee, approved the engagement of Anton and Chia, LLP as its independent auditor. On same date, September 27, 2012, the accounting firm of Anton and Chia, LLP was engaged as the Registrant's new independent registered public accounting firm.

(b) On December 4, 2012 the Board of Directors of Entest BioMedical, Inc. (the “Registrant” or the “Company”) approved of the dismissal of Anton and Chia, LLP (“Anton”) as the Registrant’s independent registered public accounting firm.

Since September 27, 2012 (the date on which Anton has been engaged as the Registrant’s independent registered public accounting firm) Anton has neither reviewed nor completed an audit of any of the financial statements of the Registrant. Therefore, no reports of Anton on the Registrant’s financial statements for either of the past two years or subsequent interim period contained an adverse opinion or disclaimer of opinion, or was qualified or modified as to uncertainty, audit scope or accounting principles as no such reports have been prepared. The Company disagreed with the conclusion arrived at by Anton while performing audit procedures for the year ended August 31, 2012 that the Company had not appropriately accounted for the conversion features of convertible notes payable and that the Company had not appropriately accounted for certain equity transactions. The accounting treatment for the conversion features of convertible notes payable was discussed by Anton and the sole Director of the Company and the Company has authorized Anton to respond fully to the inquiries of the successor accountant concerning the subject matter of all disagreements.

On December 4, 2012, the Board of Directors of the Registrant, acting as the Registrant's Audit Committee, approved the engagement of Seale and Beers, Certified Public Accountants LLC (“S&B”) as its independent auditor. On same date, December 4, 2012, the accounting firm of S&B was engaged as the Registrant's new independent registered public accounting firm.

Item 9A. Controls and Procedures

a) Evaluation of disclosure controls and procedures.

The principal executive officer and principal financial officer have evaluated the Company’s disclosure controls and procedures as of August 31, 2012. Based on this evaluation, they have concluded that the disclosure controls and procedures were effective to ensure that the information required to be disclosed by the Company in the reports that it files or submits under the Securities Exchange Act of 1934 is recorded, processed, summarized and reported, within the time periods specified in the Commission’s rules and forms and to ensure that information required to be disclosed by the Company in the reports that it files or submits under the Securities Exchange Act of 1934 is accumulated and communicated to the Company’s management, including its principal executive and principal financial officers, or persons performing similar functions, as appropriate to allow timely decisions regarding required disclosure. David Koos is the Company’s CEO and acting CFO. He functions as the Company’s principal executive officer and principal financial officer.

b) Management’s annual report on internal control over financial reporting.

Management of the Company is responsible for establishing and maintaining adequate internal control over financial reporting as defined in Rule 13a-15(f) promulgated under the Securities and Exchange Act of 1934. Rule 13a-15(f) defines internal control over financial reporting as follows:

“The term internal control over financial reporting is defined as a process designed by, or under the supervision of, the issuer's principal executive and principal financial officers, or persons performing similar functions, and effected by the issuer's board of directors, management and other personnel, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles and includes those policies and procedures that:

Pertain to the maintenance of records that in reasonable detail accurately and fairly reflect the transactions and dispositions of the assets of the issuer;

Provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the issuer are being made only in accordance with authorizations of management and directors of the issuer; and

Provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use or disposition of the issuer's assets that could have a material effect on the financial statements.”

The Company’s internal control over financial reporting is a process designed under the supervision of the Company’s management to provide reasonable assurance regarding the reliability of financial reporting and the preparation of the Company’s financial statements for external purposes in accordance with U.S. generally accepted accounting principles.

In designing and evaluating our disclosure controls and procedures, our management recognized that disclosure controls and procedures, no matter how well conceived and operated, can provide only a reasonable, not absolute, assurance that the objectives of the disclosure controls and procedures are met.

The Company’s management assessed the effectiveness of its internal control over financial reporting as of August 31, 2010 based on the framework in “Internal Control over Financial Reporting – Guidance for Smaller Public Companies (2006) issued by the Committee of Sponsoring Organizations of the Treadway Commission.” Based on its assessment, management believes that, as of August 31, 2010, the Company’s internal control over financial reporting is effective.

Management's report was not subject to attestation by the Company's registered public accounting firm pursuant to temporary rules of the Securities and Exchange Commission that permit the company to provide only management's report in this annual report. This exemption for smaller reporting companies provided under the temporary rules referenced above has been made permanent under Section 989G of the Dodd-Frank Wall Street Reform and Consumer Protection Act.

(c) There have been no changes during the quarter ended August 31, 2012 in the Company’s internal controls over financial reporting that have materially affected, or are reasonably likely to materially affect, internal control over financial reporting.

Item 10. Directors, Executive Officers and Corporate Governance

On June 19, 2009 the Board of Directors of the Company elected David R. Koos, 52, a director of the Company and appointed Dr. Koos President, Chief Executive Officer, Secretary, Chief Financial Officer, Principal Accounting Officer of the Company.

Dr. Koos resigned as Chief Financial Officer on March 31, 2010 and assumed the position of Acting Chief Financial Officer and Principal Accounting Officer on August 8, 2011 upon the resignation of Tammy L. Reynolds who served as Chief Financial Officer from the period from March 31, 2010 to August 8, 2011.

Dr. Koos has served as Chairman, CEO, President, Secretary, and Acting CFO of the BMSN since June 19, 2006, and as Chairman CEO, President, Secretary, and Acting CFO of Entest CA since August 22, 2008

education:

DBA - Finance (December 2003)

Atlantic International University

Ph.D. - Sociology (September 2003)

Atlantic International University

MA - Sociology (June 1983)

University of California - Riverside, California

Five Year Employment History:


Position:	Company Name:	Employment Dates:

Chairman, President, CEO and Acting CFO	Bio-Matrix Scientific Group, Inc.*	June 14, 2006 (Chairman) to Present June 19, 2006 (President, CEO and Acting CFO) June 19, 2006 (Secretary) to Present
Chairman, CEO, Secretary & Acting CFO	Frezer Inc.	May 2, 2005 to February 2007
Chairman, CEO & Acting CFO	BMXP Holdings, Inc.	December 6, 2004 to June 2008
Managing Director & President	Cell Source Research Inc.	December 5, 2001 to Present
Managing Director & President	Venture Bridge Inc.	November 21, 2001 to Present
Chairman of the Board of Directors, CFO & Secretary	Cell Bio-Systems Inc. (New York)	July 17, 2003 to December 1, 2003
Registered Representative	Amerivet Securities Inc.**	March 31, 2004 to February 2008

* As of January 28,2012 Bio-Matrix Scientific Group Inc. owned 10,000,000 common shares of the company

** Amerivet Securities Inc. has not been active during the period as the Chief Executive Officer was on deployment in Iraq through the U.S. Army Reserves.

Code of Ethics

On November 11, 2009 we adopted a Code of Ethics pursuant to Section 406 of the Sarbanes-Oxley Act of 2002

Director Independence

Audit Committee and Audit Committee Financial Expert

The sole member of the Company’s board of Directors may not be considered independent as he is also its sole officer. The Company is not a "listed company" under Securities and Exchange Commission (“SEC”) rules and is therefore not required to have an audit committee comprised of independent directors. The Company does not currently have an audit committee, however, for certain purposes of the rules and regulations of the SEC and in accordance with the Sarbanes-Oxley Act of 2002, the Company’s Board of Directors is deemed to be its audit committee and as such functions as an audit committee and performs some of the same functions as an audit committee including: (1) selection and oversight of our independent accountant; (2) establishing procedures for the receipt, retention and treatment of complaints regarding accounting, internal controls and auditing matters; and (3) engaging outside advisors. The Board of Directors has determined that its member is able to read and understand fundamental financial statements and has substantial business experience that results in that member's financial sophistication. Accordingly, the Board of Directors believes that its member has the sufficient knowledge and experience necessary to fulfill the duties and obligations that an audit committee would have.

Nominating and Compensation Committees

The Company does not have standing nominating or compensation committees, or committees performing similar functions. The board of directors believes that it is not necessary to have a compensation committee at this time because the functions of such committee are adequately performed by the board of directors. The board of directors also is of the view that it is appropriate for the Company not to have a standing nominating committee because the board of directors has performed and will perform adequately the functions of a nominating committee. The Company is not a "listed company" under SEC rules and is therefore not required to have a compensation committee or a nominating committee.

Shareholder Communications

There has not been any defined policy or procedure requirements for stockholders to submit recommendations or nomination for directors. There are no specific, minimum qualifications that the board of directors believes must be met by a candidate recommended by the board of directors. Currently, the entire board of directors decides on nominees, on the recommendation of any member of the board of directors followed by the board’s review of the candidates’ resumes and interview of candidates. Based on the information gathered, the board of directors then makes a decision on whether to recommend the candidates as nominees for director. The Company does not pay any fee to any third party or parties to identify or evaluate or assist in identifying or evaluating potential nominee.

Because management and the Board of Directors of the Company are the same people, the Board of Directors has determined not to adopt a formal methodology for communications from shareholders on the belief that any communication would be brought to the Board of Directors’ attention by virtue of the co-extensive capacities of the Board of Directors.

Executive Compensation

SUMMARY COMPENSATION TABLE


Name and Principal Position	Year	Salary ($)	Bonus ($)	Stock Awards ($)	Restricted Stock Awards ($)	Option Awards ($)	Non Equity Incentive Plan Compensation ($)	Nonqualified Deferred Compensation Earnings ($)	All Other Compensation ($)	Total ($)

David Koos Chairman, President and CEO	From September 1, 2011 to August 31, 2012	$120,000*	0	0	400,000*****	0	0	0	0	$520,000

David Koos Chairman, President and CEO	From September 1, 2010 to August 31, 2011	$208,000****	0	$2,000**	0	0	0	0	0	$210,558

Tammy Reynolds, Former CFO and Director (resigned from all positions with the Company effective August 8,2011	From September1, 2010 to August 31, 2011	$65,961	0	$47,000	$50,000***	0	0	0	0	$162,961

* Includes $102,000 in salary earned by David Koos which was accrued but unpaid for the fiscal year ended August 31, 2011

***** On April 3, 2012 the Company issued 50,000,000 shares of common stock to David R. Koos as a restricted stock award (“Bonus Shares”).

David Koos may not offer to sell, sell, transfer, pledge or otherwise dispose of the Bonus Shares prior to April 2, 2017 (“Restricted Period”).

In the event that, prior to the expiration of the Restricted Period, David Koos voluntarily ceases to be employed at the Company or is terminated for cause the Shares shall be forfeited.

** represents 5,000 shares of the Company’s Series AA Preferred Stock

**** Includes 190,558 in salary earned by David Koos which was accrued but unpaid for the fiscal year ended August 31, 2011

***The Company and Ms. Reynolds had agreed that Ms. Reynolds shall receive:

	a)	Compensation of $70,000 per annum for her services as Chief Financial Officer.
	b)	Fifty Thousand Dollars worth of the Common Shares of the Company (“Compensation Shares”) to be granted to Ms. Reynolds upon the completion of twelve months employment as CFO of the Company under the condition that80% of the Compensation Shares (“Restricted Comp Shares”) may not be sold, transferred, assigned, pledged or otherwise encumbered or disposed of by Ms. Reynolds (“Transfer Restriction”) except as follows:

Upon the expiration of one year from the date of the grant of the Compensation Shares, Transfer Restrictions shall no longer apply to 25% of the Restricted Comp Shares.

Upon the expiration of two years from the date of the grant of the Compensation Shares, Transfer Restrictions shall no longer apply to an additional 25% of the Restricted Comp Shares.

Upon the expiration of three years from the date of the grant of the Compensation Shares, Transfer Restrictions shall no longer apply to an additional 25% of the Restricted Comp Shares

Upon the expiration of four years from the date of the grant of the Compensation Shares, Transfer Restrictions shall no longer apply to an additional 25% of the Restricted Comp Shares.

As Ms. Reynolds is no longer employed as CFO of the Company, any Restricted Comp Shares still subject to Transfer Restrictions shall be forfeited by the Ms. Reynolds, and ownership of the Restricted Comp Shares shall be transferred back to the Company. As such, 80% of the restricted Stock Award paid to Ms Reynolds during the fiscal year ended August 31, 2011 is subject to forfeiture. Ms. Reynolds is currently not party to a written employment agreement with the Company.

On December 29, 2011 75,000 common shares previously issued to Ms. Reynolds were returned for cancellation by the Company. Of that amount 40,000 were subject to forfeiture and were cancelled pursuant to those forfeiture provisions at the company’s option and Ms. Reynolds has consented to cancellation of the remaining 35,000 common shares.

Item 12. Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters

The following table sets forth information known to the Company with respect to the beneficial ownership of each class of the Company’s capital stock as of January 28, 2013 for (1) each person known by the Company to beneficially own more than 5% of each class of the Company’s voting securities, (2) each executive officer, (3) each of the Company’s directors and (4) all of the Company’s executive officers and directors as a group. As of November 1, 2011 the Company had 20,890, 501 common shares outstanding and 5,000 Series AA Preferred Shares outstanding

Based on 446,539,900 shares issued and outstanding as of August 9, 2012 (Except as otherwise indicated)


Title of Class	Name and Address of Beneficial Owner	Amount and Nature of Beneficial Owner	Percent of Class
Common	David R. Koos* C/o Entest Bio Medical Inc., Inc 4700 SPRING STREET, SUITE 203, LA MESA, CALIFORNIA, 91942	60,000,000	13.4%

Common	All Officers and Directors As a Group	60,000,000	13.4%

*Includes 10,000,000 common shares owned by Bio-Matrix Scientific Group, Inc. (David Koos is CEO, President and Chairman of Bio-Matrix Scientific Group, Inc.).

Based on 3,201,397 shares issued and outstanding as of January 28, 2012


Title of Class	Name and Address of Beneficial Owner	Amount and Nature of Beneficial Owner	Percent of Class



Series B Preferred	David R. Koos* C/o Entest Bio Medical Inc., Inc 4700 SPRING STREET, SUITE 203, LA MESA, CALIFORNIA, 91942	1250000	39%

Series B Preferred	National Financial Services, LLC 200 Liberty Street New York NY 10281	201,585	6.2%
Series B Preferred	Sleezer family Trust c/o Charles Sleezer 12550 Carson Street Hawaiian Gardens, CA	687,500	21.4%
Series B Preferred	Ronald J. Titterington and Kathy Snell 3880 W 11th Street Eugene Oregon	312,500	9.7%
Series B Preferred	All Officers and Directors as a Group*	1250000	39%

*Includes 1,250,000 Series B Preferred shares owned by Bio-Matrix Scientific Group, Inc. (David Koos is CEO, President and Chairman of Bio-Matrix Scientific Group, Inc.).

Based on 5,000 shares issued and outstanding as of January 28, 2012


Title of Class	Name and Address of Beneficial Owner	Amount and Nature of Beneficial Owner	Percent of Class
Series AA Preferred Shares	David R. Koos C/o Entest Bio Medical Inc., Inc 4700 SPRING STREET, SUITE 203, LA MESA, CALIFORNIA, 91942	5,000	100%
Series AA Preferred Shares	All Officers and Directors As a Group	5,000	100%

Based on 75,000 shares issued and outstanding as of January 28, 2012

Item 13. Certain Relationships and Related Transactions, and Director Independence

Director Independence

Audit Committee and Audit Committee Financial Expert

The Company’s sole director may not be considered independent as he is also an officer. The Company is not a "listed company" under Securities and Exchange Commission (“SEC”) rules and is therefore not required to have an audit committee comprised of independent directors. The Company does not currently have an audit committee, however, for certain purposes of the rules and regulations of the SEC and in accordance with the Sarbanes-Oxley Act of 2002, the Company’s Board of Directors is deemed to be its audit committee and as such functions as an audit committee and performs some of the same functions as an audit committee including: (1) selection and oversight of our independent accountant; (2) establishing procedures for the receipt, retention and treatment of complaints regarding accounting, internal controls and auditing matters; and (3) engaging outside advisors. The Board of Directors has determined that its sole member is able to read and understand fundamental financial statements and has substantial business experience that results in the member's financial sophistication. Accordingly, the Board of Directors believes that its member has the sufficient knowledge and experience necessary to fulfill the duties and obligations that an audit committee would have.

Nominating and Compensation Committees

The Company does not have standing nominating or compensation committees, or committees performing similar functions. The Board of Directors believes that it is not necessary to have a compensation committee at this time because the functions of such committee are adequately performed by the board of directors. The Board of Directors also is of the view that it is appropriate for the Company not to have a standing nominating committee because the Board of Directors has performed and will perform adequately the functions of a nominating committee. The Company is not a "listed company" under SEC rules and is therefore not required to have a compensation committee or a nominating committee.

Shareholder Communications

The Board of Directors has determined not to adopt a formal methodology for communications from shareholders on the belief that any communication would be brought to the board of directors’ attention by virtue of communication with management

Item 14. Principal Accounting Fees and Services

The following table sets forth the aggregate fees billed to us by John Kinross-Kennedy, CPA during the period beginning September 1, 2010 and ending August 31, 2011:

Audit Fees	$	4,600
Audit Related Fees		400
Tax Fees		0
All Other Fees		2,800
	$	7,800

Audit Fees: Aggregate fees billed for professional services rendered for the audit of the Company's annual financial statements.

Audit Related Fees: Aggregate fees billed for professional services rendered for assurance and related services that were reasonably related to the performance of the audit or review of our financial statements and are not reported under “Audit Fees” above. In 2010 these fees were primarily derived from review of financial statements in the Company's Form 10Q Reports.

All Other Fees: Audit of the financial statements of Pet Pointers, Inc.

The following table sets forth the aggregate fees billed to us by John Kinross-Kennedy, CPA during the period beginning September 1, 2011 and ending August 31, 2012:

Audit Fees	$	4,000
Audit Related Fees		1,300
Tax Fees		0

	$	5,300

Audit Fees: Aggregate fees billed for professional services rendered for the audit of the Company's annual financial statements.

Audit Related Fees: Aggregate fees billed for professional services rendered for assurance and related services that were reasonably related to the performance of the audit or review of our financial statements and are not reported under “Audit Fees” above. In 2012 these fees were primarily derived from review of financial statements in the Company's Form 10Q Reports.

All services listed were pre-approved by the Board of Directors, functioning as the Audit Committee in accordance with Section 2(a) 3 of the Sarbanes-Oxley Act of 2002.

The Board has considered whether the services described above are compatible with maintaining the independent accountant's independence and has determined that such services have not adversely affected the independence John Kinross-Kennedy.

Item 15. Exhibit Index

EXHIBIT INDEX

Exhibit No.	Description
3(i)(a)	Articles of Incorporation
3(ii)(b)	Bylaws
10.1 ( c)	Agreement by and Between David Koos and the Company
10.2 (Incorporated by Reference to Exhibit 10.2 of the Company’s Form S-1 filed June 12, 2012)	Terms of Employment Agreement by and between the Company and Tammy Reynolds
10.3 (d)	August 2010 Agreement by and between the Company and TheraCyte, Inc.
10.3 (e)	Asset Purchase Agreement by and between the Company, Dr. Gregory McDonald and Pet Pointers
10.4 (f)	Exhibit A to Asset Purchase Agreement by and between the Company, Dr. Gregory McDonald and Pet Pointers
10.5 (g)	Exhibit B to Asset Purchase Agreement by and between the Company, Dr. Gregory McDonald and Pet Pointers
10.6 (h)	CRO Agreement by and between the Company and RenovoCyte LLC
3(i)(2)(i)	Certificate of Designations Series AA Preferred Stock
10.7(j)	8% ASHER NOTE $42,500
10.8(k)	8% ASHER NOTE $37,500
10.9(l)	8% ASHER NOTE $35,000
10.10(m)	8% ASHER NOTE $32,500
3(i)(3) (n)	Amendment to Certificate of Incorporation dated June 4, 2009
3(ii)(2) (o)	Bylaws of Entest BioMedical, inc., a California corporation and wholly owned subsidiary of the Registrant
3(i)(4) (p)	Certificate of Incorporation of Entest BioMedical, inc., a California corporation and wholly owned subsidiary of the Registrant
10.11(q)	8% ASHER NOTE $37,500
3(i)(5) ( r)	Certificate of Designations Series B Preferred Stock
3(i) (6)(s)	Amendment to Certificate of Incorporation
10.12 (t)	Equity purchase Agreement, Southridge Feb 27, 2012
10.13(u)	Registration Rights Agreement, Southridge
10.14(Incorporated by Reference to Exhibit 10.14 of the Company’s Form S-1 filed June 12, 2012)	Line of Credit Promissory Note December 1, 2010 Bio Technology Partners Business Trust
10.15(Incorporated by Reference to Exhibit 10.15 of the Company’s Form S-1 filed June 12, 2012)	Line of Credit Promissory Note December 1, 2010 Venture Bridge Advisors, Inc.
10.16(Incorporated by Reference to Exhibit 10.16 of the Company’s Form S-1 filed June 12, 2012)	Line of Credit Promissory Note December 1, 2010 Bombardier Pacific ventures
10.17(Incorporated by Reference to Exhibit 10.17 of the Company’s Form S-1 filed June 12, 2012)	Line of Credit Promissory Note December 1, 2010 David Koos
3(i)(7) (v)	Amendment to Certificate of Incorporation
10.18(Incorporated by Reference to Exhibit 10.18 of the Company’s Form S-1 filed June 12, 2012)	Agreement amending terms of outstanding Debt by the Company
10.19(Incorporated by Reference to Exhibit 10.19 of the Company’s Form S-1 filed June 12, 2012)	Agreement amending terms of outstanding Debt by the Company
10.20(Incorporated by Reference to Exhibit 10.20 of the Company’s Form S-1 filed June 12, 2012)	Agreement amending terms of outstanding Debt by the Company
10.21(w)	Form of Bonus Share Agreement
5.1	Opinion Regarding Legality
14 (y)	Code of Ethics
10.24 (aaaa)	Assignment dated June 15, 2009 by and between Entest BioMedical, Inc. and Bio-Matrix Scientific Group, Inc.
10.22 (z)	Lease
3(i)(8) (aa)	Text of Amendment to Certificate of Incorporation
10.23(aaa)	8% ASHER NOTE $42,500
10.24 (aaaa)	Assignment dated June 15, 2009 by and between Entest BioMedical, Inc. and Bio-Matrix Scientific Group, Inc.
10.25(Incorporated by Reference to Exhibit 10.25 of the Company’s Form S-1 filed June 12, 2012)	Advisory Board Letter Agreement
10.26 (aaaaa)	Equity Purchase Agreement Southridge June 1 2012
10.27(Incorporated by Reference to Exhibit 10.27 of the Company’s Form S-1 filed June 12, 2012)	Amendment to Registration Rights Agreement
10.28(Incorporated by Reference to Exhibit 10.28 of the Company’s Form S-1 filed June 12, 2012)	Termination Letter February 27 Equity Purchase Agreement

Exhibit No.	Description
10.29(zzzzzzzz1)	AGREEMENT AMENDING TERMS OF OUTSTANDING DEBT BY THE COMPANY
10.30(zzzzzzzz2)	AGREEMENT AMENDING TERMS OF OUTSTANDING DEBT BY THE COMPANY
10.31(zzzzzzzz3)	AGREEMENT AMENDING TERMS OF OUTSTANDING DEBT BY THE COMPANY
10.32(zzzzzzzz4)	AGREEMENT AMENDING TERMS OF OUTSTANDING DEBT BY THE COMPANY
10.33(zzzzzzzz5)	AGREEMENT AMENDING TERMS OF OUTSTANDING DEBT BY THE COMPANY
10.34(zzzzzzzz6)	AGREEMENT AMENDING TERMS OF OUTSTANDING DEBT BY THE COMPANY
10.35 ( incorporated by Reference to Exhibit 10.35 of the company’s amended Form S-1 Filed August 17,2012)	ASHER NOTE $63,000
10.36( incorporated by Reference to Exhibit 10.36 of the company’s amended Form S-1 Filed August 17,2012)	TERMS OF COMPENSATION DAVID KOOS

10.38 (incorporated by reference to Exhibit 10.1 Of the Company’s 8-K filed December 12, 2012 )	Settlement Agreement with G. McDonald
3.i (8) (Incorporated by Reference to Exhibit 3 (i) of the Company’s 8-K filed October 19, 2012
10.39	Line of Credit Promissory Note Sherman family Trust
31.1	CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002
31.2	CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002
32.1	CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO 18 U.S.C. SECTION 1350 AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
32.2	CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO 18 U.S.C. SECTION 1350 AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

(a)	Incorporated by Reference to Exhibit 3(1) of the Company's Form S-1 Filed November 4, 2008
(b)	Incorporated by Reference to Exhibit 3(2) of the Company's Form S-1 Filed November 4, 2008
(c)	Incorporated by Reference to Exhibit 10(1) of the Company's Form10-K Filed November 17, 2009
(d)	Incorporated by Reference to Exhibit 10(1) of the Company's Form10-K Filed November 16, 2010
(e)	Incorporated by Reference to Exhibit 10(1) of the Company's Form 8-K Filed December 17, 2010
(f)	Incorporated by Reference to Exhibit 10(2) of the Company's Form 8-K Filed December 17, 2010
(g)	Incorporated by Reference to Exhibit 10(3) of the Company's Form 8-K Filed December 17, 2010
(h)	Incorporated by Reference to Exhibit 10(3) of the Company's Form 8-K Filed October 24, 2011
(i)	Incorporated by Reference to Exhibit 3(i) of the Company's Form 8-K Filed June 10, 2011
(j)	Incorporated by Reference to Exhibit 10(9) of the Company's Form 10-K filed November 3 2011
(k)	Incorporated by Reference to Exhibit 10(10) of the Company's Form 10-K filed November 3 2011
(l)	Incorporated by Reference to Exhibit 10(11) of the Company's Form 10-K filed November 3 2011
(m)	Incorporated by Reference to Exhibit 10(12) of the Company's Form 10-K filed November 3 2011
(n)	Incorporated by Reference to Exhibit 3(i) (2)of the Company's Form 8-K Filed June 10, 2011
(o)	Incorporated by Reference to Exhibit 3(ii) of the Company's Form 8-K Filed June 10, 2011
(p)	Incorporated by Reference to Exhibit 3(i) of the Company's Form 8-K Filed June 10, 2011
(q)	Incorporated by Reference to Exhibit 10.1 of the Company's Form 10-Q Filed January 11, 2012
( r)	Incorporated by Reference to Exhibit 3(i) of the Company's Form 8-K Filed February 9, 2012
(s)	Incorporated by Reference to Exhibit (3)(i) of the Company's Form 10-Q Filed February 9, 2012
(t)	Incorporated by Reference to Exhibit 10.1 of the Company's Form 10-Q Filed February 9, 2012
(u)	Incorporated by Reference to Exhibit 10.2 of the Company's Form 10-Q Filed February 9, 2012
(v)	Incorporated by Reference to Exhibit 3(i) of the Company's Form 8-K Filed March 22, 2012
(w)	Incorporated by Reference to Exhibit 10.1 of the Company's Form 8-K Filed April 5, 2012
(x)	Filed as Exhibit 5.1
(y)	Incorporated by Reference to Exhibit 14 of the Company's Form10-K Filed November 17, 2009
(z)	Incorporated by Reference to Exhibit 10.1 of the Company's Form 10-Q Filed March 28, 2012
(aa)	Incorporated by Reference to Exhibit 3(i) of the Company's Form 8-K Filed April 25, 2012
(aaa)	Incorporated by Reference to Exhibit 10 of the Company's Form 8-K Filed April 25, 2012
(aaaa)	Incorporated by Reference to Exhibit 10.2 of the Company's Form 8-K Filed July 10, 2009
(aaaaa)	Incorporated by Reference to Exhibit 10.1 of the Company's Form 8-K Filed June 4, 2012

(zzzzzzzz1) Incorporated by Reference to Exhibit 10.1 of the Company's Form 10-Q Filed July 23, 2012

(zzzzzzzz2) Incorporated by Reference to Exhibit 10.2 of the Company's Form 10-Q Filed July 23, 2012

(zzzzzzzz3) Incorporated by Reference to Exhibit 10.3 of the Company's Form 10-Q Filed July 23, 2012

(zzzzzzzz4) Incorporated by Reference to Exhibit 10.4 of the Company's Form 10-Q Filed July 23, 2012

(zzzzzzzz5) Incorporated by Reference to Exhibit 10.5 of the Company's Form 10-Q Filed July 23, 2012

(zzzzzzzz6) Incorporated by Reference to Exhibit 10.6 of the Company's Form 10-Q Filed July 23, 2012

SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

			Entest BioMedical, Inc.

		By:	/s/ David R. Koos
			Name: David R. Koos
			Title: President, Chairman, Chief Executive Officer
			Date:

Pursuant to the requirements of the Securities Exchange Act of 1934, this Report has been signed below by the following persons on behalf of the Registrant and in the capacities indicated on February 1, 2013.

		By:	/s/ David R. Koos
			Name: David R. Koos
			Title: President, Chairman of the Board of Directors, Chief Executive Officer, Acting Chief Financial Officer
			Date:

EX-31.1 2 entb0129form10kex311.htm EXHIBIT 31.1

EXHIBIT 31.1

CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO

SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, David R. Koos, certify that:

I have reviewed this annual report on Form 10-K for the YEAR ended August 31, 2012 of Entest BioMedical, Inc.;

Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal controls over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a)

Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant’s, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b)

Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles:

(c)

Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d)

Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of registrant’s board of directors (or persons performing the equivalent function):

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: February 1, 2013

/s/ David R. Koos

David R. Koos

Chief Executive Officer

EX-31.2 3 entb0129form10kex312.htm EXHIBIT 31.2

EXHIBIT 31.2

CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO

SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, David R. Koos, certify that:

I have reviewed this annual report on Form 10-K for the YEAR ended August 31, 2012 of Entest BioMedical, Inc.;

(a)

(b)

(c)

(d)

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: February 1, 2013

/s/ David Koos

David R. Koos

Acting Chief Financial Officer

EX-32.1 4 entb0129form10kex321.htm EXHIBIT 32.1

EXHIBIT 32.1

CERTIFICATION OF CHIEF EXECUTIVE OFFICER

PURSUANT TO 18 U.S.C. SECTION 1350

AS ADOPTED PURSUANT TO SECTION 906

OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Annual Report of Entest BioMedical, Inc. on Form 10-K for the year ended August 31, 2012 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, David R. Koos, Chief Executive Officer certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to the best of my knowledge and belief:

(1)

The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 and

(2)

The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Dated: February 1, 2013	/s/ David R. Koos
	David R. Koos
	Chief Executive Officer

EX-32.2 5 entb0129form10kex322.htm EXHIBIT 32.2

EXHIBIT 32.2

CERTIFICATION OF CHIEF FINANCIAL OFFICER

PURSUANT TO 18 U.S.C. SECTION 1350

AS ADOPTED PURSUANT TO SECTION 906

OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Annual Report of Entest BioMedical, Inc. on Form 10-K for the year ended August 31, 2012 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, David R. Koos, Chief Financial Officer certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to the best of my knowledge and belief:

(1)

The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 and

(2)

The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Dated: February 1, 2013	/s/ David R. Koos
	David R. Koos
	Chief Financial Officer

EX-10.37 6 entb0129form10kex1037.htm EXHIBIT 10.37

EXHIBIT 10.37

NEITHER THE ISSUANCE AND SALE OF THE SECURITIES REPRESENTED BY THIS CERTIFICATE NOR THE SECURITIES INTO WHICH THESE SECURITIES ARE CONVERTIBLE HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS. THE SECURITIES MAY NOT BE OFFERED FOR SALE, SOLD, TRANSFERRED OR ASSIGNED (I) IN THE ABSENCE OF (A) AN EFFECTIVE REGISTRATION STATEMENT FOR THE SECURITIES UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR (B) AN OPINION OF COUNSEL (WHICH COUNSEL SHALL BE SELECTED BY THE HOLDER), IN A GENERALLY ACCEPTABLE FORM, THAT REGISTRATION IS NOT REQUIRED UNDER SAID ACT OR (II) UNLESS SOLD PURSUANT TO RULE 144 OR RULE 144A UNDER SAID ACT. NOTWITHSTANDING THE FOREGOING, THE SECURITIES MAY BE PLEDGED IN CONNECTION WITH A BONA FIDE MARGIN ACCOUNT OR OTHER LOAN OR FINANCING ARRANGEMENT SECURED BY THE SECURITIES.

Principal Amount: $63,000 Issue Date: September 21, 2012

Purchase Price: $63,000

CONVERTIBLE PROMISSORY NOTE

FOR VALUE RECEIVED, ENTEST BIOMEDICAL, INC., a Nevada corporation (hereinafter called the “Borrower”), hereby promises to pay to the order of ASHER ENTERPRISES, INC., a Delaware corporation, or registered assigns (the “Holder”) the sum of $63,000.00 together with any interest as set forth herein, on June 25, 2013 (the “Maturity Date”), and to pay interest on the unpaid principal balance hereof at the rate of eight percent (8%) (the “Interest Rate”) per annum from the date hereof (the “Issue Date”) until the same becomes due and payable, whether at maturity or upon acceleration or by prepayment or otherwise. This Note may not be prepaid in whole or in part except as otherwise explicitly set forth herein. Any amount of principal or interest on this Note which is not paid when due shall bear interest at the rate of twenty two percent (22%) per annum from the due date thereof until the same is paid (“Default Interest”). Interest shall commence accruing on the date that the Note is fully paid and shall be computed on the basis of a 365-day year and the actual number of days elapsed. All payments due hereunder (to the extent not converted into common stock, $0.001 par value per share (the “Common Stock”) in accordance with the terms hereof) shall be made in lawful money of the United States of America. All payments shall be made at such address as the Holder shall hereafter give to the Borrower by written notice made in accordance with the provisions of this Note. Whenever any amount expressed to be due by the terms of this Note is due on any day which is not a business day, the same shall instead be due on the next succeeding day which is a business day and, in the case of any interest payment date which is not the date on which this Note is paid in full, the extension of the due date thereof shall not be taken into account for purposes of determining the amount of interest due on such date. As used in this Note, the term “business day” shall mean any day other than a Saturday, Sunday or a day on which commercial banks in the city of New York, New York are authorized or required by law or executive order to remain closed. Each capitalized term used herein, and not otherwise defined, shall have the meaning ascribed thereto in that certain Securities Purchase Agreement dated the date hereof, pursuant to which this Note was originally issued (the “Purchase Agreement”).

This Note is free from all taxes, liens, claims and encumbrances with respect to the issue thereof and shall not be subject to preemptive rights or other similar rights of shareholders of the Borrower and will not impose personal liability upon the holder thereof.

The following terms shall apply to this Note:

ARTICLE I. CONVERSION RIGHTS

1.1 Conversion Right. The Holder shall have the right from time to time, and at any time during the period beginning on the date which is one hundred eighty (180) days following the date of this Note and ending on the later of: (i) the Maturity Date and (ii) the date of payment of the Default Amount (as defined in Article III) pursuant to Section 1.6(a) or Article III, each in respect of the remaining outstanding principal amount of this Note to convert all or any part of the outstanding and unpaid principal amount of this Note into fully paid and non- assessable shares of Common Stock, as such Common Stock exists on the Issue Date, or any shares of capital stock or other securities of the Borrower into which such Common Stock shall hereafter be changed or reclassified at the conversion price (the “Conversion Price”) determined as provided herein (a “Conversion”); provided, however, that in no event shall the Holder be entitled to convert any portion of this Note in excess of that portion of this Note upon conversion of which the sum of (1) the number of shares of Common Stock beneficially owned by the Holder and its affiliates (other than shares of Common Stock which may be deemed beneficially owned through the ownership of the unconverted portion of the Notes or the unexercised or unconverted portion of any other security of the Borrower subject to a limitation on conversion or exercise analogous to the limitations contained herein) and (2) the number of shares of Common Stock issuable upon the conversion of the portion of this Note with respect to which the determination of this proviso is being made, would result in beneficial ownership by the Holder and its affiliates of more than 4.99% of the outstanding shares of Common Stock. For purposes of the proviso to the immediately preceding sentence, beneficial ownership shall be determined in accordance with Section 13(d) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), and Regulations 13D-G thereunder, except as otherwise provided in clause (1) of such proviso, provided, further, however, that the limitations on conversion may be waived by the Holder upon, at the election of the Holder, not less than 61 days’ prior notice to the Borrower, and the provisions of the conversion limitation shall continue to apply until such 61st day (or such later date, as determined by the Holder, as may be specified in such notice of waiver). The number of shares of Common Stock to be issued upon each conversion of this Note shall be determined by dividing the Conversion Amount (as defined below) by the applicable Conversion Price then in effect on the date specified in the notice of conversion, in the form attached hereto as Exhibit A (the “Notice of Conversion”), delivered to the Borrower by the Holder in accordance with Section 1.4 below; provided that the Notice of Conversion is submitted by facsimile or e-mail (or by other means resulting in, or reasonably expected to result in, notice) to the Borrower before 6:00 p.m., New York, New York time on such conversion date (the “Conversion Date”). The term “Conversion Amount” means, with respect to any conversion of this Note, the sum of (1) the principal amount of this Note to be converted in such conversion plus (2) at the Borrower’s option, accrued and unpaid interest, if any, on such principal amount at the interest rates provided in this Note to the Conversion Date, plus (3) at the Borrower’s option, Default Interest, if any, on the amounts referred to in the immediately preceding clauses (1) and/or (2) plus (4) at the Holder’s option, any amounts owed to the Holder pursuant to Sections 1.3 and 1.4(g) hereof.

1.2 Conversion Price.

(a) Calculation of Conversion Price. The conversion price (the “Conversion Price”) shall equal the Variable Conversion Price (as defined herein) (subject to equitable adjustments for stock splits, stock dividends or rights offerings by the Borrower relating to the Borrower’s securities or the securities of any subsidiary of the Borrower, combinations, recapitalization, reclassifications, extraordinary distributions and similar events). The "Variable Conversion Price" shall mean 61% multiplied by the Market Price (as defined herein) (representing a discount rate of 39%). “Market Price” means the average of the lowest three (3) Trading Prices (as defined below) for the Common Stock during the ten (10) Trading Day period ending on the latest complete Trading Day prior to the Conversion Date. “Trading Price” means, for any security as of any date, the closing bid price on the Over-the-Counter Bulletin Board, or applicable trading market (the “OTCQB”) as reported by a reliable reporting service (“Reporting Service”) designated by the Holder (i.e. Bloomberg) or, if the OTCQB is not the principal trading market for such security, the closing bid price of such security on the principal securities exchange or trading market where such security is listed or traded or, if no closing bid price of such security is available in any of the foregoing manners, the average of the closing bid prices of any market makers for such security that are listed in the “pink sheets” by the National Quotation Bureau, Inc. If the Trading Price cannot be calculated for such security on such date in the manner provided above, the Trading Price shall be the fair market value as mutually determined by the Borrower and the holders of a majority in interest of the Notes being converted for which the calculation of the Trading Price is required in order to determine the Conversion Price of such Notes. “Trading Day” shallmean any day on which the Common Stock is tradable for any period on the OTCQB, or on the principal securities exchange or other securities market on which the Common Stock is then being traded.

(b) Conversion Price During Major Announcements. Notwithstanding anything contained in Section 1.2(a) to the contrary, in the event the Borrower (i) makes a public announcement that it intends to consolidate or merge with any other corporation (other than a merger in which the Borrower is the surviving or continuing corporation and its capital stock is unchanged) or sell or transfer all or substantially all of the assets of the Borrower or (ii) any person, group or entity (including the Borrower) publicly announces a tender offer to purchase 50% or more of the Borrower’s Common Stock (or any other takeover scheme) (the date of the announcement referred to in clause (i) or (ii) is hereinafter referred to as the “Announcement Date”), then the Conversion Price shall, effective upon the Announcement Date and continuing through the Adjusted Conversion Price Termination Date (as defined below), be equal to the lower of (x) the Conversion Price which would have been applicable for a Conversion occurring on the Announcement Date and (y) the Conversion Price that would otherwise be in effect. From and after the Adjusted Conversion Price Termination Date, the Conversion Price shall be determined as set forth in this Section 1.2(a). For purposes hereof, “Adjusted Conversion Price Termination Date” shall mean, with respect to any proposed transaction or tender offer (or takeover scheme) for which a public announcement as contemplated by this Section 1.2(b) has been made, the date upon which the Borrower (in the case of clause (i) above) or the person, group or entity (in the case of clause (ii) above) consummates or publicly announces the termination or abandonment of the proposed transaction or tender offer (or takeover scheme) which caused this Section 1.2(b) to become operative.

1.3 Authorized Shares. The Borrower covenants that during the period the conversion right exists, the Borrower will reserve from its authorized and unissued Common Stock a sufficient number of shares, free from preemptive rights, to provide for the issuance of Common Stock upon the full conversion of this Note issued pursuant to the Purchase Agreement. The Borrower is required at all times to have authorized and reserved four and one half times the number of shares that is actually issuable upon full conversion of the Note (based on the Conversion Price of the Notes in effect from time to time) (the “Reserved Amount”). The Reserved Amount shall be increased from time to time in accordance with the Borrower’s obligations pursuant to Section 4(g) of the Purchase Agreement. The Borrower represents that upon issuance, such shares will be duly and validly issued, fully paid and non-assessable. In addition, if the Borrower shall issue any securities or make any change to its capital structure which would change the number of shares of Common Stock into which the Notes shall be convertible at the then current Conversion Price, the Borrower shall at the same time make proper provision so that thereafter there shall be a sufficient number of shares of Common Stock authorized and reserved, free from preemptive rights, for conversion of the outstanding Notes. The Borrower (i) acknowledges that it has irrevocably instructed its transfer agent to issue certificates for the Common Stock issuable upon conversion of this Note, and (ii) agrees that its issuance of this Note shall constitute full authority to its officers and agents who are charged with the duty of executing stock certificates to execute and issue the necessary certificates for shares of Common Stock in accordance with the terms and conditions of this Note.

If, at any time the Borrower does not maintain the Reserved Amount it will be considered an Event of Default under Section 3.2 of the Note.

1.4 Method of Conversion.

(a) Mechanics of Conversion. Subject to Section 1.1, this Note may be converted by the Holder in whole or in part at any time from time to time after the Issue Date, by (A) submitting to the Borrower a Notice of Conversion (by facsimile, e-mail or other reasonable means of communication dispatched on the Conversion Date prior to 6:00 p.m., New York, New York time) and (B) subject to Section 1.4(b), surrendering this Note at the principal office of the Borrower.

(b) Surrender of Note Upon Conversion. Notwithstanding anything to the contrary set forth herein, upon conversion of this Note in accordance with the terms hereof, the Holder shall not be required to physically surrender this Note to the Borrower unless the entire unpaid principal amount of this Note is so converted. The Holder and the Borrower shall maintain records showing the principal amount so converted and thedates of such conversions or shall use such other method, reasonably satisfactory to the Holder and the Borrower, so as not to require physical surrender of this Note upon each such conversion. In the event of any dispute or discrepancy, such records of the Borrower shall, prima facie, be controlling and determinative in the absence of manifest error. Notwithstanding the foregoing, if any portion of this Note is converted as aforesaid, the Holder may not transfer this Note unless the Holder first physically surrenders this Note to the Borrower, whereupon the Borrower will forthwith issue and deliver upon the order of the Holder a new Note of like tenor, registered as the Holder (upon payment by the Holder of any applicable transfer taxes) may request, representing in the aggregate the remaining unpaid principal amount of this Note. The Holder and any assignee, by acceptance of this Note, acknowledge and agree that, by reason of the provisions of this paragraph, following conversion of a portion of this Note, the unpaid and unconverted principal amount of this Note represented by this Note may be less than the amount stated on the face hereof.

(c) Payment of Taxes. The Borrower shall not be required to pay any tax which may be payable in respect of any transfer involved in the issue and delivery of shares of Common Stock or other securities or property on conversion of this Note in a name other than that of the Holder (or in street name), and the Borrower shall not be required to issue or deliver any such shares or other securities or property unless and until the person or persons (other than the Holder or the custodian in whose street name such shares are to be held for the Holder’s account) requesting the issuance thereof shall have paid to the Borrower the amount of any such tax or shall have established to the satisfaction of the Borrower that such tax has been paid.

(d) Delivery of Common Stock Upon Conversion. Upon receipt by the Borrower from the Holder of a facsimile transmission or e-mail (or other reasonable means of communication) of a Notice of Conversion meeting the requirements for conversion as provided in this Section 1.4, the Borrower shall issue and deliver or cause to be issued and delivered to or upon the order of the Holder certificates for the Common Stock issuable upon such conversion within three (3) business days after such receipt (the “Deadline”) (and, solely in the case of conversion of the entire unpaid principal amount hereof, surrender of this Note) in accordance with the terms hereof and the Purchase Agreement.

(e) Obligation of Borrower to Deliver Common Stock. Upon receipt by the Borrower of a Notice of Conversion, the Holder shall be deemed to be the holder of record of the Common Stock issuable upon such conversion, the outstanding principal amount and the amount of accrued and unpaid interest on this Note shall be reduced to reflect such conversion, and, unless the Borrower defaults on its obligations under this Article I, all rights with respect to the portion of this Note being so converted shall forthwith terminate except the right to receive the Common Stock or other securities, cash or other assets, as herein provided, on such conversion. If the Holder shall have given a Notice of Conversion as provided herein, the Borrower’s obligation to issue and deliver the certificates for Common Stock shall be absolute and unconditional, irrespective of the absence of any action by the Holder to enforce the same, any waiver or consent with respect to any provision thereof, the recovery of any judgment against any person or any action to enforce the same, any failure or delay in the enforcement of any other obligation of the Borrower to the holder of record, or any setoff, counterclaim, recoupment, limitation or termination, or any breach or alleged breach by the Holder of any obligation to the Borrower, and irrespective of any other circumstance which might otherwise limit such obligation of the Borrower to the Holder in connection with such conversion. The Conversion Date specified in the Notice of Conversion shall be the Conversion Date so long as the Notice of Conversion is received by the Borrower before 6:00 p.m., New York, New York time, on such date.

(f) Delivery of Common Stock by Electronic Transfer. In lieu of delivering physical certificates representing the Common Stock issuable upon conversion, provided the Borrower is participating in the Depository Trust Company (“DTC”) Fast Automated Securities Transfer (“FAST”) program, upon request of the Holder and its compliance with the provisions contained in Section 1.1 and in this Section 1.4, the Borrower shall use its best efforts to cause its transfer agent to electronically transmit the Common Stock issuable upon conversion to the Holder by crediting the account of Holder’s Prime Broker with DTC through its Deposit Withdrawal Agent Commission (“DWAC”) system.

(g) Failure to Deliver Common Stock Prior to Deadline. Without in any way limiting the Holder’s right to pursue other remedies, including actual damages and/or equitable relief, the parties agree that if delivery of the Common Stock issuable upon conversion of this Note is not delivered by the Deadline (other than a failure due to the circumstances described in Section 1.3 above, which failure shall be governed by such Section) the Borrower shall pay to the Holder $2,000 per day in cash, for each day beyond the Deadline that the Borrower fails to deliver such Common Stock. Such cash amount shall be paid to Holder by the fifth day of the month following the month in which it has accrued or, at the option of the Holder (by written notice to the Borrower by the first day of the month following the month in which it has accrued), shall be added to the principal amount of this Note, in which event interest shall accrue thereon in accordance with the terms of this Note and such additional principal amount shall be convertible into Common Stock in accordance with the terms of this Note. The Borrower agrees that the right to convert is a valuable right to the Holder. The damages resulting from a failure, attempt to frustrate, interference with such conversion right are difficult if not impossible to qualify. Accordingly the parties acknowledge that the liquidated damages provision contained in this Section 1.4(g) are justified.

1.5 Concerning the Shares. The shares of Common Stock issuable upon conversion of this Note may not be sold or transferred unless (i) such shares are sold pursuant to an effective registration statement under the Act or (ii) the Borrower or its transfer agent shall have been furnished with an opinion of counsel (which opinion shall be in form, substance and scope customary for opinions of counsel in comparable transactions) to the effect that the shares to be sold or transferred may be sold or transferred pursuant to an exemption from such registration or (iii) such shares are sold or transferred pursuant to Rule 144 under the Act (or a successor rule) (“Rule 144”) or (iv) such shares are transferred to an “affiliate” (as defined in Rule 144) of the Borrower who agrees to sell or otherwise transfer the shares only in accordance with this Section 1.5 and who is an Accredited Investor (as defined in the Purchase Agreement). Except as otherwise provided in the Purchase Agreement (and subject to the removal provisions set forth below), until such time as the shares of Common Stock issuable upon conversion of this Note have been registered under the Act or otherwise may be sold pursuant to Rule 144 without any restriction as to the number of securities as of a particular date that can then be immediately sold, each certificate for shares of Common Stock issuable upon conversion of this Note that has not been so included in an effective registration statement or that has not been sold pursuant to an effective registration statement or an exemption that permits removal of the legend, shall bear a legend substantially in the following form, as appropriate:

“NEITHER THE ISSUANCE AND SALE OF THE SECURITIES REPRESENTED BY THIS CERTIFICATE NOR THE SECURITIES INTO WHICH THESE SECURITIES ARE EXERCISABLE HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS. THE SECURITIES MAY NOT BE OFFERED FOR SALE, SOLD, TRANSFERRED OR ASSIGNED (I) IN THE ABSENCE OF (A) AN EFFECTIVE REGISTRATION STATEMENT FOR THE SECURITIES UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR (B) AN OPINION OF COUNSEL (WHICH COUNSEL SHALL BE SELECTED BY THE HOLDER), IN A GENERALLY ACCEPTABLE FORM, THAT REGISTRATION IS NOT REQUIRED UNDER SAID ACT OR (II) UNLESS SOLD PURSUANT TO RULE 144 OR RULE 144A UNDER SAID ACT. NOTWITHSTANDING THE FOREGOING, THE SECURITIES MAY BE PLEDGED IN CONNECTION WITH A BONA FIDE MARGIN ACCOUNT OR OTHER LOAN OR FINANCING ARRANGEMENT SECURED BY THE SECURITIES.”

The legend set forth above shall be removed and the Borrower shall issue to the Holder a new certificate therefore free of any transfer legend if (i) the Borrower or its transfer agent shall have received an opinion of counsel, in form, substance and scope customary for opinions of counsel in comparable transactions, to the effect that a public sale or transfer of such Common Stock may be made without registration under the Act, which opinion shall be accepted by the Company so that the sale or transfer is effected or (ii) in the case of the Common Stock issuable upon conversion of this Note, such security is registered for sale by the Holder under an effective registration statement filed under the Act or otherwise may be sold pursuant to Rule 144 without any restriction as to the number of securities as of a particular date that can then be immediately sold. In the event that the Company does not accept the opinion of counsel provided by the Buyer with respect to the transfer of Securities pursuant to an exemption from registration, such as Rule

144 or Regulation S, at the Deadline, it will be considered an Event of Default pursuant to Section 3.2 of the Note.

1.6 Effect of Certain Events.

(a) Effect of Merger, Consolidation, Etc. At the option of the Holder, the sale, conveyance or disposition of all or substantially all of the assets of the Borrower, the effectuation by the Borrower of a transaction or series of related transactions in which more than 50% of the voting power of the Borrower is disposed of, or the consolidation, merger or other business combination of the Borrower with or into any other Person (as defined below) or Persons when the Borrower is not the survivor shall either: (i) be deemed to be an Event of Default (as defined in Article III) pursuant to which the Borrower shall be required to pay to the Holder upon the consummation of and as a condition to such transaction an amount equal to the Default Amount (as defined in Article III) or (ii) be treated pursuant to Section 1.6(b) hereof. “Person” shall mean any individual, corporation, limited liability company, partnership, association, trust or other entity or organization. Any transaction relating to a potential merger with veterinary hospitals will not be considered an Event of Default under the Note or Purchase agreement, provided that the Borrower maintains controls of the merged company.

(b) Adjustment Due to Merger, Consolidation, Etc. If, at any time when this Note is issued and outstanding and prior to conversion of all of the Notes, there shall be any merger, consolidation, exchange of shares, recapitalization, reorganization, or other similar event, as a result of which shares of Common Stock of the Borrower shall be changed into the same or a different number of shares of another class or classes of stock or securities of the Borrower or another entity, or in case of any sale or conveyance of all or substantially all of the assets of the Borrower other than in connection with a plan of complete liquidation of the Borrower, then the Holder of this Note shall thereafter have the right to receive upon conversion of this Note, upon the basis and upon the terms and conditions specified herein and in lieu of the shares of Common Stock immediately theretofore issuable upon conversion, such stock, securities or assets which the Holder would have been entitled to receive in such transaction had this Note been converted in full immediately prior to such transaction (without regard to any limitations on conversion set forth herein), and in any such case appropriate provisions shall be made with respect to the rights and interests of the Holder of this Note to the end that the provisions hereof (including, without limitation, provisions for adjustment of the Conversion

Price and of the number of shares issuable upon conversion of the Note) shall thereafter be applicable, as nearly as may be practicable in relation to any securities or assets thereafter deliverable upon the conversion hereof. The Borrower shall not affect any transaction described in this Section 1.6(b) unless (a) it first gives, to the extent practicable, thirty (30) days prior written notice (but in any event at least fifteen (15) days prior written notice) of the record date of the special meeting of shareholders to approve, or if there is no such record date, the consummation of, such merger, consolidation, exchange of shares, recapitalization, reorganization or other similar event or sale of assets (during which time the Holder shall be entitled to convert this Note) and (b) the resulting successor or acquiring entity (if not the Borrower) assumes by written instrument the obligations of this Section 1.6(b). The above provisions shall similarly apply to successive consolidations, mergers, sales, transfers or share exchanges.

(c) Adjustment Due to Distribution. If the Borrower shall declare or make any distribution of its assets (or rights to acquire its assets) to holders of Common Stock as a dividend, stock repurchase, by way of return of capital or otherwise (including any dividend or distribution to the Borrower’s shareholders in cash or shares (or rights to acquire shares) of capital stock of a subsidiary (i.e., a spin-off)) (a “Distribution”), then the Holder of this Note shall be entitled, upon any conversion of this Note after the date of record for determining shareholders entitled to such Distribution, to receive the amount of such assets which would have been payable to the Holder with respect to the shares of Common Stock issuable upon such conversion had such Holder been the holder of such shares of Common Stock on the record date for the determination of shareholders entitled to such Distribution.

(d) Adjustment Due to Dilutive Issuance. If, at any time when any Notes are issued and outstanding, the Borrower issues or sells, or in accordance with this Section 1.6(d) hereof is deemed to have issued or sold, any shares of Common Stock for no consideration or for a consideration per share (before deduction of reasonable expenses or commissions or underwriting discounts or allowances in connection therewith) less than the Conversion Price in effect on the date of such issuance (or deemed issuance) of such shares of Common Stock (a “Dilutive Issuance”), then immediately upon the Dilutive Issuance, the Conversion Price will be reduced to the amount of the consideration per share received by the Borrower in such Dilutive Issuance.

The Borrower shall be deemed to have issued or sold shares of Common Stock if the Borrower in any manner issues or grants any warrants, rights or options (not including employee stock option plans), whether or not immediately exercisable, to subscribe for or to purchase Common Stock or other securities convertible into or exchangeable for Common Stock (“Convertible Securities”) (such warrants, rights and options to purchase Common Stock or Convertible Securities are hereinafter referred to as “Options”) and the price per share for which Common Stock is issuable upon the exercise of such Options is less than the Conversion Price then in effect, then the Conversion Price shall be equal to such price per share. For purposes of the preceding sentence, the “price per share for which Common Stock is issuable upon the exercise of such Options” is determined by dividing (i) the total amount, if any, received or receivable by the Borrower as consideration for the issuance or granting of all such Options, plus the minimum aggregate amount of additional consideration, if any, payable to the Borrower upon the exercise of all such Options, plus, in the case of Convertible Securities issuable upon the exercise of such Options, the minimum aggregate amount of additional consideration payable upon the conversion or exchange thereof at the time such Convertible

Securities first become convertible or exchangeable, by (ii) the maximum total number of shares of Common Stock issuable upon the exercise of all such Options (assuming full conversion of Convertible Securities, if applicable). No further adjustment to the Conversion Price will be made upon the actual issuance of such Common Stock upon the exercise of such Options or upon the conversion or exchange of Convertible Securities issuable upon exercise of such Options.

Additionally, the Borrower shall be deemed to have issued or sold shares of Common Stock if the Borrower in any manner issues or sells any Convertible Securities, whether or not immediately convertible (other than where the same are issuable upon the exercise of Options), and the price per share for which Common Stock is issuable upon such conversion or exchange is less than the Conversion Price then in effect, then the Conversion Price shall be equal to such price per share. For the purposes of the preceding sentence, the “price per share for which Common Stock is issuable upon such conversion or exchange” is determined by dividing (i) the total amount, if any, received or receivable by the Borrower as consideration for the issuance or sale of all such Convertible Securities, plus the minimum aggregate amount of additional consideration, if any, payable to the Borrower upon the conversion or exchange thereof at the time such Convertible Securities first become convertible or exchangeable, by (ii) the maximum total number of shares of Common Stock issuable upon the conversion or exchange of all such Convertible Securities. No further adjustment to the Conversion Price will be made upon the actual issuance of such Common Stock upon conversion or exchange of such Convertible Securities.

(e) Purchase Rights. If, at any time when any Notes are issued and outstanding, the Borrower issues any convertible securities or rights to purchase stock, warrants, securities or other property (the “Purchase Rights”) pro rata to the record holders of any class of Common Stock, then the Holder of this Note will be entitled to acquire, upon the terms applicable to such Purchase Rights, the aggregate Purchase Rights which such Holder could have acquired if such Holder had held the number of shares of Common Stock acquirable upon complete conversion of this Note (without regard to any limitations on conversion contained herein) immediately before the date on which a record is taken for the grant, issuance or sale of such Purchase Rights or, if no such record is taken, the date as of which the record holders of Common Stock are to be determined for the grant, issue or sale of such Purchase Rights.

(f) Notice of Adjustments. Upon the occurrence of each adjustment or readjustment of the Conversion Price as a result of the events described in this Section 1.6, the Borrower, at its expense, shall promptly compute such adjustment or readjustment and prepare and furnish to the Holder a certificate setting forth such adjustment or readjustment and showing in detail the facts upon which such adjustment or readjustment is based. The Borrower shall, upon the written request at any time of the Holder, furnish to such Holder a like certificate setting forth (i) such adjustment or readjustment, (ii) the Conversion Price at the time in effect and (iii) the number of shares of Common Stock and the amount, if any, of other securities or property which at the time would be received upon conversion of the Note.

1.7 Trading Market Limitations. Unless permitted by the applicable rules and regulations of the principal securities market on which the Common Stock is then listed or traded, in no event shall the Borrower issue upon conversion of or otherwise pursuant to this Note and the other Notes issued pursuant to the Purchase Agreement more than the maximum number of shares of Common Stock that the Borrower can issue pursuant to any rule of the principal United States securities market on which the Common Stock is then traded (the “Maximum Share Amount”), which shall be 4.99% of the total shares outstanding on the Closing Date (as defined in the Purchase Agreement), subject to equitable adjustment from time to time for stock splits, stock dividends, combinations, capital reorganizations and similar events relating to the Common Stock occurring after the date hereof. Once the Maximum Share Amount has been issued, if the Borrower fails to eliminate any prohibitions under applicable law or the rules or regulations of any stock exchange, interdealer quotation system or other self-regulatory organization with jurisdiction over the Borrower or any of its securities on the Borrower’s ability to issue shares of Common Stock in excess of the Maximum Share Amount, in lieu of any further right to convert this Note, this will be considered an Event of Default under Section 3.3 of the Note.

1.8 Status as Shareholder. Upon submission of a Notice of Conversion by a Holder, (i) the shares covered thereby (other than the shares, if any, which cannot be issued because their issuance would exceed such Holder’s allocated portion of the Reserved Amount or Maximum Share Amount) shall be deemed converted into shares of Common Stock and (ii) the Holder’s rights as a Holder of such converted portion of this Note shall cease and terminate, excepting only the right to receive certificates for such shares of Common Stock and to any remedies provided herein or otherwise available at law or in equity to such Holder because of a failure by the Borrower to comply with the terms of this Note. Notwithstanding the foregoing, if a Holder has not received certificates for all shares of Common Stock prior to the tenth (10th) business day after the expiration of the Deadline with respect to a conversion of any portion of this Note for any reason, then (unless the Holder otherwise elects to retain its status as a holder of Common Stock by so notifying the Borrower) the Holder shall regain the rights of a Holder of this Note with respect to such unconverted portions of this Note and the Borrower shall, as soon as practicable, return such unconverted Note to the Holder or, if the Note has not been surrendered, adjust its records to reflect that such portion of this Note has not been converted. In all cases, the Holder shall retain all of its rights and remedies (including, without limitation, (i) the right to receive Conversion Default Payments pursuant to Section 1.3 to the extent required thereby for such Conversion Default and any subsequent Conversion Default and (ii) the right to have the Conversion Price with respect to subsequent conversions determined in accordance with Section 1.3) for the Borrower’s failure to convert this Note.

I.9 Prepayment. Notwithstanding anything to the contrary contained in this is thirty (30) days following the issue date, the Borrower shall have the right, exercisable on not less than three (3) Trading Days prior written notice to the Holder of the Note to prepay the outstanding Note ( principal and accrued interest), in full, in accordance with this Section 1.9. Any notice or prepayment hereunder (an “Optional Prepayment Notice”) shall be delivered to the Holder of the Note at its registered addresses and shall state: (1) that the Borrower is exercising its right to prepay the Note, and (2) the date of prepayment which shall be not more than three (3) Trading Days from the date of the Optional Prepayment Notice. On the date fixed for prepayment (the “Optional Prepayment Date”), the Borrower shall make payment of the Optional Prepayment Amount (as defined below) to or upon the order of the Holder as specified by the Holder in writing to Borrower at least one (1) business day prior to the Optional Prepayment Date. If the Borrower exercises its right to prepay the Note, the Borrower shall make payment to the Holder of an amount in cash (the “Optional Prepayment Amount”) equal to 110% multiplied by the sum of: (w) the then outstanding principal amount of this Note plus (x) accrued and unpaid interest on the unpaid principal amount of this Note to the Optional Prepayment Date plus (y) Default Interest, if any, on the amounts referred to in clauses (w) and (x) plus (z) any amounts owed to the Holder pursuant to Sections 1.3 and 1.4(g) hereof. If the Borrower delivers an Optional Prepayment Notice and fails to pay the Optional Prepayment Amount due to the Holder of the Note within two (2) business days following the Optional Prepayment Date, the Borrower shall forever forfeit its right to prepay the Note pursuant to this Section 1.9.

Notwithstanding anything to the contrary contained in this Note , at any time during the period beginning on the date which is thirty one (31) days following the issue date and ending on the date which is sixty (60) days following the issue date , the Borrower shall have the right, exercisable on not less than three (3) Trading Days prior written notice to the Holder of the Note to prepay the outstanding Note ( principal and accrued interest), in full, in accordance with this Section 1.9. Any notice or prepayment hereunder (an “Optional Prepayment Notice”) shall be delivered to the Holder of the Note at its registered addresses and shall state: (1) that the Borrower is exercising its right to prepay the Note, and (2) the date of prepayment which shall be not more than three (3) Trading Days from the date of the Optional Prepayment Notice. On the date fixed for prepayment (the “Optional Prepayment Date”), the Borrower shall make payment of the Optional Prepayment Amount (as defined below) to or upon the order of the Holder as specified by the Holder in writing to Borrower at least one (1) business day prior to the Optional Prepayment Date. If the Borrower exercises its right to prepay the Note, the Borrower shall make payment to the Holder of an amount in cash (the “Second Optional Prepayment Amount”) equal to 115% multiplied by the sum of: (w) the then outstanding principal amount of this Note plus (x) accrued and unpaid interest on the unpaid principal amount of this Note to the Optional Prepayment Date plus (y) Default Interest, if any, on the amounts referred to in clauses (w) and (x) plus (z) any amounts owed to the Holder pursuant to Sections 1.3 and 1.4(g) hereof. If the Borrower delivers an Optional Prepayment Notice and fails to pay the Second Optional Prepayment Amount due to the Holder of the Note within two (2) business days following the Optional Prepayment Date, the Borrower shall forever forfeit its right to prepay the Note pursuant to this Section 1.9.

Notwithstanding anything to the contrary contained in this Note , at any time during the period beginning on the date which is sixty one (61) days following the issue date and ending on the date which is ninety (90) days following the issue date , the Borrower shall have the right, exercisable on not less than three (3) Trading Days prior written notice to the Holder of the Note to prepay the outstanding Note ( principal and accrued interest), in full, in accordance with this Section 1.9. Any notice or prepayment hereunder (an “Optional Prepayment Notice”) shall be delivered to the Holder of the Note at its registered addresses and shall state: (1) that the Borrower is exercising its right to prepay the Note, and (2) the date of prepayment which shall be not more than three (3) Trading Days from the date of the Optional Prepayment Notice. On the date fixed for prepayment (the “Optional Prepayment Date”), the Borrower shall make payment of the Optional Prepayment Amount (as defined below) to or upon the order of the Holder as specified by the Holder in writing to Borrower at least one (1) business day prior to the Optional Prepayment Date. If the Borrower exercises its right to prepay the Note, the Borrower shall make payment to the Holder of an amount in cash (the “Third Optional Prepayment Amount”) equal to 120% multiplied by the sum of: (w) the then outstanding principal amount of this Note plus (x) accrued and unpaid interest on the unpaid principal amount of this Note to the Optional Prepayment Date plus (y) Default Interest, if any, on the amounts referred to in clauses (w) and (x) plus (z) any amounts owed to the Holder pursuant to Sections 1.3 and 1.4(g) hereof. If the Borrower delivers an Optional Prepayment Notice and fails to pay the Third Optional Prepayment Amount due to the Holder of the Note within two (2) business days following the Optional Prepayment Date, the Borrower shall forever forfeit its right to prepay the Note pursuant to this Section 1.9.

Notwithstanding anything to the contrary contained in this Note , at any time during the period beginning on the date which is ninety one (91) days following the issue date and ending on the date which is one hundred and twenty (120) days following the issue date , the Borrower shall have the right, exercisable on not less than three (3) Trading Days prior written notice to the Holder of the Note to prepay the outstanding Note ( principal and accrued interest), in full, in accordance with this Section 1.9. Any notice or prepayment hereunder (an “Optional Prepayment Notice”) shall be delivered to the Holder of the Note at its registered addresses and shall state: (1) that the Borrower is exercising its right to prepay the Note, and (2) the date of prepayment which shall be not more than three (3) Trading Days from the date of the Optional Prepayment Notice. On the date fixed for prepayment (the “Optional Prepayment Date”), the Borrower shall make payment of the Optional Prepayment Amount (as defined below) to or upon the order of the Holder as specified by the Holder in writing to Borrower at least one (1) business day prior to the Optional Prepayment Date. If the Borrower exercises its right to prepay the Note, the Borrower shall make payment to the Holder of an amount in cash (the “Fourth Optional Prepayment Amount”) equal to 125% multiplied by the sum of: (w) the then outstanding principal amount of this Note plus (x) accrued and unpaid interest on the unpaid principal amount of this Note to the Optional Prepayment Date plus (y) Default Interest, if any, on the amounts referred to in clauses (w) and (x) plus (z) any amounts owed to the Holder pursuant to Sections 1.3 and 1.4(g) hereof. If the Borrower delivers an Optional Prepayment Notice and fails to pay the Fourth Optional Prepayment Amount due to the Holder of the Note within two (2) business days following the Optional Prepayment Date, the Borrower shall forever forfeit its right to prepay the Note pursuant to this Section 1.9

Notwithstanding anything to the contrary contained in this Note , at any time during the period beginning on the date which is one hundred and twenty one (121) days following the issue date and ending on the date which is one hundred and fifty (150) days following the issue date , the Borrower shall have the right, exercisable on not less than three (3) Trading Days prior written notice to the Holder of the Note to prepay the outstanding Note ( principal and accrued interest), in full, in accordance with this Section 1.9. Any notice or prepayment hereunder (an “Optional Prepayment Notice”) shall be delivered to the Holder of the Note at its registered addresses and shall state: (1) that the Borrower is exercising its right to prepay the Note, and (2) the date of prepayment which shall be not more than three (3) Trading Days from the date of the Optional Prepayment Notice. On the date fixed for prepayment (the “Optional Prepayment Date”), the Borrower shall make payment of the Optional Prepayment Amount (as defined below) to or upon the order of the Holder as specified by the Holder in writing to Borrower at least one (1) business day prior to the Optional Prepayment Date. If the Borrower exercises its right to prepay the Note, the Borrower shall make payment to the Holder of an amount in cash (the “Fifth Optional Prepayment Amount”) equal to 130% multiplied by the sum of: (w) the then outstanding principal amount of this Note plus (x) accrued and unpaid interest on the unpaid principal amount of this Note to the Optional Prepayment Date plus (y) Default Interest, if any, on the amounts referred to in clauses (w) and (x) plus (z) any amounts owed to the Holder pursuant to Sections 1.3 and 1.4(g) hereof. If the Borrower delivers an Optional Prepayment Notice and fails to pay the Fifth Optional Prepayment Amount due to the Holder of the Note within two (2) business days following the Optional Prepayment Date, the Borrower shall forever forfeit its right to prepay the Note pursuant to this Section 1.9.

Notwithstanding anything to the contrary contained in this Note , at any time during the period beginning on the date which is one hundred and fifty one (151) days following the issue date and ending on the date which is one hundred and eighty (180) days following the issue date , the Borrower shall have the right, exercisable on not less than three (3) Trading Days prior written notice to the Holder of the Note to prepay the outstanding Note ( principal and accrued interest), in full, in accordance with this Section 1.9. Any notice or prepayment hereunder (an “Optional Prepayment Notice”) shall be delivered to the Holder of the Note at its registered addresses and shall state: (1) that the Borrower is exercising its right to prepay the Note, and (2) the date of prepayment which shall be not more than three (3) Trading Days from the date of the Optional Prepayment Notice. On the date fixed for prepayment (the “Optional Prepayment Date”), the Borrower shall make payment of the Optional Prepayment Amount (as defined below) to or upon the order of the Holder as specified by the Holder in writing to Borrower at least one (1) business day prior to the Optional Prepayment Date. If the Borrower exercises its right to prepay the Note, the Borrower shall make payment to the Holder of an amount in cash (the “Sixth Optional Prepayment Amount”) equal to 135% multiplied by the sum of: (w) the then outstanding principal amount of this Note plus (x) accrued and unpaid interest on the unpaid principal amount of this Note to the Optional Prepayment Date plus (y) Default Interest, if any, on the amounts referred to in clauses (w) and (x) plus (z) any amounts owed to the Holder pursuant to Sections 1.3 and 1.4(g) hereof. If the Borrower delivers an Optional Prepayment Notice and fails to pay the SixthOptional Prepayment Amount due to the Holder of the Note within two (2) business days following the Optional Prepayment Date, the Borrower shall forever forfeit its right to prepay the Note pursuant to this Section 1.9

After the expiration of one hundred eighty (180) following the date of the Note, the Borrower shall have no right of prepayment.

ARTICLE II. CERTAIN COVENANTS

2.1 Distributions on Capital Stock. So long as the Borrower shall have any obligation under this Note, the Borrower shall not without the Holder’s written consent (a) pay, declare or set apart for such payment, any dividend or other distribution (whether in cash, property or other securities) on shares of capital stock other than dividends on shares of Common Stock solely in the form of additional shares of Common Stock or (b) directly or indirectly or through any subsidiary make any other payment or distribution in respect of its capital stock except for distributions pursuant to any shareholders’ rights plan which is approved by a majority of the Borrower’s disinterested directors.

2.2 Restriction on Stock Repurchases. So long as the Borrower shall have any obligation under this Note, the Borrower shall not without the Holder’s written consent redeem, repurchase or otherwise acquire (whether for cash or in exchange for property or other securities or otherwise) in any one transaction or series of related transactions any shares of capital stock of the Borrower or any warrants, rights or options to purchase or acquire any such shares.

2.3 Borrowings. So long as the Borrower shall have any obligation under this Note, the Borrower shall not, without the Holder’s written consent, create, incur, assume guarantee, endorse, contingently agree to purchase or otherwise become liable upon the obligation of any person, firm, partnership, joint venture or corporation, except by the endorsement of negotiable instruments for deposit or collection, or suffer to exist any liability for borrowed money, except (a) borrowings in existence or committed on the date hereof and of which the Borrower has informed Holder in writing prior to the date hereof, (b) indebtedness to trade creditors or financial institutions incurred in the ordinary course of business, (c) borrowings from one or more shareholders of the Borrower, so long as these borrowings are not repaid during the term of the Note or (d) borrowings, the proceeds of which shall be used to repay this Note.

2.4 Sale of Assets. So long as the Borrower shall have any obligation under this Note, the Borrower shall not, without the Holder’s written consent, sell, lease or otherwise dispose of any significant portion of its assets outside the ordinary course of business. Any consent to the disposition of any assets may be conditioned on a specified use of the proceeds of disposition.

2.5 Advances and Loans. So long as the Borrower shall have any obligation under this Note, the Borrower shall not, without the Holder’s written consent, lend money, give credit or make advances to any person, firm, joint venture or corporation, including, without limitation, officers, directors, employees, subsidiaries and affiliates of the Borrower, except loans, credits or advances (a) in existence or committed on the date hereof and which the Borrower has informed Holder in writing prior to the date hereof, (b) made in the ordinary course of business or (c) not in excess of $100,000.

ARTICLE III. EVENTS OF DEFAULT

If any of the following events of default (each, an “Event of Default”) shall occur:

3.1 Failure to Pay Principal or Interest. The Borrower fails to pay the principal hereof or interest thereon when due on this Note, whether at maturity, upon acceleration or otherwise.

3.2 Conversion and the Shares. The Borrower fails to issue shares of Common Stock to the Holder (or announces or threatens in writing that it will not honor its obligation to do so) upon exercise by the Holder of the conversion rights of the Holder in accordance with the terms of this Note, fails to transfer or cause its transfer agent to transfer (issue) (electronically or in certificated form) any certificate for shares of Common Stock issued to the Holder upon conversion of or otherwise pursuant to this Note as and when required by this Note, the Borrower directs its transfer agent not to transfer or delays, impairs, and/or hinders its transfer agent in transferring (or issuing) (electronically or in certificated form) any certificate for shares of Common Stock to be issued to the Holder upon conversion of or otherwise pursuant to this Note as and when required by this Note, or fails to remove (or directs its transfer agent not to remove or impairs, delays, and/or hinders its transfer agent from removing) any restrictive legend (or to withdraw any stop transfer instructions in respect thereof) on any certificate for any shares of Common Stock issued to the Holder upon conversion of or otherwise pursuant to this Note as and when required by this Note (or makes any written announcement, statement or threat that it does not intend to honor the obligations described in this paragraph) and any such failure shall continue uncured (or any written announcement, statement or threat not to honor its obligations shall not be rescinded in writing) for three (3) business days after the Holder shall have delivered a Notice of Conversion. It is an obligation of the Borrower to remain current in its obligations to its transfer agent. It shall be an event of default of this Note, if a conversion of this Note is delayed, hindered or frustrated due to a balance owed by the Borrower to its transfer agent. If at the option of the Holder, the Holder advances any funds to the Borrower’s transfer agent in order to process a conversion, such advanced funds shall be paid by the Borrower to the Holder within forty eight (48) hours of a demand from the Holder.

3.3 Breach of Covenants. The Borrower breaches any material covenant or other material term or condition contained in this Note and any collateral documents including but not limited to the Purchase Agreement and such breach continues for a period of ten (10) days after written notice thereof to the Borrower from the Holder.

3.4 Breach of Representations and Warranties. Any representation or warranty of the Borrower made herein or in any agreement, statement or certificate given in writing pursuant hereto or in connection herewith (including, without limitation, the Purchase Agreement), shall be false or misleading in any material respect when made and the breach of which has (or with the passage of time will have) a material adverse effect on the rights of the Holder with respect to this Note or the Purchase Agreement.

3.5 Receiver or Trustee. The Borrower or any subsidiary of the Borrower shall make an assignment for the benefit of creditors, or apply for or consent to the appointment of a receiver or trustee for it or for a substantial part of its property or business, or such a receiver or trustee shall otherwise be appointed.

3.6 Judgments. Any money judgment, writ or similar process shall be entered or filed against the Borrower or any subsidiary of the Borrower or any of its property or other assets for more than $50,000, and shall remain unvacated, unbonded or unstayed for a period of twenty (20) days unless otherwise consented to by the Holder, which consent will not be unreasonably withheld.

3.7 Bankruptcy. Bankruptcy, insolvency, reorganization or liquidation proceedings or other proceedings, voluntary or involuntary, for relief under any bankruptcy law or any law for the relief of debtors shall be instituted by or against the Borrower or any subsidiary of the Borrower.

3.8 Delisting of Common Stock. The Borrower shall fail to maintain the listing of the Common Stock on at least one of the OTCQB or an equivalent replacement exchange, the Nasdaq National Market, the Nasdaq SmallCap Market, the New York Stock Exchange, or the American Stock Exchange.

3.9 Failure to Comply with the Exchange Act. The Borrower shall fail to comply with the reporting requirements of the Exchange Act; and/or the Borrower shall cease to be subject to the reporting requirements of the Exchange Act.

3.10 Liquidation. Any dissolution, liquidation, or winding up of Borrower or any substantial portion of its business.

3.11 Cessation of Operations. Any cessation of operations by Borrower or Borrower admits it is otherwise generally unable to pay its debts as such debts become due, provided, however, that any disclosure of the Borrower’s ability to continue as a “going concern” shall not be an admission that the Borrower cannot pay its debts as they become due.

3.12 Maintenance of Assets. The failure by Borrower to maintain any material intellectual property rights, personal, real property or other assets which are necessary to conduct its business (whether now or in the future).

3.13 Financial Statement Restatement. The restatement of any financial statements filed by the Borrower with the SEC for any date or period from two years prior to the Issue Date of this Note and until this Note is no longer outstanding, if the result of such restatement would, by comparison to the unrestated financial statement, have constituted a material adverse effect on the rights of the Holder with respect to this Note or the Purchase Agreement.

3.14 Reverse Splits. The Borrower effectuates a reverse split of its Common Stock without twenty (20) days prior written notice to the Holder.

3.15 Replacement of Transfer Agent. In the event that the Borrower proposes to replace its transfer agent, the Borrower fails to provide, prior to the effective date of such replacement, a fully executed Irrevocable Transfer Agent Instructions in a form as initially delivered pursuant to the Purchase Agreement (including but not limited to the provision to irrevocably reserve shares of Common Stock in the Reserved Amount) signed by the successor transfer agent to Borrower and the Borrower.

3.16 Cross-Default. Notwithstanding anything to the contrary contained in this Note or the other related or companion documents, a breach or default by the Borrower of any covenant or other term or condition contained in any of the Other Agreements, after the passage of all applicable notice and cure or grace periods, shall, at the option of the Holder, be considered a default under this Note and the Other Agreements, in which event the Holder shall be entitled (but in no event required) to apply all rights and remedies of the Holder under the terms of this Note and the Other Agreements by reason of a default under said Other Agreement or hereunder. “Other Agreements” means, collectively, all agreements and instruments between, among or by: (1) the Borrower, and, or for the benefit of, (2) the Holder and any affiliate of the Holder, including, without limitation, promissory notes; provided, however, the term “Other Agreements” shall not include the related or companion documents to this Note. Each of the loan transactions will be cross-defaulted with each other loan transaction and with all other existing and future debt of Borrower to the Holder.

Upon the occurrence and during the continuation of any Event of Default specified in Section 3.1 (solely with respect to failure to pay the principal hereof or interest thereon when due at the Maturity Date), the Note shall become immediately due and payable and the Borrower shall pay to the Holder, in full satisfaction of its obligations hereunder, an amount equal to the Default Sum (as defined herein). UPON THE OCCURRENCE AND DURING THE CONTINUATION OF ANY EVENT OF DEFAULT SPECIFIED IN SECTION 3.2, THE NOTE SHALL BECOME IMMEDIATELY DUE AND PAYABLE AND THE BORROWER SHALL PAY TO THE HOLDER, IN FULL SATISFACTION OF ITS OBLIGATIONS HEREUNDER, AN AMOUNT EQUAL TO: (Y) THE DEFAULT SUM (AS DEFINED HEREIN); MULTIPLIED BY (Z) TWO (2). Upon the occurrence and during the continuation of any Event of Default specified in Sections 3.1 (solely with respect to failure to pay the principal hereof or interest thereon when due on this Note upon a Trading Market Prepayment Event pursuant to Section 1.7 or upon acceleration), 3.3, 3.4, 3.6, 3.8, 3.9, 3.11, 3.12, 3.13, 3.14, and/or 3. 15 exercisable through the delivery of written notice to the Borrower by such Holders (the “Default Notice”), and upon the occurrence of an Event of Default specified the remaining sections of Articles III (other than failure to pay the principal hereof or interest thereon at the Maturity Date specified in Section 3,1 hereof), the Note shall become immediately due and payable and the Borrower shall pay to the Holder, in full satisfaction of its obligations hereunder, an amount equal to the greater of (i) 150% times the sum of (w) the then outstanding principal amount of this Note plus (x) accrued and unpaid interest on the unpaid principal amount of this Note to the date of payment (the “Mandatory Prepayment Date”) plus (y) Default Interest, if any, on the amounts referred to in clauses (w) and/or (x) plus (z) any amounts owed to the Holder pursuant to Sections 1.3 and 1.4(g) hereof (the then outstanding principal amount of this Note to the date of payment plus the amounts referred to in clauses (x), (y) and (z) shall collectively be known as the “Default Sum”) or (ii) the “parity value” of the Default Sum to be prepaid, where parity value means (a) the highest number of shares of Common Stock issuable upon conversion of or otherwise pursuant to such Default Sum in accordance with Article I, treating the Trading Day immediately preceding the Mandatory Prepayment Date as the “Conversion Date” for purposes of determining the lowest applicable Conversion Price, unless the Default Event arises as a result of a breach in respect of a specific Conversion Date in which case such Conversion Date shall be the Conversion Date), multiplied by (b) the highest Closing Price for the Common Stock during the period beginning on the date of first occurrence of the Event of Default and ending one day prior to the Mandatory Prepayment Date (the “Default Amount”) and all other amounts payable hereunder shall immediately become due and payable, all without demand, presentment or notice, all of which hereby are expressly waived, together with all costs, including, without limitation, legal fees and expenses, of collection, and the Holder shall be entitled to exercise all other rights and remedies available at law or in equity.

If the Borrower fails to pay the Default Amount within five (5) business days of written notice that such amount is due and payable, then the Holder shall have the right at any time, so long as the Borrower remains in default (and so long and to the extent that there are sufficient authorized shares), to require the Borrower, upon written notice, to immediately issue, in lieu of the Default Amount, the number of shares of Common Stock of the Borrower equal to the Default Amount divided by the Conversion Price then in effect.

ARTICLE IV. MISCELLANEOUS

4.1 Failure or Indulgence Not Waiver. No failure or delay on the part of the Holder in the exercise of any power, right or privilege hereunder shall operate as a waiver thereof, nor shall any single or partial exercise of any such power, right or privilege preclude other or further exercise thereof or of any other right, power or privileges. All rights and remedies existing hereunder are cumulative to, and not exclusive of, any rights or remedies otherwise available.

4.2 Notices. All notices, demands, requests, consents, approvals, and other communications required or permitted hereunder shall be in writing and, unless otherwise specified herein, shall be (i) personally served, (ii) deposited in the mail, registered or certified, return receipt requested, postage prepaid, (iii) delivered by reputable air courier service with charges prepaid, or (iv) transmitted by hand delivery, telegram, or facsimile, addressed as set forth below or to such other address as such party shall have specified most recently by written notice. Any notice or other communication required or permitted to be given hereunder shall be deemed effective (a) upon hand delivery or delivery by facsimile, with accurate confirmation generated by the transmitting facsimile machine, at the address or number designated below (if delivered on a business day during normal business hours where such notice is to be received), or the first business day following such delivery (if delivered other than on a business day during normal business hours where such notice is to be received) or (b) on the second business day following the date of mailing by express courier service, fully prepaid, addressed to such address, or upon actual receipt of such mailing, whichever shall first occur. The addresses for such communications shall be:

If to the Borrower, to:

ENTEST BIOMEDICAL, INC.

4700 Spring Street - Suite 203

La Mesa, CA 91942

Attn: DAVID KOOS, Chief Executive Officer

facsimile:

With a copy by fax only to (which copy shall not constitute notice):

[enter name of law firm]

Attn: [attorney name]

[enter address line 1]

[enter city, state, zip]

facsimile: [enter fax number]

If to the Holder:

ASHER ENTERPRISES, INC.

1 Linden Pl., Suite 207

Great Neck, NY. 11021

Attn: Curt Kramer, President

facsimile: 516-498-9894

With a copy by fax only to (which copy shall not constitute notice):

Naidich Wurman Birnbaum & Maday, LLP

80 Cuttermill Road, Suite 410

Great Neck, NY 11021

Attn: Bernard S. Feldman, Esq.

facsimile: 516-466-3555

4.3 Amendments. This Note and any provision hereof may only be amended by an instrument in writing signed by the Borrower and the Holder. The term “Note” and all reference thereto, as used throughout this instrument, shall mean this instrument (and the other Notes issued pursuant to the Purchase Agreement) as originally executed, or if later amended or supplemented, then as so amended or supplemented.

4.4 Assignability. This Note shall be binding upon the Borrower and its successors and assigns, and shall inure to be the benefit of the Holder and its successors and assigns. Each transferee of this Note must be an “accredited investor” (as defined in Rule 501(a) of the 1933 Act). Notwithstanding anything in this Note to the contrary, this Note may be pledged as collateral in connection with a bona fide margin account or other lending arrangement.

4.5 Cost of Collection. If default is made in the payment of this Note, the Borrower shall pay the Holder hereof costs of collection, including reasonable attorneys’ fees.

4.6 Governing Law. This Note shall be governed by and construed in accordance with the laws of the State of New York without regard to principles of conflicts of laws. Any action brought by either party against the other concerning the transactions contemplated by this Note shall be brought only in the state courts of New York or in the federal courts located in the state and county of Nassau. The parties to this Note hereby irrevocably waive any objection to jurisdiction and venue of any action instituted hereunder and shall not assert any defense based on lack of jurisdiction or venue or based upon forum non conveniens. The Borrower and Holder waive trial by jury. The prevailing party shall be entitled to recover from the other party its reasonable attorney's fees and costs. In the event that any provision of this Note or any other agreement delivered in connection herewith is invalid or unenforceable under any applicable statute or rule of law, then such provision shall be deemed inoperative to the extent that it may conflict therewith and shall be deemed modified to conform with such statute or rule of law. Any such provision which may prove invalid or unenforceable under any law shall not affect the validity or enforceability of any other provision of any agreement. Each party hereby irrevocably waives personal service of process and consents to process being served in any suit, action or proceeding in connection with this Agreement or any other Transaction Document by mailing a copy thereof via registered or certified mail or overnight delivery (with evidence of delivery) to such party at the address in effect for notices to it under this Agreement and agrees that such service shall constitute good and sufficient service of process and notice thereof. Nothing contained herein shall be deemed to limit in any way any right to serve process in any other manner permitted by law.

4.7 Certain Amounts. Whenever pursuant to this Note the Borrower is required to pay an amount in excess of the outstanding principal amount (or the portion thereof required to be paid at that time) plus accrued and unpaid interest plus Default Interest on such interest, the Borrower and the Holder agree that the actual damages to the Holder from the receipt of cash payment on this Note may be difficult to determine and the amount to be so paid by the Borrower represents stipulated damages and not a penalty and is intended to compensate the Holder in part for loss of the opportunity to convert this Note and to earn a return from the sale of shares of Common Stock acquired upon conversion of this Note at a price in excess of the price paid for such shares pursuant to this Note. The Borrower and the Holder hereby agree that such amount of stipulated damages is not plainly disproportionate to the possible loss to the Holder from the receipt of a cash payment without the opportunity to convert this Note into shares of Common Stock.

4.8 Purchase Agreement. By its acceptance of this Note, each party agrees to be bound by the applicable terms of the Purchase Agreement.

4.9 Notice of Corporate Events. Except as otherwise provided below, the Holder of this Note shall have no rights as a Holder of Common Stock unless and only to the extent that it converts this Note into Common Stock. The Borrower shall provide the Holder with prior notification of any meeting of the Borrower’s shareholders (and copies of proxy materials and other information sent to shareholders). In the event of any taking by the Borrower of a record of its shareholders for the purpose of determining shareholders who are entitled to receive payment of any dividend or other distribution, any right to subscribe for, purchase or otherwise acquire (including by way of merger, consolidation, reclassification or recapitalization) any share of any class or any other securities or property, or to receive any other right, or for the purpose of determining shareholders who are entitled to vote in connection with any proposed sale, lease or conveyance of all or substantially all of the assets of the Borrower or any proposed liquidation, dissolution or winding up of the Borrower, the Borrower shall mail a notice to the Holder, at least twenty (20) days prior to the record date specified therein (or thirty (30) days prior to the consummation of the transaction or event, whichever is earlier), of the date on which any such record is to be taken for the purpose of such dividend, distribution, right or other event, and a brief statement regarding the amount and character of such dividend, distribution, right or other event to the extent known at such time. The Borrower shall make a public announcement of any event requiring notification to the Holder hereunder substantially simultaneously with the notification to the Holder in accordance with the terms of this Section 4.9.

4.10 Remedies. The Borrower acknowledges that a breach by it of its obligations hereunder will cause irreparable harm to the Holder, by vitiating the intent and purpose of the transaction contemplated hereby. Accordingly, the Borrower acknowledges that the remedy at law for a breach of its obligations under this Note will be inadequate and agrees, in the event of a breach or threatened breach by the Borrower of the provisions of this Note, that the Holder shall be entitled, in addition to all other available remedies at law or in equity, and in addition to the penalties assessable herein, to an injunction or injunctions restraining, preventing or curing any breach of this Note and to enforce specifically the terms and provisions thereof, without the necessity of showing economic loss and without any bond or other security being required.

IN WITNESS WHEREOF, Borrower has caused this Note to be signed in its name by its duly authorized officer this September 21, 2012.

ENTEST BIOMEDICAL, INC.

By: /s /David Koos

DAVID KOOS

Chief Executive Officer

EX-10.39 7 entb0129form10kex1039.htm EXHIBIT 10.39

EXHIBIT 10.39

LINE OF CREDIT PROMISSORY NOTE

$700,000 Date: June 10, 2012

FOR VALUE RECEIVED, Entest BioMedical Inc., ("Borrower") promises to pay to the order of the Sherman Family Trust ("Lender") the principal sum of Seven Hundred Thousand Dollars ($700,000), or so much thereof as may be disbursed to, or for the benefit of the Borrower by Lender in Lender's sole and absolute discretion. It is the intent of the Borrower and Lender hereunder to create a line of credit agreement between Borrower and Lender whereby Borrower may borrow up to $ 700,000 from Lender. This agreement shall also be the terms and conditions of any and all borrowed amounts outstanding as of this date.

INTEREST & PRINCIPAL: The unpaid principal of this line of credit shall bear simple interest at the rate of ten percent (10%) per annum. Interest shall be calculated based on the principal balance as may be adjusted from time to time to reflect additional advances or payments made hereunder. Principal balance and accrued interest shall become due and payable in whole or in part at the demand of the Lender.

REPRESENTATIONS AND WARRANTIES OF BORROWER

Borrower (a) is a corporation duly formed, validly existing and in good standing under the laws of the State of Nevada and (b) has all requisite power and authority, and has all governmental licenses, authorizations, consents and approvals necessary to execute and deliver this Agreement and to consummate the transactions contemplated by this Agreement.

None of the execution, delivery and performance of this Agreement by Borrower, or the consummation of the transactions contemplated hereby and thereby (a) constitute or will constitute a violation of the organizational documents of Borrower, (b) constitutes or will constitute a breach or violation of, or a default (or an event which, with notice or lapse of time or both, would constitute such a default) under, any indenture, mortgage, deed of Borrower, loan agreement, lease or other agreement or instrument to which Borrower is a party or by which Borrower or any of its properties may be bound

BORROWER:

By: /s/ David Koos

Its: CEO

EX-101.INS 8 entb-20120831.xml XBRL INSTANCE FILE 0001449447 2011-09-01 2012-08-31 0001449447 us-gaap:CommonStockMember 2013-01-25 0001449447 us-gaap:SeriesBPreferredStockMember 2013-01-25 0001449447 us-gaap:SeriesAPreferredStockMember 2013-01-25 0001449447 us-gaap:ConvertiblePreferredStockMember 2013-01-25 0001449447 2012-08-31 0001449447 2011-08-31 0001449447 2010-09-01 2011-08-31 0001449447 us-gaap:CommonStockMember 2010-09-01 2011-08-31 0001449447 us-gaap:CommonStockMember 2011-09-01 2012-08-31 0001449447 us-gaap:CommonStockMember 2010-08-31 0001449447 us-gaap:CommonStockMember 2011-08-31 0001449447 us-gaap:CommonStockMember 2012-08-31 0001449447 us-gaap:SeriesAPreferredStockMember 2010-09-01 2011-08-31 0001449447 us-gaap:SeriesAPreferredStockMember 2011-08-31 0001449447 us-gaap:SeriesAPreferredStockMember 2012-08-31 0001449447 us-gaap:SeriesBPreferredStockMember 2011-09-01 2012-08-31 0001449447 us-gaap:SeriesBPreferredStockMember 2012-08-31 0001449447 us-gaap:RedeemableConvertiblePreferredStockMember 2011-09-01 2012-08-31 0001449447 us-gaap:RedeemableConvertiblePreferredStockMember 2012-08-31 0001449447 us-gaap:AdditionalPaidInCapitalMember 2010-09-01 2011-08-31 0001449447 us-gaap:AdditionalPaidInCapitalMember 2011-09-01 2012-08-31 0001449447 us-gaap:AdditionalPaidInCapitalMember 2010-08-31 0001449447 us-gaap:AdditionalPaidInCapitalMember 2011-08-31 0001449447 us-gaap:AdditionalPaidInCapitalMember 2012-08-31 0001449447 us-gaap:OtherAdditionalCapitalMember 2010-09-01 2011-08-31 0001449447 us-gaap:OtherAdditionalCapitalMember 2010-08-31 0001449447 us-gaap:OtherAdditionalCapitalMember 2011-08-31 0001449447 us-gaap:OtherAdditionalCapitalMember 2012-08-31 0001449447 us-gaap:RetainedEarningsMember 2010-09-01 2011-08-31 0001449447 us-gaap:RetainedEarningsMember 2011-09-01 2012-08-31 0001449447 us-gaap:RetainedEarningsMember 2010-08-31 0001449447 us-gaap:RetainedEarningsMember 2011-08-31 0001449447 us-gaap:RetainedEarningsMember 2012-08-31 0001449447 2010-08-31 0001449447 2009-07-10 0001449447 us-gaap:ServiceLifeMember 2012-08-31 0001449447 us-gaap:AcquisitionRelatedCostsMember 2012-08-31 0001449447 2008-08-22 2012-08-31 0001449447 2012-06-01 0001449447 2012-08-27 0001449447 2011-09-01 2011-11-30 0001449447 2011-12-01 2012-02-29 0001449447 2012-03-01 2012-05-31 0001449447 2011-01-04 0001449447 2011-01-05 2012-08-31 0001449447 2011-11-01 0001449447 2011-12-01 2012-11-30 0001449447 2012-12-01 2013-11-30 0001449447 2013-12-01 2014-11-30 0001449447 2014-12-01 2015-11-30 0001449447 2015-12-01 2016-11-30 0001449447 2011-02-03 0001449447 2012-05-24 0001449447 2012-03-27 0001449447 2012-02-21 2012-03-06 0001449447 2012-02-29 0001449447 2011-05-20 0001449447 2011-07-05 0001449447 2011-08-29 0001449447 2011-10-25 0001449447 2011-12-19 0001449447 2011-12-20 0001449447 2012-02-28 0001449447 2012-04-16 0001449447 2012-06-15 0001449447 2012-07-26 0001449447 2012-08-21 0001449447 2011-12-26 0001449447 2011-12-29 0001449447 2012-04-03 0001449447 2012-08-02 0001449447 2012-09-04 2012-09-17 0001449447 2012-09-21 0001449447 2012-09-20 0001449447 2012-10-17 0001449447 2012-10-22 0001449447 2012-12-05 0001449447 2012-09-01 2012-11-30 0001449447 2012-09-18 2012-10-02 0001449447 2012-03-30 iso4217:USD xbrli:shares iso4217:USD xbrli:shares xbrli:pure ENTB:M ENTB:Y ENTEST BIOMEDICAL, INC. 0001449447 10-K 2012-08-31 false --08-31 No No Yes Smaller Reporting Company FY 2011 446519900 3201397 5000 75000

2268

3135

10298

7986

13000

62200

4349

111792

121571

8832

17293

405000

1052

1828

10300

1151

10300

527827

555992

74574

27564

225362

159911

121495

42430

8000

119726

67206

549157

305111

36469

79143

36469

79143

585626

384254

223493

20838

3030642

1619330

274162 274162

-3664302

-1742597

-57799

171738

17553

20838

223493

3201

75000

537415

1619330

3030642

15104

274162

-790814

-1742597

-3664302

-220742

527827

555992

3201 0

1151

39140

0.001

1000000000

223492927

0.001

5000000

0.001 0.001 4400000 4400000 3201397 3201397 0 0

42737

43901

0.001 0.001 0.001 100000 100000 5000 5000 5000 5000

1.00 1 200000 200000 75000 75000 0 0 5 5 75000 0

419336

349141

6916

426252

349141

119299

89405

306953

259736

5798

109063

126812

108596

562424

793609

428040

159518

-816121

-911050

94949

-18647

187699 -145362

-683333

-29400

-24404

-380480

-16428

-23868

-75000

-1073442

-40733

-1889563

-951783

-1889563

-951783

-1889563

-32142

-1921705

-951783

-0.02

-0.05

94990042

19895368

17553040

20840501

223492927

5000

3201397

75000

2217600

217600

2217

215383

374959

341167

780

113695

340387

261264

122041

121967

303399

164

303235

77000

-50

-77000

113695700

781712

113695700

74383

163766

50000

77000000

58491

10000

58491

350915 88998 88998 350915

259058

2000

1995

5000

201397

1123074

1170786

3272000

171750

3269

168481

2500000

700000

2500

697500

-90000

-86687

-83

-86687

15000000

15000

-15000

3201397

3201

-3201

75000

32142

6274726

23868

6274

17594

-15000000

-8187

-15000

6813

-32142

369059

391167

210000

700000

-1164

43695

42737

43901

206

-22884

104768

470901

516085

350915 88998

926584

892442

-195000

217600

-2299

8000

259058

-1889563

-951783

8461

5591

776

505

48681

55399

181540

122007

867

-3135

-2312

-7986

47010

6222

59500

10100

-39140

-1151

1059

16667

52520

-60889

-94937 683333

-927748

-825863

-2953

NOTE 1.  ORGANIZATION AND DESCRIPTION OF BUSINESS   Entest BioMedical Inc. (the Company) was incorporated in the State of Nevada on September 24, 2008 as JB Clothing Corporation.  Until July 10, 2009, the Companys principal business objective was the offering of active/leisure fashion design clothing.   On July 10, 2009 the Company abandoned its efforts in the field of active/leisure fashion design clothing when it acquired 100% of the share capital of Entest BioMedical, Inc., a California corporation, (Entest CA).   The Companys current business consists of the development and commercialization of immunotherapeutic therapies for the veterinary market as well as the acquisition and operation of veterinary hospitals.

1.00

NOTE 2.  SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES   A. BASIS OF ACCOUNTING   The financial statements have been prepared using the basis of accounting generally accepted in the United States of America. Under this basis of accounting, revenues are recorded as earned and expenses are recorded at the time liabilities are incurred. The Company has adopted an August 31 fiscal  year-end. The Company recognizes revenue from services and product sales when the following four revenue recognition criteria are met: persuasive evidence of an arrangement exists, delivery has occurred or services have been rendered, the selling price is fixed or determinable, and collectability is reasonably assured. Product sales and service revenues are recorded when the products are delivered and title passes to customers. The customers credit card is authorized and charged, or checks/cash are received at the time the services are rendered, thereby providing reasonable assurance of collectability.   B. PRINCIPLES OF CONSOLIDATION   The consolidated financial statements include the accounts of  Entest CA, the Companys wholly owned subsidiary. Significant inter-company transactions have been eliminated.   C. USE OF ESTIMATES   The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.   D. CASH EQUIVALENTS   The Company considers all highly liquid investments with a maturity of three months or less when purchased to be cash equivalents.   E. PROPERTY AND EQUIPMENT   Property and equipment are recorded at cost. Maintenance and repairs are expensed in the year in which they are incurred. Property and equipment consist of Office Equipment, medical Equipment and Computer Equipment. Expenditures that enhance the value of property and equipment are capitalized. All property and equipment is depreciated utilizing the Straight Line Method for a period of thirty months , such period being estimated by the Company to represent the useful life of the assets. For the Fiscal Year ended August 31, 2012 the Company incurred depreciation expense of $8,461 and for the Fiscal Year ended August 31, 2011 the Company incurred depreciation expense of $5,591. No depreciation has been recognized in connection with one piece of computer equipment which has yet to be put into service. <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td nowrap="nowrap" colspan="3" style="padding-right: 5.4pt; padding-left: 5.4pt; font: 11pt Calibri, Helvetica, Sans-Serif">Property Plant and Equipment</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt"> </td></tr> <tr style="vertical-align: bottom"> <td nowrap="nowrap" style="width: 43%; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td nowrap="nowrap" style="width: 1%; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td nowrap="nowrap" style="width: 1%; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td nowrap="nowrap" style="width: 11%; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td nowrap="nowrap" style="width: 11%; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td nowrap="nowrap" style="width: 11%; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td nowrap="nowrap" style="width: 11%; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td nowrap="nowrap" style="width: 11%; padding-right: 5.4pt; padding-left: 5.4pt"> </td></tr> <tr style="vertical-align: bottom"> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt">Acquisition Cost</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td nowrap="nowrap" colspan="4" style="padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt">Estimated useful Life (Months)</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt">Total</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt">Office Equipment</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt; text-align: right">30</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt; text-align: right">3,235 </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td nowrap="nowrap" colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt">Medical Equipment</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt; text-align: right">30</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt; text-align: right">17,523 </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td nowrap="nowrap" colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt">Computer Equipment</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt; text-align: right">30</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt; text-align: right">2,126 </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt">Subtotal</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt; text-align: right">22,884 </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td nowrap="nowrap" colspan="3" style="padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt">Less Accumulated Depreciation</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt; text-align: right">(14,052)</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt">Total</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt; text-align: right">8,832 </td></tr> </table>   F. FAIR VALUE OF FINANCIAL INSTRUMENTS   Fair value is the price that would be received for an asset or the exit price that would be paid to transfer a liability in the principal or most advantageous market in an orderly transaction between market participants on the measurement date.  A fair value hierarchy requires an entity to maximize the use of observable inputs, where available. The following summarizes the three levels of inputs required by the standard that the Company uses to measure fair value:   Level 1:  Quoted prices in active markets for identical assets or liabilities   Level 2:  Observable inputs other than Level 1 prices, such as quoted prices for similar assets or liabilities;  quoted prices in markets that are not active, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the related assets or liabilities.   Level 3:  Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities.   The Companys financial instruments as of August 31, 2012 consisted of $261,831, of Notes Payable, $121,495 of Convertible Notes payable (net of discount), $8,000 due to TheraCyte, Inc, $4,349 of Employee Receivables and $39,140 due from an affiliate. The fair value of all of the Companys financial instruments as of September 30, 2012 were valued according to the Level 3 input. The carrying amount  of the financial instruments is equal to the fair value as determined by the Company.   The Company has determined that there are no Level 1 or Level 2 inputs for determining the fair value of the Companys financial instruments. Fair value was determined by the Company utilizing its own assumptions and estimation. There were no transfers between levels for the period presented.   G. INCOME TAXES   The Company accounts for income taxes using the liability method prescribed by ASC 740, Income Taxes. Under this method, deferred tax assets and liabilities are determined based on the difference between the financial reporting and tax bases of assets and liabilities using enacted tax rates that will be in effect in the year in which the differences are expected to reverse. The Company records a valuation allowance to offset deferred tax assets if based on the weight of available evidence, it is more-likely-than-not that some portion, or all, of the deferred tax assets will not be realized. The effect on deferred taxes of a change in tax rates is recognized as income or loss in the period that includes the enactment date.   The Company applied the provisions of ASC 740-10-50, Accounting For Uncertainty In Income Taxes, which provides clarification related to the process associated with accounting for uncertain tax positions recognized in our financial statements. Audit periods remain open for review until the statute of limitations has passed. The completion of review or the expiration of the statute of limitations for a given audit period could result in an adjustment to the Companys liability for income taxes. Any such adjustment could be material to the Companys results of operations for any given quarterly or annual period based, in part, upon the results of operations for the given period. As of August 31, 2011 and 2010, the Company had no uncertain tax positions, and will continue to evaluate for uncertain positions in the future.   The Company generated a deferred tax credit through net operating loss carry forward.  However, a valuation allowance of 100% has been established.   Interest and penalties on tax deficiencies recognized in accordance with ACS accounting standards are classified as income taxes in accordance with ASC Topic 740-10-50-19.   H.  BASIC EARNINGS (LOSS) PER SHARE    The Financial Accounting Standards Board (FASB) issued Accounting Standards Codification (ASC) 260, "Earnings Per Share", which specifies the computation, presentation and disclosure requirements for earnings (loss) per share for entities with publicly held common stock. ASC 260 requires the presentation of basic earnings (loss) per share and diluted earnings (loss) per share. The Company has adopted the provisions of ASC 260 effective from inception. Basic net loss per share amounts is computed by dividing the net income by the weighted average number of common shares outstanding. All convertible debt has an anti-dilutive effect on the EPS , therefore Diluted earnings per share are the same as basic earnings per share.

A. BASIS OF ACCOUNTING   The financial statements have been prepared using the basis of accounting generally accepted in the United States of America. Under this basis of accounting, revenues are recorded as earned and expenses are recorded at the time liabilities are incurred. The Company has adopted an August 31 fiscal  year-end. The Company recognizes revenue from services and product sales when the following four revenue recognition criteria are met: persuasive evidence of an arrangement exists, delivery has occurred or services have been rendered, the selling price is fixed or determinable, and collectability is reasonably assured. Product sales and service revenues are recorded when the products are delivered and title passes to customers. The customers credit card is authorized and charged, or checks/cash are received at the time the services are rendered, thereby providing reasonable assurance of collectability.

B. PRINCIPLES OF CONSOLIDATION   The consolidated financial statements include the accounts of  Entest CA, the Companys wholly owned subsidiary. Significant inter-company transactions have been eliminated.

C. USE OF ESTIMATES   The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.

D. CASH EQUIVALENTS   The Company considers all highly liquid investments with a maturity of three months or less when purchased to be cash equivalents.

E. PROPERTY AND EQUIPMENT   Property and equipment are recorded at cost. Maintenance and repairs are expensed in the year in which they are incurred. Property and equipment consist of Office Equipment, medical Equipment and Computer Equipment. Expenditures that enhance the value of property and equipment are capitalized. All property and equipment is depreciated utilizing the Straight Line Method for a period of thirty months , such period being estimated by the Company to represent the useful life of the assets. For the Fiscal Year ended August 31, 2012 the Company incurred depreciation expense of $8,461 and for the Fiscal Year ended August 31, 2011 the Company incurred depreciation expense of $5,591. No depreciation has been recognized in connection with one piece of computer equipment which has yet to be put into service. <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td nowrap="nowrap" colspan="3" style="padding-right: 5.4pt; padding-left: 5.4pt; font: 11pt Calibri, Helvetica, Sans-Serif">Property Plant and Equipment</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt"> </td></tr> <tr style="vertical-align: bottom"> <td nowrap="nowrap" style="width: 43%; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td nowrap="nowrap" style="width: 1%; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td nowrap="nowrap" style="width: 1%; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td nowrap="nowrap" style="width: 11%; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td nowrap="nowrap" style="width: 11%; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td nowrap="nowrap" style="width: 11%; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td nowrap="nowrap" style="width: 11%; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td nowrap="nowrap" style="width: 11%; padding-right: 5.4pt; padding-left: 5.4pt"> </td></tr> <tr style="vertical-align: bottom"> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt">Acquisition Cost</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td nowrap="nowrap" colspan="4" style="padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt">Estimated useful Life (Months)</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt">Total</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt">Office Equipment</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt; text-align: right">30</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt; text-align: right">3,235 </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td nowrap="nowrap" colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt">Medical Equipment</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt; text-align: right">30</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt; text-align: right">17,523 </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td nowrap="nowrap" colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt">Computer Equipment</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt; text-align: right">30</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt; text-align: right">2,126 </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt">Subtotal</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt; text-align: right">22,884 </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td nowrap="nowrap" colspan="3" style="padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt">Less Accumulated Depreciation</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt; text-align: right">(14,052)</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt">Total</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt; text-align: right">8,832 </td></tr> </table>

F. FAIR VALUE OF FINANCIAL INSTRUMENTS   Fair value is the price that would be received for an asset or the exit price that would be paid to transfer a liability in the principal or most advantageous market in an orderly transaction between market participants on the measurement date.  A fair value hierarchy requires an entity to maximize the use of observable inputs, where available. The following summarizes the three levels of inputs required by the standard that the Company uses to measure fair value:   Level 1:  Quoted prices in active markets for identical assets or liabilities   Level 2:  Observable inputs other than Level 1 prices, such as quoted prices for similar assets or liabilities;  quoted prices in markets that are not active, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the related assets or liabilities.   Level 3:  Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities.   The Companys financial instruments as of August 31, 2012 consisted of $261,831, of Notes Payable, $121,495 of Convertible Notes payable (net of discount), $8,000 due to TheraCyte, Inc, $4,349 of Employee Receivables and $39,140 due from an affiliate. The fair value of all of the Companys financial instruments as of September 30, 2012 were valued according to the Level 3 input. The carrying amount  of the financial instruments is equal to the fair value as determined by the Company.   The Company has determined that there are no Level 1 or Level 2 inputs for determining the fair value of the Companys financial instruments. Fair value was determined by the Company utilizing its own assumptions and estimation. There were no transfers between levels for the period presented.

G. INCOME TAXES   The Company accounts for income taxes using the liability method prescribed by ASC 740, Income Taxes. Under this method, deferred tax assets and liabilities are determined based on the difference between the financial reporting and tax bases of assets and liabilities using enacted tax rates that will be in effect in the year in which the differences are expected to reverse. The Company records a valuation allowance to offset deferred tax assets if based on the weight of available evidence, it is more-likely-than-not that some portion, or all, of the deferred tax assets will not be realized. The effect on deferred taxes of a change in tax rates is recognized as income or loss in the period that includes the enactment date.   The Company applied the provisions of ASC 740-10-50, Accounting For Uncertainty In Income Taxes, which provides clarification related to the process associated with accounting for uncertain tax positions recognized in our financial statements. Audit periods remain open for review until the statute of limitations has passed. The completion of review or the expiration of the statute of limitations for a given audit period could result in an adjustment to the Companys liability for income taxes. Any such adjustment could be material to the Companys results of operations for any given quarterly or annual period based, in part, upon the results of operations for the given period. As of August 31, 2011 and 2010, the Company had no uncertain tax positions, and will continue to evaluate for uncertain positions in the future.   The Company generated a deferred tax credit through net operating loss carry forward.  However, a valuation allowance of 100% has been established.   Interest and penalties on tax deficiencies recognized in accordance with ACS accounting standards are classified as income taxes in accordance with ASC Topic 740-10-50-19.

H.  BASIC EARNINGS (LOSS) PER SHARE    The Financial Accounting Standards Board (FASB) issued Accounting Standards Codification (ASC) 260, "Earnings Per Share", which specifies the computation, presentation and disclosure requirements for earnings (loss) per share for entities with publicly held common stock. ASC 260 requires the presentation of basic earnings (loss) per share and diluted earnings (loss) per share. The Company has adopted the provisions of ASC 260 effective from inception. Basic net loss per share amounts is computed by dividing the net income by the weighted average number of common shares outstanding. All convertible debt has an anti-dilutive effect on the EPS , therefore Diluted earnings per share are the same as basic earnings per share.

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td nowrap="nowrap" colspan="3" style="padding-right: 5.4pt; padding-left: 5.4pt; font: 11pt Calibri, Helvetica, Sans-Serif">Property Plant and Equipment</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt"> </td></tr> <tr style="vertical-align: bottom"> <td nowrap="nowrap" style="width: 43%; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td nowrap="nowrap" style="width: 1%; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td nowrap="nowrap" style="width: 1%; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td nowrap="nowrap" style="width: 11%; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td nowrap="nowrap" style="width: 11%; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td nowrap="nowrap" style="width: 11%; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td nowrap="nowrap" style="width: 11%; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td nowrap="nowrap" style="width: 11%; padding-right: 5.4pt; padding-left: 5.4pt"> </td></tr> <tr style="vertical-align: bottom"> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt">Acquisition Cost</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td nowrap="nowrap" colspan="4" style="padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt">Estimated useful Life (Months)</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt">Total</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt">Office Equipment</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt; text-align: right">30</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt; text-align: right">3,235 </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td nowrap="nowrap" colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt">Medical Equipment</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt; text-align: right">30</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt; text-align: right">17,523 </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td nowrap="nowrap" colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt">Computer Equipment</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt; text-align: right">30</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt; text-align: right">2,126 </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt">Subtotal</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt; text-align: right">22,884 </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td nowrap="nowrap" colspan="3" style="padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt">Less Accumulated Depreciation</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt; text-align: right">(14,052)</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt">Total</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt; text-align: right">8,832 </td></tr> </table>

261831

1.00

P30M P30M P30M

22884

8832

-14052

3235

17523

2126

NOTE 3.  RECENT ACCOUNTING PRONOUNCEMENTS   On May 2011, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) No. 2011-04, "Amendments to Achieve Common Fair Value Measurement and Disclosure Requirements in U.S. GAAP and IFRSs." The amendments in this update generally represent clarifications of Topic 820, but also include some instances where a particular principle or requirement for measuring fair value or disclosing information about fair value measurements has changed. This update results in common principles and requirements for measuring fair value and for disclosing information about fair value measurements in accordance with U.S. GAAP and IFRS. The amendments in this update are to be applied prospectively. The amendments are effective for interim and annual periods beginning after December 15, 2011. Early application is not permitted. The Company does not expect this guidance to have a significant impact on its consolidated financial position, results of operations or cash flows.   In June 2011, the FASB issued ASU No. 2011-05, "Presentation of Comprehensive Income." This update was amended in December 2011 by ASU No. 2011-12, "Deferral of the Effective Date for Amendments to the Presentation of Reclassifications of Items Out of Accumulated Other Comprehensive Income in Accounting Standards Update No. 2011-05." This update defers only those changes in update 2011-05 that relate to the presentation of reclassification adjustments. All other requirements in update 2011-05 are not affected by this update, including the requirement to report comprehensive income either in a single continuous financial statement or in two separate but consecutive financial statements. ASU No. 2011-05 and 2011-12 are effective for fiscal years (including interim periods) beginning after December 15, 2011. The Company does not expect this guidance to have a significant impact on its consolidated financial position, results of operations or cash flows.   In December 2011, the FASB issued ASU No. 2011-11, "Disclosures about Offsetting Assets and Liabilities." The amendments in this update require enhanced disclosures around financial instruments and derivative instruments that are either (1) offset in accordance with either ASC 210-20-45 or ASC 815-10-45 or (2) subject to an enforceable master netting arrangement or similar agreement, irrespective of whether they are offset in accordance with either ASC 210-20-45 or ASC 815-10-45. An entity should provide the disclosures required by those amendments retrospectively for all comparative periods presented. The amendments are effective during interim and annual periods beginning on or after January 1, 2013. The Company does not expect this guidance to have any impact on its consolidated financial position, results of operations or cash flows.   A variety of proposed or otherwise potential accounting standards are currently under study by standard setting organizations and various regulatory agencies.  Due to the tentative and preliminary nature of those proposed standards, the Companys management has not determined whether implementation of such standards would be material to its financial statements.

NOTE 4.  GOING CONCERN   The accompanying financial statements have been prepared assuming that the Company will continue as a going concern. The Company generated net losses of $3,664,302 during the period from August 22, 2008 (inception) through August 31, 2012. This condition raises substantial doubt about the Company's ability to continue as a going concern. The Company's continuation as a going concern is dependent on its ability to meet its obligations, to obtain additional financing as may be required and ultimately to attain profitability. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.   Management plans to raise additional funds primarily by offering securities for cash. Management has raised $197,500 net of legal expenses in the twelve months ended August 31, 2012 through the issuance of convertible notes. The Company has also raised $261,475 from other borrowings during the twelve month ended August 31, 2012.   On June 1, 2012 the Company entered into an Equity Purchase Agreement (the "June Purchase Agreement") with Southridge Partners II, LP, a Delaware limited partnership ("Southridge").   Under the terms of the June Purchase Agreement, Southridge will purchase, at the Company's election, up to $10,000,000 of the Company's registered common stock (the "Shares"). During the term of the Purchase Agreement, the Company may at any time deliver a "put notice" to Southridge thereby requiring Southridge to purchase a certain dollar amount of the Shares. Simultaneous with the delivery of such Shares, Southridge shall deliver payment for the Shares. Subject to certain restrictions, the purchase price for the Shares shall be equal to 91% of the average of the two lowest Closing Prices during the Valuation Period as such capitalized terms are defined in the Agreement.   The number of Shares sold to Southridge shall not exceed the number of such shares that, when aggregated with all other shares of common stock of the Company then beneficially owned by Southridge, would result in Southridge owning more than 9.99% of all of the Company's common stock then outstanding. Additionally, Southridge may not execute any short sales of the Company's common stock.   Any sale of Shares pursuant to the June Agreement is subject to a Registration Statement filed under the Securities Act of 1933 remaining effective for the sale by Southridge of those Shares.   June Agreement shall terminate (i) on the date on which Southridge shall have purchased Shares pursuant to this Agreement for an aggregate Purchase Price of $10,000,000, or (ii) on the date occurring 24 months from the date on which the June Agreement was executed and delivered by the Company and Southridge.   The Company has also agreed to pay the following to Capital Path Securities LLC for acting as the Companys exclusive advisor and placement agent in connection with the June Purchase Agreement a  cash placement fee of 5% of funds received by the Company through the sale of Shares to Southridge as such funds are received by the Company.   On June 12, 2012 a registration statement on form S-1 was filed with the United States Securities and Exchange Commission registering 46,238,705 shares of the Companys   common stock that will be put to Southridge pursuant to the June Agreement which was declared effective by the United States Securities and Exchange Commission on August 27, 2012.   There is no guarantee that the Company will be able to raise additional capital through offerings.

3664302

261475

197500

10000000

0.91

0.0999

0.05 46238705

NOTE 5.  NOTES PAYABLE    As of August 31, 2012 <table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td nowrap="nowrap" style="width: 79%; padding-right: 5.4pt; padding-left: 5.4pt">     Current :</td> <td nowrap="nowrap" style="width: 21%; padding-right: 5.4pt; padding-left: 5.4pt; font-size: 12pt"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">Bio Technology Partners Business Trust</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">13500</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">Venture Bridge Advisors, Inc.</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">32508</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">Southridge Partners II LLP</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">40000</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">Sherman Family Trust</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">79000</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">Officer Loans (Note 6)</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">30,180</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-right: 5.4pt; padding-left: 5.4pt">Current portion of amounts to be paid on</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; font-size: 12pt"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-right: 5.4pt; padding-left: 5.4pt">behalf of Gregory McDonald and Pet Pointers, Inc. (Note 10  )</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">30174</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">8% Convertible Notes (Note14 )</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">105,500</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">10% Convertible Note (Note 14)</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">59000</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">Total:</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">389862</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; font-size: 12pt"> </td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; font-size: 12pt"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">Long Term:</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; font-size: 12pt"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">Long Term portion of amounts to be paid on</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; font-size: 12pt"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">behalf of Gregory McDonald and</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; font-size: 12pt"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">Pet Pointers, Inc. (Note 10  )</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">36469</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">Total:</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">36469</td></tr> </table>   Both of Bio Technology Partners Business Trust and Venture Bridge Advisors have provided lines of credit to the Company in the amount of $200,000 each or so much thereof as may be disbursed to, or for the benefit of the Company by Lender in Lender's sole and absolute discretion. The unpaid principal of these lines of credit bear simple interest at the rate of ten percent per annum. Interest is calculated based on the principal balance as may be adjusted from time to time to reflect additional advances or payments made hereunder. Principal balance and accrued interest shall become due and payable in whole or in part at the demand of the Lender. The Sherman Family Trust has provided a line of credit to the Company in the amount of $____ or so much thereof as may be disbursed to, or for the benefit of the Company by Lender in Lender's sole and absolute discretion. The unpaid principal of this line of credit bears simple interest at the rate of ten percent per annum. Interest is calculated based on the principal balance as may be adjusted from time to time to reflect additional advances or payments made hereunder. Principal balance and accrued interest shall become due and payable in whole or in part at the demand of the Lender. $40,000 loaned to the Company by Southridge Partners II LLP bears no stated interest rate and is payable at the demand of Southridge Partners II LLP.

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td nowrap="nowrap" style="width: 79%; padding-right: 5.4pt; padding-left: 5.4pt">     Current :</td> <td nowrap="nowrap" style="width: 21%; padding-right: 5.4pt; padding-left: 5.4pt; font-size: 12pt"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">Bio Technology Partners Business Trust</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">13500</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">Venture Bridge Advisors, Inc.</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">32508</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">Southridge Partners II LLP</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">40000</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">Sherman Family Trust</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">79000</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">Officer Loans (Note 6)</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">30,180</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-right: 5.4pt; padding-left: 5.4pt">Current portion of amounts to be paid on</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; font-size: 12pt"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-right: 5.4pt; padding-left: 5.4pt">behalf of Gregory McDonald and Pet Pointers, Inc. (Note 10  )</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">30174</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">8% Convertible Notes (Note14 )</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">105,500</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">10% Convertible Note (Note 14)</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">59000</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">Total:</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">389862</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; font-size: 12pt"> </td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; font-size: 12pt"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">Long Term:</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; font-size: 12pt"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">Long Term portion of amounts to be paid on</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; font-size: 12pt"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">behalf of Gregory McDonald and</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; font-size: 12pt"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">Pet Pointers, Inc. (Note 10  )</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">36469</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">Total:</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">36469</td></tr> </table>

0.10

200000

40000

13500

32508

40000

79000

30174

30180

105500

59000

389862

36469

NOTE 6.  RELATED PARTY TRANSACTIONS   During the quarter ended November 30, 2011 David Koos made loans to the Company totaling $8,400. These loans are due and payable at the demand of David  Koos and bear simple interest at a rate of 15% per annum.   During the quarter ended February 29, 2012 David Koos made loans to the Company totaling $7,550. These loans are due and payable at the demand of David  Koos and bear simple interest at a rate of 15% per annum.   During the quarter ended February 29, 2012 David Koos granted to the Sherman Family Trust, an irrevocable trust for the benefit of Blossom Sherman, all rights to and interest in $25,956 in unpaid indebtedness owed by the Company (bearing simple interest at a rate of 15% per annum and due and payable at the demand of the holder) as well as $3,051 in unpaid interest owed by the Company.   During the quarter ended May 31, 2012 David Koos made loans to the Company in the amount of  $13,625. These loans are due and payable at the demand of David  Koos and bear simple interest at a rate of 15% per annum   As of August 31, 2012 the Company remains indebted to David R. Koos in the principal amount of $30,180 due and payable at the demand of David  Koos and bearing simple interest at a rate of 15% per annum   As of August 31 , 2012 Bio-Matrix Scientific Group, Inc. (BMSN) , a major shareholder of the Company, is indebted to the Company in the amount of $39,140. This amount is non interest bearing and is due at the demand of the Company.

8400

7550

13625

0.15

25956

3051

0.15

30180

0.15

39140

NOTE 7.  INCOME TAXES   <table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr> <td style="font-size: 1pt"> </td> <td style="width: 17px; font-size: 1pt"> </td> <td style="width: 159px; font-size: 1pt"> </td> <td style="width: 1px; font-size: 1pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: black 2.25pt solid; font-weight: bold">As of August 31, 2012</td> <td colspan="2" style="border-bottom: black 2.25pt solid; text-align: right"> </td> <td style="border-bottom: black 2.25pt solid"> </td></tr> <tr style="vertical-align: bottom"> <td> </td> <td colspan="2" style="text-align: right"> </td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td>Deferred tax assets:</td> <td colspan="2"> </td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>Net operating tax carry forwards</td> <td>$</td> <td style="text-align: right">1,250,503 </td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td>Other</td> <td style="border-bottom: black 2.25pt double"> </td> <td style="border-bottom: black 2.25pt double; text-align: right">-0- </td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>Gross deferred tax assets</td> <td> </td> <td style="text-align: right">1,250,503 </td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td>Valuation allowance</td> <td style="border-bottom: black 2.25pt double"> </td> <td style="border-bottom: black 2.25pt double; text-align: right">(1,250,503)</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td></tr> <tr style="background-color: #CCEEFF"> <td style="vertical-align: bottom">Net deferred tax assets</td> <td style="vertical-align: bottom; border-bottom: black 2.25pt double">$</td> <td style="vertical-align: bottom; border-bottom: black 2.25pt double; text-align: right">-0- </td> <td> </td></tr> </table>   As of  August 31 ,2012  the Company has a Deferred Tax Asset of $1,250,503 completely attributable to net operating loss carry forwards of approximately $3,677,949  (which expire 20 years from the date the loss was incurred) consisting of:   (a) $ 13,647 of Net Operating Loss carry forwards acquired in the reverse acquisition of Entest BioMedical, Inc., a California corporation, and (b) $ 3,664,302  of Net Operating Loss carry forwards attributable to Entest BioMedical, Inc.   Realization of deferred tax assets is dependent upon sufficient future taxable income during the period that deductible temporary differences and carry forwards are expected to be available to reduce taxable income. A valuation allowance is recorded when it is more likely-than-not that a deferred tax asset will not be realized. In addition, the reverse acquisition in which Entest BioMedical, Inc. was involved in 2009 has resulted in a change of control.  Internal Revenue Code Sec 382 limits the amount of income that may be offset by net operating loss (NOL) carryovers after an ownership change. As a result, the Company has recorded a valuation allowance reducing all deferred tax assets to $ -0-.   Income tax is calculated at the 34% Federal Corporate Rate.

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr> <td style="font-size: 1pt"> </td> <td style="width: 17px; font-size: 1pt"> </td> <td style="width: 159px; font-size: 1pt"> </td> <td style="width: 1px; font-size: 1pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: black 2.25pt solid; font-weight: bold">As of August 31, 2012</td> <td colspan="2" style="border-bottom: black 2.25pt solid; text-align: right"> </td> <td style="border-bottom: black 2.25pt solid"> </td></tr> <tr style="vertical-align: bottom"> <td> </td> <td colspan="2" style="text-align: right"> </td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td>Deferred tax assets:</td> <td colspan="2"> </td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>Net operating tax carry forwards</td> <td>$</td> <td style="text-align: right">1,250,503 </td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td>Other</td> <td style="border-bottom: black 2.25pt double"> </td> <td style="border-bottom: black 2.25pt double; text-align: right">-0- </td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>Gross deferred tax assets</td> <td> </td> <td style="text-align: right">1,250,503 </td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td>Valuation allowance</td> <td style="border-bottom: black 2.25pt double"> </td> <td style="border-bottom: black 2.25pt double; text-align: right">(1,250,503)</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td></tr> <tr style="background-color: #CCEEFF"> <td style="vertical-align: bottom">Net deferred tax assets</td> <td style="vertical-align: bottom; border-bottom: black 2.25pt double">$</td> <td style="vertical-align: bottom; border-bottom: black 2.25pt double; text-align: right">-0- </td> <td> </td></tr> </table>

1250503

-1250503

3677949

P20Y

13647

3664302

0.34

NOTE 8.  ACQUISITION OF ENTEST CA   On July 10, 2009 the Company acquired 100% of Entest CA, a California corporation and wholly owned subsidiary of the Company, from BMSN for consideration consisting of (a) the issuance to BMSN of 10,000,000 newly issued common shares of Entest and (b) the return by Mr. Rick Plote of 10,000,000 shares of Entests common stock previously issued to him by Entest for cancellation.

10000000

NOTE 9.  ACQUISITION OF THE ASSETS OF PET POINTERS, INC.   On January 4, 2011Entest CA acquired from Pet Pointers, Inc., a California corporation doing business as McDonald Animal Hospital (Seller), and Dr. Gregory McDonald DVM (McDonald) all the goodwill from McDonald and assets of Seller except cash and accounts receivables used in connection with the operation of a veterinary medical clinic located at 225 S. Milpas Street, Santa Barbara, CA 93103 (the "Business").   Consideration for the acquisition consisted of:      I. $70,000 in cash      II. $210,000 of the Companys  common shares valued at the closing price per share as of January 4, 2011      III. Payment of no more than $78,000 to a creditor of the Seller to be paid in monthly installments of $1,500 per month      IV. Payment of no more than $25,000 to additional creditors of the Seller to be paid in monthly installments of $825 per month      V. Payment of $50,000 to McDonald on the first business day of the fourth month following the closing of the acquisition (Closing)

70000

210000

1500

78000

25000

825 50000

NOTE 10. COMMITMENTS AND CONTINGECIES   On November 1, 2011, the Company entered into an agreement to lease approximately 2,320 square feet of office space beginning December 1, 2011 for a period of five years.   Rent to be charged to the Company pursuant to the lease is as follows:   $2,996 per month for the period beginning December 1, 2011 and ending November 30, 2012 $3,116 per month for the period beginning December 1, 2012 and ending November 30, 2013 $3,241 per month for the period beginning December 1, 2013 and ending November 30, 2014 $3,371 per month for the period beginning December 1, 2014 and ending November 30, 2015 $3,506 per month for the period beginning December 1, 2015 and ending November 30, 2016   This property is utilized as office space. The Company believes that the foregoing property is adequate to meet its current needs. While it is anticipated that the Company will require access to laboratory facilities in the future, the Company believes that access to such facilities are available from a variety of sources.   On January 4, 2011, as part of the asset purchase agreement with the Company and Gregory McDonald and Pet Pointers, Inc., the Company pays on behalf of Gregory McDonald and Pet Pointers monthly rent of $7,526 to Anthony Marinelli for the terms indicated in the Gregory McDonald / Pet Pointers lease.  These payments are not obligations of the Company but, are payments the Company agreed to make on behalf of Gregory McDonald and Pet Pointers as part of the Asset Purchase Agreement.   On January 4, 2011, as part of the asset purchase agreement with the Company and Gregory McDonald on behalf of Pet Pointers, Inc., the Company pays on behalf of Gregory McDonald and Pet Pointers monthly payments of $1,500 to Anthony and Judi Marinelli towards the extinguishment of a total note of $78,000. These payments are payments the Company agreed to make on behalf of Gregory McDonald and Pet Pointers.   On January 4, 2011, as part of the asset purchase agreement with the Company and Gregory McDonald on behalf of Pet Pointers, Inc., the Company pays on behalf of Gregory McDonald and Pet Pointers an installment agreement due to the Franchise Tax Board in the amount of $11,405 with monthly payments of $400. These payments are payments the Company agreed to make on behalf of Gregory McDonald and Pet Pointers.   On January 4, 2011, as part of the asset purchase agreement with the Company and Gregory McDonald on behalf of Pet Pointers, Inc., the Company pays on behalf of Gregory McDonald and Pet Pointers an installment agreement due to the Internal Revenue Service in the amount of $13,595 with monthly payments of $425. These payments are payments the Company agreed to make on behalf of Gregory McDonald and Pet Pointers.   On February 3, 2011, a Complaint (Complaint) was filed in the U.S. District Court Middle District of the State of Pennsylvania against the Company, the Companys Chairman and BMSN. by 18KT.TV LLC (Plaintiffs) seeking to recover general damages from the Company. in excess of $125,000. The Complaint alleges breach of contract and unjust enrichment relating to an investor relations contract executed by the Company and Craig Fischer (on behalf of 18KT.TV LLC). The Complaint also seeks similar damages from BMSN. The Company believes that the allegations in the complaint are without merit and intends to vigorously defend its interests in this matter. At this time, it is not possible to predict the ultimate outcome of these matters.   On May 24, 2012, a Complaint (Complaint) was filed in the U.S. Bankruptcy Court for the District of Oregon against the Company by Titterington Veterinary Services Inc. (TVS). The Complaint is an adversary proceeding filed by TVS arising from TVSs bankruptcy case currently pending in U.S. Bankruptcy Court for the District of Oregon. The Complaint alleges Breach of Contract resulting from the Companys alleged failure to pay certain expenses the Company was required to pay pursuant to an agreement with TVS, Dr. Ronald Titterington, DVM and Dr. Kathy Snell, DVM (TVS Agreement). TVS is seeking a judgment and money award against the Company in an amount to be proven at trial which TVS estimates in the Complaint to be up to $50,000. TVS is also seeking a judgment and order against the Company to provide an accounting of all revenues received by the Company pursuant to the TVS Agreement, all expenses paid, unpaid, and due and owing  pursuant to the TVS Agreement as well as a revenue share which TVS claims is due them pursuant to the TVS Agreement. TVS is also seeking a judgment requiring the Company to turn over a sum of money equal to expenses the Company was obligated to pay pursuant to the TVS Agreement. TVS is also seeking attorneys fees and expenses.  The Company believes that the allegations in the complaint are without merit and intends to vigorously defend its interests in this matter. At this time, it is not possible to predict the ultimate outcome of these matters and an outcome unfavorable to the Company may have a material adverse effect on the Company. On September 19, 2012 the Plaintiffs Claim for Relief for turnover and an accounting under 11 U.S.C. § 542 and the Plaintiff's Claim for Relief for attorney fees were dismissed with prejudice and , as per the claim of breach of contract, the proceeding was transferred to the United States Bankruptcy Court for the District of Southern California for all further proceedings.   On October 10, 2012 a Complaint(Complaint) was filed in the Superior Court of the State of California against the Company and David Koos by Dr. Gregory McDonald, a former employee of the Company, alleging breach of contract and breach of the covenant of good faith and dealing in connection with the assumption of lease obligations by the Company in connection with the acquisition of the assets of Pet Pointers, Inc (Acquisition) (Note 9) breach of contract and breach of the covenant of good faith and dealing in connection with an employment agreement enters into with Dr. McDonald inc connection with the Acquisition, breach of contract in connection with the Acquisition purchase agreement, breach of the covenant of good faith and dealing in connection with the Acquisition purchase agreement, implied indemnity in connection to amounts owed by Dr. McDonald to Anthony and Judi Marinelli, the Internal Revenue Service, and the California Franchise Tax Board, intentional misrepresentation, negligent misrepresentation , failure to pay wages and violations of Sections 2802, 203, and 2806 of the California Labor Code. The Complaint seeks judgment for nominal damages, actual damages, compensatory damages, lost wages, compensation, expenses wage benefits and penalties pursuant to California Labor Code Sections 203 et al, 2802 and 2806, indemnification, accrued interest, punitive damages, costs of suit and attorneys fees.   There were no other legal proceedings against the Company with respect to matters arising in the ordinary course of business. The Company is not involved in any other litigation either as plaintiffs or defendants, and has no knowledge of any threatened or pending litigation against the Company.   On June 1, 2012 the Company entered into an Equity Purchase Agreement (the "June Purchase Agreement") with Southridge Partners II, LP, a Delaware limited partnership ("Southridge").   Under the terms of the June Purchase Agreement, Southridge will purchase, at the Company's election, up to $10,000,000 of the Company's registered common stock (the "Shares"). During the term of the Purchase Agreement, the Company may at any time deliver a "put notice" to Southridge thereby requiring Southridge to purchase a certain dollar amount of the Shares. Simultaneous with the delivery of such Shares, Southridge shall deliver payment for the Shares. Subject to certain restrictions, the purchase price for the Shares shall be equal to 91% of the average of the two lowest Closing Prices during the Valuation Period as such capitalized terms are defined in the Agreement.   The number of Shares sold to Southridge shall not exceed the number of such shares that, when aggregated with all other shares of common stock of the Company then beneficially owned by Southridge, would result in Southridge owning more than 9.99% of all of the Company's common stock then outstanding. Additionally, Southridge may not execute any short sales of the Company's common stock.   Any sale of Shares pursuant to the June Agreement is subject to a Registration Statement filed under the Securities Act of 1933 remaining effective for the sale by Southridge of those Shares.   June Agreement shall terminate (i) on the date on which Southridge shall have purchased Shares pursuant to this Agreement for an aggregate Purchase Price of $10,000,000, or (ii) on the date occurring 24 months from the date on which the June Agreement was executed and delivered by the Company and Southridge.   The Company has also agreed to pay the following to Capital Path Securities LLC for acting as the Companys exclusive advisor and placement agent in connection with the June Purchase Agreement a  cash placement fee of 5% of funds received by the Company through the sale of Shares to Southridge as such funds are received by the Company.

P5Y

2996

3116

3241

3371

3506

7526

78000

1500

11405

400

13595

425

50000

NOTE 11. NON VOTING CONVERTIBLE PREFERRED STOCK   On March 27, 2012 the company issued to Southridge 75,000 shares of its nonvoting convertible preferred stock to Southridge in accordance with the terms of an Equity Purchase Agreement entered into by and between the Company and Southridge which was terminated at the Companys option on June 1, 2012 (February Purchase Agreement).   Non Voting Convertible Preferred Stock is convertible at the option of the holder into shares of the Companys common stock at a conversion price equal to seventy percent (70%) of the lowest Closing Price for the five (5) trading days immediately preceding written receipt by the Company of the holders intent to convert.   CLOSING PRICE" shall mean the closing bid price for the Companys common stock on the Principal Market on a Trading Day as reported by Bloomberg Finance L.P.   PRINCIPAL MARKET" shall mean the principal trading exchange or market for the Companys common stock.   TRADING DAY shall mean a day on which the Principal Market shall be open for business.   The issuance of 75,000 shares of the Companys nonvoting convertible preferred stock to Southridge resulted in recognition of a beneficial conversion feature in the amount of $32,142. Accordingly, the Company recorded a deemed dividend on the 75,000 shares of the Companys nonvoting convertible preferred stock of $32,142.

0.70 0.70

75000

32142

NOTE 12. DIVIDEND OF SERIES B PREFERRED SHARES   On March 6, 2012 a dividend of 3, 201,397 shares of Series B Preferred Stock was paid to the Companys common shareholders of record as of February 21, 2012.

NOTE 13. STOCKHOLDERS EQUITY   The stockholders' equity section of the Company contains the following classes of capital stock as of August 31, 2012:   Common Stock:   $0.001 par value, 1,000,000,000 shares authorized 222,791,778 shares issued and outstanding as of August 31, 2012.   Preferred Stock:   $0.001 par value 5,000,000 shares authorized of 100,000 shares authorized is authorized as Series AA Preferred Stock , $001 par value of which 5,000 shares are issued and outstanding  as of  February 29, 2012  and 4,400,000 is authorized as Series B Preferred Stock of which 3, 201,397  shares are issued and outstanding as of August 31, 2012.   Upon any liquidation, dissolution, or winding up of the Company, whether voluntary or involuntary (collectively, a Liquidation), before any distribution or payment shall be made to any of the holders of Common Stock or any other series of preferred stock, the holders of Series B Preferred Stock shall be entitled to receive out of the assets of the Company, whether such assets are capital, surplus or earnings, an amount equal to $0.10 per share of Series B Preferred Stock (the Liquidation Amount) plus all declared and unpaid dividends thereon, for each share of Series B Preferred Stock held by them.   If, upon any Liquidation, the assets of the Company shall be insufficient to pay the Liquidation Amount, together with declared and unpaid dividends thereon, in full to all holders of Series B Preferred Stock, then the entire net assets of the Company shall be distributed among the holders of the Series B Preferred Stock, ratably in proportion to the full amounts to which they would otherwise be respectively entitled and such distributions may be made in cash or in property taken at its fair value (as determined in good faith by the Board), or both, at the election of the Board..   Non Voting Convertible Preferred Stock having a $1.00 par value:   200,000 shares authorized of which 75, 000 shares are issued and outstanding as of August 31, 2102.   Non Voting Convertible Preferred Stock shall convert at the option of the holder into shares of the corporations common stock at a conversion price equal to seventy percent (70%) of the lowest Closing Price for the five (5) trading days immediately preceding written receipt by the corporation of the holders intent to convert.   CLOSING PRICE" shall mean the closing bid price for the corporations common stock on the Principal Market on a Trading Day as reported by Bloomberg Finance L.P.   PRINCIPAL MARKET" shall mean the principal trading exchange or market for the corporations common stock.   TRADING DAY shall mean a day on which the Principal Market shall be open for business.

NOTE 14.  CONVERTIBLE DEBENTURES   On May 20, 2011, the Company issued a convertible promissory note in the amount of $42,500 which was received May 26, 2011. The note bears an interest rate of eight percent (8%), matures on February 23, 2012 and may be converted after 180 days from execution of this note for shares of the Companys common stock. The note may be converted at a forty two percent (42%) discount to the average of the lowest 3 closing bid prices of the common stock during the 10 trading days prior to the conversion date. The issuance of the note amounted in a beneficial conversion feature of $16,398 which has been amortized under the Interest Method. $42,500 of the principal amount due and $1700 in accrued interest has been converted into 1,012,425 shares of the common stock of the Company.   On July 5, 2011, the Company issued a convertible promissory note (the Second Note) in the principal amount of $37,500. The Second Note, which matures April 11, 2012, bears interest at the rate of 8% per annum. At any time after 180 days from the execution of the Second Note, the Second Note is convertible into shares of the Companys common stock at the election of Asher at a conversion price equal to a 45% discount to the average of the 3 closing bid prices of the common stock during the 10 trading day period prior to conversion. The issuance of the note amounted in a beneficial conversion feature of $37,500 which is amortized under the Interest Method. $37,500 of the principal amount due and $1500 in accrued interest has been converted into 6,193,242 shares of the common stock of the Company.   On August 29, 2011, the Company issued a convertible promissory note (the Third Note) in the principal amount of $35,000. The Third Note, which matures May 25, 2012, bears interest at the rate of 8% per annum. At any time after 180 days from the execution of the Third Note, the Third Note is convertible into shares of the Companys common stock at the election of Asher at a conversion price equal to a 45% discount to the average of the 3 closing bid prices of the common stock during the 10 trading day period prior to conversion. The issuance of the note amounted in a beneficial conversion feature of $35,000 which is amortized under the Interest Method. . $35,000 of the principal amount due and $1400 in accrued interest has been converted into 21,708,333 shares of the common stock of the Company.   On October 25, 2011, the Company issued a convertible promissory note in the amount of $32,500. The note bears an interest rate of eight percent (8%), matures on July 27, 2012 and may be converted after 180 days from execution of this note for shares of the Companys common stock. The note may be converted at a fifty two percent (52%) discount to the average of the lowest 3 closing bid prices of the common stock during the 10 trading days prior to the conversion date. The issuance of the note amounted in a beneficial conversion feature of $7,634 which is amortized under the Interest Method. $32,500 of the principal amount due and $1300 in accrued interest has been converted into 24,635,165 shares of the common stock of the Company.   On December 19, 2011, the Company issued a convertible promissory note in the amount of $37,500. The note bears an interest rate of eight percent (8%), matures on September 21, 2012 and may be converted after 180 days from execution of this note for shares of the Companys common stock. The note may be converted at a fifty two percent (52%) discount to the average of the lowest 3 closing bid prices of the common stock during the 10 trading days prior to the conversion date. The issuance of the note amounted in a beneficial conversion feature of $37,500 which is amortized under the Interest Method. The principal balance and $1,500 in accrued interest was satisfied by a payment of $57,647.   On December 20, 2011 the Company amended the terms of $30,000 in existing debt as follows:   (a)  Due and payable December 31, 2012 (b)  Simple interest of 10% from December 20, 2011 to the date the debt is fully converted or paid in full (c)  Convertible into the common stock of the Company at the option of the holder at a 50% discount from the average of the lowest three Trading Prices  for the common stock during the 10 trading day period ending one Trading Day prior to the date the conversion notice is sent by the holder. "Trading Price" means the closing bid price on the applicable trading market as reported by a reliable reporting service.   The amendment of the note amounted in a beneficial conversion feature of $16,153 which was fully amortized by February 29, 2012. The entire principal balance of the convertible note was converted into 1,249,975 shares of the common stock of the Company prior to February 29, 2012.   On February 28, 2012 the Company amended the terms of  $85,500 in existing principal indebtedness as well as 3,710  of interest accrued but unpaid to be as follows:   The aggregate indebtedness of $89,210 shall bear simple interest, be payable upon demand of the holder, and be convertible into the common shares of the company at a conversion price per share equal to 60% (the Discount) of the lowest closing bid price for the Companys common stock during the 5 trading days immediately preceding a conversion date, as reported by Bloomberg. provided that if the closing bid price for the common stock on the date in which the conversion shares are deposited into Holders brokerage account and confirmation has been received that Holder may execute trades of the conversion shares ( Clearing Date) is lower than the Closing Bid Price, then the purchase price for the conversion shares shall be adjusted such that the Discount shall be taken from the closing bid price on the Clearing Date, and the Company shall issue additional shares to Purchaser to reflect such adjusted Purchase Price (Bonus Shares). The company has agreed on a limitation on conversion equal to 9.99% of the Companys outstanding common stock. The amendment of the note amounted in a beneficial conversion feature of $59,473 which was fully amortized by February 29, 2012. This aggregate indebtedness was converted into 21,307,702 of the companys common shares.   On April 16, 2012 the Company issued a convertible promissory note in the amount of $42,500 which was received April 21, 2012. The note bears an interest rate of eight percent (8%), matures on January 18, 2013. and may be converted after 180 days from execution of this note for shares of the Companys common stock. The note may be converted at a fifty two percent (52%) discount to the average of the lowest 3 closing bid prices of the common stock during the 10 trading days prior to the conversion date. The issuance of the note amounted in a beneficial conversion feature of $11,805 which is amortized under the Interest Method.   On June 15, 2012 the Company amended the terms of $102,349 in existing principal indebtedness as follows:   The Aggregate Indebtedness of $102,349 is convertible at Holders option at a conversion price per share equal to 60% (the Discount) of the lowest closing bid price for the Companys common stock during the 5 trading days immediately preceding a conversion date, as reported by Bloomberg (the Closing Bid Price); provided that if the closing bid price for the common stock on the date in which the conversion shares are deposited into Holders brokerage account and confirmation has been received that Holder may execute trades of the conversion shares ( Clearing Date) is lower than the Closing Bid Price, then the purchase price for the conversion shares shall be adjusted such that the Discount shall be taken from the closing bid price on the Clearing Date, and the Company shall issue additional shares to Purchaser to reflect such adjusted Purchase Price (Bonus Shares). The company has agreed on a limitation on conversion equal to 9.99% of the Companys outstanding common stock. The issuance of the note amounted in a beneficial conversion feature of $102,349 which is immediately amortized . This aggregate indebtedness was converted by the Holders into 36,838,692 shares of the Companys common stock.   On July 26, 2012, the Company issued a convertible note in the principal amount of $63,000 to Asher Enterprises, Inc. The Note bears interest at the rate of 8% per annum and matures on April 30, 2013. The Note is convertible any time during the period beginning on the date which is one hundred eighty (180) days following the date of the Note into common stock of the Company, at Ashers option, at a 39% discount to the average of the three lowest closing bid prices of the common stock during the 10 Trading Day period prior to conversion as Trading Day is defined in the Note. The issuance of the note amounted in a beneficial conversion feature of $63,000 which is amortized under the Interest Method.   On August 21, 2012 the Company amended the terms of $59,000 in existing principal indebtedness as follows:   The Aggregate Indebtedness of $59,000 is convertible at Holders option at a conversion price per share equal to 60% (the Discount) of the lowest closing bid price for the Companys common stock during the 10 trading days immediately preceding a conversion date, as reported by Bloomberg (the Closing Bid Price); provided that if the closing bid price for the common stock on the date in which the conversion shares are deposited into Holders brokerage account and confirmation has been received that Holder may execute trades of the conversion shares ( Clearing Date) is lower than the Closing Bid Price, then the purchase price for the conversion shares shall be adjusted such that the Discount shall be taken from the closing bid price on the Clearing Date, and the Company shall issue additional shares to Purchaser to reflect such adjusted Purchase Price (Bonus Shares). The company has agreed on a limitation on conversion equal to 9.99% of the Companys outstanding common stock. The issuance of the note amounted in a beneficial conversion feature of $53,000 which was immediately amortized .

42500

37500

35000

32500

37500

42500

63000

0.08

0.42 0.45 0.45 0.52 0.52 0.50 0.52 0.39 16398 37500 35000 7634 37500 16153 11805 63000 42500 37500 35000 32500 57647

1700

1500

1400

1300

1500

1012425

6193242

21708333

24635165

30000

0.10

1249975

85500

102349

59000

3710

89210 102349 59000 0.60 0.60 0.60 0.0999 0.0999 0.0999 59473 102349 53000 21307702 36838692

NOTE 16. STOCK TRANSACTIONS   During the twelve months ended August 31, 2012 the Company issued 113,695,700 Common Shares in satisfaction of $374,959 in debt and accrued interest.   During the twelve months ended August 31, 2012 the Company issued 3,272,000 Common Shares for services rendered valued at $171,750.   During the twelve months ended August 31, 2012 the Company issued 2,500,000 Common shares for acquisition of intangible assets valued at $700,000.   During the twelve months ended August 31, 2012 the Company issued 6,274,726 Common Shares valued at $23,868 pursuant to contractual obligations contained in certain convertible notes outstanding.   During the twelve months ended August 31, 2012 the Company issued 75,000 shares of its Non Voting Convertible Preferred Stock for services rendered valued at $75,000.   On December 26, 2011 an employee of the Company consented to the cancellation of 15,000 common shares previously issued as compensation.   On December 29, 2011 75,000 common shares previously issued to the companys former Chief Financial Officer were returned for cancellation by the Company. Of that amount 40,000 were subject to forfeiture and are cancelled pursuant to those forfeiture provisions at the companys option and the companys former Chief Financial Officer has consented to cancellation of the remaining 35,000 common shares.   During the Quarter ended May 31, 2012 a dividend of 3, 201,397 shares of Series B Preferred Stock was paid to the Companys common shareholders of record as of February 21, 2012.   On April 3, 2012 the Company issued 50,000,000 shares of common stock to David R. Koos, the Companys Chief Executive Officer, as a restricted stock award (Bonus Shares).David Koos may not offer to sell, sell, transfer, pledge or otherwise dispose of the Bonus Shares prior to April 2, 2017 (Restricted Period). In the event that, prior to the expiration of the Restricted Period, David Koos voluntarily ceases to be employed at the Company or is terminated for cause the Shares shall be forfeited.   On April 3, 2012 the Company issued 27,000,000 shares of common stock to seven employees as a restricted stock award (Bonus Shares).No employee may offer to sell, sell, transfer, pledge or otherwise dispose of the Bonus Shares prior to April 2, 2017 (Restricted Period).In the event that, prior to the expiration of the Restricted Period, any employee voluntarily ceases to be employed at the Company or is terminated for cause his or her Shares shall be forfeited.   On April 3, 2012 the Company issued 15,000,000 shares of common stock to a consultant as a restricted stock award (Bonus Shares).The recipient may not offer to sell, sell, transfer, pledge or otherwise dispose of the Shares prior to April 2, 2017 (Restricted Period). In the event that, prior to the expiration of the Restricted Period, the recipient declines to provide if requested to provide, or is unable to provide if requested to provide, consulting services to the Company of a nature that have been customarily provided by the recipient to the Company the Shares shall be forfeited.   On August 2, 2012 an employee of the Company consented to the cancelation of 15,000,000 common shares issued to her as a Restricted Stock Award.

15000 75000 40000 35000 3201397 50000000 27000000 15000000 15000000

125000

NOTE 17. SUBSEQUENT EVENTS   Between September 4, 2012 and September 17, 2012 the Company sold 26,802,465 common shares to Southridge for the gross amount of $50,000 pursuant to the June Purchase Agreement.   On September 21 , 2012 the Company paid $20,000 of indebtedness due to Southridge.   On September 20, 2012 the Company issued a convertible promissory note in the amount of $63,000 cash from which was received September 27, 2012. The note bears an interest rate of eight percent (8%), matures on June 25, 2013. and may be converted after 180 days from execution of this note for shares of the Companys common stock. The note may be converted at a thirty nine percent (39%) discount to the average of the lowest 3 closing bid prices of the common stock during the 10 trading days prior to the conversion date.   On October 2 , 2012 the Company sold 10,837,849 common shares to Southridge for the gross amount of $14,300 pursuant to the June Purchase Agreement. Total gross proceeds of $14,300 were utilized to pay $14,300 of debt due to Southridge by the Company.   On October 17, 2012 the Company issued 23,000,000 common shares in satisfaction of $19,320 of outstanding convertible indebtedness.   On October 17, 2012 the Company amended its certificate of incorporation in order to authorize 2,000,000,000 shares of Common Stock   On October 22, 2012 the Company issued 10,810,811 common shares in satisfaction of $8,000 of outstanding convertible indebtedness.   On November 28, 2012 the Company executed an agreement (Agreement) with Gregory McDonald ("McDonald"), Pet Pointers, Inc. ("Pet Pointer") whereby Mc Donald and Pet Pointer would acquire from the Company all assets ( with the exception of cash and accounts receivable) utilized by the Company in the operation of the McDonald Animal Hospital, a full service veterinary clinic owned and operated by the Company and located in Santa Barbara, California (McDonald Asset Sale).    On October 10, 2012 a Complaint (Complaint) was filed in the Superior Court of the State of California against the Company and David Koos by McDonald, a former employee of the Company, alleging breach of contract and breach of the covenant of good faith and dealing in connection with the assumption of lease obligations by the Company in connection with the acquisition of the assets of Pet Pointers, Inc breach of contract and breach of the covenant of good faith and dealing in connection with an employment agreement enters into with McDonald inc connection with the Acquisition, breach of contract in connection with the Acquisition purchase agreement, breach of the covenant of good faith and dealing in connection with the Acquisition purchase agreement, implied indemnity in connection to amounts owed by McDonald to Anthony and Judi Marinelli, the Internal Revenue Service, and the California Franchise Tax Board, intentional misrepresentation, negligent misrepresentation , failure to pay wages and violations of Sections 2802, 203, and 2806 of the California Labor Code. The Complaint sought judgment for nominal damages, actual damages, compensatory damages, lost wages, compensation, expenses wage benefits and penalties pursuant to California Labor Code Sections 203 et al, 2802 and 2806, indemnification, accrued interest, punitive damages, costs of suit and attorneys fees.    As consideration to the Company for the assets acquired, McDonald and Pet Pointers provided to the Company a General release whereby McDonald and Pet Pointer waive, release and discharge the Company and their respective assignees, officers, directors, shareholders, boards, owners, employees, attorneys, agents, trustors, trustees, beneficiaries, heirs, successors, and representatives from all known and unknown claims, demands, causes of action, attorney's fees, costs, or expenses including:   (1) All claims relating to the Complaint.   (2) Those owed by McDonald to Anthony and Judi Marinelli which the Company became obligated to pay on McDonalds behalf pursuant to the asset purchase agreement entered into between the Company and Gregory McDonald and Pet Pointers, Inc on January 4, 2011. The balance due on this obligation as of December 5, 2012 was $55,000.   (3) Those amounts owed by McDonald to the Internal Revenue Service which the Company became obligated to pay on McDonalds behalf pursuant to the asset purchase agreement entered into between the Company and Gregory McDonald and Pet Pointers, Inc on January 4, 2011. The balance due on this obligation as of December 5, 2012 was $6,369.69.   (4) Those amounts owed by McDonald to the California Franchise Tax Board which the Company became obligated to pay on McDonalds behalf pursuant to the asset purchase agreement entered into between the Company and Gregory McDonald and Pet Pointers, Inc on January 4, 2011. The balance due on this obligation as of December 5, 2012 was $3,474.   Assets disposed of pursuant to the Agreement include approximately $4,897 of Property Plant and Equipment net of accumulated depreciation as well as all inventory held at the McDonald Animal Hospital.    Assets disposed of pursuant to the Agreement also include    (i) Essentially all intellectual property, including computer software, utilized in connection with the operation of the McDonald Animal Hospital.   (ii) All telephone numbers, fax numbers, service marks, trademarks, trade names, fictitious business names, websites, business email addresses, vendor lists, promotional materials, vendor records and any and all business records including, but not limited to, such items stored in computer memories, microfiche, paper record or by any other means relevant to the operation of the McDonald Animal Hospital.   (iii) All customer lists, customer contacts, and any and all customer records that are related to the McDonald Animal Hospital.  As a result of the agreement, the Company anticipates recording a non-cash pre-tax charge for the impairment of goodwill recorded in connection with the acquisition of the McDonald Animal Hospital of approximately $405,000 for the quarter ended November 30, 2012.    Pursuant to the Agreement, the Company is obligated to make payment of $13,000 within five days of the Closing of the Agreement as such term is defined in the Agreement.    Pursuant to the Agreement, the Company agrees to waive, release and discharge McDonald and Pet Pointer from all known and unknown claims, demands, causes of action, attorney's fees, costs, or expenses.

26802465

10837849

50000

14300

20000 63000

0.08

0.39

14300

23000000 10810811

19320

8000

2000000000

55000

6369.69

3474

4897

405000

13000

528715

EX-101.SCH 9 entb-20120831.xsd XBRL SCHEMA FILE 0001 - Document - Document and Entity Information link:presentationLink link:calculationLink link:definitionLink 0002 - Statement - Consolidated Balance Sheet link:presentationLink link:calculationLink link:definitionLink 0003 - Statement - Consolidated Balance Sheet (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 0004 - Statement - Consolidated Statement of Operations link:presentationLink link:calculationLink link:definitionLink 0005 - Statement - Consolidated Statement of Stockholders' Equity link:presentationLink link:calculationLink link:definitionLink 0006 - Statement - Consolidated Statement of Cash Flows link:presentationLink link:calculationLink link:definitionLink 0007 - Disclosure - ORGANIZATION AND DESCRIPTION OF BUSINESS link:presentationLink link:calculationLink link:definitionLink 0008 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES link:presentationLink link:calculationLink link:definitionLink 0009 - Disclosure - RECENT ACCOUNTING PRONOUNCEMENTS link:presentationLink link:calculationLink link:definitionLink 0010 - Disclosure - GOING CONCERN link:presentationLink link:calculationLink link:definitionLink 0011 - Disclosure - NOTES PAYABLE link:presentationLink link:calculationLink link:definitionLink 0012 - Disclosure - RELATED PARTY TRANSACTIONS link:presentationLink link:calculationLink link:definitionLink 0013 - Disclosure - INCOME TAXES link:presentationLink link:calculationLink link:definitionLink 0014 - Disclosure - ACQUISITION OF ENTEST CA link:presentationLink link:calculationLink link:definitionLink 0015 - Disclosure - ACQUISITION OF THE ASSETS OF PET POINTERS, INC. link:presentationLink link:calculationLink link:definitionLink 0016 - Disclosure - COMMITMENTS AND CONTINGECIES link:presentationLink link:calculationLink link:definitionLink 0017 - Disclosure - NON VOTING CONVERTIBLE PREFERRED STOCK link:presentationLink link:calculationLink link:definitionLink 0018 - Disclosure - DIVIDEND OF SERIES B PREFERRED SHARES link:presentationLink link:calculationLink link:definitionLink 0019 - Disclosure - STOCKHOLDERS EQUITY link:presentationLink link:calculationLink link:definitionLink 0020 - Disclosure - CONVERTIBLE DEBENTURES link:presentationLink link:calculationLink link:definitionLink 0021 - Disclosure - STOCK TRANSACTIONS link:presentationLink link:calculationLink link:definitionLink 0022 - Disclosure - SUBSEQUENT EVENTS link:presentationLink link:calculationLink link:definitionLink 0023 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) link:presentationLink link:calculationLink link:definitionLink 0024 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables) link:presentationLink link:calculationLink link:definitionLink 0025 - Disclosure - NOTES PAYABLE (Tables) link:presentationLink link:calculationLink link:definitionLink 0026 - Disclosure - INCOME TAXES (Tables) link:presentationLink link:calculationLink link:definitionLink 0027 - Disclosure - ORGANIZATION AND DESCRIPTION OF BUSINESS (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 0028 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Property Plant and Equipment, Acquisition Costs (Details) link:presentationLink link:calculationLink link:definitionLink 0029 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 0030 - Disclosure - GOING CONCERN (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 0031 - Disclosure - NOTES PAYABLE - Notes Payable, Current and Long Term (Details) link:presentationLink link:calculationLink link:definitionLink 0032 - Disclosure - NOTES PAYABLE (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 0033 - Disclosure - RELATED PARTY TRANSACTIONS (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 0034 - Disclosure - INCOME TAXES - Income Taxes - Deferred tax assets (Details) link:presentationLink link:calculationLink link:definitionLink 0035 - Disclosure - INCOME TAXES (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 0036 - Disclosure - ACQUISITION OF ENTEST CA (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 0037 - Disclosure - ACQUISITION OF THE ASSETS OF PET POINTERS, INC. (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 0038 - Disclosure - COMMITMENTS AND CONTINGECIES (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 0039 - Disclosure - NON VOTING CONVERTIBLE PREFERRED STOCK (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 0040 - Disclosure - DIVIDEND OF SERIES B PREFERRED SHARES (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 0041 - Disclosure - STOCKHOLDERS EQUITY (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 0042 - Disclosure - CONVERTIBLE DEBENTURES (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 0043 - Disclosure - STOCK TRANSACTIONS (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 0044 - Disclosure - SUBSEQUENT EVENTS (Details Narrative) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 10 entb-20120831_cal.xml XBRL CALCULATION FILE EX-101.DEF 11 entb-20120831_def.xml XBRL DEFINITION FILE EX-101.LAB 12 entb-20120831_lab.xml XBRL LABEL FILE Common shares outstanding Class of Stock [Axis] Series B preferred shares outstanding Series AA preferred shares outstanding Non voting convertible preferred shares outstanding Common Equity Components [Axis] Series AA Preferred Series B Preferred Non Voting Convertible Preferred Additional Paid-in Capital Contributed Capital Accumulated Deficit during the Development Stage Estimated useful Life (Months) Significant Acquisitions and Disposals by Transaction [Axis] Acquisition Cost, Total Statement [Table] Statement [Line Items] Entity Registrant Name Entity Central Index Key Document Type Document Period End Date Amendment Flag Current Fiscal Year End Date Is Entity a Well-known Seasoned Issuer? Is Entity a Voluntary Filer? Is Entity's Reporting Status Current? Entity Filer Category Entity Public Float Entity Common Stock, Shares Outstanding Document Fiscal Period Focus Document Fiscal Year Focus Statement of Financial Position [Abstract] ASSETS Current Assets Cash Trade accounts receivable, less allowance for uncollectible accounts of $0 and $0 at February 29, 2012 and August 31, 2011 respectively Inventory Due from Affiliate Current Portion of Prepaid Expenses Employee Receivable Total Current Assets Property & Equipment (Net of Accumulated Depreciation) Goodwill Intangible Assets (Net of Accumulated Amortization) Non Current Assets Non Current Portion of Prepaid Expenses Deposits Total Non Current Assets TOTAL ASSETS LIABILITIES AND STOCKHOLDERS' EQUITY Current Liabilities Accounts Payable Notes Payable Convertible notes payable, net of discount Due to Other Accrued Expenses Total Current Liabilities Non Current Liabilities Notes Payable - Non Current Total Non Current Liabilities TOTAL LIABILITIES STOCKHOLDERS' EQUITY Common Stock, $0.001 par value, authorized 1,000,000,000 shares; issued and outstanding 223,492,927 shares as of August 31, 2012 and August 31, 2011 respectively Preferred Stock , $0.001 par value 5,000,000 shares authorized, 0 shares issued and outstanding as of August 31, 2012 and August 31, 2011 Series AA Preferred Stock, $0.001 par value 100,000 shares authorized, 5,000 shares issued and outstanding at August 31, 2012 and as of August 31, 2011 Series B Preferred Stock, $0.001 par value 4,400,000 shares authorized, 3,201,397 and 0 shares issued and outstanding as of August 31, 2012 and as of August 31, 2011 NonVoting Convertible Preferred, $1 par value 200,000 shares authorized, 75,000 and 0 issued and outstanding as of August 31, 2012 and as of August 31, 2011 Additional Paid in Capital Contributed Capital Accumulated Deficit Total Stockholders' Equity TOTAL LIABILITIES & STOCKHOLDERS' EQUITY Uncollectible accounts Common stock, par value Common stock, shares authorized Common stock, shares issued Common stock, shares outstanding Preferred stock, par value Preferred stock, shares authorized Preferred stock, shares issued Preferred stock, shares outstanding Series AA Preferred shares, par value Series AA Preferred shares, shares authorized Series AA Preferred shares, shares issued Series AA Preferred shares, shares outstanding Series B Preferred shares, par value Series B Preferred shares, shares authorized Series B Preferred shares, shares issued Series B Preferred shares, shares outstanding NonVoting Convertible Preferred shares, par value NonVoting Convertible Preferred shares, shares authorized NonVoting Convertible Preferred shares, shares issued NonVoting Convertible Preferred shares, shares outstanding Income Statement [Abstract] REVENUES Revenues from Veterinary Services Online Revenues TOTAL REVENUE Cost of Revenue GROSS PROFIT COSTS AND EXPENSES Research and Development Rent Costs General and Administrative Incorporation Costs Consultant's Expenses Miscellaneous Expenses Total Costs and Expenses OPERATING LOSS OTHER INCOME AND EXPENSE Other Income Loss on Early Extinguishment of Debt Income generated from Revenue Share Agreement Expenses incurred from Revenue Share Agreement Loss on Impairment of intangible assets Interest Expense Interest Expense attributable to amortization of discount Expenses attributable to issuance of shares pursuant to contractual obligation Expenses attributable to issuance of Non Voting Convertible Preferred Shares in connection with Stock Purchase Agreement TOTAL OTHER INCOME AND EXPENSE LOSS BEFORE INCOME TAXES Income Taxes NET LOSS Beneficial conversion feature attributable to issuance of NonVoting Preferred Stock NET LOSS available to common shareholders BASIC AND DILUTED LOSS PER SHARE WEIGHTED AVERAGE NUMBER OF COMMON SHARES OUTSTANDING Beginning balance, Shares Beginning balance, Amount Common Shares issued for Cash, Shares Common Shares issued for Cash, Amount Common Shares issued for Debt, Shares Common Shares issued for Debt, Amount Common Shares issued to Consultants, Shares Common Shares issued to Consultants, Amount Common Stock issued to employees, Shares Common Stock issued to employees, Amount Restricted Stock Awards issued to employee, Shares Restricted Stock Awards issued to employee, Amount Common Shares issued for services, Shares Common Shares issued for services, Amount Common Shares issued for intangible assets, Shares Common Shares issued for intangible assets, Amount Cancellation of Common Shares Issued, Shares Cancellation of Common Shares Issued, Amount Restricted Stock Awards to consultant, Shares Restricted Stock Awards to consultant, Amount Expense Recognized Discount on Convertible Debt recognized Increases in Contributed capital Preferred Stock issued for Accrued compensation, Shares Preferred Stock issued for Accrued compensation, Amount Series B Preferred Dividend paid, Shares Series B Preferred Dividend paid, Amount Preferred Shares, Shares Preferred Shares, Amount Recognition of Beneficial Conversion Feature Shares issued pursuant to Contractual Obligations, Shares Shares issued pursuant to Contractual Obligations, Amount Cancellation of Restricted Stock Award to Employee, Shares Cancellation of Restricted Stock Award to Employee, Shares Net Loss for the Year Beneficial Conversion Feature Deemed Dividend Ending balance, Shares Ending balance, Amount Statement of Cash Flows [Abstract] OPERATING ACTIVITIES Net (loss) Adjustments to reconcile net loss to net cash used by operating activities: Depreciation Expense Amortization Expense Stock issued as Compensation to Employees Stock issued as Compensation to Consultants Change in operating assets and liabilities: (Increase) Decrease in Trade Accounts Receivable (Increase) Decrease in Inventory (Increase) Decrease in Employee Receivable Increase (Decrease) in Accounts Payable (Increase) Decrease in Due from Other (Increase) Decrease in Prepaid Expenses (Increase) Decrease in Due from Affiliate (Increase) Decrease in Deposits Increase (Decrease) in amortization of intangibles Increase (Decrease) in Accrued Expenses (Increase) Decrease on gain realized on cancellation of stock Increase (Decrease) in Loss on Impairment of Intangible Assets Net Cash Provided Used in Operating Activities INVESTING ACTIVITIES Purchase/Sale of Equipment Net cash Provided by (Used in) Investing Activities FINANCING ACTIVITIES (Increase) Decrease in Goodwill from acquisition Stock issued in Payment of Debt Increase (Decrease) in Common stock issued for cash EX-101.PRE 13 entb-20120831_pre.xml XBRL PRESENTATION FILE XML 14 R39.htm IDEA: XBRL DOCUMENT

NON VOTING CONVERTIBLE PREFERRED STOCK (Details Narrative) (USD $)	Aug. 31, 2012	Mar. 27, 2012
Equity [Abstract]
Shares of nonvoting convertible preferred stock issued to Southridge		75,000
Non Voting Convertible Preferred Stock conversion price percentage	70.00%	70.00%
Beneficial conversion feature		$ 32,142

- Definition

Number of shares issued for each share of convertible preferred stock that is converted.

+ References+ Details

- Definition

The redemption (or callable) amount of currently redeemable preferred stock. Includes amounts representing dividends not currently declared or paid but which will be payable under the redemption features or for which ultimate payment is solely within the control of the issuer.

+ References+ Details

ZIP 15 0001554795-13-000067-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001554795-13-000067-xbrl.zip M4$L#!!0````(`,U>04(:YY/B27D``*IF!``1`!P`96YT8BTR,#$R,#@S,2YX M;6Q55`D``T+S"U%"\PM1=7@+``$$)0X```0Y`0``[%U; MLA%W?+K[1+4O$X[IL1VV9V;G:0,7*IL="NH`YE-7F`8N8'_]0@<2T<3Z,\#Q_6?OA[]?C^=W9]=71U- M_OGM/_]C@OY\^:_I='+I0L\YG9P'\^F5OPC^,;FVE_!T\@OT86C'0?B/R1^V MM\:_!)>N!\/)6;!<>3"&Z$%*Z72B'*OV9#JE:/8/Z#M!^/O=U;;9YSA>G9Z< MO+Z^'OO!B_T:A']'Q_.`KKG[8!W.X;8MZ,>/$I`MH"R"<`FDOX_?%HB!2?"*!!Z"?JN`4J)1$8CM>1ULBTILI2:J$_J2??WE[##WW%/]S@N3O M1Z=OD?OUB.#K53D.PJ<369+`R?_\]N-^_@R7]M3UH]CVY_`H^\IS_;_+O@.6 M99TD3[-7"V]BXAD-Y00_?K2C7@@7E9#U$_0T>]&-`E4&1AU_Z1O9 M!^MH^F3;J^T'"SMZ3%[>/"@!@YZ$@0>CTF^2)R4?^8'OKY?EN)PX/(G?5_`$ MO31%;\'0G6^_:_XH_P'"@'\N1Y<\*4%W1B^W$T>0D:RH=)_/`C^%; M/'&=KT>78;!$#8"I9"%P<9"B-*<[^MO/$#$W?M_^NOW==?"3A8L,4X(2YD27 MJ=C9U:]'W]"(!:IJJ:KQY63_XQVYDU)Z&VHK)/;`*:)`XR>,L9GYMF,G:VGW MK/`9,H;91QN^=^2=W"?9[SD`V8\;D5;+>1;=++#YPQH@:_^++/@R\._C8/[W M;W#Y",,/D_9.@/!IB9X2#S:/'`3F;>6YKC-@#W%%AKB[\\\ M.T*\)JS-WMSHZ%OV2H'G+R>ES9/03LJQ\:E(:F3C;[M^V,IE\Z23OKY'C<#H M^RT:L3`,H?.Y>KV&^T_5_[-/W?^EW'^2_C\+?#0AB-U'#WY2'6B0P$^N!^., MIP@A[05&G0@)C%U(H$LA;:)TB8C2QRFP7)0N\43IH,LHO5K./W'$?O&O-<*- M0#I/Y"G$-_#Z"_.XW6\G'_ MH;\'T-^=3F%JHL;/D/NIUX(!Y7\&'DGNN8F#Z@Q(=3[(=1QT8)@ZT(<[*9M1 M?H:E)!I]&,1RTCAFF0?5&:#J#,"4W$$'PJ7]Z,'/LCY5KQW4\CB8F3HS?*/[-7;FQ[GTH_:F5PF"#3>K.#*@U9E0;KM:2# M^@Q3?3YH:>:@!\/5@S[S;@<]&*X>?%2T>A,_PW`GE,^H$G4B.,2J=0'&07D& MI3P?%%X%%G(2G/X)-=!X7Y<(7YH/CST/-#ZOD^8\Y#SP^IY_LX4"F-\GQ@OX81.VIC M"J31"BECH!<;<@_#%W<.?[@+^).8#_?)1PW/D<1FC[^T-H^Y$]QT\*V\GRXOC)#>$'6;+B/GN5,Z(AD+(61NW!\K8 M89:SUL,!1?17'9EL\XD7S$#7QA7]U7Z2<"AC9WCA4&+`QQP.;1CH6!E)#_03 M>'HN#]2]IY<).2OCE[/,(V>E!SDKA)S5\M! MSAHA9WW\==Y(JCZI')-A^Y8@:ZSIUH4WG$X?V&@:Z%I(P]P:1T MG6!*)_W;"3F:S>HC$]C^A!RSPSP'PGQWG1(>85(IKXQD=JBK/3#(*HS-K^9M M/V:@:R$9B,RHA600>8KN=E.->;AM&.A82$":RJ/6I(2!KH6$YMBCUJ2$@>Z% M-&[#G3#0=3R*:)CC%=*&@:Z%I$[!V&+0O)`P`UT+"4W%1VRX-PQT+21C*H]; MDS`#70L)A1DC7IK9,-"#=QNQ)FT8Z$%(8X^3.HZX$^RGPD[8 MS.0LC2]R*\H9F,QREHB`KZM`1!F?#N^O9BL"?>S:=U,)_7Y_7A#+$MK1.H3? MW"A096"RQK)'>1*XM8KV[Y_M$$:5)#::DKS$30/ANZV@X[@OJ#^*LL7? M7J^7,+3C@#RBQBZ#?8QEK1)$SZ$?+%V_B6RS7/;IEC6M MT']R=]AO2"6?JY7BXOKA^^EOW*W_!>VPH?&_Z!MWH'MZD8S;._CD1G&(!MZU MO823S;BZ@XNZ\C5'F.#%_S'_\]N;H^._YR4M5RD?(9,ARA M[5WY#GS[%;Y3DR:-4V5K)+GS8+[&1S,?WE?T#"+[_6O:/OEY6;.WB7VZ2$T\ M=?OD3OO*UDAR,_34P6]<>O83-9F%[44PI9!K@&SY;!V&^&UC-67J8D M(U6M%17@3^AYO_K!JW^/]#7PH7,516ODG6C)7@>D`E2T5B3[1^"M?>3%WR]= M#X81)[F]5DK4.Y7#'5P%8>SZ3[CLQ9J>VE_81#:U5J2:H#E#XGX*0OHA=;^T M/?3=9-O\!%?EL/UW$D*NZ;*!D'9YJL"7Z#=Z9B__R@^"0DO5Y+"&L1'#OY>1 MV[94TI>[2Q%3EWRSCG&PXF!1D70WH=GF@OJ22R0GV`HGKVY\^\2!)/_IZ M='5]>?1-574-6)8DY7J_AKXXM'67#37B5G!#EO%1J,MO6VM$K4D?(>BSADM6 M&F$;/+AW]0[F`3)=T1V<0_<%7W)R#>.-?2E#G0V<'2H<7A.0T!1$EG4T0Z*A MT!8-H$"C`$7C0W.%.L9'P>8[>H57%D"2+4(89).LY&B8-2Q3IZ.&=&UEN\[% MVPKZ$6S9XT!)5+"V;6X`-'SKLLP,X'P-L6>X6*Z\X!W"J*4,5$6U=@@J&F^! M@48,7!AF403CMMP#``Q+)L89V2@S11I>@0PT`U!2O`V#%3*R[[<>+@OC.[C: MV`I[^Q9#VS05F52Y:@IMT5")PY`MA0_.+T'@O+J>QZWYDI8;_EE[+'2HM)N2 MSA4*Q?TG[%!3G4`L7[S-O37V?VUY!9(FDP:VF9(H=%1*8,IF.W1YRWD=^'-F MN_`6N:>^ZWT]BL,U/)J5E M49,-$Q\TRK=&3X.&(4W3K*(#J0H0;^WWY$*^=EUGJ)JA%F/#?./\$&C8E@U- M9X9P'<10D`AD65-T0NPE37-2I])BU.<`,%$GIDL"Q8"""=4BI@GU5-ICHG)W MLJI(O)!0[/<0S!8+UW/MN*UTS)S;+6V:FSZ-)#CHHX&$O(_SP[4?T7NQVSJ\ M!\`R9#TW4LL)M$)"-=*KNK$#*NL:5[R=--[H"J,Y'?R:1_K[+-?UC8W`!X!,`+@5GA3T\G! M3S3)2(U*Q4U5UE0J:D2J[P_;6W/KM2PK*CE]W&^7ARY5^".9BDE/MN)".VYU M1D&TKI)!9WG[+6!014$ZL!32U3?`2-9W43@0A^[C&E>H;2<%V5`!#@$KFN6@ M2A?X4E&M*@"/O-YZN4X*])[#!:[%R\O^5-%U%&@16M!,2PPZ&C%-@8&,@66T M09>,I^?`E, M$(Q@]JRH*#`R'Y@]5R):-'1+?"4^O#L!#192T_)MB4N4)=`=JCOH0+A,IJW4 MJYXE06`^#2S:$-3?'%S;GPIR:AUT*MW=UDPAANB>Y8=6",)$]V?M98WUV2D@ MJ=WU)C>N+'3JJB\'!ZSAVK/:B,6P)!-TV(L\F`HQG7@[RPZJ$`8+[KUZZK(L M&6Q&@)@5SWQ'7(R[O]C11$<$+IX%$EIK('+CJ-V27G[5,M\F.T5&+AO(I=M61"U> M*!90\ZL'9:VW`,'*/!V`F><%K[8_AY=!>!ZL'^/%VBMN7N,5"IELHB(D#AZC MN/C@$5/66SN\"9-K!IUD/-W",-D522VZVXI]E]*Q1,Z5*$@*0EDJP5Y0IC1F MZ_@Y"-U_0X=.AA7(@)3]*86W3ZLEK*+0>H*5G#QH)ZDDI2);9%120:8%&FH! M"433L$5:J(!J-D&SXA(JJAI<^6B@+T-&1U4"G'G>V!IY,5+8Y"=;[=+7 M*N,0LO660*CV(K`#J15I6\%0#Q6QT%BV+##!VNWU?H'^&E*7,ZK-'.`=@,09 MEJQM%IH209/J)(MJ`14TTTQVG-W;'HPV;^P70N#D6;<`P7$9%5XD%))HVD'2 M`;^JK,MD?8(&9L7P6=OC#0C.@BB^66R>BY```)9,GE#($6"FSLJ]::F21DG\ MES"(HMLP6+A"NEZ1=(L\D4`TSTB9E6F\E9$T+#64[V`$[7#^//.=";/*#O*0%N&!LI6`4)=O<$>GD&*(]CU%8^^+.8210@539E-1< M]H>&LCB\S`-1LS1@ML6;=.WF&6\02Z4^=30$Z,G-"A>\1L'[E3\/EO`';?HJ/YB MNWZ$Y8"F_?[%&Y;-VHV>L=.^69S#1R%AW!28NDJL'S<2%8*RQ1!))K>IP%(; M'D,'M[J)>I,TR>PIA'"YOWV:-V`Q#1WW&!-A86C;2BHS5%=IM8IN134%:EK= MB8VT.,`"3._5;?T3S,P44C\6&SZ\"'FZ*R M60#X$-I^A`)"U*A0Q5-,LI8T)Y0..1+E#V9Q6@`%'V9Y"/`J#C[S3T1=?XT^VDQ8`C_Z#A=!"-/W'NPW M&)VC_XAB=RXH0#!V*<2J*#$B7PH.C*UX$>.6M6]P*AV3 MQ4X:2`M`VBC<.J0:-](_H?OTC'Z?H8%D/\'K-39)-XOD4V+W4FM15X"W5'Q] M%6DZ^`!UQU9]OU3M.K60U5;(J:D8MJBVL]%4+*S"C+KG M]WP=HA?2:Q+)O<"705@X<%@367,-%V#HA8J,5*@H^4DV1_*P4[]QB0YVD7C7 MJ)DKKH+]6G*#X(*_)J0,-,7BH5J:E9]7TM`6B9E]BRL`NC$XS(Q&PR!7KCZ"A;($"F,- M;J#HY*4]0^F(%K5P54DQ/UBUROJEA277@4Q><#64/A)IQT5C$V/&Z[S+;@$4 M7^T-_2A)Y@O9-RC+DKI?09P)16]\L!K,_2+"`^6J19%P&5@Z923YT5SV%8>U M0]G]2,XN]]VL+>'K7H7$.)*B%"[ZH(?0#P>LX8)..8(_CJ%65?1E9?_J@<'Q MU]>H;0&Q^R%[!U%&SA@1<6"R0RR,MD0;K)S; M3ZL,HWB]RF#8$VLUI^/JQQ:,CJY3^W(5K8'VE'0CD^<J]<`DA6)(++F@ M'!+Q?`A:E#!,8`!Y.&RQVN6^.JQVK::[^755KZDT>?\Z<$S\=33WJ.H[73%T MG9([_B`]_;[3@*AF`9AV&;"ME^'@4M`03%QI!XR2YZ!%'ETW58L\8EJDP@F$ M_6Q_3FB=`FD.>5E.I3/2;I&!ZTI$8J/)/E5*:"#8`D:[,"\YNY*=L[K)G#3> M)X*]]QV@AJ.BHA'M!U:`DC3QN2DN\:]3M0P+A MB)@&3>_H^*^!':P*",K5N"^N`WTGVBOAC/\A9`CE@L`Z:AT@$W&9>=^06P3< MEL6).__*]LMTSB=6UE3;K6OQM`:?5LO?NGQE*NDT._OSNZZ9(.+:B?AD?LOJ M47L;QF1%(O=Q[!/A`<$\#0:&9)@Z/0BZW=19V0)AJ6%%-F3Z+$@9UQN5&2=;UYRD(&[LAF7:VN&PF5HEBD<)BX^E8N5][DJ;NF[N;VVE(]\] MCR")'E2G^`Z&%E6JO%^.,#T2LK ME'U7-CG,W_8^?$Y;#,@NF*5-\''-#O>K%5"D]5K@Z;+.`@7RBN2PD!F=1I/Q M%PN(2YJBH-,L[.PMGF*WL]OE*+"TV5YE,U'0/ICE-@OR_0B$+NUZ'?AS.\*M M14BQPLK]IUSV2Y<-U9!I=V368NJ=.YYI2/_\YG.;90T)F8WLEXGF!M,[6XRS M$]R#X^2S11K=T*SNF"9R#/TFTXHY@68\+!P(S)V!NLP,,HQB\_L,'Q' M'=[J@FA5-A0CCZJ1EC"`=&*SR.1/OP`EJDV)>DMXMR&^X"%^QXG4&.]W0E\F M5YZF%\9V-E#RJ5)F"%VQP7X%DFR:JEA>KF&<#-`PP.[3^?[^>X0/CEXE26_4 MC[-YC!QK[(K9N41T!#UAL9#;"IT==W;C7*X?\!4TVUAV.VD1NM514@W=W-V2 MQT!^7^+%KZ^#&$:W]GN2/,2WPHFY7D@UI)P1I"(L#"VK:FA`ETR-$VU%MU3, M%(2?"J.F+`YOFQ-BS'`;ANNEZ]O^7+A]LV1=HS`6)=3%XF:_M5[.W1?%CQM? MI_;J>EZ'7A!8^6E]/4D.*RRZNC0CZ69[MG^EI$";AMP=6?6-FG8SZ/,U?`AF MBX7KN78L2&US>M!(LE$5_/1&.>@(M&+942AJHB71YL*-N[L9:M<^&^765\54 M$SZ'JQ!]RKG44Z(GJDX$%63KK)290P3-HJ2\6V1#9H"\H5-(SL(@IFZ5E%I! M8I8,>:,--:2]FBCXT`Q]A1KF:-34RD8L]UZ06O M%XL%G(O9Y@Y,H!4NJN&'U`.'/+62I?U;2<1Q6!(USY.#Z=$=G$/W!4]+A-A7 M,JE,0U044&8?I`"E=L+&`Q5/_?TX"`7-(::R0E8MJZ77&ARS``V+/+C8$EPF M[J7W_R`H`@14J4+/E2YFQOMRU31`)(Y`V93X*'NAFMN3[VP/_JN/Z5 M=#S$W1F`S>2/I.>1T3N8;"V#=Z_7[N$%XZ8TK`A.H)L\\,^F(-!"]),&DVP@ M9AN3.#ALM;`O^\9$E`QC#G2?]^V&7_=ZS6ZW?;@RCIDS_'8)7YOI#YN=PTP+ MZ`T)SXV"(5G:$]QJL+#7::T(P.4,G27Y:!ZYOHRB$QF-0G>&AP(\'^R3&E&Y M0P3?H:-R`_0>>6LPU1?R05P%4\>O\0AF#2C?=&@1>$OXF'.S>6YMDA_G`QN#D5C7WQG\YT]OD_&@?USX.K MK_V+L_^_?W,VN"#B^AVE/@D2@F@H[] MTNWN9PR$./ZC_N#P\R?QX$3"]4=!.`O@R,DQ_"+P2]?`BE($$YC%O3-V1.`# M];.8$M9$LUT3X-$?"OCRWX_$L1?$=W!:Q;%Z#?#P/B^06;[O?NQZXN]S[Q&6 MB+[=J]%`&9H./D=B%@)%[@PF,51'1@3#?TN4!9((QN\%DXG$]"BDT:$__=63 M;C0/I9B`2,$PTUA&L+!BI,C;WSG++-G/-\!'`Y_VARC2>V1OD7"&CC\.?&02 MT,-R,@G".-(,,W&E-RZ_&3"N].$]\/C_S+':&69<_Q6_#R\C$B(,$HF1NJ*` M/S"?BX3':\3D->&(8Y@Z4..[CA@E/%@3'Q/>5]\^[EO<7W'$>@'EZ0A@&_C[="K#D8NV(4>!X4%W.IW[`;H0SDS. M8WT-V`_Z47W,L:#[H2/.+T_);R.27@`TU(H:>`DF9$T6C#3128PBO6& MNR`B?HI*;'W^9A1KU\1"6%_3%]D*L/I#H!R?O8[ES$H`Q2RH^!$,4PGOB]%= MH',D+V&1\?6W>0EP:#IT]QIUR]RYA$.Z6,:_;X<`FK8!=/W]V[?^U;_`SB'2KL^^7IQ].3ON7]R(_O'QX/O% MS=G%5W$Y.#\[/CM]?A-HG4FFA=JKHJV_+X[ZUV?7:$XFR_KZZ'SB&C9WHB7P MY[T(O'J>_6>AR!YZ,)//8H42(6(GG%4#NCQ"VY+J+,6=`R;=4((I,,,H)MH! M*&QN2:@/46"R2:$EA+AE3',P(^%#-$B-Q?H=)!K\1H8K?:L/^@8$S#[\92Q# MH@%,CRCOM341@KKRY_!%-#I""58$^*.H7:03HL6#2D7JM,7T,S$-'\,2"\\* M$N%#+L?%QOO"5J5(R1V\VAD'-`''%_WY+:R^:#7`CHK0?$^XX!$HV)/^.*VQ MQ`YV2-MYH89OCO2RB`G(7A%I0#E,"=F@3S MT'Q?O9)O?T,7];%#*S25P+2@K*,Y[,H]TR&IQ&5$[@>LC1.&CG]+#`-;@#9& M#?25!T^C0H=U#$:\R@(L!D-CPEE@I\#^RS'[&Q%8#4@>.!DP`C#"Q/W!7QVC MF3`%+AUZLD:$L-WB>>!Z\+X^XA?0Z0_P*>#!"&U7P7 MA(3%3=,!J_H6UP(F/+J3HS^COV+]H*9.POAIEN8UXT7E1:$GK24-Y?`1YP&[ MA@MKED?R\CAJ)],+N2]>TO9^G2IM.P0?`3=>G5T@[&`=('".QY<7(/] M<,)!EKW\G0BP0T"*W:,L91BM0=ZP9N/I7)=^!84ST@R9>.N%D9)'NX" M5(/!`ZJG:#Z,X/B!B[,O+-,:!@*9!I0FBB=.TBIL(0F2!T4?4/VB3O'/S![' M8(E7I]<_:M?Z/L^==/_9M;[AO2KFA4DL=*E,$1*SB/>'`G`:A_T/$/ M;GR79VA:9J@*47ID(I&O&P']OJ/,%-#44^=/*;!69DKV*.I>5(=3B@9$RAH% M1>M03A,=S/_KGIQ<'\\3 M=^[M'<@8SP4A@JZL!N&+6`HY0$T,)PND$AW94(++!`/?16C`>QAX)5?"0"6@ MZ!EBV!QL>IE4K.[^,#U#4'O]FS$TA0>7IU'3Y/R6=I0BR\`$_9'.S=Y.-]05EQX`_/ M44.3PI7^'1%/=PM4*`Y#S(H)L6ZAT(L&90;'-O]Y]+?'NO@!0UDQZ-[_U6KQ M&DQO..VQ.'=]*;Y)T'=CNN5PE)[D(^[B:]49KX%A/[KC&``_,I3X.JTDX??' MU!4=G/X0"8C("H$_S",YF7L@7R9:Z2OS8%]\41U8[H,[CN]^H\O3SV*(9Q7=/<]S M9I'\3>B??DGH05)"/0YAV<&V:"DR#.(XF"9/XY4-?6,L_.`A=&;__0O_]Q=\ M-4S$_^]?6H9J-9&]$+G\-]'9;V,<4G_JR4GRH9I@`R:(=[?#T*V)WZ5W+Y$< MF!SXJ'LTPY20$@0!0&QECCBM=SPN0_*Z9.8)\6JD-S42_1ANG_O5&]3I:[=^ M30C;_<+H,_]^!JU&K49]P6.^IF*SKN'XYME*3L$>:#^[T"UK.;2WM<"GQAQ6 MYNXYFKL?OY$1_6F'BY!/SDT`OL(3V3/OQO8_CH]/3[]\>4;.S7I>KY*?JI%R MMB\=':#O$S6M^D\QW]>XLK5FJ[,U];0\8Z.TB&UN2Q)\RT9LXOKFZOO MWYXE4?'GSTG\XKB<>,L)4&ZD:I%&3CBZXU0XD]4-(\-7D6Y*ZO[A3N&\Z]0JS!P*AI@'1-D]KC^;8W7:`Q9% M">?><3W\G&NUDLJX:#X%@JF^CLJL**O3PWIYRJ_FM]A4F#2O*';\,19VT7+; M"5-S52"FIFM-[+$XU[1T;9$^P($@*/&2^H.^(AMI/3LC$NN#_26TS M;FH$HL%SPOPM_6R-E_JJ2BP,L:H@CIDS_,"`IS"DVJ,J\=%?LVH&46_? MV1K$KA:J.."5`/`D95NN'\7A7-5M,?)!)G];Y=)+RC#_T#QH@$,"?T-T+^S< M(Q0`;TU\:#0;M7:O@W^R6EVKQV8*&OBC+SD+&I["(C2L#/M4PZ3O>KTNQL`P MP$(W".1S_!A+0FF"O[9KK7:/<)P43)Y(T*>YENQ#JU=KM/D-5!&&]J:&C%5& ME,V4S)">IZ543I'LLE5*\,Q:=;50#VBWT>NYVB^DBG9U(%@3M/C(J?I[U0:. M*:$2.>N@*K+R:0";&XP[^'#QN#F1P2)8R/!_KD*>MW:JK)-"*?O6`FI;&4UR MTJM$BM;K(,GXQZ:6I1,+"$5M1L+PK`TLX%;FWSW(449T9$IX$A*1A!C+7CP M[:I1KC;A9#?$V*-#)IEK_<3;BHQ?I)P*78.A:DA4?8@N]:X@SRQF_KHOSBZ. M!]^X3ONF_W]>MD#[#:Q8MK[1X!F0H^./`@01<7X`10FR3Q(,F'(9%++D*'2' M+._ZU\>BVP:AG,#W(44N#G?&;[S!-S+_NM9*M0\_,]R/(*@??CN#N8PE'`WT MI8&8PA)I`F%)1"]55*I``IS)"\*-(' MNTS1%E+!.`=47-!N0[3R$&X1Z\2+*NLL\I):/'YE0!7;8<0JE(BPD7[",7R! MY!-73SD8IN`*N0!1-C'>D[=V[B2]/@^2BMMPMCKP(3223PV1'G$_@E#N>>Z? MTGO<0^]J#YP)/GU1(\P442:'G03Z)`E:[/0X94JT6X MD\GWU&8@"(Y_2ZMJUIO=L,@N&5/(J%,RH#UL#Z4C5RQ&B6:%Y,&1'-K%)-+T M1HS,5Z&_GR1Q9C//E6.-IW3O1J0LT1!F0;+7J.]U4N(DP1RD,LCOP*,A]F8' MB73F"UO&)(*EIDX;0QTA(C9X^^0TF>)$[2'.&E,+!KH$I"N:H[&1V% MY%R/3NQ(F/\T@73Y(L)IY6$U[(.YCX!/S)4Z;CC%UP4S$%(X`@@`%S9G3B"\ M*I`8SQD'`H%?&(TR(LN)P*;4,<*J2$]J'$WU%A/\G;D)QF;ZI42$_6(N<[UU M[X$@QR)704$P,(0*]#JF2Y9>QQQ;*]$@634#ZP&2S=3-6F\;Z?`TU@J$;F)[ MY[Q?0U5@@%=CB:IIP-MY(F"^@Z>-,6GZV$=K7I?IHF2LX80P)LT*:#Y3DK+X MW?A7?K=!SLAQZ+BP%H',4^!`L'MXJ57$3@FD&8E-Q@MA7TVR])<9;DPX46/\ MSK&.NI)KSR37&(*&XFYI]:<@WN([>-'MG?#Q1D9#YK.F(L<4M_/!")+MUK]-YW)&)MVGZW3R$"T1Z+T_[5Q=G%UVOQ\7QP??V)Z+H\O1+7O_>O M3M\(W[ZY@Y80K)VA+\:HLJS":W-FC@*\&*NSU?Y\ZH084(K$)?BGU`/1_(F5,]N7$3AN>#[9IV!@"H5G/[.P MP[,88.JNF*.+J,BE'NXCJH1/:%((!M6GO^*E-@Y"1WPV!P$_4E=`=XCD/Z*V MS;"BP>C/?1(!,)D$[(S-6XN:@-Q!D!'%PS+!'C8!+GZ*&T=DPWD:*C??Q$?* MV./#BU8*'8-SKH@0%78I0Z_Z<`LD,)$+KAB,`@?.8I"^\CH%C1E94?2R',<\.-S-V]VAQ M<`K&?34TG%Y>"X6V"KLGQ4EV':UIA0JUU9E2+#FS+=9*KSRQ^6>W#`1^.7SW M!=A[ALC/?..1__U$5/CG$/(5QGB%,5YAC%<8XQ7&^*O&&+=:FY12.%DU=6Q` MGH'77DHY56CA;]L1^;G1PI,CMNRP9`_6]T@.)AK-I72OS%=RE"I\[PK?N\+W M?C*^=R(YTM)@00F#2='WQ_B?TP3H^&UKXPJ:NX+FSM&@93@]>SPT9BI!IL*W M#2;(FPFF5.C=*Y>H0N^NT+LK].X*O;M"[WX?)>?O;"1O?="+=;`M*O3NYQFT M&K4:M4+O?BM"MZSE4*%W[PZ<;#LSJ="[W\A(%>[HRZ]LA=[]YC;W-;)1=4!W MM+(5>O?;W.!7R$K5(=W5RE;HW:]Z'ZN1JI$J].X*O;L:J4+OKM"[JY'>\T@[ M1^].\K?*IF)E4[@0..P/S'$93$R-ZEF"+,;??KWY6Q6B=X7H72%Z5XC>;^<0 M58C>;W?'*D3O"M'[U1-<(7J_=PZH$+TK1.\*T;M"]-X]HG<2?R@51\@&'Q@# M]<;Y\;8K*BL\[Z=H*!*"%9YWA>==X7E7>-X5GG>%YUWA>5=XWI5 M[V?O?QX\[\2/+'()LZZCQCF^E"&A'+\9Q)$*H_NU$5QA=%<8W15&]S*AO$+8 MEH:%NAZ!.3#WY&"2@NXVM<\1/'SB1F!#.EZTF2RO0%0J$)5JI`I$Y:WCF;QI ML(UJU)]SU!T?\PI$I0)1J4!4*F/K]8Y4E7^__,I6("IO;G-?(QM5![0"4:E` M5%XW*U6'M`)1J4!4JI&JD2H0E0I$I1IINR>E`E%YA;M7C52-]/I`5#9+7,CF M15`]I*J:3"4U]*/!Q$ID$'/?Y3]\OS[Y18Q!N4WAO9BY\+?F0>.PU4A(MM^Y MD".G4V%,4MT5*,PK"4./J#P2*#^FLH8S_T3EBL)#?2J4^$-G>O9-HF?)/(R$ M_,MY*&WZSRZ^_/*WQGZ];J66;)=&O02G%S='OW%8W6SB=[JTH#N+XL7_O]?< ML@6SOT98,[2 MA8R746&=J"NNBL![O$A1M/18-,'H+7&0-16ER?X:4FKT+F@^!'%5@F2B($NO M9?_:YB_\S*47\(+^%*NB_I=;XA:]?#$F[U@;/=YKJ)Z'9X?XP\7@YE2T[)SR MJ]-C$-JB?WP\^'YQ5W``'IJ&5/N><@M3BX? M^.*;\TBU5#75KW!9OCA14SIG_/N,6BI_[%]__R0N@GW!K-FVLL;[P-ACSNJ. M`WC+G2OO*3D:TXP)+8#J[\4W"[H,7D]TG"3IX5=V>KCKB^_[U_OB:[]_2?F> M9U^NKJ-],R85]#G)P%33Y49BSN0F_:V3EI*I`D?*S*8R$"+CL%FOB>$Q#YPJ!!9P:`I6+8Y8B.93MF"ZA+-!"B!G;'+<#EMN(50I\3C'UQJ MRYV47#K#`(BP'K?@WKB@D:M]J:(QF:ZNP:-.D;3L5@MO[G2:2;W/I4UORJ20 M2+&037B27X]%5%B5>24 M6Y/;U8Q8"@8GBJ`PG`G>EIW($>.F-#I2_<[$ZS^EV[HYU^?F=K%64&]):%G1G9B`NQ'M/Z_\>2E4Y+>54`>UMNT!&(8#*J^219/E=I(5V'8 MT:'V;U7LQ/7G"/:94]TN2"Z)^`'[[X(605)1Z>"YER,NK,DMBB=J,@RMRZ:1 MQW+DWX1[%B.T1B0^)O/4V*/]3+:$KS?N5#EV'%':S# MO1/SR4K^9,#\U#G[V/BD$5QR[`SU$!7;->I[S?I>NX/\@A\<-CI8Z-ONL'B! M5S4_(53DOXEY`\;$A4,SD@I4,L*#X*OU<4!D@S33!]C`8MZ&4G)+=S>$N2KC M!#D6#$4%N*FZQN>1G50DER(=@2`T8DBYY&V45Y;.U>*&/; MDC+VGD.E?U.22C@-;2PEX%K+;:XQ6Y.ES"Y48J$2-W]WX*&0Z6!`B-9&9A4V M7M^"B-$GQ-,513/QX_(=@;860N9(+QU?!5%XU./-*">#.4MVBE!"$?EE@$! M[*#!"8%Z&',I9DOAGFMU@3D1E\4'!A*^@X$N1F]!GC<3,R37BN!18!D==<#1 MQ4)FLW"S]&EV$3UFFK54"#\W696'/%069,=\O9ZW[_D<4!SLL:Y762B.#^].;%.T(N$ M_FC$A\95->=YS,QR&&%6\%B"'F%\Y?F4K>L,OGL:M0<]*G$;X)-XO29#/ZT# M$NP8722O,,X0_[55.SAHUUKUIM9!%JH95=HKO*%F$]5+_9"L82Z]_V109S(0 MLRJ\`L2,N6PK=%Q$O[/PI4$QS8>Q%;6QIO<7-+,8T`F.?]EI_B72CRJ?9^%Q MC$",Y0Q]3]\H.C62]EBF$BT-U&M#V'D6N#5"OQL2#A+>8^.',`.UC6CCH!!\ M9.0Y93R@?`7]2'55'LW#B1E(*0PF;JQ&53"VJ5B%Q1/C@*2I#JCA7EJ>'+/% ME)#V%&@6;1BN)*PHH]5-E+69@)I5L#T[(OB;T8,<<_(M=>IUQGR:"$_>PLO1 MSO.C!$F>U/X#8@.(*17T"8Z]9%&A]5'&Y]$KTA!0-J"%CTD):=E"\!88]=5$ M(9YTN]LA5F0A0^I_B"CTV.\BLN6,35@^7<^%5_RHF2(=Q)=T!"SDGHD M1!H`L6`'.+1@K3NI\IEZ#E8]JPFE)T?L<I)EN?-H[J528R11$$T3`K>% M[D@;#FA,:<*Y-U+Z'6HP,!T,_GNO\:N>BX(?TL8:B\P`3+@'&$4 M.,.EM%5$"P=41E(A5B5?9G^6WX#F&75_`JOQ%I;TU@)]-2%XC2,U21_8],G& MG[&7BT^P?Z8Y2_"@.@(D--:4"YV`J%KTP_/((`B\S-UL>ON]'O':8ML$LJ8M M@HB"--J5,6B\QP6IAE*!%PDC\VRZ1G=X%Q`YGHR6#_9.V(Z@:1U/6DP'H@(M M+P-V2THDT=YDTD6IV*NX(I&OP'>OS5W)Q/40S\'HINO$KNR/2%8V>JV68'!@ MY(KT_0?CBWDRS5W)S1N&B)00?!^;E=X));4YR$4)'NXG@PT/O_/QU)#L"ZJ% M?'VM%L;YFP_[G`RGV^UI,9)H99+]U,@EL0L(+_VCZW[29&BR1##"F"-N=[.M MW0'C,_(3-HY\9M)X=:L.]%A=/9"*7&A+0G],9OU.6"37+:)[#E(D8$,P<++N M_*=##L>LD\$"1XL\.:?GY\>\\:-8!1D*`K"@B;PY7:TZXWLW(EX!8]US1BI; MZ!;_3=DMOL_69&(0X1YS)MFB3^%8(3\*Z2?OG$CBN@ZI#W9H37/(##/8GF5& MWJ7UJ\-.*^E0?J43RJ+7OA.F,@YB4WF(CC+RE<2W;L=]?1LU%==[#3JMK`7, M7G_WR8TC+1'9K$:0@#]4*P1,/7.CB.)VRI]`_FL?U)JMPUJWWK&,EGR.M*Y/ M:<42)DJ;%%97"_01TMRP7!U=:,:ZL\,\KJ$K=S)X2]DK(@5HVI:!A!R@N'*9_$R`D="RO32&[SVYYE MMS79FQU*`4IE`'$"D*XZ&$QN$(E]X8JG?HC7.LUF01E-3B;ZP4&[5;?LEB MK52=_Y>0_21:4I5"?8X9`&<\!.<4*%!Q`@X3G&*8X2:X-`/!AWJ`R8 MZ?HL,(\NM77T16*[-+1@KK3Q\B3Z.KI>:_D@*8)X00<33B17[*6C@S>!I6B+ M:C^:W=6,W#X`FZ!K""P]:':C\7B^J6OS)U9V=.S;=/SD6ESV_]4_.C^U;M.? M[P+L-5_.K4U;7IN<9BDR-P$9+S&5%P,93\/%=GOKP\7J`?0@N[MH>X.C''/^ MEOC-&F3M>GFU.[6-R'WF$71$1 M&^8FG.\4_+<0^*X%!N8.5G1W8"+TTC^`-3&E[XBU?)]#0Q$U8-Y_@65L-3OU MP[?(F/F7Y.+\_/(%5K&-;L/;8\9K<`Y!GHHOSA0S7E[J*'=[NUF]G?,@XU.$ MXCS`I**/B`XB#G8+S5T$W5AK'#XO`VZT8%HWJQ:R=,FIV@%Q9>3,<;%=[4Z7 M\%4IZ8V6<2CO'&^"J_89?YM=()1.[X`NI2QN`RH:D$I%L6;C;KEW[P, MGS:Z[;8AT;]4YM-^;/SF5FH[ZXF)H]VR^QEIT= M:9\=\R2!T/WV$F?XL'=XT'QCK+>.U'_["F?'K'<>^+?@%(;3W;+?J]+3VUVX M=V8`[9@?EYM#/]=2[IQ'7['Q>-`^Z+T][GPY15UBO1)D,[HCDKR M`S&=<\9?*%%-F&JVL1L-YV%$^6N45*A30SD5.Z/SLU%G:\D0**&5):@$JW3*@8.A[5 M4B7+RC5\4M574M4$;IP[-=)>.,[QE'"[9`E2/@"\=2X+91HN\^ M9H-F1\5U'XW".1<2,=VZYH!*!,=S50W.8+.-YE+PO)B?)0(:=C5H9U8EU__+_SO1?A4V#R*U!1S&7!"9FI#@H[),)EX M"H,1"5M@,K$Y@W&BZ-.93*S-8!_:++2\P/'54F28!S8U)4B*P_9J;_R`LR$WJ`EDY+R9Z^.7;1B4HR(Q8R&4R2-;XA1ND_/D:;5=WX*_P=KJZ M`W][+E%U!U[=@;]*QJSNP*L[\)?FP>H.O+H#K^[`JSOPZ@Z\N@-_/Z'UZ@[\ MM2NW8&_"1Y]Q<9C=0>^PSMPJ_!W2>`^ISL<22_5%U)?$QU) M!^OE]:_8:+%<&\J">M-&/=7BK>20BW#(/DSJF&_#-NV*F:F2MM^YT#1.HZBJ MGH>1!<>_Z?CM]/#+AEAOK[1KOB%=%(XMNTEJK(62V[F\"51'-XSIP1R>2!5% M-ZV;J\(!%E@%(SJ*^"?2D-FQG#>OV"CL6R$5<0N]WM MPW!!(96E-I*V7,7IHD%(!>!W@3>&WYY.W&$]PUM+!\J2EL&">.H!K'=2)S#_ M[4MHV$;/X$Z:K0K>GMNM&'ANBX>.G=1,\^+\(4I(H8O`'SV1'M3%2P51,L:R M9LX[IJO,4%GRK.<>;T)87H>A1M\@>$+*<$^@$0[232_/^S>G)^*R?W7S+W%S MU;^X[A_?G`TNLJTN7QITP,SAE76WM%!]_V<.3"-#A;-]$=QS1Z16G1M5$2$G MSCUXQ/\(`I7ZXP4*Q#P%Z(8V-K[UPV$-]"UE?T7Z6<*3S63[+*30T##)2O&` M^#?,S"%"C\:J5+/>^"OE3.:>%&?I'#$'L`B69/05ULL)'=&NBS M:B-?]T;>$L3:6.]BWGUR#6%"L:'6?3!BP#7*PLS)ASS"/B#!5+^E1AC`Y,Y& MW-1KG$Z-=7WQH=FI]3H'U"F0LR!=('P()%%N2O"PB/WX<<@^2%XB9`$;,++H M`N-QRM]"?B`;?9\P\?%!P@S@OQ]:M7JGD:)2#9I#X7MG.FQ];'I`\&E&2E8( MCE2B+J(")Q+@0Z-5.VAVMB1+."M;R9,UF.A][.HZ!@JA(A$]BYT_DHUE/.C( M'&S<>)9`5_LLA-QLZG&"OO^!$R/2:;CYV\XE`.74R'KBXWWL?`;C2JBM/'*# MO6].'+H_Q/7(Q1YT$]6B^RNPQ4Q'F#54:_?ST;?K"_W;X>=/`MM^3)U_!PJ8 MGJ5K)GV^AMG1-H,LDPS`%+U:HUWGEE!\G/EO!!SJ)UNJMUJE7Q/?Y&6$+Q7< MF^=9K^%897TR6-10.A%X_OS?,[_8LUOEE&'[T;U6?:D;>=BVW?YU1M\^Y>A% M&G>RN=?L+0^$@97Y.B@':EL6Y9W5$5=0:MLA'0-$9Z93JQU"9RVM6G:LS2A% MT?Q.NIA@]=#;)'@9?[Q"@I>SQ;,1G&8N#?:[C1/8[(`%7TQN_L#ER%5!;%.\ MM`5J6V#(KR(V,VP>K1P9173O`7@XKN]X_*ID<_CV;6DC>.I4Y0=LB2L=&3N<2]3(6`'S=>Q!X8,RNMAMPA M?#L5-_W_JK+/( M*P?9_5J7)CEGC39?@)?,+*-XG9S($'N:Q,X/[`,MXVA94I,U]U'U9Q;D,E?:W;JM4Z]]2I6:`4/D/7] MM#.*3;:]7!WVQ%<6"9>]^MZK6-JES/SWDL2:%^6%9_&".OPW@Y9;J,:O"46`"J'M4[GRDTIQY4EU,KF(SRG MQ-P)UM;N_*77=#F6D&Y=KM#=2O(7^[Z#&CT*8ZYA'[`^A.YS'NA^:GS*%\%:>;2$B1]M#5+HRFX7!#W?JT&L^M&H'W6ZMU^Y9 ME'WDKGCRQ\P-)3@5XI&0;M(M/O$'&@:;Y[F<:#;^A!&'R(V(B&#RVTMNW$[O MU.C_VO5L(K]-P$?GD_@@\!Z[W<6%1WDT,#MT#DM'E*0M5N&,L'=YTD4[E!CR MD_QYY.H"I%,_QN#HD1M\DV,4)7PIAQ=OQT`+O,YW'=B,:*:MY@948 MXDK`0ART:ZVZ?0:RRT(4G1OFM98EP^X%\_^96&P[,NE*8I]V8@&B"E8\1RG2 M5:F<83('O'8^P^Z:<\R+=JE+ZYS@3^!QA;JEP+A,,LB,;T*H:>-8CNZ0BN!\[?PBG MFYN.4M-W/PX#+Q44Q8@W`K)=`17^'%7-F/IWB]9A4WCNU(VCS!T[+ZG*D(*Y M*PBX8#+!20\?\W3,QXO!^2?>R@!G*YQ)3#D4V":>6]TI.F&K(FH[BU.HB:SV M,]OE)!O*K&(VE3B`[O9A^?.8&+CD@P!+J$3'SU=Q-M^<@7-F<0@L>QJX4J59 MM-J_BB\2S%C@O6.E?Z3`BY>=-F)==@VR#.6.N0B^1_86E1LDY3.O&@"OBMY7 MT?LJ>E]%[ZOH_4\5]'[*GI?1>\WC=[GHX2LX?@LIO-EOFSB M=QBZ.T8E;L(ZFU;&PZ&%,VOG\Y4>5L'W6ZO;97HK^;5TXN;H]]. M\<*%UFDP`4(7O_6E!&%_NVS6__5??UWOA4NVPY(*^E-XK?0QOYM_O00G8;?]!NU2T(BS*#E3D*3T36 M6'$B"D`U3B<3.8K=>VEB:QC%NY)`Q`@V@@]TK&)]F%4]CX/P,?5PV9#9RM3N ME@4ILP6ZLE/5R/C'P73H^O2&]Y1.?6C?'/2/__G][/H,X3&(ML$7`<+D]/I& M'/>)]N=,KWX#-VP#7_Q][O%%>X-0,.J]U/6&N=+%J*UU>7O<+[ZNI?I%[&WC M/=)-"AB?\V'DCEV\3"6(U9V1-`:G$VUV^[HKG(=_9#!_%MW!? M7+EP9BZ]0-77)N_.OD??NAU\CLQ0B,4D9J&\=X-YE%`"Q-ZY4[R-4B30='$> MGN?D]`';[BU#.3FQ<-]`TSW32YD5X2A`NGL-NPB/O[$@!QOU>@;*SGYURI8X MMI9D,.''!I-C6ES"N=H2(>4&*Y*WEJ[&"\M;9M@KB74[HY@NF,$Q(2VJ:F!0 MI4<_OT3NK9#(-[^?BO[U]>G-M8#?+D]OQ.7@#*3TU75-G%T<[U>".E]0.SYB MHQ!1;08L,L(XD=,D3Q_+^!(W!LVP7&6J`T M$"M)1=D+V"'P9T_A:RY-7%M+?B?$YOQTQDT//W39`,)#!,=MYVM;9HX_T2+K M56ZRK9DQE&TK,_E2VK3%W*,DEP4-.Q3LL]`=498;/X;R'5ZME(E0BJ3:S"UO MIMK-2^XBBBON!P(3]S`USQTR0@SIMJE!@9D1JDV"Y\?CASL8A6(^T0_`+7@WHA&(M>-63MG%B M&<#'_)1E_SZ'[_]4GW4!SAD,@;YR/="%[:0O+W4@!>B\=;A$SVD>CI=5YC]#4) MIZ-@W=YLGLA!T_%7&,@:^01_GNQ=VP]*E)9*4!('W M(AJQ<&Y#*4G6P^\>`G]E"B*;M5:S+B*$MP4+17()9D`M(@1F\B/Z,A06?S$.^M M8OTY;Z)+05@=$D'&1#+BWXMQB+J<8L?2QAF4!_K_Y MDBN_S@JT:HW&IBO07+8"K;>S`LUV8\,5:"U;@?8SW3BM-]E6MR&*)LIWUD63 M;2^;;.=53K93/]APLIUEDSVH[A+U(AL8:K`=8%UCS$\0\]BE6F".#RER/R07.H!==Q%.G&FK]>CTPW0>&DGQ_O.3#<`Q:0>3-#GRQ1DM[$Z@- M=<2P6^LT#Y#_^O"'`-[\#8';I>>Y1F#!%Z>$$>_RE;'B234846$&_&MZ.+(* M[1P*[B,Q8Y^4^1(K^(,A;`P%\*+,;9$8SK$/2FA]*;6`N+9HG!(94^=/*=9< MD<>+II=Z[OMZ[ZFB\AJ.1VML59X3U`IR3=3E"GQ'#<,G=E'5.\&M_GX]= MZ\#$`:>%(Q&PI*!)YFYT-]7^%&5D4)KWCX MW?`P-HY*[N(L&K$3AW+9OX2./P(#2A+0U5$`O)O3\0,6H%WO$"$TO]S3T?Z) M>/CGQP]Y9WR^@,&C&CZGF5V+:&QYU>EUQ!)F3QIB;9?93=KAJQ':/_DIT$WZ MB*J6.0:T>9X#ZY^ZYM8?VHF>B!$U`>?/2,[O^]?[XL2-XM`=Q?"B.9RG;^YX M#&Z7^51G4L2JY=6E]/WHT;MW?-=A'KC%OETIMS%]7*P4JN,[QZ7.@<@X6$"P MCUGYC<-_W.S?_"'.SX_M.5S2!-S))+(G$4GY)UWY!X3_="]#<2M]+-LA:L;. MU+F5%O"@;MJ$<\:LU4B92)Q`DKC9O(1P-B5^?1A*![Q2C9/EC+AN8>[C!@KI MP]*0K00T>`J+`N\*V*WVP='%O"+^&[H)YB7RAQS-X\5NA?CRX]!Q;\47-QIA MJ>G'U.FSENC3(LU10,L28;,R<)O#Q97@M5X>4J"Y*X(5@XR204!FH)0)YK&8 M`HO'ID^C/Z:0P+T+XH'++K`&VQ^K$$-D^FRIM[K8WB^&C_9%/^;?8S@Z-86W MAA[6+(@B5V&XS?#6_2:`31@*T4FZP9FVN) M!+:4/_&A1"0;M8=N288!*`6_(%D0`,OB-&U-&]VT,S_R19'U16"6URE>)9PQXL;AJV9A,`*5A0>0IX##_G$-[.I2,A`Q MO_5*%$+#9&8CM!54?`PU)P>QV*A,F1$2;'6@XPI)VA,%]+D0QCAT0:E;.F]?@#@>.IR@3U!?L.+'6I2;8#+%&-"@BNV':Q MMX[SZ;&00%<9_,.)[V`;T9&L92L, M),A!=$IS^0GA"Q6Z']O[*JDO!!7@4_)MZ(+9Q$B).!1('!(61I@E&\-?G<$ M_8_3T`QY1IKFT$A@#45*CX55<.^.)2TP5T2HC#1J<$62O=^40EDKRE3 M2\EMXQMQID)T^=Q? MELP8=#@,:8N.B93<'52/G@D7+FA77IH=:5A12KLR"=O2L%SMXYN_S_V)I30XCD0(F-KZ[01+^.-G#[F?1:?-5;6J\OQ0, MHUF$^>)!8J]A-YJZ$18]D5R%M05F1_\-7\I>JPQ-'UHZ5+C&B_9F336[-?H- M^3K&1E\:X(97^[OO(I^3?1Z5TU;7L'E@8K(TM:K3:$I8_X4YMD!E,GBT$Y3D MES:;!J,X(":KZSOZ1$=L9#A=S^F^-%1KGW6=K*7.TQ^D79.>ZZ`<\BKZT+Z# METR5(I)`6_`H]4%-/#"2-51AF._*)!^S&`*I[W`4#>L`T=R(N;1OC&C%$[\ M(C[6AI@3.=.5?)Q=8]^29/1<03E@!J[<1'6BW)B,;7-8Z9K9/?J(W5%%[],N MEP$$#&]#)JQ#B621LB;AN-+#N*-);!MMDM'8RRG(*,RVZYM!C;F8(L?V!Y*+<_2&XS:TGA9S4AQZ]3E!)%K M>GNP9345D8#X#B7([0A;/?(.^/(6F!FW=.&/(-,SEOD#>=TX^KT;Z```5"TF$;X]4#'\S+TGN,U.Z%P9UT+=O>-'862VP^FV-Y3*+\?7CZ* MY_;O:&J`T<+7]N93#X%WB&9>"O,4S=Q86?@$6#6^G*#106W5@7$\NK"WC:M< MZJVYUUM"HF=4HV4P"U#3?#+!>UM7.QT.=U@U1DX-Q@)>PO1(:UH1BXAHKFRF M(LNM@OK/R4F1"M2>K!<_$`&I?K13/=L`R-58)`Q@7Q"!GZ/&RD94WK=2B^`V ML>,/1A@:?FCOJ`J-5$R*CR(;J#:6/0ZER(*]9Z4BI$N?H$%EXH0PDC*-@1LC M/EX(%`_3^M,/'D!3,_8].1EW(`CAU&/%NOA44IO/'$;V:NCBYF&-!O8($&=G-7%^6:,..!YW M*`!*9NJ9.W=F!Y?@?7)\F04,UFYKHCGM: MT)/Z3M)8`ZDQYL-_*PFM:4)EBNX@*F7E:6K"N7`]_0XUV%`F\9=>XU=CI0,! MH(MM(R9^","R>""4%%67>1E2S-=J`9,@!7/]#PISFNW((=P3RHMD=L7S#9+= M]1-G*Y/M]#/YIJ@3_3D%0-!P5%L0L$6<90&B!54FWFY)MGF3+]-Z*J`"C$/5 MN+>-HUNPJS@%[BZKV`1G*W4V,XEN,;Z$S<&1"U]FW1UY(RKI[^[W>KSI>NB`W4@01!?"J"`X/JNY]D52Z>8\+`@P%`"\2 M7<"1)(CN`O#2(\>3V42^S&#O1$?T<4U@-2RFR\9-25\DBEH9;%$B8!QPQ%"Z M*V`?BGVP4*)`R=RH(7`)0!*0_]#GL%2CUVH!GTQ!/B%72`W9:&01T9;B+MT[ M#WS$R,B[][%9Z9U0`AJ%)6+,2?'1_:0CJ]AZ3Z??S<*.`X/?MI(73A1+*4@L(1[ M3)3DN`^.#<*#V&/).R<<`^V0^IC,\Y#';$>J7.J9IN-J<&DW.*Q.:"*E#Q]B]_N^QHW.?4=XKQ MKO&O$59=*ASE+.:VJ;+&XFI=90V_MNK+:_)[O8,\[.NET27 MSB->Z&)_A\"_O0&C`N$:-I[)X2IPEO5I6<`=3U4P8*^*8=QGAWOK`"W%8VV^ M[`I.W<(9V<;*-QKM>F>3E5].3G::"K((8W./-\X/C;`_ES=!?S(A>'49Y<'1 M;[@=;7LWUAE\F_N3Q879>(]:G=Z6]BA+4LHF^,;9X0IA):(%TI=GZNY,IYIO M8XL,.$WY<1=VQ^0R4/)%Q&=L,/F"GB1_=$Z=>&^"(WDB?3PUEV]" M)X,?M?[(6>(O0]4T@;"LWP`B31[X3&-?7`PNQ!\#Q)M!W)D_3J]NSH[.3\7E MU>F7TZNKTQ-Q?3,X_L=NL5]>^N[CFP,'4#2[UNW'2*IV,JCU M>&WJ!_Y]0+X3L`&UA,*TJ9EF%1W92OD@+FDHGB@Q=>>-W"&2+V M!&AC!^D])>XR,KIIJ0C'5089^+^MLL7J/2/S$V1E:21JE\HNO3A5-'W MX9Y?8%8TL\.QQ0Y&<@C&W'!A;(VV.6&[@NU*A5*I M9SF/$5$Z!X5P3*0_0BD=8W9T.*([O&[]UT]VL#\OT&^"=H1E]+'S"7/7Z(IU MC)53[A0AOAD^:88.-:>XA9AV[+.'/8NS?GMJHMD\:4[AH#L.7JUWPD56GMKY MX!KE].75V?%I.GZ1!HE'*-U`TX! MV")C,7:QBL,W>,1Y-"QR/E"$E@<;'I;=D?[>L5E=TN:7 MK/HQ![!4.[F"CFQ=C?[Y!`)V/)'67K/[O!-)XOT%;[#[-7V?88="P_FEYE#0 MCZF;AL'=8/CE/N^5'$M."L$Q!42FQ?BAE-2Q-_90=+0MNH8#R8H[F1TE'R7 MYO1&O7*092=G?YR=G%Z<8".GZ].KL]-K<63[Y+_WKW:-#?MF4ERU`T\D'9A* MCT3&3P17T]=:O:XEXYEG<%TS#MD#04^X6931/-L+7\;N"KV2-8TJF<`/M$\L MFLIAWDDGNO4.PT(G.IRTF@1'&C`N_Z;0EO-.46N?0U>_#\Y/3J^NQ>D_OY_= M_.LYSLS/C%.!UF)D,4>Y(R.GT^'R5PN]*W3=^GZ]KM!UG9"[2M5$P^10 M61Z(`]Y2$%)Z;+/9K'5[C5JW>ZC_JF+25`>>Y$?F'YL*L&='!!OM6IV<%SDY MHK/DT%!GX:(_NJG?L,DD&X+]_H(E6!,?8&!A!M5!<8XGI8(&F#A6<#"3]>8C MFOR>F(>Z#-YZ%M[2KK75-`J()H(6+5A#HF7X)F]>37&^*!%OA%W>''^CU\U. M`UA+G@O&U%B59XYA@P)OSK\$H7AP>8/FLX5Z\(<[2?G]]_`\V%M86Q)RE9WZ M]2.,ZW'&-4;(3*IEN_OY/!ESH?/L4"(4->73CPEC8#AG(R_4&'-)#'7JC"7C MSV0N8@6*,XQMQ/1-RSH2HU84B2VFYDYY.?)U6 MQL.."#Z;8!V==>C/[4-?R*()@X,W-4
5==B>I4[T76@=<%M\S7E%N0PS%$ M10[7N+Z8S#WB9JHA6'T":URU@Y3@$<2"8RP&7SX7(U64+04G2=6/62-R14G1 MJ*$3.T/J^$AH^4%("Z#"-S0'#4.`*`WZ,NA1E2Z1#'I`U("AU-7.)"1U>@7+ M$EPP$@VV&(RH\$B+/M7"ER5O`MP?.W\RA!7FB$P<5YLP'T'/CB6G7_"%B`71 MP&>0%3P"&7PB!3`$8DUYIB[*U`M$S^T_%RCM3D.#ZR10W#GW##OUH;&/+5NU MM?;;&YU[L8QI+K-XF:^[G9J`1[BN80-#KU$ON+'ZZ2X^2W)74H.I[OO$FMDY MHR"=V$L9Z/'48NUTF^]A;NI$OW+FW;Z)AV]OC)Z='I MQDW=1*:];SFI=J0RV0?!0A*B;A?U,QE,4FJW:26,4G2 MMRER)6QIOC9O,%H3O6*(W4F5?VK@N=#1HO"!=&_OXB1A^/!7\$ZFE*1%31.2 MN&;+ZHZH/"5%.$YB$B,ZXV&=+1*J"^=R;V-8N3KI*F;MN%;BLS6=Q;%CQEE$ M]^PA2*;2;H)5!1[>2&,0%P"@*(NK9=K2&RUN&7Z6NK9@41KUM"4V(TA)-91E M!&)Y/$_!RL\S`3&:%N^P0M%:GCW')?L'M5;O4+$!EHP/L4H`W@*,]+\I^`;= M25U\D^!DC/<-"UDD)'I1<9J&)_[0Z&+,FBH;4OANR9C)3I#)W*@AM'F[V5DP MG@LQ2GX*/W=[/53F*E[1V5AJ9,*0UQ(>'@M4>W9_!B5;%O8>-D=\:'611QC) MZ89!0/0[:HKKM)CHPQL\T6AH5'L2.`FC*"=+"YS#7RF6ZOC^?$K(QP;I*4^( M:,,M(TPR]&0^R!1B;%AHD8G+$!G]B)#LEOMXCFAW?BV2/)J`S<0-']A$Y.A> MKD;P)%0MR!NQL:QA7E"[KN1X.4FCOJD&7R)E.NM)&94AUNAAG]OF:Y(TK]!X M7T_\<`B)[9;>MB30S9T;KB6`/K2XZ8N1/\D;LN*'S)[.CH1/8L78)H--3/KW MG8@>D8@=*WSUS*+'MG1T^.H91`]?S6O1DQ@X1,(2T;-OOKM:^+37-'&:C5JW M?EAKM5IVW&,2^=X2D?!DC\F=9#VFSA*/211X2^FX MYVX]I@(QHI(;5HF2;NV@U#(4^Y80=:V4J".B5HN[-JQ6P?>%55(WW$L++,H!L\^XYA9=E M`V5MNR4N6+E`STU*%@P=CTAA05`K\+B("`PK8E^!:.+R59-C,L20F`Z(TG;W M9;,(=Y^SL.$9%SK:FV)V=IFE/U:POP84Y$-+I85B@S@WHDOL,0))8<<:JK"( M=I^-_`Q+2O_7)KVV#:'ZT>'\N83H$Z7C9HQ"ENR'SGK=^2IN>XK#[!2OL5.+ M3"0[)4?_RN(WA_U8+A$T*_V`7`6B`[.H'BV!2NF?[E@GB;VY91IEE^DXZW^O ML%66IH&0NNG4+:?:A`9RE8L*J8=2FJM[!:>>$)A<,)?1,SK&I_I>!+Y,)06D ME)#9[$2-Z%L7ZDR-/1U]DPO"4]Q/@/53%"<7Z7BQ&]G)#HG>U,D+SFSF@=E+ MO>742]1MNI6TP(;Z([4N]%QZF/^$CT<,+589CJD*/=(9!B#J*9&4QD&MT6E9 M]X8L!Q)#`C9FH8J!;0B5`6I,"=Y'94X8FRDY=$0?#K%P-=1L]VJ][AI^1,+> MB[3]M.;';AJ1-P]S>L+DVB3)[#X<=K2A:*R3Q*+$1E!#V%W,VK!;D[9J71!A MR5L04\T$9"W/&LS\,`?]FK-1MTDVC@A M]ARW[8<:=>55YA(FL8.),'6XSCY1#S4%0[<8UK:/+G>`2?M06K?FW)4EU10F M='T`.C9S:W"B5*Y]9Y#VY!;UD=*M94)DMLKME$FI=+).7JTP)6]?-Q@>*X,` M<\8G!3HTUQZPL?==.Y7*HL%*"QX#%9%K1.WON.''# M*=<:F""022LAVOE]Y(WKOARX8+8,SU+U41Q[T@G93HGE)WUSB%N'\U7YDSK3 M]0B6@^P.J_2@H-/-XE@FF\P9XXF2*K_?M//5G&3E`,/#G,UO[+E"XR8U#ZM= M8:K^@0(X,+[N;&):N00&[C'D*J8)WNSPS0'5)VF2,XT9+$#&H\"?1\)NLV2U M7-68+X9HC'GRI$N>3J_6 M[O)=ROKF"09#3&^+E!#,L4":C5JKWJUUZTV1EE-%T2BK3\G[4D9X$\QY'0>) MV9`F9@U<`JMGX):3WIA(`\JR*A"JN7W5!8[C$Z,UV&9J[6\Q#KKBP#U?')0( M>?:TMT4QHK+7:O9+N MPVLP_7_F3<2#V$_Y#&=9G\%L6#J+Q1B`.3C26S;PU@UXVB;043//KE_FO0DD-=$;4@<[27)7YD)2*+,L1/6C1U2EL M(R=(GJ+A!T]&2-Z9/V*VO$B\@3)IH M=7LSE+!*/E_@)'+<<#C>ZMS!#F*U,ODFC^(C^!6?2%L1&0GNKPBQ25+OVDVZD^PIKAT%/ M?G^=$[&]W%1F/RML\;K\D1<,'#`*0=-N0K]IP"#?L>CT%I(F*K_B%?L5>K]^ M.K_7V7N/@I5FTB2S:7$[&06LCWKB^`X&B&[$F MS42.6,Q_<7]0@V#R#*Y0]Y8ZQP5=3NJ'%M[)>N/NANS,N7\K9&?DQ!LA.RM7 MW@K9&3GT)LA>E%MOA>R,G-L=V:K=4BR3_D/:+'ZRH,/^0BO>_S0RR@FN=F?' M9)031+LFHZ1@Z>QX4TH*BF<@HPR+=NJ[)*.T_-GM:I26)ZW>>F0<&2\N>?B+ M\N$V]'0:!ZW>H:)BR>N?2$993V?'9)3U='9+QFI/IWO0:N^?\Q0K#J@*P0E*CU,V'6@F.1CL#:(8C3R81;?BSO M'EW:EVL4QGU7C)I29+R.@XFUM,=)8'_]!!;(.=@K[%">=2;K7;O MV>@!(=-8;L[TEEQ(+"M%20,@Y4B*+)>QBQM4(&,/-#TK MA]D*49G->AU$9?9MNT2=F_R,@6]]NZO#3^5'VRZ1:\K0%Z)RM7RU8E<;$JDL,[+34J99 MKKPNM^>%CDJKWNW6FT:LK#/R]HG.\$`!T:V#P];A0>]I1"=7G/"]5',8,%'H MPR,GDN-+1KU["[U>\MJZ'.R+ZYO!\3_$S57_XKI_?',VN+C>;?.4%\T]/TD2 M<^,'A&(5P!KQ720XASS3!EDEG2Y4HC0:K=I!KU/#SA>ZTZWJU^XK6$3'0'-_ M:'7;M5Z':EP9M\\?+X`JOI,V4=M9_E:MV6U2HF9Z\:F"GD'",&\:RRO@:>H/ M2=7P'QK=1JW;J5>+O<9B$ZZ"O=A1LMC."`1BY&I.!V9V_%M.W.<^L-;:=_DM MU=JOL?8'P.CM6K=YD&%T:UF;K=KAP2&FJ&,*M.[&&(<@?S"U.A@";0YWK\7/ M'=U]=@1:T'$-DG.JI"Z5;EUMV!H;UNW8/5OQ2,`A*-E\=*7TZG;>T0%Z"GZV M;G&&V"YR.O."1RDSM07(]PATR7WCJ>P"8YF>YVAAUN"M3,'\8,'.O1O,(R\I M2J7*GYGT(_KF>P0">M)6*:AS?7)6+7<"*I>M$('C,Y6A.+YSY42U.\5"CP&V M3L>&Z'":X%2!+X4"$,^:O>$:=]3BD'WX*E?MJ'KB-FM!>E$T'_X;*V>`''C5 M1+KD$9)A%QI6@G%LL1S?!9&T'Z>RK(A$,]<&:5RIA>(75?"FBGW6G_P=5[DG M#)]E=BIUEE-0""BEN"W**T.Y^IGK(UGY&*7RS[D3(FP4JQ[L7M0R8/MB[&(M M'V,P%8=1%/<-8: M/RG4:LY@FIB]$,OOB23UP3"(XV!J?^+)2:Q]7=651D$$Y$`C*=G6(0&3,2!2 M9:6P<2<.;+^XVA?_"(*H5K2/+`A.&6@,;!DE"&I<,!T1OG(4A^Z(ZA.YJ=2# M`]M;HMJ/*<#AJ083#$:@<\(5A1$(E9KZ-]B@?C1!>-`9B$+NGQP`O>&#JTHI MQVXT0YFH!)`]8%+NK^#;:-FZ-GU7R0PN"2(@A7MXQC63U$R=Q'@M#4(F?\S< MQ2;G"^^L"6NZ]X$'BL`!>L!^H+(\A4JKC(RQ1HW0&PO#N1$5I8-(CHW>F4<, MP7UM58QJQ$FE'^1XFW;>%IGY9SELS6Z)PQ8A^Q@3DJ`"2I\<(F/Q]%P$B4F* MQV?]HR/6.C9L9:US=,J?'%%\:G"ES3RM<\-&Q1//#F+ZP"\(Z&(?(5$=GV<[ M/NP=K3@^!&H0S;T8+>`G:IT;91Z#&>+.7&3-S95/]@1MH'*(EB>IG26'AZUQ M/<^Q''G8]AY?H9`<$,,AE/\SEY$F)?E;39VBQ$&1L1 MB76$SQ=?Y!3=.?=2]0(#C@.N-*?;H$TH?RJ92>:=617X;L_O>I@YINU646Q# M.6ZY\8U,>"/'YTX<;>HHBJ?68E'V)/IX:O-W:'/8@W4OVM*WBY9#:U+7>$*% MF7$')3+CK`3XXB%R4OFN5*3A2Q#:W\/[P.-)4$Q3B=S1KD53F<'2ZS0)3,XF M1C!N@B\F(`'+W0_EL0E>/(7(=MU:N/)C+MG3*QV>@->5V]\29+8*][=HN!2% M)\H7'TS8Z3XR+C>=DTMTMG.N@YM[]99U'=S!Z^#5I"*P7$_7*)08>56"Z1D= M])O@^'106`Y4;ZTF#)>PGF7)HI'*$G6-&O14&][]*!%!]!@)H"=1W>R6I;H, M*:77VMA#.YA2HU-Z(U:045*TZM?IQ3$O*S&EP[UZ<^TI/9&4A=0.Q[MW;E$& M@60*`[XGNY*CX)[.U!]X]5*0YM],[TA.,E(SC1=39JP%^N;#"`TV/SZ]?\,Y M)MU]\9!NJ>MR'%Y*6;^H5DWER*4ZF#EJF'SY-0>O,NU MJ[^"+B`*[W?D1'<,J)?3#\0BN5O8$T0!R"YKD)S7U!U.DFHZ__2&(`K3=W5S MY!Q`O"4-0>#]80P+Z/HRF4FK5]P2)`<8<_DA+OKCX)P%JCH+"QP$(XYL.P`OP8A<+9H MZBW)1+YU>AY!YKXW)FXVE]P3@+RB_V^49.)#6MF7Y.$WGVAP`3XEVS=V/U<+ M+%IMD4)/'F,HV='BWK[N,#K`;J_YX,9WXFLH;]$,^S8Z08!A1+UA^3[X'Q!EIEB*,(-0R:5-:SXB&8XZ>8A@SZQT`H MFQ-/W68I$_DC$6Y2;.2/D33-O,E<5%GYJ"6UL8@7*)\2K9965MKZ#,"(2EWH MF#7I^Q@.$+\'$0'YUK`;VUS=]*M[%G$O81JNCZDT>,OCCD3PX$N>*+]Y<6#\ MFQ>,'(5K?`TZW!%'3CAT0J_=OK4 MR3/JIV[2M7#3/,=-'RSS8>I@82,"U^--I;NQ.;6^".$=\]#TS[R.E;ZR-MJY MA9=%\<(E$'**E;\R3`XL,2,G#1;<(M7P]&!+$C#R0^F`%T4WO)Q:SAU_S<=L MPM]+WV$3\S8(QF+BZ`.'#X\ED`OOXI1S7[+$)V%"O@:HBZDYD!XF"*1RUQ?/ M7NY;TO4(ZL4R-AT5%X304^8F5LS+W-"17#42EFB11`(#Y-/#YH""&9([MWXR MMUH>U05+8GTM:99K:&'1O(W)EAA+8'-IE_A[+*>^&V?V45]DLZL"=M4#RSZS M-'@U[X,IIF3@W^=C5WQ#I%'I>6XMZ:2"D/=7&+4'?^.:!:T%E9\,X^\K[/RI&X5R!N8*%M[RZOOR%CB3P(6.:/1[-_`4.U.:YHA_;F)0#\1%BVF$7P]LE]NB]]P9DC08JYZ9B6R) M@CE&)OX]']\2LZ'OYP>8.>.!0SU%$N#M7!)B?C=YZZC)S:?@V,=,=,WD(^OL M]AKF+\`O,J(G%*!^S-.#/SA>C*FGMF>92[XU^7I+P)E$[8CK8%:@IIF$[',< MFB5)IFRN!F,!(V&*HS6M**85CN:N*K8#T1WZ,ITQ+3&?^96KE==.7U^W0O8C M=ZS-H$R6APY#*#M,V6J@@,RQSAAUD=6O)/TJ1WP%A@N!AT/)*D)9B$1%T?N` M58$_:N8[),C<"*13>"L7#"OXW0TQ3VG&@#U(-RR5Q`4,.(L6?AK#%$#7XX]V MGK02IRA(\'&PY/`)DS]8,YR(/Z(`P0S>$/-G0OT3/68:5>#54$T@23C2?#22 M&/Z,6%+8DN=>JEBB3B7]TX?AZ;&YSS^/0%1,D78)3('T43(=G13VOQ+R_L+G M0YTERB@R!Q_TDS='K^RWU\F3K_W,?&QPJZ$^^":\)!-D7=K95=V-Y)WC38P2U%:-D8$Y MII$@9-HT/PIGLB; M![7606\?_GF=N__JN;.]#GS*.J$"8E0Y^91XF$K`Q]*H^V:NUNNV+0 M#?T,$\11J?M4_IAE#Q.O5D8J<,@,?(D?[I0;N'UHUPY[7?SF98C!U?A17'J. M:C^(*<M.>J:4 MI2@27/F=S\T/CA<%FBE>^^1>.WT?7=86IQ'ZGBZP_Z,Z`S'F<'.0::8.6"WQ M%RG>-$>'/`HF\0-XS;7D;J4@HKCJA_`)_A4DZC@(A>=2"`)SOP(=DG7PT@S.M'F(B],Y#JG5 M/544Z1'T`X8;H.2E9)1R^H6ZH\`DXYAB8T'6<"ID;=Z+K,9XE:SS!EC;XFTN M5).&I8?\XCF'P8$(2@1S[&JJ]ZLJE*FU?[@;]'M^A@)NW%(#!4=%4'?UWXNAN2*E:W2@^NYZE7J!+& M\G=Z18M-5EO&XJLSKHPFY']2T!HF4Z)53Q*O7_V6O7;Z+G,B7_U\?DK<)SY* M4^=/B;ZAYI0/#=60&;@!^&/"%SV/23*L2D-5OUH&7T1=K9D$&4YQI+&<:/2S MU,/O<\-+Y#M=%MG3&:&`'T=ZMY?>MA3>T>B["_'$>PM.FBZXN]AZQ6I1?4Y. MH9$<3"@[\((L*?C%*ELZ\V^P7%UEP>47#/;VZFU=V]/;:W1+5+@='-:;;;MQ MQSID[&0*C4,UA4:]7/E7_;#5/;0;*VQI"L?VC>65J@P8/&T;Z]D2L/+C M[X;XP@W(Z\C4>C+Q5+1G@RN?S.5-8.5_Y]<&]E9A:#>MFL`EKT^300QB`3!> MFFJ2H@8J3,KRGC1V*[H50Y1O4M./&0KBU"\JG^RMW?2[U&CI[FH&;7XPT=TX M!Y/+((IP;@E$^9-(--T_RXZ6746%"S"8*-@[_Q9K+'6U*T9KCRDA9/M'HN3( MA2CHS"Y?@G"0I#I;S+,:#ATH+J4(6NDBVLU(V.DTFN64`?[3V,XTNF)04#YG_@6, M>D/XP=\8/G@32IJH5NA"LY"6W,%21S3SA9O`7-;=.#_XJF[#56JUN[HQ[^I! MLHMVI")R5JZHKCFC3C5]CU+;X6/=$(IB_?3OF^!(GJAX_V"R*?GM0T31V#X] MV9E^55$.4`IG!AB=OG>61$,*K4Q=R-]H[+56M*.MI[FVS+@%2C2Z"?JHT.7C:F+'TOWMU(_=^/%R/O33X]]>M\]Z?7ZW3\^7\^)Q9!Q\M.[%J13UZW_X\*$; M75TWS;5\N:/N^AZGW34[&\IPE92T3W'"R#F+V+OV'11$`TMZ&T/8@G_KK)MU M^$^=_DGGM'_\PA9':^5'&J2^BZ=X:?#_88!L[LI!/?9PT.47N@!.N(*?3&]A M>0$)7CE2=!4Q"LQ'E!XH7GXZXOW@AOV3WOOX=C^H]`U>'V&2,,+'^)'1W8'# M@>\QWR4+&'2+"^1RK,`YDW,GZU`[7Q]\=P'FTOH6PKC;D6#"3AY@YE#SR;^/E1 M(TN8(&"#',HH=G+D#]3WXZ$3(2KE5Z[T_EU<^ M$(?!YV`JM?]%;??G8.0'F$W0*[KC%,HY*&I["*1O;=^$,]L2(4" M`G-K`OQ@2KDK`IR`*2(##CF((>+MYN]``1E%2CJOT/X+4J MARTUQR=K:(;X#JZ%"LHJ[70@#54QN,(.AX@Q[AC^%L*/UI.*?Q:U;RK:.6S4 M<_CH1^V^<^[(#R1#EM9AXQ(U/L4]#AH)J#$C[-!,!C'$`2(N&R'*T\0G:62W M#\VF1FL'@G!(>X/7B8OB*@@8Z<>H(O(63PQ\%JPY/FE*M;[43UL MSE.5=Y6^A[4]G?2704AI7(&[]KW[.:8KQ:&V.\7#2E-5WRI]Z\L`JW);EN;A]WI5A_+EY5EEWIU9&K5XYIE"G4E,M7'_X5B-20Z^^DX&9\ZG9N M7SV^5>M?QJF#7"=THW3H&KYG>N"7`&8)7JSI<*;W6.Z%GWG_7J_7-SK&ND?Z M(_(61MS=R/2OA67I.NZ&W1/@<;-6!I_3/8VDJQ'W31A=L^KZ3H8]ER_5^S0+ M;,)=M!Z_1.PN6I0/6><>H<[TU%42=#-CY M+0Y)BR[C:2$GU"$`Z;K_DOHKH:82K?C;7*:U!>2/C&=,[A\"8$RK=I,DE_'% M/?+$4YH1#B1#H[2+&AHGVM!0$;AU*-D>M]H^?1UA$2K9)FHHG&I#H4B@UFE] M&.)+$,M<+HE+P(*73PMA:S4LSK1A(1&S=;!`"/Z(R,)Z><0>DX`B:*L&R<_: M("D5L76`)`/(@J#1?\58$ED(6ZN!\D[W/!&)V3I88H$@&W<4(KUTL];,;2GO MXN:M"`KS_(LG>4';M@VH(7[T&0E8+)QH>F\U:D4\6`Y$L5RM4W^IVJNIN^9Q M7QAW%YK7MNE8N*XI#KS+N[1B^!=;'[FDK8/GRO<7S\1U!5"\76Y%_E.D]FT) M6J=BVPN0=\]KL(GIQ('UXK@A?P!)HGZUKJU(AXIS4G7)U6#3DE:(C>]W$&)< M$W0'66A`9%E$4<,6E-&R.Q@D!;3MQII]MUCW1?6S8DE;-Z`*]I4(4"ELJ=E] MJT%2(F/K\$BM\:E#(^NDV=NKH:0F>>L`&X9X[JN70(O::O;X:O"4RMDZ5,`* MTQ`OE-UE27O-08NRURF7MW4(I5B5EK$$;75RGVR\+'JZ;9OYPJ;MB67*:S]E M@K9Y3,E'4ILP*-3\GG-97R@FD>8[2+/$CW5MC:>BAEJCQ]7*]R*FHJ,[A/'B M=C/-4Z'D,3J_C.V6#I_L;LXR)`I;:I[):F"4R'A`//([]?B]_\QM-DT_L;H] M18O;:LZ)U)1<*F?KAKVY6$1[S)$[061A>P/T2`(DJH8*6VM.A]20D+1R4]M,ZJI7(VTULHYT3R;NU)O$OE$N2OWTL:KBR;[!`3D8@? MN]L27L/W)A\P*3Z!;_.TR:GRTR;&CQE2_VC@09GRD_DV,IR5R?!VP5\:*2H: M*R?(Q6R*G[`78O&>H%PKK;%;Q(:H8OAV67>-I%BSV2`L*TKK/,H8)AA5&R+% M37671N08E(G8.CRNJ,_8A/I+88*2::%Y!A1PFW%CWXG2^;DOXV7"J#!IS[31 M/.PEBB\4J$#M'?UZYT%1LJ%<9/#SS;0Z)X9!AP_1^4I/V/6C+:@):T*/5=I' M\R06H9#U8PI2MVY>7V/$,+`\!5Z16XZ1H*WF>:Z"3:F4K<,D/M/?!7[-Q8IX MA`7Q\_SEZ$A[:5X\4,%)4?+6(1;%3[O!IM95\_*""G95=-`Z`'F<@!F+UD:2 M4WHHR+NI?AXUY35YLAA?\>(:D3!,=SV?>4QPM'PC04>^N.2&J#E)5 MS=2/U=IQV/'NV,I@5>BO.06JCE9EW;3/Z]JK1T1H;`2VGZ2]A/0NP"XD=PO1 M3%3MK3DQVF$B5M-+"X'E1^AB)BG*YEII3I9VL9B%$ M10_E3BA>D7`E@$BAG^9-8-5!4]9%^V",#/L%8GC!#Q?@J15(CI/#I=95E-3I MLN7S;V=JFO>958=\3[T=)09'S(?@L!O MVZLN\-*G./T&`_C``N*4IE$[4M1""T5I6IM`EJ=:DSV_0+ M1TO;X.71N^VQ@$8G_*?\[P7VHD=LD!O_R-<<+S'BKX<08+P;*\G3U/YN;#^WT80\^=>H;\1XIRP&)V+$5+2:9<['A/K\ M73F+B]<;R,UL[Y)X$%*#RS$A4GXJ.[2B"@'-]NEM]B23BS.ZGF_FBA<>^B4V M2:V[?H=3$<]M$U1%2PWDXV!5*=_5-\3Q_SR!VYA4GOKAQ:5/2]XS4H6`?B>R M!WC5-=6^NEI>ANVR>_E1617Z:UX5/#36$CVU9J9*=FU5):)YM;")&=O^33MY M.;('\JF#G>NG>.KG MLBKVU;RJ>&ALFSF]M8*'5#PH1ZVKYO7`PWO#"H?LU!_.5#M"JD)_S0MQAX:M M^O%3'2W%JC&]1UZR_R!ZFH\YE#S&NQ$N0D8\S`H*/+_P-YD2YK@^"RF&+^/I ME3FR_VO.[?'(,$=#8VC-!E-[$GT?7QH7-S-[9,UF-96H9AQA^CI>SLB]1Y;$ MX:\$B<]Y!^PFODN<-'(;.=YORS&[^?S9G'[A+,_LJY%]:0_,T=PP!X/QS6AN MCZZ,R?C:'MA679+PMSIF>*>^!Q^=J&)6(,&';0FFUL#:XG@Z'L'G@?49+M3% M]Y4?+SD[F.9?@MOO;7-Y->:<#<;`U714$TN%)^)N6.IOLS0:SZV9,3&_F!?7 M5FWH1@=N31`-7M/O7:Y_EG`]_]TRS-G,FL_XMXDU!T-D@R33 MV4]<]\>UU?Y7*Q)$MB=Y1`ZF.2XTIOUWVR+`B/ALSR.K$_D$F.[<(%DUFL_R MW2^9PSDW?.>)Q;JUIK.;3`)8$>M2VLZA3DXFX\'_ZI)@B'A`8BW M`%^V?;9HM'DGSW_.B0WM6WMH@<*Y%[.FH&WC(LW][^:T-@`45KGZ.9\5Z?/W M\?40AK-AP;B??ZEO+6L]+(;X#JZ%12H]R?FK]#@86ASC)>:]( MA4VXA5EXQ_"WD!_W\%08DISD7-?LYF(&J/*PQ+JM,091BP*%T>!)SJFI1X/& MCVNR=9U,IB;\8R98JYO#5"0D8C#G^]+Q M4-W\J>1P0W[\J\M&B,:'%.1%V#FG,WY,B!L;ZGHG04?X:LA4;!8]#IPPGE?& M'HDA-%[?WX@8,)"W,#8L_&2DF#`B+C8*U*LV^1#).^X*5J2Q09).1:4RG9:G MI@VRG;:#G8(2+8SC];M>1,/VM#RIY=\Y72,A_).1D(Y&*"=N<.JU#\>T<'*` M#WX&E$U M(K*\:4+8"-"+@2+2M8^U]/9@*4ZY,"/KQ1M#IK#2(6<_%X2(*A^Z1!%40^22 MY6*3BM61!@465TSD8N:BCK(*2J.N2595D04(4JN;YUA$``,G5 M```5`!P`96YT8BTR,#$R,#@S,5]D968N>&UL550)``-"\PM10O,+475X"P`! M!"4.```$.0$``.U=6W/B.!9^WZK]#][LP\Y4#0&2=,]T=GJW'"`9:A)@@62W M]R6EV()XVU@9RV888;,D7?!%3W0]I,-+Q=\YW)!U)Q_+/_WQ=V=HS MILPBSN>C[G'G2,..04S+67X^NIVU]%EO.#S2F(L<$]G$P9^/''+TSW_\^4\: M_/OY+ZV6=FEAVSS7^L1H#9T%^;LV0BM\KEUA!U/D$OIW[0[9'K]"+BT;4ZU' M5D\V=C'\$-SX7#L]/D-:JY5![!UV3$)OI\.-V$?7?3IOMU]>7HX=\HQ>"/W* MC@V23=R,>-3`&UG8<1\ZW9-/W=,%H:MNY^OQZP(4Z",7?CSI=$_;G9-VISOO M?CP_ZYYWSS+>Q$6NQS8WZ;S^U.F<=>!?4/UGVW*^GO,_#XAA#1AQV/DKLSX? M151[.3TF=-D^Z72Z[?_<7,^,1[Q"+RV^0]MX-%; MP27=,0>.:[EOG%2Z\H$">%_2(\6+ST>\'MRP>]+Y*;C=7[/4==^>H#TQBS>' M(ZU=`&&/.(S8E@G^:5X@FUMU]HBQFX8NK5YUR":(0L%'[%H&LHO"3!12+F;> M9C$G<+P8/_&.#'AC>?!*!52&=>82X^LCL4WH60>_>>!W!3&+!56&O8?8XZ5- M7HJ:.59_?Z1CND2.];M/'K3D/F8&M9[XM_'BPF.6@UDJVCPR]D<\\U8K1-^` M0&OI6`MH(-`'&0;QH!-REA,PFV'A5,SYI.R/>HH-O'4'2ASX:/C,IJ+-5GM_ ME%<$A(/S&9BF]O])9?=',"(N9A/TAAZX!#F"I+)E,&7S9@<]L/LVI\AAR,C4 M-:;5VQ_9$.+6%9ZCUW3W3BBZ__UU`[I)9@4-&\9\S-P>2D,BK50R)ITQ[++Q M8@(#*'BG"ST[&.(X%\04&66,#:N5Y?H-%SI+:$"\0>,L?59ZS3+:GW-'W*!E MPZS)M:!M30`/II0/13!DIK?*K!+V1]NWGBT3YDO0C6,*=KAXO]$C1%"I%LU: MOX11*W?84G%\LJ:FCQ_@-R^#L:252K)0G@Y76*&,&..!X=\\N#AXSC(^B\K7 M%>V4&_64'_UDN^^<#^0EZ;`MJ]RX)!M.<8U2(X%L8(05ZIE!]+&++)N-$.73 MQ.?4R&X?F75Y:PN"<)CVNF\3&P6K(-!)/_DK(N_Q1(\P=XVT',>V=I6YU,\"\ M://**75<:$4_]\.H%KX%\YN,?E)47JF:Y#5[AJH5S87S(LTEI)ZY\EXJY)19 MY5PZKQ[Y)=4QU\[?/Q:56/U55,5?/'=-DEE#17#Z_^^<04L%/;;/5E2!$UUF"3"D<)G7[W0Z7:VEK6M$/R+'U(+J6K1^B'>-V";&%DR;I[\0 MFFA?WRX+Q!Y\XWBLM43HJKK4XWS'?Y:WCY?K-!#K;!0_BX MF8;8Z`';_KWO!Z/Y15+!M@*XY]$-3!'FL-`NWG?/T.D:>>A6&=MNX,OG!H2\ MX$L#V[\;M`>\Y!_6L!:4K.26#*U&Q-BC=@4(1QJA$"!]/NIVWE'8A&'S\Y%+ MO01EFR"G9R/&PFP1_=5*]:UX^5(I2QQTI11M&S^)'I&*<:9..HV2$@7:#X?O M1#:2"I9*0SR,D'(@M#"18_[C\7#?38!>%A7KP7.O+JT85[Y>(KI.&Z:+K%;$ M\<'>A(%D,EN[Y>Z3_&P_LK;CV20B).V`I&$5MI=NLX/)[@)&*A62&O=)WJ0& M*6FHA>U#!7KTW/0DUK@_4YP>,6H1/6?-TB-C]CPU0D&WF(H0K MLGL9`WP^L_=`!XKL((63QQHMOUX#F8-8@<&C112V M(.7!,_E1:BIVWRAZ`P>-XA4%1C9;7`9K)X5W::"FP^%89 MA2T=QRF,:VJT<)A8*7V;0\8\810IK:,P&>FX18Q\K)V1.V)[CHOHF__PM&B!-;&L\@PDX159_L?Z M8\B@R4[Q$Z$\:R1XC%L>2B9649X'"6P1'3_53H?O(SU0:DFH/*#?*JF\\>-H M13;_5+O-)]Z#;1F7-D&NU.*1Q>K;-^M[A[G?=DVR.(:>ZY_]`:T27F_ M(ZFH/"&IX(4,-3&[#2*X8*)R"==$`X*PO,)\R#$+:6AB%OP>2&RT*)2:@0O>8AWH\2'S$I$I?U-"^4I MD",3:^_?$J^^)5[M2T[@WOPH->+XCV5D2+Y*KJ-\`I9,5>62?W;`2O-_!&6; M3,62VIJD0O^CDJ)^7M9>Q/TQT[,:B/'ES4*:H%7Q)JXJ^3_E-Z0264D#7NE" MA"H)=$UD->9D2`Q<.``UR]`4FQBO_",$"J5K9:[?2/IC9O;RJ2$,*GP_4>5B9%@%E'RL>%H(N/.4WRO MYI.RJ^K)6!6-MX6+HK%UG=V"*C.0#%88KS5/@9\-9/8]RL_9\K?"`B\*KE\2 MRL^;EE&328#JE&570ABNJ4BE_RJ&/9B,US\\(@4Z",.Y1GGLXPRPK0,U\HR;R9(4IK:H-B*6RTB!K68D+8-DB:##XSA- M&1'%9:355M20!ZLGF[QA?($=L+S+#]@MTHH3Q!P>O7)51.26D;];3?O=FUN1 ME,.C5JJ)<,6@V3U2J9=.,402EN&&"^SZ"Z+F%25,G"Y21-CA$9U%(54W_"2N M6Q+=<>-1XA.G`^BCP(FUU5\;AD2K10TAJLXM4,N_O_[;<1[ZSS-,KA)DCQ<0I3/1>*@E9 M;W:):D>G]T74J&*%&,\DZG#8SJZ.,,&BV14K/U_M"CN8(GOPRM?&1=UR0DF% M>1*A%=)0="$)Q]ZDP6]_W[>8_VZXL;/]SA)WB@VR=*S?WQ_7W-U*3:^IL-VS MHA?RT.P:CV[^SV/!^Y7F1)!QZ[N6,+\X8WV%*%S_O<,TDN,^.LI]Y@H9!&O,.FEJBCRDH8/1]UF5$G*O0"Y09'>G\&[E0>]1YMR9/%4@ MST>`/L]^Y"'O0N;;>SQM=GEHA-VA8Y`5OA9G36Z549B(.$ZAT1M^$&P=JJ=- M/A0V]C9&H:$CJRU-G-8:.7^3/_-Y:9.7A+-#/V8^=I,+T4(I59P=.J9+Y%B_ M^X.S[IA]S`QJ/?%OX\6%QX`0EH#_1_Y29HOQ@QLAEH[WQ[6@^'%UID_'UL#<< M5*3(%!MX"SHE#GPT?'=(4.#3K@+306^P`W@Z'L'GWN`&?J@(]A4!K.##!J;Q MEWEW.[L@K\8<6&\,H*:C:A"-B(O9!+UM'7^Y0=3=130:SP=?]'F4WTTTWN\955$9S"FS=%K M0IOIGNZB&XYZXYN!-M?_4U6KT(W?/(M90:F]?]T.9\-U M'P3^/YC-M9Y>`\H@27.\F&!W`HW#Q92!58_CH#^D@)[_,M#TV6PPG_%OD\$< M>J`A*#*=_<`M?US5B=*KE16L\L"@`"V;=T8XL1/M?MS5`-SA9CCWNQM_*("& MSGNB077=)LPT[X@;]$')!Y_%8<>&L!$8_&X\#[NFN\%T/H3.`/K/P>5@.H7F M-YN/>[]6H\`ZMH$1;/<(OJUYYSO\V-#5']X-^P,P-Q^[!E.PM781!?^+/JW* M_!D.&N_&1BK?FK^,K_O@RMH`?'[^I;+3T2.KD?";EV30D]@H%76"_N`"W/FV M6@M*1X63V)CE&["&T6#F/3#\F\=/P7U.C$).8@/6[/9B!I3R2&1P5UW8D2WL M$X9_)[&A+'OXIWVW%EO1"PFRZ>8?[YV@66PHS*-9(+0BO:*!F0A];$S<"L\J M!A@)?D3X8B->-`2J&%Z6^5J?GXIGLQ&B?-'U.1X`GQ2>OVG?A<*UC?1&&T`+ M9DA/T+N_\30,%PS"QY\G_V"7]W"L1YB[-DK<%GM,`J'P^OZ:#T!#CJEM(/R@ M14!H/HJ-_;[_]NZ,XKB_O3OC2+UW9T2;Z<;K^?0!&M<38&@WFQFW+N>X4JU'Z_*S]V7U6GD721E M$9>NF9#%DA\Y&R]`';R94MPRO/!L[E`"3H3E&WEW1<;'^J28U6POEQX%P\&$ M$7SKTGKU%Q5E!T$)RRO,BQRS,#`IMP'<8)._]S-["Q!74-C4*:"%@WK3CY8D MK[W('J:45U*8H@S`1305S;@2-`E^WJGG8IJ]34AJ*&SQ--0B;:W6#C$?0 MBKY%?40V-(@K*,Q-"F@1-8T_"R=IPJ/W]VOGZK.@GL)$9<,NXJO99]ETP_!6 MGA]_]_$3Q8;E[WO`9QN'&R#ZBE`WW`\1JBJ^7QG/'LFQGUW7CF4T"S)5I5-Y5F1]J*,; M\JWHEYY'*?9][)HXRSFF*]$6ZJD\GY)_YW*U4/`/6BC:WRWEPC4N/;(U6KFB MZ?3$4-IJN02R[19Q&6I\ZD>R*5O1S/TQW@V]!ZJ30UV*I+5O) M%_#5EZKY8GG14+#FHE<-^:*K=K2(7NDLQ7)=MG-)ZN(E,<4V'7TL$T:46Y^2:2F_ MJ2J>Q2*(3"G`-69PQ=*"TW5*SG+=3A.NLVTEI`ZG*Q&+'9)3B6MF(E?T9"[B=@IP./R$!=B`L``00E#@``!#D!``#MO6USXSB2+OK]1IS_@-N[9ZUO\$_J$(YQX69S\C+YZX9Y]$M^2$"=H'&]W(5+!QEJ\NK MCS]>?;^.D^W5Y6\?7M;4@!LOHU]^O+SZ_KO+C]]=7BVO_O=//US]=/6#Y8]D M7K9/JQ^Y?/G#Y>4/E_1_.?N_AB3Z[2?VGY678D3?2)3^])*2/W[3,.WY^P]Q MLOGNX^7EU7?_\?ENX3_BK?>>1.S-^/B;DHM)D?%=_?CCC]_Q;TM2@?)EE83E M;WS_7:E.)9E^2S3T#4U2\E/*U;N+?2_CP#+^#%)2L'^]+\G>LX_>7WU\__W5 MAY:%1RG?Y.Q=[7M\W!.O^?I_TG0FP<<]Z09G6^V0 M?7A'_]92'+]D=`K"0:DZDZ5QC\J\^?H?#+"T_><\^>7]Y57C'?RH^_I5.N-LX6F2Q_]MGO%WAZD>X MA7_\1D/W75=KQC%*2M6]Q#?87U!\Y\=T?LZR3>:G^^>$"QANC7 M<%7)RY\D_4F%XBVR!*=\\G=ZD4WM34^OT&P;4DH63N'H_9?%-_\GIT/IHTE_`@$4G8=Q>OU`1>(DP8'9#VDY>@656?46K-3D M<(!EU+$+K9P#7:-=R0/7=W%51\Y04W#T#S6MZB+4I.3`H*;340&UT>@-8&T< M1T\XR<@JQ`YX,W+U&W!9F=`.O[0L8+!GIV<7?_C\-J(`<$/=1EEU0%"Q#?IFSK(4`/IF],HJ5P56 M+Z8_USS'`<9;CT[;QP5H#OQ]NFQGLYI@M&8&X\I=-98%C!H,Q"27$%%&4)6>TSNA`%A:XYSCP2X6#B M)1%UN:EA@I43]SN;ZA1N3YTR2C`HTJHG."G?WV_W(3OT1#=X37R2H6"?L$F2 M@I%^](3#>,<64"QC98-A@(L&FD_$QW=DC4T[N5VZGO=OY6IV5@5M(C!`4FDF MK)?3C&PY@O8I7N]#Q#C0N\_4-3VFWP)!#-E$A,+;B[*13]?W*?>QZ2@*;DBZ MBU,O3*\/R\2+4L]GW^@V;8X2U2ON3C"V!1+UF M*0VM#J@A#]1Y:T/K.>;>?ARGF7Y2-O#TNJJP4;^UJM`Q@(&HC9;BA%WQ($9] M@7A:&`R85;NM2[9,-VW)%D2#['*W%)1N:W,*,%"1JB7XJ9((_963`7$^E5IW M-"R=TK\:CT,:A(.@0U!4BI"*"AY*NJIID,)($:<]*UQ2['_8Q$_?!9CD2*%_ MZ0*$?O3K),I(=ICC#4DS.GEF+#N^8YV:K`]PF)1DT%#1#`X,@V)"),])44W+ M+RL,!XLQ16CBA=,HP"]_P@>E<0)=O\!0J-E&1H<($#3DFBFP41`C3HTH^1#H MN(G]/9\,J5B)6>VO^\*"3*D2`LWO0+QYB4+=%UZ2($8SY%NN;IVP*U<:6SIT M?;]WJ9I=`+2(0"%!IID2$CDQFK#U+R4?`ATCJDC`E+D-O8W$KL[W?:%!JE:) M@M:7(-Z^3"-AR5G2($8TQ+L>[Y.$Z4A2WPO_@KU$[0S4I'TAP*1L"085'0A< M&)03CJ%RHAQOO^-L:*2%^7,_S8<]K6*W2 MG:6LE!80>K0**D'TNQ15'$5]!E1(&A!-',UC.H]NXD2]`]*AZA<[4A7;D&F1 M`$**3"_%SD=1J*2@'0X0#_M52/S;,/8RI5DMFG[!(%&O#84&`2`@B%HI8)`3 M(DXYX!Q3WY%9\/M'L_KZD=HM:IEZGF\L#.C,.AH.0$"R4%.UM9H7`>"L%RAG M1K/7N>/HN@>7+^SR;9];^IDLG-'0]KT7IU2WNQ\G$()`DDD[Y;YIFP@K?JSD[4LZ0+3!;WY+(BWQ"1T"< M9[R,5NQ8TN_&/6ZL@V046!@CS3'0\`V.O2.45>2RC)* M4YRE!AAVB7K-E),JV$J-:U&``9%4+>$D8K&8+!>0H%#L#U@A0J#M'Q@*=45\ M=`B!P42NG>I0(N>!@9JQESXJ3,N_ZK761T.95HT(^CF8-]Y01GC!]"L8KW7D M^_$^RM(Y]C%Y8KF7]S@K\*="LI:EW^QJL_+MY&HU/1C86"C9A=,R\0*,O((1 M)17G!0IQFB(O#.-G5L\6K>,$[2,_#D/LY[>(*RX:Q_SS);\8P/Z@439>)7MV M*O'QQPM6+?@C_VZTW^S3#'U_Q3^[HK^5[IBH)QR>=6?Q>$1/HR?ZI.+D0!^; MXA&W2?I$K$RY)D*;WX-!I$0IX2BB)(&!@9L]OJ7/?;1>DY#00%WOT)34?2+# MH'(3)`I2,'C1ZR"28O.QRE!@0I:/O$CU;=)GJD MA&"PH]-.%28_L)-/NN:F,UC!C@I^(+%S,2`FVUT8'S!.K=R12#V`.U*I+'%' M75(PD-+K)QQI%&2HCK]@@*BU@+199`ZX3#`C9C>$H8%7@>.$#=0"L9^EWVC(KWYZ]U/1@/(Z%DEUXE2SH7[SM M[F=4<:!WE(?-;.UZ%SNZQB.\'0F0,@6?XCAX)J'JB=1?]PFNKE)-()7?@0%- M1Z$N0,JO8;SN:911Y=@&0NX)*4@G+WZX9Z?]!BC8L?:[*+# MLN+BOF0MYCVI4QIM61C^=TA.J;"4(L#AL$-&WG\@I59:C*E$6C"H,R@HJW0( M,\1JKDIKL;2!-$>\:A7;(>IU M,T"J8&L/H$4!!C52M80-R(((!ABZ'M/2L0X[1]G,31"7_$8_DJ_ZH4Y+6H3MWQ%N1D&2L[GR4EXU^C,,`)VE>]]\0W=JS M]XD85Z.:F++E!3,=.2K3=='0]O9LNIY,%&MW?H,5R-O[3+[.[F\E\\3LT M^?(A MLI/D"LORDMJ48#"D54]2ESG/)RJH88#G/LZP'7*DE'W"1J-J$S,2,C"`4>LF MKM,I)2RH-%ILV*/&Q#10(SQ++.DYP,#*2DU)GX&J8TK$T;;+V2Y0E&]B!R3E M+@L&_&[V>!G;)Z[):'O.$U&KV\D2$0G!0$NGG2QA+8L1[WD!`S-TSDWV.!!C M/?6$KJ+O.4#2J]V)D>3$8#!DTE`2*3%Z8)O1UB`:&CUVL!D8+\8]*&NTM/./ MP*W.&@I9G[<:>`8"D]W)JY8!C$NRT5)W=`8/9G&T6>)DVXS_5+9+27L%E4;9 M%I8D='`@I%9.NYA#[YO')D#0(QL.+D,'@%.R=D9@Y[DC#MW@^:%:(;/!@Z'& M@!6P"-$>R35.06!@P?DD#LK9F]MIVQLX7W,^48-[@M8HQO75"_>J($G M4:YD>V^Q30,&+`K%Q/W#9FVS?[[\<'EYA79>@IX8TP7R]MECG)"_TX7\U<7E MY67Y?Y3R,F@_(\+J_@;\\G1?P2=ON&]5NY M==UN9ZV#K)2RY[Q(E:J=E,@N&1CLJG43[Y44E#F"D0AA]+\ZD&U`^@)5'RI@ M;(W94V%*P\`5!]_E'PKH3>Z7UZS5)\NF\-I/Y,%+9!"TXN@#B@ZJ,TA:D`\. M37L=A4F8,Z'1"'7`*L'JE1JI_ZOYA0JMF12J,A"_+F"OVT](_2P%PI[AJ5"T M@\H.%20PRE538/#:`H(_7/R@!N'W%_2-7WS_X^\YKHYWGGTBDBZTGV)6.KQQ M5%H]!ITGM63L#;%.AE0(MN*"@6@7527;NE\Y+VJ>B%?<%.A-D']40_SWN:/- M\0T#V&Y=7XJ)QTG M%35BY(A$J&!X)2=)!TV6D-6>M3J6XD))U9O[4ZM8^3J1I-?W3]W.*DZQ;!=0 MKYXDJ:/,(Q$.)EX244>8-B[(WN`U\8EJ3]"&L4_/8F](T\F8 MN<#X&VM5)6D;C4(,G!(&]L3=3^MMTJ'WG>WVFV&=5RCUDQ]G-HK%9Z&RA6!15 M%49:,O<:I3L9U`K:K3C!S*E.ZG:!^D5:EA8&)!MG1729/4MX]?^`+[_Q)41:_3G._<^6?.`9IMLS#9:FXA&IVG&`@ MZ:2N.KT%9LS6-LXR;#,Q#0=#F^!-SP$4=I8AG``WH%&/R8[!G#3:LF>#@34Q\K+E>0,8TT9A%O@Z3T!V#+;4H98C+PR4*<(N)\8W M@#=S"&8!NKZBL6OG8$S-,=R-!9M03$4."5$&'2TN,_0;AW7UM0_#S)P#H\DR M"#.Q04:76P@F0UF_$9A8B^YWE:AEP4K M"'R9`R\C'WRD68==&KB]?M2EO=EE#L&8C@+ M2VP"NJ/$0,*F,=0[0L:;P:IE$&B+V;XB0FO+U.&ALPAXF%4$CH[\;PRKVI#2 M$:>O&E]:6V0(-H^3`P^MNC#T&"%O#+?F`-41O.!R\Z:1'V\Q3^K:FJL"*ZG[ M;0FL5;G=!5A*.C@*[?03>_TR:E21H[^6#/\)`TQS_(2C/0U-]"@2R?J]/2U7 MLGU7NDT#!C`*Q;I(F4^^3NZ_0"G"62IML&D8&.A>/[C7KGK=Q=>(F8B^X@PG M)/*2`UK@Y(GX4`KS\JX<"R_$::'P/5:Y"#EIG_C0*=O$BHP.#&XTRG4Q-(NH M`(Q**,%`C!U8!L6)!42&1(>Y5((5.O*;ZL6T`@,;XSC-9NM"=^^0J=TUVW(:$%Y$(V" M@C.9+99YR^3)?SQ,[A=P%BTIID_PD5IR0_U<&._8DKLP2AFF:WGZ7=Y8J-]> M\V@8P(#+1DMQ=93S\!J7#2X8.+O#7HJI.7.JD1?J\:6@[;66DT[=5@$G&2$8 M'.FT$_$398A[-1B(^80CG'@AU7X4;$E$F'ME[0;TV#%R]1H1V9G0BI+T+&"0 M9:>G$$CE7'EQ_A8?#,SQC83C@&?'VOO6SA$0M.$#@T,'967G#,DN9J2LSQ<< MS\?6(CA->6UA:A.O-$LCRW*74X]#6^9^;[JZ&-2^\&K#"0:-3NI**@JG^S#S MHNQW*;".O'R4E2KI1F)-T[NGZZHGN+22``Q:9%IU0?&9I#X.Z4TPFVBC37ZZ?Q>G2C\BH^S5FZA5 M;?D4D0P6;M0*"H=B#Y/Y:#F]_X3N9@L@&U/<.>::V^]SFIAZGY2,!@BSE)(# MUK1E4E.`V/*7R1Q-[\>SSY/F-B@XL)F-'@Q&!LQ`!(@*#8P"Y20P$/#)(U'* M7"1.9]'DA;G-/4D?V0;J;'V#5\K3-C-?KSM.MF:T]IQ,3&"09:MI%V^,!=%% M_L1+P@-J,[(C7L;Z2JG6.OHLO241R7!( MGI2U(ZVY>TW@=S.IE=!OQSHX7(_35S4[UU+8G$PJ.FT59&M&JTN0B0D,PFPU-6$.>5G>_Y'U$T)9C+R&8.:_@D(L#'#R M2?_:2W'P*8X#MIU\'T=XNPOC`\;E^=0R\:+4\YD%>O=VM+1>4]9/,[F5VGZ< M*#"@/TU_97S9'0+LSC+KO<7@7]P$W>T3]EG&OO:+X]"]%Z)X%9(-'RNOO/P9 M-71AW$>9/Y,\D>\R[`]#W\LBRJFR63SW\>._+K]X> MJ+!\>_5?'GR\#F+N4<.;*H&T-\(711F#B`W[0A7T3'7)VY"B4AMH"U&^-4VM MB]NG9Q;)7QJFW@\,C`8(9PA*#F"'FC:ZRJ]UP3Z"J@]IV78/RQPBT9[:5YSB MQE%ZC==Q@G.ZI?>"TQOZES0COG(M=8+$_BL=G&2Z6`WA*'P#GLT'89&%7 MF*XGM[/YI!P#R]%_0+F&4ME1#.1K'&'U%39,:VH0],G4J3J-?'1(H`UW\I4$XH#39:`$H?8ELXT2K-DSX+*1G": MH]HG7IA_R-)T;[&7[95-^8X3U2>T3C&VB1;=WD'5K:H+X3`P/7$2R(ZZ-*R22$^4YX7 M&[GZQ*VE"4V<&EC`>&8[/04G/%I,QWR%?C.]^[*+T-(.;\#U.$AA4GZ1^%^Q_ MGDP__<(P/OHZF8\^3=#]E\_7%.FS6T07Z9]G]SGF%VCV9;E8TD$QO?\$8P"8 M*L1JZ'H_!C0UUARV@NL.)R0.%IF79+H)WK98ZS7>D(CY7;3R0A:?7A2[\3K< MO.8;:(0>D[_M27:0O@*!ZM>/(-^"6D^+%S':`LH)8);D-:MO]@E5\R%_`HU: MUK=Q,O;21]VCL!30ZY!W-DP`HA4WF!G)667Q[C&/[\M#.\Z!UG&"&(^-^Q@< MM;RMQ0F@E?$#P*S:+`O(BLS0$:O4V!&PD-PLVYZJ]Y^*[2D9*T\4%./\1)2 M,0#P;332VH=+9$#'MDEQ%;)YBG$-[/*JPQMRW2>C6BT%`*A-)MIZ[#<(:8/> M[HA^,XYZCNDJ@_ATO<')1L]>$O#B^\?X!(TP`/BV--C:=2LE04>[G?J26N8% M?0%\SI%*\/]V'/J9T&^2!0#\=N;:NO@W"WTK[4]!_IMQ_-6&?GG5]*1CK%H( M`*P;#'0_5RPE0$>W7FWKC<.TX'L[?OQ$,*MD`,"RWCSG\\:W@F2MUD<`^M4_N"H`.9*W6UD`6ZBZ]'==\&J`5(@#@66N< MK5]^:VC6*7T*F,&YYSG>%58&O%531A+9N-8]/6L1O8/9T3@!S);\L,#LIK0` M9I8I&H95(:DVN/.!`M`G&XWF`_JDQU9(@`?BEFGN&.;L;PS"39V/0S`D1]S9 MIFDN;N]Q5MSM2.GR8.F]L((Z+/^;76Q2/,+CQ?7?'.$ZC3"IJ/X2C\6XH:$/M.QFIP;R4'*N9=E#\2[Y!\?K-U MH'UOQ\%;.5IV;H16@E*MFZ+^')IC/]Y$Y.\X>*42D67AUUF9",O6B2R3M?[E MCC'V;+V5970PHBJH:,$S.&X<%>V"J.1$O+5G7:"0,:/D;,@Z4^7HX+_V:<;2 MK]-E/`H"DO$.D@\>":;1V-N1S`OY^%&,+0?^7BM)NYK5JBAMRSPX4H_56%)7 M*V']NGG13-XZE-6:H1.JG_/"P&I=:91-\S?DB00X"E+M'I6!I]]6M!;JMSO0 M:AC`8,]&RR[>.G6*FMNF(]]/V-_]1BXQK,5*96+;N*D%@4'Z* M]EWX+R@KG>VO&Q7C2@EH1Z,&6![W(8E]C`->D+8N1MX>[*,HR#_`]$N=+SY6 M6,]=ZT\PN-/%_@A)8#!_DOKNH`?GY.V"W.%C6]N0%G0D>UP`R\E@^4M%/.06 M/8&(2QU"4C`PTNMG1A(D)V2SL=#9'V,[]K95CL\G'MKFDLM#<=U[LI$-9C2< MV2#Q\(?OIY;'_8TBRK4$5(B`,:3LDMKO*0R]E#V&E#J3Y.@B$0:!8)9Q5H:[ M7VF020,S-$XV00AP6TF(S?YGXT;_LUG5_PQ8V&*5)"]['"?=@U`(!#`R'`QW MOB$AE09]9-B;<(:1`2D,Z^;%'9VB"RTQ][ATW#>4A'MTZJT\JX4A=@+W_K'" M<)?T6V!)MT>EV@Z;8$NCWE6J277L>D+[BZW3L?]1OU6>='Y'K)73, MP!GB+>S9N57VB-%?L)?`\`?5+HAIEV2@?2;MSA(8&'0UTC0-$M>[Z(9U-ZTW MN8>JP7Y<%?PA*K!/HD#K-I5*"HF$_.NW7@3_>X"O0*VEZ1W`"NB]C'<>GJU9 MU>C;,'Y.1ZN4KT24ENM8^HV1S,JWD:6F!^-I+904%I4E"[]H1)D0YT)_+?G^ M$P;8:)3`M'M(8C8/!->'+RFKNSLK^QB/_(S.$!G!)@@>(ZCG-FQ'&MH)"1VE M@`'QT:IWH3U[F,Q'R^G])S0:+Z=?I\LIE':]U+8UR33=5IL$/>=L=!3KY&$4 MWX(!BZ"2;'7Q+J3??POCU;>.DMC!3^23$+=62LOX/)[N=7YJL$/*,S\LY8'E MF7X'S!!Y1>.Z@ZWQ4VS_)"E_#$5T%+)!R#YE?V=[WFA/?P6M#B@N?P=YU0_] M!&.TWN`=-8+H3B[;)/UV7A"5:W=7J+\'@T:)4L+=HP8)*FZSP8!#C>_;.*%+ ML20C?]=A0T,_C!M5J"WWA1UB,!`R:2AXI08)+#QURABGHRAP:CG@P-]K1UY7 MLUJ]>6V9P>#156-Q"=ZXO.&EJ,G2/(:`8U]=5.Q4J;WW1#W]$0A[Q\>+!#,8SF.'ZQ!I=-Z`,4C*RZ@W M./^S$4T7^8*&Q9N+@#ZA[VY8$^7VW&``[:RR<-[\2/^%V:7DQD*'%]-#7A2@ MD'@K$D):](@6CWQ>#""EJT=,GKQ5J$J$L&,=%J]J8_1(%?D`8U2I;!>=[TK> M;U')S:!*/72`42D%U6*@0G0:/=$%0H.+M9H_9?;XR-A_ODX0J;/U@5.S#HE!OE!Z0S1(BX))FJGT4."V05[ M?:E#,]NP[E-NA-Y[MGG`HE&AJ"4&"][R?`#H-E(QXD;K-0D)'6^.+K/)!\!3 MBF98.,B:"2P259JZNL-*`$PPTA`:[^*4*/?T=0P#+W0ZBAN6-@4U6,`)*MHB MK>""BB\>#[`KDOG:3-N5QII[X-URG4F&K7(9*V!,ZO2U7-%XS:/[>-WH1P,6 MLT7EO;MZ6]]E\2>P#K[:5AAC7'!W^`#C5*FL_;*;UUH\5^BH*+?=57P6??)( M-,=>R"HQSZ+FO<;96E8LZ7@QO97C/L'(JCSW$3(&1^>)BMO,]]2#;J@XE!3R MV`=^YRYLRF3VA-]IQ%)/9]%T2Q=>27YK95KY=^E:'$:5%FYKN%1T,,&G!4LF"`VW[\GNP`H'KFTSPR&-`ZJRP+-/Q6H+$Z MH'=%L/$MJ@2]E6CCED1TF7J&:$,K"`"F+0RUP+9&"G2,FU7O8OUV>C^Z'T., M-MCUAV<2ADYQA8FI3Y#:&=`$I)X##/BLU+0\02MEY0>VGD^#@I070&A*]GKL^7MN:J512E`9\VU]XM8-HAW*#>6F.S> M=D3S3M^-RK&W<<(Y#A]+?E%POI M8$QMLCS_]HZN:SJ\DG_H6QE:LTPW-*3,@X/W6(VM;VYT-N+1NPAG)U??.SQP_C6@(P5]HUS=&=ENR#H_)XG4]TJQATPB>_IK*,G1,^)7R#7RV2F6&\ M4]1D&ARDKII:0I,E?&;Q^=(]K7TEUYK?V,^KD=J-29%K0)^H,D'C![LL@\/* M34\W4#7XH7JX^YB.F.+*DFO@*.4=UM-IS-%[.PGCX-`\1EM+@'(!Y[JJYA`> M5HWAB_(-MH&(R#=H**@R0QL`=ID&QY>KIM;!7L6/"@&](4S1'\[.<"7S@%@S M&*0!G((3*NKTZMIF`U=">#]>CL;S(+#O0[:3SVZ@'JJ==IC6*WJSF`)'M_7M MK+?)"5L)X1$=6DASH*-#U_K+D[1MJUN9T46=D'*"?RB+SDDSG!5T4 M%_N!4>?G9>@:;T@4,9\7KU$.[($.<5_Y_0%L2N2FN.H-TA^Q>W<]%DO=[W8A M[Z_BA66IRVFTCI,MOW-C:I=CR]UK\5,WDUI%3NU8P4QQ;OH*204-;G1#4C^, M4];1C$*T:/M*9\$R%X^5@EQ741>X0OBZ9K;\GJ_J"9KYH#0I;IEAVXN8,\'! MJZ6FIO27W7G37UX?@J,Z\>J8/MIM=BB`E!EEB\LF[YN`IT1A$TH;+`RIG_T; MMNL2H%%$MM3C_A*G@+9=&K9?F1_/U6`HE&8&-K^'B*8K&\0T&Z8O299AAL", M8F>T23"&@T4C&@D@-< M(\7K?4HBG*8W./43LN-Q;!1<>RE)9^L'^@A9O,H^7>*7[#H4JTB<(JA/.!YO M:!.F[E+`P/=HU85&BO-/H_OI_S=:3F?W:'1_@VXFB_%\^L#_/;M%UU\6T_O) M`LC%BP791&1-?';E3QC`)E#;,O?WD1]F=],QF/M!LV3C145I*]:^A)H9>,48;0[. MV;HXC/'"JE>O*2(XD^P^07[6Q]$<`V<1#&:(G-,:P2%[F?+R0(]C/XRNKZ;P(!/HXG$ MH=$CTK3<,;/U"2A;(YK(,O&`@9BEHD)PE;,ASH>:C.![?F)`$",BW= MGP,[>+S:N\GYY&ZTG-Q01SE?_@4MYZ/[!2LU,[L'LB*81GZ\Q4OOQ3I\TW+T M?'?*I'KGQI2*'`S>S#I*KA%0#D19(`=V$KM,;E#/,C#.M(Y.1P\9:297-KT? MSSY/T'+T'U`VP%GZ=_L."%#TM[GC<;__F6ZF)9'U9-[NNA=HO$(%B@;J6S3 M*,.;A%LYQZQ^F9_Q7+E1%#0;+8[C-#.>9I]/_!#`/M=#D4'_5-G@!L>9##(, MG^4O$S1:+";+!?O7PV2)'F93.J3FBPM$HXL/,$85*_5#LOS(,PK877!J/8Y8 M%H'U(LE11J_7NXXQKW5-R$4`&*0?H[5P4ZB6P8^T6U(@K[^LC#=-!ZY"P(%: MZ]K=)+PM6)O<-%W7?9XN^3DU3]`;S_@1]@1.NA.[UI<=#$ZW2]0G`.4*-@'6 MI@`#(*E:78#D1.#>$] M^CI;%JD+7R?SY?3Z;H(>YI/;R7P^N4&+Y6S\IU"NO8 MFU!5U#&S#(XE-ST%3/$:8%DLS25\)2C=$%;FA*Z%U@NSH6(?ZCOP]W[1T,4LX1:B#?/@:#U68^%.`YM1?YG=W4SF"S3Y]R_3 MY5]@P)-E&O%Z'?R&[1VKZ--8K1CW)>W9^\X$M(CC6PY5$<98,![I.)2 M]PHPI6>Q7Z7X;WMJPN3)XK:7FKS?LD!ZI=MU@.2T<`"F5U"L]%.2HYP>W$9+ MUR"C\U/3#PDJO3M3$8.%E?E.Z_6"AGWL7M+D*YQ+2,45\LX=7C`X MLU!2:+`\G]Z/IP]W$PXQNKY8S.ZF-[SF!`R4?4GQ;#U),[+5].'I$O6))+F" M3>RT*<"@1:I6%Q]?%A.>P+583C^/EE#6FO+"I98^R(YW^,K!-E[)AA$,X%RT M%78^1HM?^%[G>#HKV[/T>M;H9U3Y[M>,%@TE'A<7I<_8P83>4 M6/H'@^<#RP:!`=H.!_CTJ1 M*/->D,>%PL"\Y.KO(L.[QH20IW^P*X_TB6?3B'^58$P#/9\5*]VH^K:=1_3` M%[Z/?AB&Z^#.7@R+-23ZBUS.GK(!>&N[W=TU5RQJ[11L$M>6%_2S\E<:HZ[=30 M][HA:U*[M0FK(AX<2+8:FK!T@?BV[2OYF,*W63H9'75O7L:L4M8IF2)W)[?0QQ]UCU7T."SXX,UW##/O)CC*!09VMII(['UD,IKWHR/?W MVSVOZW6#=PGV25XG#^]"7+0'&FWC)"O:^RB-5CRD\XGON2'E61]*IWWE662# M&0=G-J@[7.Y8@=#&;Z#FC\`80TJ3=-&`B0F$IU9&!7H.,-BT4K.+N*7).[_B MFVB"6_;,4_V[D)&"?!M:1862>P4AHFX2DRKV-7=WA5 MA,@K*6$,+KZ-PW8*$_Q(8]3J.93;.[,U-5;QZ"QY>^V3[6).JP^V#2,8T+IH M*X2B.$,A71?JI]M>]Q5\C(.435?C.*)S6T9H,,!25-7K735'SSL*)M4[VPDJ M)G=D\)!GIX_VSQS@A?Z=!0WR-:^)`\6Q.E-E[M=)3S16\L+0Z\PJGC1ZH`6,96)ZRTTY@]%5 M[LH)L@:'^)D,$#+'8QJ<,J'(SZ6B'1>+,)/+(%_B/?^B2C4',B?D MZ?.?,1W?P93&/"GO73)[CG"2/I*=\=Z%`W__[3\RM45YV"=\@'QY^]CH*GRZE^@H&FH@AL:4)Y(?(:>ZQ9:.>( M4$P6L^'M.=G/WIQ.)I^9$0SJ7+05RMF0&"VQ_QC%8;PYH`OZ!U; MCZ`%>3FYN,BKN$J74,Z.=4#G:!W>V?"!`:*#LHJ5+=JQ"T)Y>1QORX659W@> M"1#]8H4?O7#-OO^4X$V<'-!G_R:.O##@)=<><(8>8L(6-6E9/8?C^NH2`<%U M)V=$CV05<<\-1C0*=UJ+2"C!X%.K7A>1?_B?J$&/\NL).99NJ589QA$\0%G< M7%%2#P0ITWT6!2E$4%G<D*R8A>.]:A3F5= ML&S#!^V^H(/.H.=B$N'9>IS@@"CGWA9)KW.M1+G6W-KX'HS+DR@E>#AV/,J3 M13@5VB7Q$PGRA&2[0U7NWI0'8]CS'V'`2W^\7/Z372`\ZGRZ+0!.>H#,,/L< M@28W&%@[JRPTW(SXK+VCY#[9>2$*VZ/@`J5DNZ.+8%+(0@D5AG8XH6"/]D"Z M)I21LHW?E)(.L58Q^E$)'1C@:923^56%6X5[LE8UPUO@Y(EE[C=."Q6/1,_2 M:ZEL"^5;U;(U]&`09Z&DN&;QHCS)DUWD9!>-O>C0OE\$,P.!+HH2[*7X!N=_ M3B-U8*MX7&XB>FYLZ&QH>HLT@Y&;/PI('G)!8=7/4EKG7;2`G@]HEX&PXP:#425T9/M]$M-BU MLCTR#75[;9F'Q*?>(!T^Y9Q@\:E55['4(5%`I>"`+=OAX#$_;TQ)',T2LJ&A M3IC;6H_`O-V=YL'8B^@;FZ[&=1%JRP\*IXY*6Z#U+7K5(M>R--MI7`N\P_M4 MA3EFE]IA!(546VV5$,VI8,!PM-DD>$/'Q[0QJV-B=EA&!@ MI--.;$N9D[!53+UTN:CW(&$`21T++S*^6#/50'`1`&,UHS+,;D73Y08#3F>5 M;1$+>CYN["D0%+7Q"!P!K[XX^)?%^!^D6GU"ME*[P#'EI>I9^?:U9^;9W5=.# MP:&%DF(?`:'W-)!4"\&8&?7C7D:BS5V_N'J M_+J0_:6`CEZ,'^,:)@>.USCE#>O'2#X0*9%UF*2J"3EQU)^'PV6[/V(H+>MW($N3+W5@G4V:"J$J@U MY^`H.TI=H4U;Q<\RD:/7QM_9@YQ&KFOYZ23OQEG^\R$.B7\8^7_;DY3P;D^Q MYKC]=,$#!5`G/@C%S'ZDU,''QME-EVLJ_:F)@>#2[..%B=C%SQ`>8*Z M]V+3:G*4W>*`CK&095CLJ2*'%K'BZ9U%,K2&I9:/PK5)J4$LF!%Q/EN$CGTY M#QK'R2[F&3B,F,8AC)4-IX$VG,H[X>-XNR(1-W"1X5TCX,K[LI2)2--HE,=0 M6)]Y=0ZY\+:HSFJ5T)))&H2.1S`<:=Z>8IJF>W4?O19)KVWQ),JUNMPUO@?C M;"1*B>'?L,6+Y@PS2#P\U>1\- M!R`+]8Z3"`;D9S'#-`Z:4SB,`<%*C='1.4M8)G;QCX;6[#H"M7&_Q<&5XL$Y M2>BWEIRS:>V20&-B_(Y)?\B?^0JZO< MZ=+R#'>A2:&^^@Y3AP$,\&RT%*`61]DC6]]0/B\,&64*#V^&(<4W]QOG6*$'!)7ECA_K4R2K1C=%3I,2[5D"T^W67T MMN`_UKQJ_>\J8'"0GJ*UK3.&@L]E7-9E=GX(3588:!2-L0-AS?<&L"L8"+1CJK^R'RIMTDP9G,E M#(Q/7MBPI6NA1Z937B%LQ+MLJ/(K-`R]IL(8%6]EN"BIP>#1J*(1>D40QF-^ M7$E#49P!R>22[,\_%./B(2$^9M<#?7ZXV6I!Q#IRG%#2B_[#8XJ M*X.$-.,]3V6_3;S(?R1T`"V]%W0=>TGPAD99JP"6]U+>:V'=S$;K-<\F-76= M=A,Q6$DS2^.4):-KGPPH^@5C%+,'^R&'T_>88<7<_R$(_IYT9"E-9$PPM>:3!0[T84C*+;* M4^Y$2ET+50M-9;NO+MR][6&[FU1M<-NS#@[CX_2UG0=TD(4Q(2R\\,G;L!72 M8K]*X@T?J>R&S!-.Z(CD27&*D6_'VNN]`0=C6O<)+/@&1^H1R@H%OG#$;RT% MWI9*2!%5;/,()+Z^]J+?DOTN\P_CT"/;--_NFJUO28B#_*,[\AL.#\OX&M_@ MB*C3=X^1U&N<<;RIK7#"70P8$!^ON]`ZEV34OY)HD\41^HKYW[WD4'K9E.V( MX@/RV/5J4(#/>W1D[*3A(2DNXO+['LV+1%]VK$1"V!?RBNN<34=*85Q+P:^EH5XK/+P"5U\UH-%)W'GRE*/@^CKYR MA936UM;QQ8&RC\'IXGJ+D\]@=!4XGR!K<*2?R0#ASB1SZSG*&S)1)11QJ<4( M8&)9+P^?=T0H!,-P]^VG,, MTU!Z35A+V";TUMAC_=<'NOS?-N2&L%;'49#F$X;Y!748X%W7MU-7V#TJZ!!O M&,7N(S1N;3W&88!/SX!]C:LPMYZ/MW&&=EK]8Z5[E#A:7@DC=9Q5ZWJ;1UDRH[3DO:'$0ND*)AI:*/&7I9YG M"Y%/N1%2]G',Y^T;X?!"2=7?W1"EBO4%$8$$ALM0ZM5]]14A\C@E.P^#$0J5 M,V&1&:A/V%$1]QG8Z!5NQB]RRL&18Z6>F(O)FP#7`0GU''!REQO%F?+%YV*_ M2OV$K'!PO<^^1$175LV6N=\->A>#VGOR-IQ@0.BDKGKGO5EAJ]Q\IVAE#Q5Y M'>C"@"SO"F\HS;L:JA2OH%IWTP":+Q-U$AS8%DD)_::D,&"VF->;9=9F6"``%25>M!0='MKNPNPM`W=U90:R(W"6%#\>E M8V5%ZJJ0\MH+6>5#1EGMOK&EJ2Q@/8/0WM8%9WL`U3+B9(F#@_NL9APWG>^J MIVY9%=XL-#!KM=56!LHH,RD7.:I^A M?<1.5E\I+!AM-@G>T#ADV@!_88!LLM#3]S:9VZA=S=,ZXL'!8ZNA`)F2Y:QN M2X$2,:F(3^[Z]#(+IOZJF]L:4%L&2K?@4E$P,,)%EJ*52MJMC8'G(S3?"U8<0GS;Q^!UN% M.)YDNG#W-ZTYFU1/Y\UC3&M,HB[L,(!YE,[B]-IL/M,]P7`.W5XSLDGI'Y$0SU05R>9 MRHIV3DU2('[9I)^I@=-9NXEH3UGFF$8;$9TUXJ2I!)M$QNM8O0=OXNOYK,3. MC,YQB)X)!I0<-%4<:B0%+VLLC/PFT/@,/[Z=O98/6L=58L5_83];QE3]-28L MO!U%P2C!A2U"?HP[>W]>RMVHVFW9\\(`G[O"@F.[G96199K+8-=NUI44Y$4! M8CLY?BFHEPEQCK<>B=C=Q'7L-CFJ.0>:*$VF*"9-%1L0X+GH:II,DY*=^;I> MIM8R9IRM%[P0QW4[=GSPB+S5@0U;?VT.[(VH6QR8>6``S%Y1Y1U"BJR<%UT+ M%^U?\11,D@*15PQ8QN/)S#)IHL4Q9%J+1'5=SDJ#'`:.K'2TS#:IJS-0UO[1 MLV`UJ2;;71@?,&MW-,=IEA`_*X;$B%5-<7P$=B(AX,_%>!N`VL@#CV`'(YPA MGC+9")?"6WU0G+OB%=O2I5FET.],MJ$^I-%`MA<=#+>8@?22AZ,$7`>(YSV,AN# MH?3];"!4THL2/J-SC(.S5<7$=)7`U+K?;UI4MHJEP5C[E3?H1P5W7`GD>I:OR4OC)NP$G/L;L`V&`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`U6Q\.G8L8RK5L)+[X4W$I8%SS9`+7\[B'Z)TQW)O+#GBA-Y!K?LZI804$JI?@UBO[<7 M1'^+GT=[DCP[HXI"DGEYYZS3]O("_?/EA\O+*_JR$O3$-QQ_N/CA\O+B\O*R MW'"L-FF""_3]!1WH%]__^'M^!?>RLR?)/FON27H9^DPCU>^O+A#S#_FU79[J M/MIO]FE6?G,U!`[&=$F7D-6>0G7L<31*SD.Z)+`0H-1/DJ50$B(_IZ3OC!>5 MRF+VCZ=RKSF_49`]TE?7[&^('KTGNH*@KL#/P@.+@7B05=3[87(8!/)]:#HO M18#E_"M=/,8;Y'#>M56NG9?.^L_6.5K)O3=")K* MI*$LJ\>)4M4%U7=,B.K+I@!J$D4)Q1!#1KPKD_I+G.#DVY_1!D<$FXIM$-VGK);SCKJ@P(7/E_Y3O^#FQO`6P*G;N@6])WM_5>R':_ M11'/E.=^10*;?.Z@;W5+LBR_WK$J^UZB%<5/A*B6)#O\+D74W209;R?(O@J] MYQ0<"*9"CQM+EK?S\EOZ"B^>SR3U*S<[E1P`9_0JS:NBS=GK'8G\:[RXX`//:$-1GY3-H@KUTGQR^_<"C'0IAZM68O]W1 MH+FAH\U@J&.M#VCR4NALT)470@F]-"5K@GF`Q4Y_P0T/Q1F^"]_;&2BBTNKR MUODL7*"#'>LS^/0_(Z-'''*WRYF+D?,!W<14=CY#<6#BKI(8+/I.QY`\+12(<_R;?_=X2$PDNPC`F-?&\"<>>("MO0>;-AH>+9 M:.-"+<\;`L#ID:$,!.=T+\ZQH4RA_H)#V:_KHD.EMN#"0P6"S/&AF?$-#9C7 MB1!?>8IVC!&5F(03)-['T1.ON]RZE&@7,#KPP@*FN^)G"B2C\H<[5SE%Q-I1 M_J,'F!8ORAAL'B'CS:'UI"#4"+4W&)!:/S-%<.K(_T8!6AW.5_WL5-@@6IY$?;_$GKG71*FW."A'O M,9^UJB1P`8ZVC+`0Z:BU6.J+L1\SF_"+',D'CU7X8)J;[,5D+2:RC`5L.D4('-)99-]=B*UJ]40<]4 MEZ*@<*G-L."N"D1%#2M8S;(Y]N--)-WTL^"!!2A[A66;>LV:I/6+YL6&JNI8 M^0X'2S]/R(9$//Y(*N%ER-+$#_]W51>N7("EZ("S8@^0_B[]K;\/M`2C_IQM MPM#'E/\YBSYY))IC+V0JT2?9JM0MO^=PA`Q8P#G>@"Z0WI6BOD6E,':A=L,V MO9)"'F\!WBE5SH-@".]_&MW%:3J+ZIMALW7G5IE8\^D8(;`1X&"!)';-W_N[ M4MBW;'9@\MB;;U^YJV6B7"@,#`B=*7C[Q_31XLVK6*&_;X/>EF^Y+/G5;+^1 M=[],'^&^VC(2.O+UENQO\15W=#_Q->-"&HQ7G9?5KH]V+%YOEP7Z*U7H:_D: M;XHBXC4_C!=G<:W0A@GZR[.^>J@1\(+63M':JCU2U1P M0G^3>K4M7VQY&]XN+QA?4KS>AW=D+1X8*"EAO363 MFL(E?$Z/*@8T23.RY;NQ.2]BS.PMY86M!EF^?L9LXS^T>4UJ4ECOR:AG]T45 M#,#?%`V9=M13)S:O2D,+ZUV9%974!.8T#Z'G\RWM6TPMO=U'05KV@A+'M)X>UINV4U9HT(U3 M/R'5>;7'5_UH5\I!:\Q/HU35FD[5K>#&EE\K"8X%7^3`TQ^L]MR<4F(57W@1IQI/:Y)L?Y>V$TEY*1]>]3E/_MRVKW/Z?M7MC4@3V1>)]2IU/GO3^2 M+9.9\Q4;];62@\"@W4@L;QU&_**:7KU%,J8^G61Q(GH+5P&P0'*D]D)@71WF M9QP]>3U+%GUQ>65=P;1P#,P-K&(Z05;MUM@,LDOHMV3']Z,*FL=:A24NE3H3*W;%5/ M_Q&&\3/[(?:57ZSX"DJO+D6,WC%W]O'RYV)1R/]U]?.W@R`N?^RS]1W;LQ5P MU?H6%GIDJHFW0HK8E[V%D.]/XRB/G2D,XHL"+57<,"B+J_+C+]Y/ MA4*P3,?$R1/Q)?N?UJRPWIVSWL9E.5N'RQ;?/->K3M:Z:'@#CP<3><%]SD]E M[:-5G"3Q,W,D^2(F7U91\$1T_?.[M(@T?79,Y?G9GO^]E#+4C0A-2F71V+OH M^<@WF>HND0*>3I`%"V"G&R*+6'=\CZZQW=.Z3,&=?B65(LJC\2UU.'1E$Y3+ M%!&1PX09Y(D$%-$T9)<6*UOBE^PZE*U/K#EAX<%5;<'?D)3-Y_O\3>_BD/@' MOK8(L!]Z2;D_08,(]M>@^#7N.R0EEM-J?R^75-X!',9]9(W&LF6Z+6MR+/$. M*E)8+]NHI^SM\F"274Q!^S1?2*X)?:,9'_;Y/EE5#-F+RLSB/-V7'VU3,%0; MLL507^^Y!_#8MAG];+?G#%N^855<9^(R!WGQUSC":T+GR[!^5K>YSQ+>O(86 MUJLW*ZI>1M`@PGN*D_R^&GWG'D>!ESOL?(C2EYT]LTW8K)5XNGS7"'K8]MLPBXYRV94__1O)E4V1!!;2E/JI`58O-@.*B#T+ M*.4QZ@K3J85]'NQ]OIVYCZH;!8VVW@GS3%NRW]*HECFE@8JKBYM^XW(0L!ME MU8.ZSOM-,O\!4';7P M:AXU756IOX9GV1F,BE6UDHWB@5Q'5>BAV:R9+B29VQ;3%#3$L$!BH:G\"-'/ M&UBAD'@K$N932S'9K)+X-YR\#[`7XN2"+F'9F0A]@>SB"GYA3YFO;WDA%!KL M#'1;25R(<9QJ5JE&#EBOUE;=?^@5YQVA04=^3!0U'HCZ)9L88+UC2VUEKSBL M6,OMYG^8ESZBOQSD%ZW8/.:RXK!GA04$9[UUZQ&O%/;?"Y'7RV!E,1D/C%I! MF70^EB6U.K##0NI1NK]V#%I#V:L*>I&&&@"R.)K/S9"^T20%]O)->G9?]'WW M)>?+URB.WA?5?'">=]:X&.^5IV_-,H)%,L90U>5)!TK MUJ-Z)EBOUT'C5WO12?'K539AG&RIH/'MC,](G(9^'@V,"/HDBDJ#^]5_89^U MWHZ3-29L9AM%P2C!XU(_<;3;\\+"A[OB0\&$!;VI_XB#?5A5V!T8,"W7.>?% M3]E!XSIVF!E4;,!@XJ+S4`C)R\]>H-6>TK-.QX,C1'/8F!>,)++"/$8>6-BP M5UARVI9?\2V2-["7,%2E>118'9=VJPEV2QI3;_5(8<"*-'GIXP6E9^F_V>$" M\93//*6=LT+9%L\+%"SC\61FL^?=((?UZJUTE:T4ZA//NJ5LE?C//`._7+,F M$1V^_$B=+AJ>\D4J??O\BLLCP6LT>:&K5UX9,K_0FD![PPN6PS39[L+X@'$Z MHI$8@[R?%8-CQ#+272!@(^_-8,3!&..<4J`GV"=EVF61T5>6.:>XJ>47Y=OX M+Z07*,+Y2C,ZE.+6>10TZ.)$/J[B*-V'F1=EIX/)).O-`,G2$%L0\3TVOY+Y M#P(J]4J_?(SE4*P>HA98)\J#!:[S&&,$6!6._H-@JKDQF%?K4=_OU-#"PH)9 MT=<_@.6)(:UKO\.\7P[^5NILO*5>,DX.TH0-`SVP]VREK"Q\W23L5J$\?A4' M-C]-Z1S6=4Y*ZD.8H:Y^%">,LW559W7]0(UDVM4'5F)NEB4CK!?OJ+4,`4$K M4=3;[4*2N^Y=(:7YLEM)H(.?;E75\1J]5!J#P/J8RT$.K-=_FA&2FB_L'FIQ MG)7+0U0@:DAL59>>#GV*-6/;)>/JS'49WR8T+'DD*5YZ+]>Q+-8SL\!ZQ=;Z M"N662,2;O]7'CS'?7&H<4;.6%/S#9\)J*.RPG[>1*LL0>"]Q%&\/C=Y4-7/* M[KR'Q"=9>$#;.,"AR-B\F<2V,MGO\=00[F!H\!!'F_>LSD-1""%.LOR?9;N? MYN]=\`K625"<_N^CZI\5=;P*R88_24J=[JDK.W0EL#H3Q47]XG8D\A+Z1#>X M(.$WZNB?#-E\`X[EJZ)G3L1FM0NTV7OL[YC]'4=/)(DC_@9#MFV+`U+DO31U MX?J=XKH2T7\K?8]GO;I^XWG[7[-R_N.\P"P M.7JD!+]^_#5Q2C1ZR6DHG"J"U30#?J0[^/(-SWGF@;F@#US]F,$]7,,C'>@QWM7K08V'$*D`/5Z--)IUY M:349GD6J7W\8_)E;*-=][$W2WY6EY$:=7DH/'@S',HH"N[=CXH'I@O2J:OP2 M7T+EY$,-&B]DZ8>\D,<]EDZ^'1)`KT"E6?>)%R1TLL5##89/;$?Z(8G71/J, M&U\#>KXRK;K/EM.@G&B@9SN.TXR-05DC%14-H*>L5$V<:2EA[C*&Z712:EP5 MD\P[A;*2DK)G+B$#]-AUV@G5^*MRE45OU'>,_-NA'C_;W*3KAKAM00$*Z9O0 M%'K-6S,!&DWVNDK7BJC!BG)>E#-?(,X^ MG(?D!?^3F*6I!]>'+U3!:71;YA:/JM1BA7.TY`;T)H]06N82F0Q4"F%W+MXQ M.8A$WZ)*%*IE#16=4RUI=,O^8"O=)[IFBVB\F_$BY%1#Y=BT8@3D--WT%8)[ M]C)9;,__TA!PP6YAES(&':GY%+ST7AYX+3QIZ4$3+:!1:%11TCF-A2"4XP+E M/.BOQ9^,&7'N_QS*C<89+LO0S/-,U0FE.Z@I.DS&C@OL"%?RH M$`#@+.:FN$A%(9:?B++ASM,M1JQ@-4M.EKU#"S9`K]!%6[&:<''3C&64E.?P M%3^J!+SE,HW#SVC6*G9?CX9'\D::']W1O]&/RX_H?U8T4*6?_/]02P,$%``` M``@`S5Y!0OO)5W1.,@``J!H#`!4`'`!E;G1B+3(P,3(P.#,Q7W!R92YX;6Q5 M5`D``T+S"U%"\PM1=7@+``$$)0X```0Y`0``[7U;KTG$H0N]7]^<_7V\DV/^$NZ7?[^]F7-%!@Z$?OC^\NK#^\NW[^[O%I_[P ME@:;=^\O+Z_>_>_GV_GRD6R="]?GS"S)F[T4KZ5*[NK''W]\)_ZZ+UHJ^?(0 M>/OO^/!NWYQ#S>ROKJ)\IB6A^U,HFG=+ETXD.I;V:WK2$ORWBWVQ"_[1Q=7[ MBP]7;U_"U9L]^`+!@'ID1M8]_G_600[?RDE]ZY/H'?_#.T9.O&4?]?W5R(_< MZ)4S%6Q%0UGC14V/`5G__(;+L2^\>G_Y0_)U_P&1C5YWS$A"E_?Q-[UW-5HX MH'Y(/7?%.MWJVO$XJO-'0B)=ZW1RW;5LZ@2LX".)W*7CU6UF927MMID;(N$$ M3M:3'1^=&&^A27N5%736UGE$E[\_4F_%ALO1'S'K=S7;+*^HL[8/G/#QQJ// M=6$NR3=OZ238.+[[+T$>L^0A"9>!N^._3=;7<>CZ)-2VUJ2.YBV>Q]NM$[PR M`MV-[ZZ9@;`Q:+FD,1N$_,V4P;9TB;;-9K4T;_6,+$GN&P+JLQ^7@EEM:V'2 MS5OYB;+*6>=;DD`[_E>5;=Z".QJ1<.J\.@^\!G4+JLJVP93'S8Z-P-'K(G#\ MT%F"AD:=7/.6C9DSNB4+YT7?O2N*-O_^_I(-DZ&;&#:;\TD8#1Q=2Y1"+;>I M'X8D"B?K*9M`6>^,V,C.@'AKU$1-'6W,#=NM&PG#98,E,R!NT`0R9NDEV[`_ M_PN-$LMF2Z'(9;8U9>TA0<"G(C9EZJT26D/SU@[=)W?%%D%L&"2X M7GCG!'R9^*3U[)K4>:K>>L&<<+;LC5ZGGI/L@K!!>B=V1([^Q("&T;ZE[73L MVE][*EQ,N6Y6:[MK'M.V0V3;'7LNLK\,XB!(=N!NJ;]9D&`+[&KU:VQ7&U.\ M(;+=K0!-6VM:3ZOSPD7VYV'JU;+?DO4-L)_4K:]534QA!XAVM!8V;:E1):=9 M*S=2P;#.+M?2IGJ8UW2*M;;Y^%BWQN[7XJ:ZU*VOB[6ZL4\#KJ&CM;QY]S>H MI(.U?BV`3S.G%M?VYOXM3%[5TAUC@\F*]=`M^R`G0EXB9B9DM:^(M[K!>2_[ MF,M?7EY>]2YZ>XGLCXZ_ZB7BO:Q\VN)]FSVZS#73XP?@--#!-;I;7/^F:F?_ M(8P"QOJ^(L]Y()ZH_CQ*:3B2'[MA`_B7#X.+S:.LWO'E7A'O"C< M?R+4NKB\2H_G_R/]^+?#>=XB>VY1T*)8J-C>;(?H!_FV.\%R7RO[,=<;RA$% M:8EW.W'@?+%\=+U#1UH'=&L*;-H0*E>%!FQ4_/G-U>6E'30P>R)C]F.HHR)3 MT`(ZJKM1)?"9AJ?@?[`%_('GA&%Z%M]_<;4,O$=F)-NP(=TZ MKB^AHJJ@31S(>E26CBH=;.&!K4.H+UKVF6P?2""CH5S.`A;DO2@'?[GM>_2O MD,>EXDI#RX-2XFP846JQGS.LX*9OS(U$XLRXD6B10+-]NZ-.[%7$3BM@/16;81[\E;OJ,;%SNG?L1#\"64%%=5(=_ MJM5EIQ-ZR3_/`J]2,=,O3@SY@#4[<+PQ6Y6__(V\*C$OE06"?H6.ND1+#-CW M:],%JU:S+Y`4`8+\'A'D*ITPL9VR>8BRI?^*7P#1@%PH"T3[@P5H5VJ)`7N? MM6;%6W3C.1L)W(4R0)@_(L)]S>?/OMSXH34)ZMQ&,92?U$C`V3B>_2)4Z,U'AU?J!C_]5U)&?8-OW<2I**]NG\(4'G?N^@=-&8_9R5[ MJ6@OD;7@K'NROG%]UB27=7F:A$QJ8EE@HHC[_DG`IT:+8B$K=I4!9.3V+2H5 M;7.8:DK"/G(?PD6I+.J>LP3;$OH2#>T@@:=FD.T=B3^A[CBK`:3%MMH$;'H5 M*.0I$-PG'F!S1Z)4$UDG5XJ@;D:#B8"H;0=!8Y^'M;*UY!V1$9(O@KI-#2:@ M2BT[`!_&Y(;IU%^O7<]ETYG:&*2E43>NP31HE+6#D6E`=HZ[&KWLB!]J^)"4 M1=V\!K.A5-0.+M(.,]KN//I*2`BRCG)IU-UL4^N0*6L'(SEM('XI\C8V?(ZN M4BR#^6X?"G2;*"MMFVA81"/'$R61QS+)]7+Y]*X60=T8UZ\M(/K:84>?*%T] MNYXG8>'X9]S=<3WD147L@'?,$/(W/(0OT8#Q/WI9>C'?&]9`#Q/%W2;7TV(" M@!V4I>VD_M)@\Z.J..ZF.70#1*ZH'73DO<-C:T&><+8X[AZZ%FRI0UQ6V0YB MAF3']SC#1#.9*UPH!"6ARW4ZC(1J]>R`OJ@'<&B"P]_E^AP&OTS%<_>$E=9B M:B5=+MQ-:/I:R+EUG0?719?>:U/Z/(YP[3',H4"T-IZF9_``!UQ:%,M<)VD%*1 MS4W"2&5)\#&E!70H5+6#B\RU0#@M.B$H0]UL(Y@Q!`/`#K*&,5E0^*%:55DH M-=UL(YA1HU37#D;8>^B`)OHFIDH,1VLVW1DM=M^T;K/C=OU0,H1;HJBT)9ZF;7`H8TU2EA M%2-5*IE8$)R3;C8:S#E1:?P5#8QZ$N'4=;[58$S=UT*8\09@"UM^[SN^RV>X MY72_>>H$*IQU0E#(N[K59P(Y#(!.T2_0K@2]5!:*=5]I?+>!N+IWV&9.TN7=D:`R(();FK\`(3DN%` MV#',R5_0U"X&X<1TE4K'R`O0/!5ZONMZW8:N?G=&(@:EMZLU?LV=:24(K9)M M0\:'J0#RD43N,C.A'-(_?`"G?^C]*5?5?WU+!]&-7^EY])FC?D.#(8T?HG7L ME2\RR]Q,H/!9IH\P`L:.V3.SA<6,9Q((W5=B-3,E@4B?I-^ZDTO:D>;8D$<# M3*PC,4EXU8^C1QJX_SJ.RW+RRA)VI$VN3YH,`TO)$GE!P43M2]N1;;DI27G= M+25(GS^OE[?*",LE4-P(P MQZ@%<5-]=,'+"6>8Z@9`)QB`-&Z&CR[8.=WTHHR-`\TU1C6<9ZZ.&B#AT06< MDFK5A)NQHT/Z3CQ9@5NDG+F,:\'-Y-$Y?2>9T\"MT4]P]:K"S?_1.8FPJ0\K M]BFC_F1'`E'W\8K>(>[IHRKNZ?@'NNYE:L%,K+JD6W)HER;(25H:-0+XB?@Q MT3UT4RZ&&:ND@3T?V%NMGQWG$OO6:5!'#BF28EB!LUWX3J)'$LP=CX1I^^29 MOJN+HD8%07!7:6@'!S#XZR+?S48;!'D]Z&<9ECZ@(9NC4[TD9!7*H(;Z0*BJ MU,D.Z_@4T#":\,C:^B0=4R/BJ=(!*&XF(^:[&X1LZ4FY/@R5V24$T?5!@WA,>$ M0#,X[*!0=+J]8H"]3\=P72^FVO+]) MUANW;#4H,YRJDKAQ/`9K)(6>9T\A'Q@2M>"K7IT0;B"0";$@[>T8)S-MU=." M'>X#!+::"KMP_^2X?LA-GH03?_3"AX'8#1^3X\TA>9!NY>GE<.-\S#D"0]%1 M5$'2V&1A$)$5?S(XW:84I^+]34"$R2N/9"'BN!$\YL28`M,1/_NFCI/LO<8$ M&$8\MR66A5V!IW&B=&O9F!HLE M7/H18;AJ=LU+I7#?Z:DS%E:J:0<'_2T-(O=?`KQDRARZHM6I!>60L3VXU6;,V?M'$88Y]]C>?B$;_PXT> MDP04<;!\Y,="0$?G!-^/^T)1?4?I9-38,;P(H)AN-+_5!#CW40CA/F)40-*]^)6;Y$-^#'U#G"B6IDBK5Q7N\TH&]#=!RD+C M[#\YKI>XA9D4?FDF:;;4D$Z3QK7@OM14U\#A^)S[$+!/X+_/\R>4XV&2KL=? M<)`MOG12N.]"&=`.U-\.&_X'<3>/K%5]-M`X&W(7;Q](,%F+AF>N,$XK%L9 M[OM3!M0V0\O.NZ"*C/^'.Z'?@>^$9FO[SUY:GQ7Y\&L\X@B217V")&WA0I'Y MOEA(9VREOMJ^Q1FQDG^*)*]+-CC6!AZ8>9(Q^U&V5*DJ:!,?N7Y4"7RFX5D_ MRP;PD^[#G*L=]=FO8?_%U?)0+7->E%3KD#V2IC&?#EC)B%+B M'+E1*I2].H%.T[4Q31*)\Z5)HE`VU@3U-NJ*D"V?+BL/(;6D&JU!KM,T.@CY/YAU8U M@V)UX7-D1Z;+/ND#MIL!S2U;/XMLMVGU2KL?I9`S388\L^..'?-)*-_)#"+\ M0X]3O`;<<8YY-7WMOPMK'W])$LYA'+#N.4U:ETG.>4.#@1,^JG@%5H":6,N` M;R,\[#C/DK1;Y#=N0&.5/&K.K48LRM&P@T0>&G&,?4B7*V1UC);(=L,K1?B( M226H>;U@=-;#Y4PX[6_Y+8/:;![$45-\M<1C`0L[&%1."<<;!=P/)WXH\*XS M5\IJ0LT,UL*DJ4;(:HK%?-$&P\J*4'.,-9]/SYC?I(..TOL_:2#PU'-JV6]E M-:C)R5HP7@4V5C,K>F9C8N6UX&8O:VZTY\IKTBMGA#D,[C)*M^_[STZP$ME? MZ]BMHC+<%&$F3VMNT.?-=&%[97\3M]&6T[$2W-1L M;>X[%8&QFM3\;DL]3F5UX"9K:W$3ZJP839]-2^\N3]9)BI$Z5EJN`S=+6PM& M*H/%:D9%9VQ&J*0*W(QOS2WT#.BC36K`32C7)IFMOM_9VN,064\\Z\'=D2B]-!6RJ7_AO/!\(/QPF4=E M2`-1ZE:'FY0.QG)3L*RD_+@MFE6E%MW`JG`SUM6BV@@D.VC./@0`?P+!DM1U M,)(4*G:4_&J?9FWB9$S^4'AC"SIQE>\A@R2Q,U#!SP6A4-@AR'T5_^,PXCK M%2ZH)$Q7]"0)C1EQV9B>#`]UCY;E=>&F2VMA MUTP'DQU,3P.Z)&0E4KT=DS_F.RA;H"8?$/9'E8G6K0PWPQIT<&T"E!UD&TR' MS69!].V5+F%]0M?RD.SWK57/6Z>M/:6#"9@VM%% M8(?8=]1?.B'7)62]/J@=,*NI$#=O6ING_BK`K"8^?]1=I4:C<`!)A;A9U5J, M#5`"9A'QF5.:VJ>/#*']!C;G!QH2 M_)N=W:60_H"Y/:3+'FW#BD6W1H$CC7I;JZB.'2C73A?PVWLX[JAA+%4-;S@J M)7?.1_X*?UQJD#'`A$'TS952RSNBT()4NOPF]8U'GX]@'#+H?@_.H,LKZ26U M6)!4,Z,4/%UNA0BN`\`;-`TH'\=7UZ_W(;]K>W@^NK^,V`@?N=H'ENM4!#33 M;HU406+!I:@)E!TS(FOXVHT4;EZV`&K*G`9(TVIU;.(AMZG'8S?\I>N1G,.Z MH.V89#=?94<^'J#5=HFV'?UI2!@!2U>U09HO@II?IU,^J$QEF_@Z(G!#@^R# MHEHC+I5'S;%S*B:U>-E!:^&N-'\UU"@GA($\:BZ>4]%NC*<=W<#T[=C])#9: MK\E2?JFJ::VH:7].U65:PMZ.CL2P"0C394B2_V?02$]^-:PVO!SG< M)#]=#:X%6.QD,>UYXF[,C'C\3&#J!!%\F%55@)O1IUU>]4#92?#8GP9DY[@K M]75)O1AN"I^VC;0:%#LI3+M>?[UV/9=U/$/3S,KA)NWIQ"++L-C)(IOER8Z& MKG0?0B6`FYJG=7>G`(2MA(G!GH>`)OZ8,C4/6!HW*T_;5"HALI57YJ$%,5G= MNLX#&SH,G)UJ4=S$/!VXKQ)P.DH_4&S"Q/_DN/Z,.!Z_=C_Q!_P&F^<).--7 M>X%T@6K"S<33+GL&T)V(S+'/=Z`G_GC+W*T@V8@<,W3]#;]48SBB0JK"3;G3 MMC'"P;-CK(5'ES0.=,).N=.,:G.@K"9X+&Z.MQ#1IJS(DO0]S6+:`%#9035K M..N-T2O/!1#U_14/H]UQ_452X^3"1M$(Y-%O-:K"31S4@#[:5'.;N@$9`M#N[(B2](6-1O:`5#9034/X7AV/<]H$-<)X68V M:D`)A>MH$XFV/6O648:C=HAM\.[9R2^?@I?6`[K=4C]SD5W]P*1)!;B9CMKA MW!PP.PR[*MXCO^@WC:*0RN/F2>J*9@U<)]OZJNINZ8DC?--+70EN;J53VFD1 M.%MM=1B3!34^JZV0PTVBU!6U$GA.9I/B^T4PJ-.":H`R%9[ MNZ.L&Z6Q5J;S8J4L;O*BKFA5P'3"^="/`O^\:X>=A:C=G@V!ZSVGD%$67?!3PLC MU#79$50)6))>";BAJU?=#BOF[>S[*_X_?I+TY'C\XE^?]=0@>&6=4I4_#BAK M27XF`^+`@#1,_,/:%D1VF&FG?<"B'$]M]H*O+(=7O-MY`B/'VV,T]MH)'X`<.(=%-^P9L@%,SFOA.SZJYO:7 M;$0*W;JIEO/B4$([BH#JAM`JA*SC57:,FB\"Y:>C_$VM\%-U!HJ1Z7`2;!P_ M34?#)O!NTM"F:_CT/5))OO8(=OA7WH7/?Z:FT?#."#LE\GL4_]N_/_Z MB_'DKM>_&_:&H_E@-IZ*WRO[^?AN-)\CICQ,;XQRJZ">NP3D'E,(()K+ MGI4,58RX:R=T0_$"S:%;+%@WN/;D@?QU*L),=Z@G,&MK]6%"MLAYO-TZP>MD M/7-"_6_3Z@\'D_FXQ MOOO4FTYNQX/QZ)M5MC")JCURI[-BM/>X:8C+8UI-6H*BG'K]EI`)A'2 M:R;W9]DQO7I?=DQO^XO1D-G#;/%K;S'KW\W[`[XG@^F2RO31&(E>#-%<9(V# MFY!1#9AF!:4O:V`UX$$VNB2Q[\)YJ=AJN?I0M+/QW6#R>=1;]/\7=3/ET&CP MS*.4P(U`+;9+9T!J$4R+`=!2B'W3ZHYL'9G#I,EZY#,/+1HX93OY6+23_N#O M]^/Y>'\JP+0=S1>]01_19O;[Q`.Z?6#.,V0F4HM8<#20:1CODPYA/\'0RV%!)SQ^;?+Y-%>ECP931;C*]O1[WI;'0SFLU&P]Y\,1G\ M#=%TDQ=;-;99+(2:*BO+@,[*I*4QS:D:\GPJ*Z62R(:Q?RI[LIX3_BY&IKGB M,>>R692B4H;C+^/AB$U@/"QE-&.S5^\Z:Q2_]&NGX"`HN?S[&P"1PV3#G*`^+WI7`),>/8 M<>X&LNGGYJP8)M/_!"2/V+VX>BI,N[W M?2F\8GY_/6=N&H_]'7U!#O0M-E][-U56'/6Z;;Y16LN1E\H\/E<4#&#PXZ+ MLKG07QAQ:A'P^Z[X?$%TMX.E^Y!,UJ,P*S)3%0N!75O"9J-;/#NRK4Y0` M304F"TX8BL^4$1IV$"A]R0/&(5P&VRZDXJ_;;F[M";F2\? MR2KV2('>8X8FGHK'#7>959>"GL.W?QU08C M/O?#T&,7XHT3>&KWHY4BYW'H"5';GKMY,O,HA4]G;^C98!U?SU6];(=)/&+6 MQN3Z"AMD,R^<&YN046UG=,&O(6)GD#%P2"+']<([)^!7-9[*B1O>U\X@V/M3 M6GGO4/LW5[63NUCSB.PR+E-RE,_OW[".%(U]\:>`$+:.XNFSG(TL'78[59^/ M4]HFE&>Q"KV0NN$9G<6-K-1TR\-!@^2%K/#^^WNB`3W'7_4.3?AS+].(GFC% M80CY-G"T$76;AF\OLAEZ2J&U^4(Z8RYU?FR;+BIP.!F]M`-\9N1DS'Z4)[\N M%[2`A.K.4PE\IN'9-_EL2?E9O;-PG@-()H8:2P?B!Z=V1,0SH M=A=')(!;@U("->H+!C=`8SOLX;/#=/5)\)KM$ZKI0"6`&N<%'*>T^MK!B]I> M[XALCQ`@AQJIU<9HE='>#K+ZRV6\C85?/20,SJ6;)!HD.X^DAV3]+0VB],Q, MJIU\W[>EZH'4=_S:J)+ZMK&THX=(FZD::G5"0#8[?C.TGB'KAES[SKCT)]KE M;"X&,9??SK0[T",[@DCCSK)%SN>,N4JU\P].KWKKHRHIUZ'(&5U@K'S'Q(K9 M*9-^)]O(01P$TW7GTE9!02V=UZ3.ZRJC1^*NA%&ZAU:7/Z&:C1N/SIW2T7I,E=\D/ M4;XSIN:,+*F_%"KSX+9'Q]^P`J5X7G[G,V'-\^BSXR]E?DWKWW)&MRX[0AAY M79E]5E*[>OR@?F;2L@7BMZCP74I^!!"01^*'AWZ]W[VKD$ZG*V,UX!(-G'INAT0!XS95&7O2=A ML`2,'=R)Y*!L[V(>XC19)SG"^W'T2`/W7\Q[H-?D6'@E MX;AAG:@+[<[Z0BM`=Q1IT&=CB[,A;*)XIK?TF;]*Q_PI\1BYNR0\&:GC+>CT MT'3VX;[)LIWM)C6B+LP[ZP`M@&S'D)'G MO==F((^ZGN^L)Q@#V%6`D1,^3CUG*5I\0WB.I=A?A6P!29@3*1O=M5*H*^C. M2`."U1%5R3@P6?-GH?BU2#&7;-R0WX1DD\6;V]M.(_]]*JQ3U07GF/UV[% MI<]SSXE212#@$269Q'ED1`$H;8=#D^ZZ[MNZOU]^31S^0J;Z*`(HB[I#`2&" M&JMD$X/BP#.]HS-U`IX#!'#&*Q%`W8LPY$JON!T$W5+'AP5(5)9$W1(PI$2A MJAU<%.R;AX8NET%,LAETC`8]=0VHJ_EF0Q\$&CLX%>-`9S&$P4=35>#/S.X-YK7`N`X[]RQ5&77$;4J16V#I2 M`)&QTM*HUS[JTV)OP*QHF=BX@#J#2@G4BQR&_`!4MX.C_:925C_-5H5:!+KR M[6;I"]^M@"AN!T45:[X[ZB]-U[M9&2A)W:QY0="K%[UE`.S@*JN2(64P42AS MW2R-39DS@:/E"%BLS7M]"&/I>>T4HFZP'K2ZYT/LL5.8^] M]BJU[!@!U;O)^U]YX'*M'?9\!:C;['"VS#&Q@\O]<`\QHLJBJ%OKYKZ@O59U M//U.4LN%F0U*"2-J$=0==C@S$+V13^XS?DTVO:/^)OR'TIN_L]%M?S$:,E=@ MMO@U]]J\95Z!3&>-?Z`7PWW'+2!.R!RXY/]C7^Z]2O0SJP+3TX`26'CTS1@@ M.T9//MX<7Q',SK?#F,_`4Q*X5!;_!A5&]47J\&F&BIU,YGND)NL35!C5:VF# M234J]C"9[&*'/+XO<#=LJO<238X],7E=2<$GO`I4CZ6\@\P+C1?;G4G8&:4Q_Z87BW`.-[%=1:T]4RXNF%?IYQ M+%''/&OML8A*Y(P>9(3H;L=H6FKI9$?XMIF_N:5A.'""X'5-@VOWT6FVF MS.IF[=V4+E`>K#--P58U/QOX),C+]1:<$?O9R9")W]ITPIXO,#R>17D>OTM?#FN7Z4K5WQF2XO&@)I1\<02U:F3'9H*B&,&B3[$DQ:\AKKK!L MCFVC9M031-/9MSTHD9>@F4EALA[Y$4\_Z.@7H]\7%Z/]P=_OQ_,Q#T+E#S0Q MD$;S16_0MVQA>AV'+C^I']#M@^L[D&!4M0BB/5.`QC>3+?7!'4I:PIUU7:=99*TU\2 MSTL7:A7)!B7H`N105ZNFD(-QL&DZ3+>UUE,23:G+#3]D4_A;_>SX%\WLN/AE MU.O/YZ/%G/\V'2UZT\F8S9BS^9_YKN[;;Y-F=SE`G/`Q';E7XIV=(^%24U1( MG-,4!U#=CH7*7C'YY"N&[DG`_\_OE/"S.L*LU=WXTOFJ::5G-<.U@Z`=O8%G M`&`]=Q+P@+WTEXQ>/(Z3-3S>DM65A'JC&LYJ6JV!C1VDYJ-ODQM$[G+JO"H> M[M;(H.[>FA('TM\.JC1]3.Q59K:@F]FBO#;4_=N6[5*'64>+$66GZZ]6HFV. ME]QKIX'\0-NT&M3MW%9-4X$2!FD+^GDYY*V!74I52*/NOK9*41D3Y#4E7^6Z M4?(2@;\:4/&.(UFZD*"?'XHKR<'D\^?QXC-#8=[KWPWY@X:+\=VGD87/WE?K M[0O%H6%!AG6T:7A)MYJL;_G].TGS"F4P5X.UT,X]2E:EKQTNR#&Z@;>"B1@9U.=>8*Q`@=G!WX_IN1&[Y6SAL\>GX&YZ+5.RL[?;K/HKGJ\2]\_Z6)[:2AFC)!5!7=8UYU$-A M!V45^T6Y!^=X#/Q28)[+Z)A]:TB:?:&ENE'7?XT[0JL`GUN?2:-A,@O>5KN- MKGK4U><)>PX,9CLZ3^Z.MO.RCU?D"7S[Z[4(H=$]KZMG$GJ`.7'40W MZ;[%;;(.1HKR5Z"F.T`=+61P=[2Q]9EI]^B]IKLVH>C,XGC*=[P9>2)^3-)D MCA+>32I`?;.A,:OF4-EA_'/'>W(VW(V9QP\!W0BX>93D$PF8\N+0419>!!)% M?>JA,:TF\-A!Z+7C_Q[$NVCY.O`<=QLF:QG^Z*I'5LE'M^[OQ'OE[Y0/B>_* MC^/KU`3>M+&3[P;HV4%_*V_5%PV]69VXSX@T'P+:0+2C";J%A^F+R=^:U(C[ M%DECIEM`TXY!P/B5^N)N'UP>]Q&3YKM_IDAU%H0,>J*^(NY1*05EQ](M.2`J MR(?'=]3_0KEJF9?C MF]%L-AKVYHO)X&^6'2L']SM^&7>?NU=Z"%ZC)LRS MZ&JJ).\2FH+3T2"I-[1C4\3LK)WH&M6(>CZMYZ\%M.SP9O*-GI$5V>X$QJH# M2YT0ZN&SGCR8SL@3W]!]L,'."Q6Y(IM5BB-!.>Q\OB]/>Z%R/:B1 MP9S"X#3)+4L"PAD_8)A]-CT99_1F>%4T0^%<_C*Y'8YF\][H[_?CQ:_?7,W& MD9;I/F'<\"@H%U`0$)@`C$MJ0=QHI&8,G&18NJ/^D_S< M"#(M&]6`&S,$.D8SA0./&.!H5:LFW$B?5H@Z\3@&;I%R4#.N!3?HIT6B3C7< MG6-0`=:*O9NH@M/F^C@T?$@>V-]BT%'U^W*:CV-8UG!TS<"Y;_-LNKTD7N!, M'K+"UB0ANW&61!GU(2^.>4"F)D&>-:>LKAT[E7,V?4;[2ZM'^[XF3L`&AAOW MY?@*NB(CO7$MJ*=H<`YKHM/9]!:1XXC,->#]24&+2@#UX`S.@%[GCL"^)CY9 MNSP6Y?CU-\3A,XP$;:4$ZI$8'&Z`UICIUB5<,>?$7[H[QTM&V*%T-5M5$/7X M"\Z,7$<[)I+].)CFTE`G$Y`51CWB@G.AUM4./DJ'W//X(5P&[@-97\: MA5M(A%'/P^!\F6%A!W]<.]V33@_&3SAU'])N%AC6 M@7JH5G<=`T2FJ].$\DL6Z19`DF/_,$E>.QY_`H.7/.P0<%=2NGYI7"_JP9S) MBJ8E!&TT6_&`'UN8&>PK%$5P#_7J6F6UXG905.TL]?T53]1=PTLL2.*>`3;U M&2MAZ"K!P&83D`T;M\?^BC6;K'CFHK0Y$@;4(KC'?7#H(8IW=1>\M($N!F"M M*P&0PSW#,W&^@1!T1,&MNW435":9ZZU:!O1BN&=S<`*@`'0U[+`):I7D8^7^ M@_F^FDD%N$=N!D.2,2B=#5#"#Q1>8R)$3+I5\.8'^0F;W%D M^]L-#=(4G[(YS[02RR\JUL/$:CY%'&=#.F5U6'[#L18B5I.91N>F^?KVCP77 ML7X6J5*CT20KJ=#VZY^-L;*(J5[93J-#9B2* M`U^,M]F6\&W;P9HJ`T!THM;?-S4`H*OSA#4]A-C]DRRC!67-6!.7'V7T_54_ M(&F;Y+&')C78?N.T!AR=927/6N6,;!W7YU>_UM1X.)(+VWZOU`R$CIA0I%I- M,ARYTN?%(9*V7QDU4/]T482)B[Z@@]%$.4/(A6R_[`E3^O2(S_F#6J/MSJ.O MA(1]-GLQ'=QEE':'_K,32%-$-*T5]QRZ$6$1'6.%51V-@+-EJ/;8\MR.\?Q)I8L8II`[4<)*:K,*QZ6AZ MS,;XB;=@YS2.'@-W)8T=5DJ@!H*8<`#0NRO$A>GFLM+0K1N&-'A57.+22J$& M;1@A#]/?CF%,?C^P'R6'8"-?NJ$!DT4-T#`AS@B+CHSG&-@_6>_S94S64QJ& MO"=I7S^#BZ/&6IBP8HJ('7:5/C_.WRL6C^+X&_YR]7[9R-<>`QI*PV;`TJBQ M%$8LFN%Q@OL2AW/]3&+;S*!M>''"J#;4:`@3UAKB98Z[])=_Q&[H`L``00E#@``!#D!``#M'>]WXC;R\]U[]S_X^'*]=R5`DMWNIIO> M<\!)_9I@#IQTMU_ZA"U`%R.QLIV$_O4WDFTPV#(VFRWL03]LP9H9S0_->&8D ME`__?IEZVA/F/F'TLM8Z:=8T3!WF$CJ^K-T/ZOJ@;9HU[=\__>VO&OSWX>_U MNG9-L.=>:!WFU$TZ8C]J733%%]H-IIBC@/$?M0?DA>()NR8>YEJ;36<>#C`, M1#-=:&-IHMN_7VXKQUT3HO M.4F`@M!?3-)\>==LGC?AOW+H=\1W%LCOWS[/V`\O??)Q;-%WX0WZ^.A;Z',G M'%KN_+?@!?WV^/+T:_^/H4U1;^YX;QY.'Z;S?TU^XY]N[GY]_"6:\H/O3/`4 M:6!NZE_64BI\/CMA?-PX;39;C8]WMP,)5XL`+UX\0A_SP%OOW[]OR-$$-`/Y M,N1>0OJL(8:'R,<+RC!*"N`)]0-$G15X-U@@I('?-*+!%5"2"_HV`B4)J(O7 MX'SLG(S94P,&`+YU6F^VZF>M!#STZV.$9@N4$?*'DG0\D(-"&:7A-%]0-^"- M8#[##0"J`Q3FQ%G@;49:10`6Q&,_ESDYDL.=T;6O%@C"%TXH#B1<\YV`PAZ> MPN-K\(T.'J'0`PM\#I%'1@2[-2U`?(P#L6C]&7)P`:5DU2-*&3@'Q(#XB7@V MFQ%8_?#@+Q_$,KG@S,,V<*R)#^#Y6;IBH`%N$PKN=.H:-"#!7/@0GTKJ-8VX ME[5""#$?S"YG=/&(4"+9`B]M:74M04U_1-35(CI:BM"'QCJ)%.'0QZY%?Y*? M9QS[0$8BW<*#&#$&42`YR'-"KQK.DI5F\SZC./N!`CW2OD"2\= M3#`.(ITK1]7Z/@4EBY")8X6G26@Q#4T2.>HZUF8/<0"V2)OL/+2)\M%"D\C;R)]<>>RYVE"64VAYO M2]M#4-,DN8.S@L7'B)(_)$^0"W6P[W`R$]^LT57H$XK]V!*E(-76^$&D2U"] M>,P/.88O5O]&[YJ_Z;9I=36]V]$ZQJ#=-WORNW6M7=T/S*XQ&!R<20;A=(KX M'*(/&5-(IQT$::KCL!#R2SKNP1)V"(Z-4A)6;99WZV89W-_=Z?U/P@(#\Z9K M7IMMO6MK>KMMW7=MLWNC]:Q;LVT:AV>8/G;PBGHYH_#1D7$D-L@&&+4AWJ\; MHF^TC37%]ZTN?&X;=S!P>.J_8:!/".(.YG$1M_)$J=I65)VH]MM;UV+5L8Z#U]$_ZU:UQ<'KL8T^D$E#P!'.; M(^HC)Y7A*T?5^CW-AH!;W38ZH.&^_4FS^WIWH+?%^_'PG-^D#IMB&[TD;[[T M`[5*S]95:G;;UIVAV?K'`WR!Z0Z4&CZ)CCHPB&\]PX;,S02S]`??"SVZ%2"^W)FV3-%D60-IALC>C(-,F;N,/K`@RM*>,`$9!@]CD>8*$.;*O]R\$9HT.>B(NI M"]4BYK"JKY8:GB">>,%&*+4A,L5DQWPP.P8X@:@FC3YX@':5-L//>O\`G4+5 MA*S2;6QEZD6YIG^V;CL0X#4#W@3VIX/3;"IZ=/`0QD*^#.YY0TK]GF:*QG0D MZ1A7$-_O#W;Q9LN=[&.U:C-UI%RZAUW?#,*ACS^'\-!X6G:3,D_52LT4CX/[ MJP&$`=%#,AX.LF%4KCFZ34-U_B6;3%-(=GQG*1O][C;`:9 M_[SGH>B\'Y16,WGV;]E_:S,_2`Q7Y;52G;AZ,7S!5BP`)XQHDI/H0&+"R_=: MBAM-LK-80,=EDV_9?/_?$E=M]&P97R'M.,:`E4WA?),50B@-<1V>K;QD=VU@<$4^%UBWPU'8JWI06W\4$6CS#]UH\APR08A9-3'/` MT3"M_WP'*H10&R;3D%A+ZX\.I#Q!D&^'TM!JFV2:$NH3!D<#K99@]?3G3KPC M`M^B?=N5^%892VVP3%=BI8"#KY*$ND+T'@&+4`O&I)S''!H2^D^WZ.*`-0V MR?0K5HOJH]ODGS/)-T$Y4+4Q,AT.U3F4HV%*GDTI8:>RF&JS91H?%<^N'*U9 M>)XEWX85X-66RW0IBLZ[',U4Z@R,*N^NC*.>97D2IM5$T]C;#J>V3?Z!A]2S.T1JJ\SFJEU494+5-,NV'_/,[ M1[/DG>DI\)'M.@_GV>,0F3,_1U/DG`-2;4-L@%(;(N>U9I!"-A/F$0$`"@=Y+3:.)>?R:UG@-D3TTK"HR MH&#O*\IZ*^B_JI"P^JH*N;9@OY*H[>4LKRHPN$Y5@5>][2O)VUE,DA8WO@JH ML;P+*/Z^?E_0!Q"<\4"CF4N'BNZ0BFZ_NF6.)%6`(K[5$[RZ>%1OG=;/6BBZ72>ON%S&S'R"8NXMO$9'(C M;A[[O>A^+GWH!QQ2T)KDNO@NKR4LBC]=U@(>@L]1XGEB2S/Y+J^=NX`019AK MRTCJAM'M.34MBJP1!%`A=&P&>"J@0!&0B\&DH8"\X2R<)8`$0(I$C-H".EKM MZ?00E]?[)<)MA-HH1A2S@F1H&-W7=%ES@!@)5H6;,LA$$9^_FGA7O;5?>Z6E MR@[NJS!=J$:5O;AUDY4%WE=A16>8DV$88+>-9B00UXA%DN6.[*L86<^1?;?- M#K8.5E[`2!*(=F)8TOEZY<+)0G![RJ7''\DX2^MERF[XG:B@[]JT2S*H<;3O4_;=GG@M61_M6Y,QQSBUQ=RQQ M="8LOK$>N]><3?OX"=,02V;U,<<2(Y&R`GR%@O//S92-EQFF/A:'>,3IZ,U" M5T'87FH7#_\$H?4@*FGD;Q69<#PQNS4J/GX1+3<*8Q3+S;!?23")2O.0.Q/D MJY7V9TRXMTM-;#V)7\M8='6#-^ACAXUI^L50#G1O)07?X!C,TL'1_RUZ@PCM M8^0)SD$HP847M??CFX93,64+U&]&$R:]9;YO47,Z0X1'%_J:%&+Z6%@X.ERH M4D5)W&](%^)4'J/2B-%;_YIQ<2&Q6@,%&-^XW$F(K"9["NL;DK\30O2783TZ M=J26.0?R&Y)3W4TL"?L-R:J[KMR_1%X/$1?DV22P&F%OI98_![/9-:$P'4'> MXB9U?WU?I@SDWNW*;#JV:>.7X,I+O:RK(%06+OH;01=!0N,5!+1&(^+@Q6_# M[WT\"KU;,EHT'HH`MBO.$JE>@?L[6-L.\@K8+X38.?_B#YY!>.,%`A2#[%P" M'5)Q-(9ZQ7YFM^Q9_&#'8[Z\ZAR6C3@\BSR;)46)?`BN$5\P&$GX922V;'6) M>]E?PX"0:/4\%%WH?HV!L>N0NKZX]YT\+8N7S6"[%2/NO(Q2^50?CXD/ZPZ[ MD&VP,)APXHZ7W?T*"#MNX4`^2'A<''5Q$/\5'#H6E4,;<3Z'G/$9<7>Q'JL@ M[-S_UHJ_K%F62W`SX(XM):IY$V;@\OQ&3\Y+G!Z:R^,:Q87Y9@ MIOBE(V@WZ71B_D2<9=Y1!6-?C;/Y-V?1@/A3K?*]W(O>2&CYHO@R$KM]*XJ* M9H_5,/:<2Q9K7/2W.=7 M0FL0NS[Q)`GU,2PE&N_D+)D56F^/V&K@WPB[:WN,6'RZ(QS^%SM0E0"G(TR$ ML^C4U3F.V4YU2RJA[%J^E=74QU-$J$AW1VSSVBN`WG4IKFYC1S\X(*F-^3*@ MVS;R7]>Q5K*D:,?09FW#*LBE5J'V(CSD\C<01:4QG7ELCK&O0UP0FR!.$)M! M%QVK$F*6)+._>A!_US?TQ-Q;ZZ`$B;T*.NG0D[1CWF^T*,95J= M:@F6A=_QCE#&BR!Y29UI31EK4[I=#7W'KF@%$\R7=XI!SL9A(4V(+VY4O&*I MJ%,*0``JF8$`!$` M&````````0```*2!`````&5N=&(M,C`Q,C`X,S$N>&UL550%``-"\PM1=7@+ M``$$)0X```0Y`0``4$L!`AX#%`````@`S5Y!0CHP6RG5#P``:K(``!4`&``` M`````0```*2!E'D``&5N=&(M,C`Q,C`X,S%?8V%L+GAM;%54!0`#0O,+475X M"P`!!"4.```$.0$``%!+`0(>`Q0````(`,U>04(4JN;YUA$``,G5```5`!@` M``````$```"D@;B)``!E;G1B+3(P,3(P.#,Q7V1E9BYX;6Q55`4``T+S"U%U M>`L``00E#@``!#D!``!02P$"'@,4````"`#-7D%"AM![!454``"N7P0`%0`8 M```````!````I('=FP``96YT8BTR,#$R,#@S,5]L86(N>&UL550%``-"\PM1 M=7@+``$$)0X```0Y`0``4$L!`AX#%`````@`S5Y!0OO)5W1.,@``J!H#`!4` M&````````0```*2!`Q0````(`,U>04*"@)12D@X``/Z*```1 M`!@```````$```"D@0XC`0!E;G1B+3(P,3(P.#,Q+GAS9%54!0`#0O,+475X C"P`!!"4.```$.0$``%!+!08`````!@`&`!H"``#K,0$````` ` end XML 16 R33.htm IDEA: XBRL DOCUMENT v2.4.0.6

RELATED PARTY TRANSACTIONS (Details Narrative) (USD $)
3 Months Ended

May 31, 2012

Feb. 29, 2012

Nov. 30, 2011

Aug. 31, 2012

Related Party Transactions [Abstract]

Loans made to Company by David Koos $ 13,625 $ 7,550 $ 8,400

Loan simple interest rate per annum 15.00% 15.00% 15.00%

Unpaid indebtedness 25,956

Unpaid indebtedness interest rate per annum 15.00%

Unpaid interest 3,051

Indebted to David Koos, principal 30,180

Indebted to David Koos, interest rate per annum 15.00%

Indebted to Bio-Matrix Scientific Group, Inc. $ 39,140

X

- Definition

Total current liabilities of the broker-dealer, less certain exceptions as defined.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Rule 15c3

-Number 240

-Section 1

-Paragraph 1

-Subparagraph i

-Article 15c3

-Subsection a

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Rule 15c3

-Number 240

-Section 1

-Paragraph 1

-Article 15c3

-Subsection c

+ Details

Name: us-gaap_AggregateIndebtedness

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition

The rate of interest that was being paid on the original debt issue that is being converted in the noncash (or part noncash) transaction. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 50

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=6367179&loc=d3e4304-108586

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 95

-Paragraph 32

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 50

-Paragraph 5

-URI http://asc.fasb.org/extlink&oid=6367179&loc=d3e4332-108586

+ Details

Name: us-gaap_DebtConversionOriginalDebtInterestRateOfDebt

Namespace Prefix: us-gaap_

Data Type: num:percentItemType

Balance Type: na

Period Type: duration

X

- Definition

Increase for accrued, but unpaid interest on the debt instrument for the period.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.4-08.(f))

-URI http://asc.fasb.org/extlink&oid=6881521&loc=d3e23780-122690

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 08

-Paragraph f

-Article 4

+ Details

Name: us-gaap_DebtInstrumentIncreaseAccruedInterest

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

Net increase or decrease in the carrying amount of the debt instrument for the period for reasons other than accrued but unpaid interest, additional borrowings, forgiveness and repayments.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.4-08.(f))

-URI http://asc.fasb.org/extlink&oid=6881521&loc=d3e23780-122690

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 08

-Paragraph f

-Article 4

+ Details

Name: us-gaap_DebtInstrumentIncreaseDecreaseOtherNet

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

The average effective interest rate during the reporting period.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 835

-SubTopic 30

-Section 45

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6451184&loc=d3e28551-108399

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 22

-Article 5

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.22(a)(1))

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_DebtInstrumentInterestRateDuringPeriod

Namespace Prefix: us-gaap_

Data Type: num:percentItemType

Balance Type: na

Period Type: duration

X

- Definition

Interest rate stated in the contractual debt agreement.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 22

-Article 5

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.22(a)(1))

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_DebtInstrumentInterestRateStatedPercentage

Namespace Prefix: us-gaap_

Data Type: num:percentItemType

Balance Type: na

Period Type: instant

X

- Definition

The increase (decrease) during the reporting period in the amount owed by the reporting entry in the form of loans and obligations (generally evidenced by promissory notes) made by the following types of related parties: a parent company and its subsidiaries; subsidiaries of a common parent; an entity and trust for the benefit of employees, such as pension and profit-sharing trusts that are managed by or under the trusteeship of the entity's management, an entity and its principal owners, management, or member of their immediate families, affiliates, or other parties with the ability to exert significant influence.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 95

-Paragraph 28

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3602-108585

+ Details

Name: us-gaap_IncreaseDecreaseInNotesPayableRelatedParties

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition

Receivables to be collected from (obligations owed to) related parties, net as of the balance sheet date where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 57

-Paragraph 2

-Subparagraph d

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.4-08.(k)(1))

-URI http://asc.fasb.org/extlink&oid=6881521&loc=d3e23780-122690

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 850

-SubTopic 10

-Section 50

-Paragraph 1

-Subparagraph (d)

-URI http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 08

-Paragraph k

-Subparagraph 1

-Article 4

+ Details

Name: us-gaap_RelatedPartyTransactionDueFromToRelatedParty

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Details

Name: us-gaap_RelatedPartyTransactionsAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 17 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; word-wrap: break-word; } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 18 R25.htm IDEA: XBRL DOCUMENT v2.4.0.6

NOTES PAYABLE (Tables)
12 Months Ended

Aug. 31, 2012

Debt Disclosure [Abstract]

Notes Payable, Current and Long Term

Current :

Bio Technology Partners Business Trust 13500

Venture Bridge Advisors, Inc. 32508

Southridge Partners II LLP 40000

Sherman Family Trust 79000

Officer Loans (Note 6) 30,180

Current portion of amounts to be paid on

behalf of Gregory McDonald and Pet Pointers, Inc. (Note 10 ) 30174

8% Convertible Notes (Note14 ) 105,500

10% Convertible Note (Note 14) 59000

Total: 389862

Long Term:

Long Term portion of amounts to be paid on

behalf of Gregory McDonald and

Pet Pointers, Inc. (Note 10 ) 36469

Total: 36469

X

- Details

Name: us-gaap_DebtDisclosureAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

Tabular disclosure of information pertaining to short-term and long-debt instruments or arrangements, including but not limited to identification of terms, features, collateral requirements and other information necessary to a fair presentation.

+ References

No definition available.

+ Details

Name: us-gaap_ScheduleOfDebtTableTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 19 R42.htm IDEA: XBRL DOCUMENT v2.4.0.6

CONVERTIBLE DEBENTURES (Details Narrative) (USD $)

Aug. 21, 2012

Jul. 26, 2012

Jun. 15, 2012

Apr. 16, 2012

Feb. 28, 2012

Dec. 20, 2011

Dec. 19, 2011

Oct. 25, 2011

Aug. 29, 2011

Jul. 05, 2011

May 20, 2011

Debt Disclosure [Abstract]

Convertible promissory note issued $ 63,000 $ 42,500 $ 37,500 $ 32,500 $ 35,000 $ 37,500 $ 42,500

Note interest rate per annum 8.00% 8.00% 8.00% 8.00% 8.00% 8.00% 8.00%

Note conversion, discount rate 39.00% 52.00% 50.00% 52.00% 52.00% 45.00% 45.00% 42.00%

Beneficial conversion feature 63,000 11,805 16,153 37,500 7,634 35,000 37,500 16,398

Principal amount due 57,647 32,500 35,000 37,500 42,500

Accrued interest on note 1,500 1,300 1,400 1,500 1,700

Shares of common stock converted from accrued interest 24,635,165 21,708,333 6,193,242 1,012,425

Amended existing debt 30,000

Simple interest rate of existing debt 10.00%

Shares of common stock converted from principal balance of convertible note 1,249,975

Amended existing principal indebtedness 59,000 102,349 85,500

Amended interest accrued but unpaid 3,710

Aggregate indebtedness 59,000 102,349 89,210

Conversion price per share percentage 60.00% 60.00% 60.00%

Limitation on conversion percentage 9.99% 9.99% 9.99%

Amendment of the note beneficial conversion feature $ 53,000 $ 102,349 $ 59,473

Common shares converted from aggregate indebtedness 36,838,692 21,307,702

X

- Definition

Total current liabilities of the broker-dealer, less certain exceptions as defined.

+ References

No definition available.

+ Details

Name: ENTB_AggregateIndebtednessPayable

Namespace Prefix: ENTB_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition

Amount of a amendment to a debt holder between the amount of debt being converted and the value of the securities received upon conversion. This is an embedded conversion feature of convertible debt issued that is in-the-money at the commitment date.

+ References

No definition available.

+ Details

Name: ENTB_AmendmentOfNoteBeneficialConversionFeature

Namespace Prefix: ENTB_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition

Amount of a favorable spread to a debt holder between the amount of debt being converted and the value of the securities received upon conversion. This is an embedded conversion feature of convertible debt issued that is in-the-money at the commitment date.

+ References

No definition available.

+ Details

Name: ENTB_BeneficialConversionFeature

Namespace Prefix: ENTB_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition

The number of shares converted in a transaction. Shares were converted from the amount of aggregate indebtedness.

+ References

No definition available.

+ Details

Name: ENTB_CommonSharesConvertedFromAggregateIndebtedness

Namespace Prefix: ENTB_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition

The price percentage per share of the conversion feature embedded in the debt instrument.

+ References

No definition available.

+ Details

Name: ENTB_ConversionPricePerSharePercentage

Namespace Prefix: ENTB_

Data Type: num:percentItemType

Balance Type: na

Period Type: instant

X

- Definition

The limitation on the price percentage per share of the conversion feature embedded in the debt instrument.

+ References

No definition available.

+ Details

Name: ENTB_LimitationOnConversionPercentage

Namespace Prefix: ENTB_

Data Type: num:percentItemType

Balance Type: na

Period Type: instant

X

- Definition

Discount rate used to find the present value of an amount to be paid or received in the future as an input to measure fair value.

+ References

No definition available.

+ Details

Name: ENTB_NoteConversionDiscountRate

Namespace Prefix: ENTB_

Data Type: num:percentItemType

Balance Type: na

Period Type: instant

X

- Definition

Amount of principal due under the debt instrument, before deducting unamortized discount or premium, if any.

+ References

No definition available.

+ Details

Name: ENTB_PrincipalAmountDue

Namespace Prefix: ENTB_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition

The number of shares converted in a transaction. Shares were converted from the principal balance of outstanding convertible note.

+ References

No definition available.

+ Details

Name: ENTB_SharesOfCommonStockConvertedFromPrincipalBalanceOfConvertibleNote

Namespace Prefix: ENTB_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition

Amount of common stock allocated to investors to buy shares of a new issue of common stock before they are offered to the public. When stock is sold on a subscription basis, the issuer does not initially receive the total proceeds. In general, the issuer does not issue the shares to the investor until it receives the entire proceeds.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.29)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 30

-Article 5

+ Details

Name: us-gaap_CommonStockSharesSubscribedButUnissued

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition

Carrying value as of the balance sheet date of the sum of short-term debt and current maturities of long-term debt and capital lease obligations, which are due within one year (or one business cycle if longer).

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.19,20)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 19

-Article 5

+ Details

Name: us-gaap_DebtCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Details

Name: us-gaap_DebtDisclosureAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

Including current and noncurrent portions, aggregate carrying amount of long-term borrowings as of the balance sheet date before deducting unamortized discount or premiums (if any). May include notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt, which had initial maturities beyond one year or beyond the normal operating cycle, if longer.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 03

-Paragraph 16

-Article 9

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name FASB Staff Position (FSP)

-Number APB14-1

-Paragraph 31

-Subparagraph b

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 20

-Article 5

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.22)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 22

-Article 5

+ Details

Name: us-gaap_DebtInstrumentCarryingAmount

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition

The stated principal amount of the debt instrument at time of issuance, which may vary from the carrying amount because of unamortized premium or discount.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 835

-SubTopic 30

-Section 45

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6451184&loc=d3e28551-108399

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 835

-SubTopic 30

-Section 55

-Paragraph 8

-URI http://asc.fasb.org/extlink&oid=6584090&loc=d3e28878-108400

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher AICPA

-Name Accounting Principles Board Opinion (APB)

-Number 21

-Paragraph 16, 20

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

+ Details

Name: us-gaap_DebtInstrumentFaceAmount

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition

Effective interest rate for the funds borrowed under the debt agreement considering interest compounding and original issue discount or premium.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 835

-SubTopic 30

-Section 45

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6451184&loc=d3e28551-108399

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 22

-Article 5

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.22(a)(1))

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_DebtInstrumentInterestRateEffectivePercentage

Namespace Prefix: us-gaap_

Data Type: num:percentItemType

Balance Type: na

Period Type: instant

X

- Definition

Carrying value as of the balance sheet date of [accrued] interest payable on all forms of debt, including trade payables, that has been incurred and is unpaid. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher AICPA

-Name Accounting Research Bulletin (ARB)

-Number 43

-Section A

-Paragraph 7

-Chapter 3

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.20)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 20

-Article 5

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section 45

-Paragraph 9

-URI http://asc.fasb.org/extlink&oid=6361293&loc=d3e7018-107765

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section 45

-Paragraph 8

-URI http://asc.fasb.org/extlink&oid=6361293&loc=d3e6935-107765

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Current Liabilities

-URI http://asc.fasb.org/extlink&oid=6509677

+ Details

Name: us-gaap_InterestPayableCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition

Carrying value as of the balance sheet date of [accrued] interest payable on all forms of debt, including trade payables, that has been incurred and is unpaid.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 03

-Paragraph 15

-Subparagraph 5

-Article 9

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 942

-SubTopic 210

-Section S99

-Paragraph 1

-Subparagraph (SX 210.9-03.15(5))

-URI http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 944

-SubTopic 210

-Section S99

-Paragraph 1

-Subparagraph (SX 210.7-03.15(a))

-URI http://asc.fasb.org/extlink&oid=6879938&loc=d3e572229-122910

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 03

-Paragraph 15

-Subparagraph a

-Article 7

+ Details

Name: us-gaap_InterestPayableCurrentAndNoncurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition

The portion of the carrying amount of short-term borrowings outstanding as of the balance sheet date which accrues interest at a set, unchanging rate.

+ References

No definition available.

+ Details

Name: us-gaap_ShortTermDebtPercentageBearingFixedInterestRate

Namespace Prefix: us-gaap_

Data Type: num:percentItemType

Balance Type: na

Period Type: instant

XML 20 R37.htm IDEA: XBRL DOCUMENT v2.4.0.6

ACQUISITION OF THE ASSETS OF PET POINTERS, INC. (Details Narrative) (USD $)
20 Months Ended

Aug. 31, 2012

Jan. 04, 2011

Business Combinations [Abstract]

Acquisition of cash $ 70,000

Acquisition of common shares 210,000

Maximum payment to creditor 78,000

Monthly installments to creditor 1,500

Maximum payment to additional creditors 25,000

Monthly installments to additional creditors 825

Monthly payment to McDonald $ 50,000

X

- Definition

Amount of the required periodic payments including both interest and principal payments to additional creditors.

+ References

No definition available.

+ Details

Name: ENTB_DebtInstrumentPeriodicPaymentAdditionalCreditors

Namespace Prefix: ENTB_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition

Amount of the required periodic payments including both interest and principal payments to McDonald on the first business day of the fourth month following the closing of the acquisition (“Closing”).

+ References

No definition available.

+ Details

Name: ENTB_DebtInstrumentPeriodicPaymentToMcDonald

Namespace Prefix: ENTB_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition

Value of equity interests (such as common shares, preferred shares, or partnership interest) issued or issuable to acquire the entity.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 141

-Paragraph 51

-Subparagraph d

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Emerging Issues Task Force (EITF)

-Number 99-12

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

+ Details

Name: us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Details

Name: us-gaap_BusinessCombinationsAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

The cash inflow associated with the acquisition of business during the period (for example, cash that was held by the acquired business).

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Investing Activities

-URI http://asc.fasb.org/extlink&oid=6516133

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 12

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3179-108585

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 95

-Paragraph 15, 16, 17

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

+ Details

Name: us-gaap_CashAcquiredFromAcquisition

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition

Amount of the required periodic payments including both interest and principal payments.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.22)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 22

-Article 5

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 942

-SubTopic 470

-Section 50

-Paragraph 3

-Subparagraph (c)

-URI http://asc.fasb.org/extlink&oid=6479336&loc=d3e64711-112823

+ Details

Name: us-gaap_DebtInstrumentPeriodicPayment

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition

The amount of debt that an Entity assumes in acquiring a business or in consideration for an asset received in a noncash (or part noncash) acquisition. Noncash is defined as transactions during a period that affect recognized assets or liabilities but that do not result in cash receipts or cash payments in the period. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 50

-Paragraph 5

-URI http://asc.fasb.org/extlink&oid=6367179&loc=d3e4332-108586

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 50

-Paragraph 4

-URI http://asc.fasb.org/extlink&oid=6367179&loc=d3e4313-108586

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 50

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=6367179&loc=d3e4304-108586

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 95

-Paragraph 32

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

+ Details

Name: us-gaap_NoncashOrPartNoncashAcquisitionDebtAssumed1

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

The amount of liabilities that an entity assumes in acquiring a business or in consideration for an asset received in a noncash (or part noncash) acquisition that are not presented as a separate disclosure or otherwise listed in the existing taxonomy. Noncash is defined as transactions during a period that affect recognized assets or liabilities but that do not result in cash receipts or cash payments in the period. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 50

-Paragraph 5

-URI http://asc.fasb.org/extlink&oid=6367179&loc=d3e4332-108586

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 50

-Paragraph 4

-URI http://asc.fasb.org/extlink&oid=6367179&loc=d3e4313-108586

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 50

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=6367179&loc=d3e4304-108586

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 95

-Paragraph 32

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

+ Details

Name: us-gaap_NoncashOrPartNoncashAcquisitionOtherLiabilitiesAssumed1

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

XML 21 R9.htm IDEA: XBRL DOCUMENT v2.4.0.6

RECENT ACCOUNTING PRONOUNCEMENTS
12 Months Ended

Aug. 31, 2012

Organization, Consolidation and Presentation of Financial Statements [Abstract]

RECENT ACCOUNTING PRONOUNCEMENTS

NOTE 3. RECENT ACCOUNTING PRONOUNCEMENTS

On May 2011, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) No. 2011-04, "Amendments to Achieve Common Fair Value Measurement and Disclosure Requirements in U.S. GAAP and IFRSs." The amendments in this update generally represent clarifications of Topic 820, but also include some instances where a particular principle or requirement for measuring fair value or disclosing information about fair value measurements has changed. This update results in common principles and requirements for measuring fair value and for disclosing information about fair value measurements in accordance with U.S. GAAP and IFRS. The amendments in this update are to be applied prospectively. The amendments are effective for interim and annual periods beginning after December 15, 2011. Early application is not permitted. The Company does not expect this guidance to have a significant impact on its consolidated financial position, results of operations or cash flows.

In June 2011, the FASB issued ASU No. 2011-05, "Presentation of Comprehensive Income." This update was amended in December 2011 by ASU No. 2011-12, "Deferral of the Effective Date for Amendments to the Presentation of Reclassifications of Items Out of Accumulated Other Comprehensive Income in Accounting Standards Update No. 2011-05." This update defers only those changes in update 2011-05 that relate to the presentation of reclassification adjustments. All other requirements in update 2011-05 are not affected by this update, including the requirement to report comprehensive income either in a single continuous financial statement or in two separate but consecutive financial statements. ASU No. 2011-05 and 2011-12 are effective for fiscal years (including interim periods) beginning after December 15, 2011. The Company does not expect this guidance to have a significant impact on its consolidated financial position, results of operations or cash flows.

In December 2011, the FASB issued ASU No. 2011-11, "Disclosures about Offsetting Assets and Liabilities." The amendments in this update require enhanced disclosures around financial instruments and derivative instruments that are either (1) offset in accordance with either ASC 210-20-45 or ASC 815-10-45 or (2) subject to an enforceable master netting arrangement or similar agreement, irrespective of whether they are offset in accordance with either ASC 210-20-45 or ASC 815-10-45. An entity should provide the disclosures required by those amendments retrospectively for all comparative periods presented. The amendments are effective during interim and annual periods beginning on or after January 1, 2013. The Company does not expect this guidance to have any impact on its consolidated financial position, results of operations or cash flows.

A variety of proposed or otherwise potential accounting standards are currently under study by standard setting organizations and various regulatory agencies. Due to the tentative and preliminary nature of those proposed standards, the Company’s management has not determined whether implementation of such standards would be material to its financial statements.

X

- Definition

Disclosure of the adoption of new accounting pronouncements that may impact the entity's financial reporting.

+ References

No definition available.

+ Details

Name: us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Details

Name: us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

EXCEL 22 Financial_Report.xls IDEA: XBRL DOCUMENT begin 644 Financial_Report.xls M[[N_34E-12U697)S:6]N.B`Q+C`-"E@M1&]C=6UE;G0M5'EP93H@5V]R:V)O M;VL-"D-O;G1E;G0M5'EP93H@;75L=&EP87)T+W)E;&%T960[(&)O=6YD87)Y M/2(M+2TM/5].97AT4&%R=%\R.&$T.3%B.5\S-V$U7S0Q9C!?839E9%\W9CDR M-S-E.&0Q,6$B#0H-"E1H:7,@9&]C=6UE;G0@:7,@82!3:6YG;&4@1FEL92!7 M96(@4&%G92P@86QS;R!K;F]W;B!A'!L;W)E&UL;G,Z=CTS1")U&UL;G,Z;STS1")U&UL/@T*(#QX.D5X8V5L5V]R:V)O;VL^#0H@(#QX M.D5X8V5L5V]R:W-H965T5]);F9O#I%>&-E;%=O#I7;W)K#I7;W)K#I7;W)K#I7;W)K#I7;W)K#I7;W)K#I7;W)K M#I7;W)K#I%>&-E M;%=O#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/E)%3$%4141?4$%25%E?5%)!3E-!0U1)3TY3/"]X.DYA;64^ M#0H@("`@/'@Z5V]R:W-H965T4V]U#I%>&-E;%=O#I%>&-E;%=O#I%>&-E;%=O#I%>&-E;%=O#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/DY/3E]63U1)3D=?0T].5D525$E"3$5?4%)%1D524CPO>#I. M86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/E-43T-+2$],1$524U]%455)5%D\+W@Z3F%M93X-"B`@ M("`\>#I7;W)K#I%>&-E;%=O#I%>&-E;%=O#I7 M;W)K#I%>&-E;%=O M#I.86UE/@T*("`@ M(#QX.E=O#I%>&-E M;%=O#I.86UE/DY/5$537U!!64%"3$5?5&%B;&5S M/"]X.DYA;64^#0H@("`@/'@Z5V]R:W-H965T4V]U#I%>&-E;%=O#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/D]21T%.25I!5$E/3E]!3D1?1$530U))4%1)3TY?3S$\+W@Z3F%M M93X-"B`@("`\>#I7;W)K#I%>&-E;%=O#I.86UE/@T*("`@(#QX.E=O#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/DY/5$537U!!64%"3$5?3F]T97-?4&%Y86)L95]# M=3PO>#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/E)%3$%4141?4$%25%E?5%)!3E-!0U1)3TY3 M7T1E=#PO>#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/DE. M0T]-15]405A%4U]);F-O;65?5&%X97-?1&5F93PO>#I.86UE/@T*("`@(#QX M.E=O#I%>&-E;%=O M#I.86UE/DE.0T]-15]405A%4U]$971A:6QS7TYA M#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE M/D%#455)4TE424].7T]&7T5.5$535%]#05]$971A:3PO>#I.86UE/@T*("`@ M(#QX.E=O#I%>&-E M;%=O#I.86UE/D%#455)4TE424].7T]&7U1(15]! M4U-%5%-?3T9?4#$\+W@Z3F%M93X-"B`@("`\>#I7;W)K#I7;W)K#I%>&-E;%=O#I. M86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/D-/3E9%4E1)0DQ%7T1%0D5.5%5215-?1&5T86EL#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/E-50E-%455%3E1?159%3E137T1E=&%I;'-?3F%R M#I.86UE/@T*("`@(#QX.E=O6QE#I!8W1I=F53:&5E=#X-"B`@/'@Z4')O=&5C=%-T#I0#I0#I0&UL/CPA6V5N9&EF72TM/@T*/"]H96%D/@T*("`\8F]D>3X- M"B`@(#QP/E1H:7,@<&%G92!S:&]U;&0@8F4@;W!E;F5D('=I=&@@36EC'1087)T7S(X830Y,6(Y7S,W835?-#%F,%]A-F5D M7S=F.3(W,V4X9#$Q80T*0V]N=&5N="U,;V-A=&EO;CH@9FEL93HO+R]#.B\R M.&$T.3%B.5\S-V$U7S0Q9C!?839E9%\W9CDR-S-E.&0Q,6$O5V]R:W-H965T M'0O:F%V87-C M3X-"B`@("`\=&%B;&4@ M8VQA2!296=I M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$"!+ M97D\+W1D/@T*("`@("`@("`\=&0@8VQA'0^075G(#,Q+`T*"0DR,#$R/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^9F%L2!A(%=E;&PM:VYO=VX@ M4V5A'0^3F\\2!A(%9O;'5N=&%R>2!&:6QE'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$2!&:6QE3PO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^4VUA;&QE3QS M<&%N/CPO'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R M/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R M(&-L87-S/3-$'0^,C`Q,3QS<&%N/CPO7!E.B!T97AT+VAT;6P[(&-H87)S970] M(G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T M<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@ M8VAA3PO=&0^#0H@("`@("`@(#QT M9"!C;&%S'!E;G-E2`F86UP.R!%<75I<&UE;G0@*$YE="!O9B!!8V-U;75L871E9"!$97!R96-I M871I;VXI/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XX+#@S,CQS M<&%N/CPO'!E;G-E'0^)FYB'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$6%B;&4\+W1D/@T*("`@("`@("`\=&0@8VQA'!E;G-E6%B;&4@+2!.;VX@0W5R'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$3PO=&0^#0H@("`@("`@(#QT9"!C;&%SF5D M+"`S+#(P,2PS.3<@86YD(#`@3PO=&0^#0H@ M("`@("`@(#QT9"!C;&%S3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\R.&$T M.3%B.5\S-V$U7S0Q9C!?839E9%\W9CDR-S-E.&0Q,6$-"D-O;G1E;G0M3&]C M871I;VXZ(&9I;&4Z+R\O0SHO,CAA-#DQ8CE?,S=A-5\T,68P7V$V961?-V8Y M,C'0O:'1M;#L@8VAA'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$ M'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%SF5D M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XR,#`L,#`P/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'1087)T7S(X830Y,6(Y7S,W835?-#%F,%]A-F5D7S=F.3(W,V4X9#$Q M80T*0V]N=&5N="U,;V-A=&EO;CH@9FEL93HO+R]#.B\R.&$T.3%B.5\S-V$U M7S0Q9C!?839E9%\W9CDR-S-E.&0Q,6$O5V]R:W-H965T'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA2!397)V:6-E'0^)FYB'!E;G-E'!E;G-E'0^)FYB'!E;G-E M'!E M;G-E7!E.B!T M97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE M860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT M96YT/3-$)W1E>'0O:'1M;#L@8VAA'0^)FYB'0^)FYB'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^)FYB'0^ M)FYB'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%SF5D M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XF;F)S<#LF;F)S<#L\ M'0^)FYB'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^)FYB'0^)FYB'0^)FYB M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^)FYB'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@ M/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\ M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'!E;G-E(%)E8V]G;FEZ960\ M+W1D/@T*("`@("`@("`\=&0@8VQAF5D/"]T9#X- M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S65E+"!3:&%R97,\+W1D M/@T*("`@("`@("`\=&0@8VQA'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$ M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S7!E.B!T97AT+VAT;6P[(&-H87)S970] M(G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T M<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@ M8VAA2!O<&5R871I;F<@86-T:79I=&EE'!E;G-E/"]T9#X-"B`@("`@ M("`@/'1D(&-L87-S/3-$;G5M<#XW-S8\'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S6%B;&4\+W1D/@T*("`@("`@("`\=&0@8VQA'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S M/3-$'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S6UE;G0@ M;V8@1&5B=#PO=&0^#0H@("`@("`@(#QT9"!C;&%S'1087)T7S(X830Y,6(Y7S,W835?-#%F,%]A-F5D7S=F.3(W,V4X9#$Q M80T*0V]N=&5N="U,;V-A=&EO;CH@9FEL93HO+R]#.B\R.&$T.3%B.5\S-V$U M7S0Q9C!?839E9%\W9CDR-S-E.&0Q,6$O5V]R:W-H965T'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA'0^/'`@2`Q,"P@ M,C`P.2P@=&AE($-O;7!A;GDF(S$T-CMS('!R:6YC:7!A;"!B=7-I;F5S'0M86QI9VXZ(&IU0T*,3`L(#(P,#D@=&AE($-O;7!A;GD@86)A;F1O;F5D(&ET6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W M(%)O;6%N+"!4:6UE2<^)B,Q-C`[/"]P/@T*#0H\<"!S='EL93TS1"=F;VYT.B`Q,'!T M(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E'0M86QI9VXZ(&IU6QE/3-$)V)A8VMG28C,30V.W,-"F-U'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@ M("`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`@("`\=&0@ M;F]W6QE/3-$)W!A9&1I;F6QE/3-$)W!A9&1I;F6QE/3-$)W=I9'1H.B`T,R4[('!A9&1I;F6QE/3-$)W=I9'1H M.B`Q)3L@<&%D9&EN9RUR:6=H=#H@-2XT<'0[('!A9&1I;F6QE/3-$)W=I9'1H.B`Q,24[('!A9&1I;F6QE M/3-$)W=I9'1H.B`Q,24[('!A9&1I;F6QE/3-$)W!A9&1I M;F6QE/3-$)W!A9&1I;F6QE/3-$)W!A9&1I;FF4Z(#$P<'0[('1E>'0M86QI9VXZ M(')I9VAT)SXS,#PO=&0^#0H@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!S='EL M93TS1"=P861D:6YG+7)I9VAT.B`U+C1P=#L@<&%D9&EN9RUL969T.B`U+C1P M="<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@;F]W6QE M/3-$)W!A9&1I;F6QE/3-$)W9E6QE/3-$)W!A9&1I;FF4Z(#$P M<'0G/DUE9&EC86P@17%U:7!M96YT/"]T9#X-"B`@("`\=&0@;F]W6QE/3-$)W!A9&1I;F6QE/3-$)W!A M9&1I;FF4Z(#$P<'0[('1E>'0M86QI9VXZ(')I9VAT)SXQ-RPU,C,F(S$V,#L\ M+W1D/CPO='(^#0H\='(@6QE/3-$)W!A9&1I;FF4Z(#$P<'0[('1E>'0M86QI9VXZ(')I9VAT M)SXS,#PO=&0^#0H@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!S='EL93TS1"=P M861D:6YG+7)I9VAT.B`U+C1P=#L@<&%D9&EN9RUL969T.B`U+C1P="<^)B,Q M-C`[/"]T9#X-"B`@("`\=&0@;F]W6QE/3-$)W!A M9&1I;F6QE/3-$)W9E6QE/3-$)W!A9&1I;FF4Z(#$P<'0G/E-U8G1O=&%L/"]T9#X- M"B`@("`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`D,SDL,30P(&1U92!F28C M,30V.W,@9FEN86YC:6%L(&EN6EN9PT*86UO=6YT("8C,38P.V]F('1H92!F:6YA M;F-I86P@:6YS=')U;65N=',@:7,@97%U86P@=&\@=&AE(&9A:7(@=F%L=64@ M87,@9&5T97)M:6YE9"!B>2!T:&4@0V]M<&%N>2X\+V9O;G0^/"]P/@T*#0H\ M<"!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L M(%-E6QE/3-$)V)A8VMG'0M86QI9VXZ(&IU28C,30V.W,@9FEN86YC:6%L(&EN2!T:&4@0V]M<&%N>2!U=&EL M:7II;F<@:71S(&]W;B!A6QE/3-$ M)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE2<^/&9O;G0@'0M86QI9VXZ(&IU M2!M971H;V0@<')E2!!4T,@-S0P+"`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`@("`\=&%B;&4@8VQAF%T:6]N+"!#;VYS;VQI9&%T M:6]N(&%N9"!0'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@ M/'1R(&-L87-S/3-$'0^/'`@6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N M+"!4:6UE2<^3VX@36%Y(#(P,3$L('1H92!&:6YA;F-I86P@06-C;W5N=&EN9R!3=&%N M9&%R9',-"D)O87)D("A&05-"*2!I6QE/3-$)V9O M;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE2<^)B,Q-C`[/"]P/@T*#0H\<"!S M='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E M'0M86QI9VXZ(&IU2!T:&]S92!C:&%N9V5S(&EN('5P9&%T92`R,#$Q+3`U('1H M870@2!T:&ES('5P9&%T M92P@:6YC;'5D:6YG('1H92!R97%U:7)E;65N=`T*=&\@65A M6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE2<^)B,Q-C`[ M/"]P/@T*#0H\<"!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA M;BP@5&EM97,L(%-E'0M86QI9VXZ(&IU2!T:&]S92!A;65N9&UE;G1S(')E=')O0T*9F]R(&%L;"!C;VUP87)A=&EV92!P97)I;V1S('!R97-E;G1E9"X@5&AE M(&%M96YD;65N=',@87)E(&5F9F5C=&EV92!D=7)I;F<@:6YT97)I;2!A;F0@ M86YN=6%L('!E6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O M;6%N+"!4:6UE2<^02!V87)I971Y(&]F('!R;W!O7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S M+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE M<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA M'0^/'`@'0M86QI9VXZ(&IU6EN M9PT*9FEN86YC:6%L('-T871E;65N=',@:&%V92!B965N('!R97!A2!T;R!C;VYT:6YU92!A'!E;G-E2!H87,@86QS;R!R86ES M960@)#(V,2PT-S4@9G)O;0T*;W1H97(@8F]R6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE2<^3VX@2G5N92`Q M+"`R,#$R('1H92!#;VUP86YY(&5N=&5R960@:6YT;R!A;@T*17%U:71Y(%!U M6QE/3-$)V9O;G0Z M(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE2<^56YD97(@=&AE('1E2!A M="!A;GD@=&EM92!D96QI=F5R(&$@)B,S-#MP=70@;F]T:6-E)B,S-#L@=&\@ M4V]U=&AR:61G92!T:&5R96)Y(')E<75I6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W M(%)O;6%N+"!4:6UE2<^)B,Q-C`[/"]P/@T*#0H\<"!S='EL93TS1"=F;VYT.B`Q,'!T M(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E'0M86QI9VXZ(&IU2!3;W5T:')I9&=E+"!W;W5L9"!R M97-U;'0@:6X@4V]U=&AR:61G92!O=VYI;F<@;6]R92!T:&%N(#DN.3DE(&]F M(&%L;"!O9B!T:&4@0V]M<&%N>2=S(&-O;6UO;B!S=&]C:R!T:&5N(&]U='-T M86YD:6YG+B!!9&1I=&EO;F%L;'DL#0I3;W5T:')I9&=E(&UA>2!N;W0@97AE M8W5T92!A;GD@'0M86QI9VXZ M(&IU2!3;W5T:')I9&=E(&]F#0IT:&]S92!3:&%R97,N/"]P/@T*#0H\<"!S M='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E M'0M86QI9VXZ(&IU&5C=71E9"!A M;F0@9&5L:79E6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@ M3F5W(%)O;6%N+"!4:6UE2<^5&AE($-O;7!A;GD@:&%S(&%L2!T:&4@9F]L;&]W:6YG#0IT;R!#87!I=&%L(%!A=&@@4V5C=7)I=&EE28C,30V.W,@97AC;'5S:79E M(&%D=FES;W(@86YD('!L86-E;65N="!A9V5N="!I;B!C;VYN96-T:6]N('=I M=&@@=&AE($IU;F4-"E!U2!T:&4@ M0V]M<&%N>2!T:')O=6=H('1H92!S86QE(&]F(%-H87)E2!T:&4@0V]M<&%N M>2X\+W`^#0H-"CQP('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O M;6%N+"!4:6UE2<^)B,Q-C`[/"]P/@T*#0H\<"!S='EL93TS1"=F;VYT.B`Q,'!T(%1I M;65S($YE=R!2;VUA;BP@5&EM97,L(%-E'0M M86QI9VXZ(&IU&-H86YG92!#;VUM:7-S M:6]N(')E9VES=&5R:6YG(#0V+#(S."PW,#4@2!T:&4@ M56YI=&5D#0I3=&%T97,@4V5C=7)I=&EE'0M86QI9VXZ(&IU6QE/3-$)VUA3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\R.&$T M.3%B.5\S-V$U7S0Q9C!?839E9%\W9CDR-S-E.&0Q,6$-"D-O;G1E;G0M3&]C M871I;VXZ(&9I;&4Z+R\O0SHO,CAA-#DQ8CE?,S=A-5\T,68P7V$V961?-V8Y M,C'0O:'1M;#L@8VAA'0^/'`@6QE/3-$ M)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)V9O;G0Z(#$P M<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)V9O;G0Z(#$P<'0@ M5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)W=I9'1H.B`W.24[('!A9&1I;F6QE/3-$)V9O;G0Z(#$P M<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)W9E6QE/3-$)W!A M9&1I;F6QE/3-$)W!A9&1I;F'0M86QI9VXZ(')I M9VAT)SXT,#`P,#PO=&0^/"]T'0M M86QI9VXZ(')I9VAT)SXW.3`P,#PO=&0^/"]T6QE/3-$)W!A9&1I M;F6QE/3-$)W!A9&1I;F6QE/3-$)W9E6QE/3-$)W9E6QE/3-$)W!A9&1I;F6QE/3-$)W!A9&1I;F6QE/3-$)W!A9&1I;FF4Z(#$R<'0G/B8C,38P.SPO=&0^#0H@("`@/'1D M(&YO=W)A<#TS1&YO=W)A<"!S='EL93TS1"=P861D:6YG+7)I9VAT.B`U+C1P M=#L@<&%D9&EN9RUL969T.B`U+C1P=#L@9F]N="US:7IE.B`Q,G!T)SXF(S$V M,#L\+W1D/CPO='(^#0H\='(@6QE/3-$)W9E'0M86QI9VXZ(')I9VAT)SXS-C0V.3PO=&0^/"]T6QE M/3-$)W!A9&1I;F6QE M/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE2<^/&9O;G0@2!B92!A9&IU6UE;G1S(&UA9&4@:&5R975N9&5R+B!06UE;G1S(&UA9&4@:&5R975N9&5R M+@T*4')I;F-I<&%L(&)A;&%N8V4@86YD(&%C8W)U960@:6YT97)E7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA6QE/3-$)V)A8VMG2!T;W1A;&EN9R`D."PT,#`N(%1H M97-E(&QO86YS(&%R92!D=64@86YD('!A>6%B;&4@870@=&AE(&1E;6%N9"!O M9B!$879I9"8C,38P.R!+;V]S(&%N9"!B96%R#0IS:6UP;&4@:6YT97)E'0M86QI9VXZ(&IU2!T;W1A;&EN9R`D-RPU M-3`N(%1H97-E(&QO86YS(&%R92!D=64@86YD('!A>6%B;&4@870@=&AE(&1E M;6%N9"!O9B!$879I9"8C,38P.R!+;V]S(&%N9"!B96%R#0IS:6UP;&4@:6YT M97)E'0M86QI9VXZ(&IU2!T:&4@ M0V]M<&%N>2`H8F5A2!T:&4@0V]M<&%N>2X\+W`^#0H-"CQP('-T M>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE2<^)B,Q-C`[/"]P M/@T*#0H\<"!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@ M5&EM97,L(%-E'0M86QI9VXZ(&IU2!I;B!T:&4@86UO=6YT M(&]F)B,Q-C`[("0Q,RPV,C4N(%1H97-E(&QO86YS(&%R92!D=64@86YD('!A M>6%B;&4@870@=&AE(&1E;6%N9"!O9B!$879I9"8C,38P.R!+;V]S#0IA;F0@ M8F5A6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O M;6%N+"!4:6UE2<^)B,Q-C`[/"]P/@T*#0H\<"!S='EL93TS1"=F;VYT.B`Q,'!T(%1I M;65S($YE=R!2;VUA;BP@5&EM97,L(%-E'0M M86QI9VXZ(&IU6QE/3-$)V)A8VMG6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O M;6%N+"!4:6UE2<^)B,Q-C`[/"]P/@T*#0H\<"!S='EL93TS1"=F;VYT.B`Q,'!T(%1I M;65S($YE=R!2;VUA;BP@5&EM97,L(%-E'0M M86QI9VXZ(&IU2!I;B!T:&4@86UO=6YT(&]F("0S.2PQ M-#`N(%1H:7,-"F%M;W5N="!I'0O M:F%V87-C3X-"B`@("`\ M=&%B;&4@8VQA'0^/'`@F4Z(#%P="<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$ M)W9E'0M86QI9VXZ(')I9VAT)SXF(S$V,#L\+W1D/@T*("`@ M(#QT9"!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!B;&%C:R`R+C(U<'0@"!C87)R>2!F;W)W87)D6QE/3-$)W9E6QE/3-$)V)O6QE/3-$)V)O6QE/3-$)V)O6QE/3-$)V)O6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT)SXF M(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/CPO='(^#0H\='(@6QE/3-$)W9E6QE/3-$)W9E&EM871E;'D@)#,L-C6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N M+"!4:6UE2<^)B,Q-C`[/"]P/@T*#0H\<"!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S M($YE=R!2;VUA;BP@5&EM97,L(%-E'0M86QI9VXZ(&IU2!F;W)W87)D6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@ M3F5W(%)O;6%N+"!4:6UE2<^)B,Q-C`[/"]P/@T*#0H\<"!S='EL93TS1"=F;VYT.B`Q M,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E'0M86QI9VXZ(&IU6QE/3-$)V)A8VMG2UT:&%N+6YO="8C,30X.R!T M:&%T(&$@9&5F97)R960@=&%X(&%SF5D M+B!);B!A9&1I=&EO;BP@=&AE(')E=F5R6QE/3-$)VUA M3X-"CPO:'1M;#X-"@T*+2TM+2TM M/5].97AT4&%R=%\R.&$T.3%B.5\S-V$U7S0Q9C!?839E9%\W9CDR-S-E.&0Q M,6$-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO,CAA-#DQ8CE?,S=A M-5\T,68P7V$V961?-V8Y,C'0O:'1M;#L@8VAA7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@ M/'1R(&-L87-S/3-$6QE/3-$)VUA6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N M+"!4:6UE0T*,3`L(#(P,#D@=&AE($-O;7!A M;GD@86-Q=6ER960@,3`P)2!O9B!%;G1E2!I2!-6QE/3-$)VUA3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\R M.&$T.3%B.5\S-V$U7S0Q9C!?839E9%\W9CDR-S-E.&0Q,6$-"D-O;G1E;G0M M3&]C871I;VXZ(&9I;&4Z+R\O0SHO,CAA-#DQ8CE?,S=A-5\T,68P7V$V961? M-V8Y,C'0O:'1M;#L@8VAA6QE/3-$)V)A8VMG0T*-"P@ M,C`Q,45N=&5S="!#02!A8W%U:7)E9"!F2!-8T1O;F%L9"!$5DT@*"8C,30W.TUC1&]N M86QD)B,Q-#@[*2!A;&P@=&AE(&=O;V1W:6QL(&9R;VT@36-$;VYA;&0@86YD M(&%S2!M961I8V%L(&-L:6YI8R!L;V-A=&5D(&%T M(#(R-2!3+B!-:6QP87,@4W1R965T+"!386YT82!"87)B87)A+`T*0T$@.3,Q M,#,@*'1H92`F(S,T.T)U6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE2<^)B,Q-C`[ M/"]P/@T*#0H\<"!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA M;BP@5&EM97,L(%-E'0M86QI9VXZ(&IU6QE/3-$)V)A8VMG'0M86QI M9VXZ(&IU6QE/3-$ M)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE2<^)B,Q-C`[ M/"]P/@T*#0H\<"!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA M;BP@5&EM97,L(%-E'0M86QI M9VXZ(&IU6QE/3-$)V)A8VMG6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE2<^ M/&9O;G0@6UE;G0@;V8@;F\@;6]R92!T:&%N("0W M."PP,#`@=&\@82!C2!I;G-T86QL;65N=',@;V8@)#$L-3`P('!E6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W M(%)O;6%N+"!4:6UE'0M86QI9VXZ(&IU6QE/3-$)V)A8VMG6UE;G0@;V8@;F\@;6]R92!T:&%N("0R-2PP,#`@=&\@ M861D:71I;VYA;"!C6QE/3-$)V9O M;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE2<^/&9O;G0@2!O9B!T:&4@9F]U6QE/3-$)VUA M3X-"CPO:'1M;#X-"@T*+2TM+2TM M/5].97AT4&%R=%\R.&$T.3%B.5\S-V$U7S0Q9C!?839E9%\W9CDR-S-E.&0Q M,6$-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO,CAA-#DQ8CE?,S=A M-5\T,68P7V$V961?-V8Y,C'0O:'1M;#L@8VAA7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R6QE/3-$)VUA6QE/3-$ M)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE2<^/&(^3D]412`Q,"X@0T]- M34E4345.5%,@04Y$($-/3E1)3D=%0TE%4SPO8CX\+W`^#0H-"CQP('-T>6QE M/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE2<^/&(^)B,Q-C`[/"]B M/CPO<#X-"@T*/'`@2`R+#,R,"!S M<75A6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N M+"!4:6UE2<^)B,Q-C`[/"]P/@T*#0H\<"!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S M($YE=R!2;VUA;BP@5&EM97,L(%-E'0M86QI M9VXZ(&IU6QE/3-$)V)A8VMG6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4 M:6UE2<^ M)B,Q-C`[/"]P/@T*#0H\<"!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE M=R!2;VUA;BP@5&EM97,L(%-E'0M86QI9VXZ M(&IU6QE/3-$)V)A8VMG6QE/3-$)V9O;G0Z(#$P<'0@ M5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)V)A8VMG6QE M/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE'0M86QI9VXZ(&IU6QE/3-$)V)A8VMG2!I2!I2!W:6QL(')E<75I2!B96QI979E M'0M86QI9VXZ(&IU0T*-"P@,C`Q,2P@87,@<&%R="!O9B!T:&4@87-S970@<'5R M8VAA2!B M=70L(&%R92!P87EM96YT2!A9W)E960@=&\-"FUA:V4@ M;VX@8F5H86QF(&]F($=R96=O6QE/3-$)V9O;G0Z(#$P<'0@ M5&EM97,@3F5W(%)O;6%N+"!4:6UE2!P87EM96YT M2!A;F0@2G5D:2!-87)I;F5L;&D@=&]W M87)D'0M86QI9VXZ(&IU0T*-"P@,C`Q,2P@87,@<&%R="!O9B!T:&4@87-S970@<'5R8VAA7,@;VX@8F5H86QF(&]F($=R96=O6UE;G1S(&]F("0T,#`N(%1H97-E('!A>6UE;G1S M(&%R92!P87EM96YT2!A9W)E960@=&\@;6%K92!O;B!B M96AA;&8@;V8@1W)E9V]R>2!-8T1O;F%L9"!A;F0@4&5T(%!O:6YT97)S+CPO M9F]N=#X\+W`^#0H-"CQP('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W M(%)O;6%N+"!4:6UE6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4 M:6UE2<^ M/&9O;G0@6UE;G1S(&]F("0T,C4N(%1H97-E M('!A>6UE;G1S(&%R92!P87EM96YT2!A9W)E960@=&\@ M;6%K92!O;B!B96AA;&8@;V8@1W)E9V]R>2!-8T1O;F%L9`T*86YD(%!E="!0 M;VEN=&5R'0M86QI9VXZ(&IU6QE/3-$)V)A8VMG'0M86QI9VXZ(&IU6QE/3-$ M)V)A8VMG0T*,RP@,C`Q M,2P@82!#;VUP;&%I;G0@*"8C,30W.T-O;7!L86EN="8C,30X.RD@=V%S(&9I M;&5D(&EN('1H92!5+E,N($1I28C,30V.W,@0VAA:7)M86X@86YD($)-4TXN M(&)Y(#$X2U0N5%8@3$Q#("@F(S$T-SM0;&%I;G1I9F9S)B,Q-#@[*2!S965K M:6YG('1O(')E8V]V97(@9V5N97)A;`T*9&%M86=E&-E6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE M2<^)B,Q M-C`[/"]P/@T*#0H\<"!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2 M;VUA;BP@5&EM97,L(%-E'0M86QI9VXZ(&IU M2`R-"P@,C`Q,BP@82!#;VUP;&%I;G0@*"8C,30W.T-O M;7!L86EN="8C,30X.RD-"G=A2!C97)T86EN(&5X<&5N2!A=V%R9"!A9V%I;G-T('1H92!#;VUP86YY(&EN(&%N#0IA;6]U;G0@=&\@ M8F4@<')O=F5N(&%T('1R:6%L('=H:6-H(%164R!E'!E;G-E'!E;G-E2!D969E;F0@:71S(&EN=&5R97-T2!M87D@ M:&%V92!A#0IM871E2X@3VX@4V5P=&5M8F5R(#$Y+"`R,#$R('1H92!0;&%I;G1I9F8F(S$T-CMS M($-L86EM(&9O2!#;W5R="!F;W(@=&AE($1I6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE'0M86QI9VXZ(&IU28C M,30V.W,@9F5E6QE/3-$)V9O;G0Z(#$P<'0@5&EM M97,@3F5W(%)O;6%N+"!4:6UE2<^)B,Q-C`[/"]P/@T*#0H\<"!S='EL93TS1"=F;VYT M.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E'0M86QI9VXZ(&IU6QE/3-$)V)A8VMG M6QE/3-$)V9O;G0Z M(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE2<^3VX@2G5N92`Q+"`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`Q,'!T(%1I;65S($YE=R!2;VUA M;BP@5&EM97,L(%-E'0M86QI9VXZ(&IU&5C=71E9"!A;F0@9&5L:79E6QE/3-$)V9O;G0Z M(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE2<^5&AE($-O;7!A;GD@:&%S(&%L2!T:&4@9F]L;&]W:6YG#0IT;R!#87!I=&%L(%!A=&@@ M4V5C=7)I=&EE28C,30V M.W,@97AC;'5S:79E(&%D=FES;W(@86YD('!L86-E;65N="!A9V5N="!I;B!C M;VYN96-T:6]N('=I=&@@=&AE($IU;F4-"E!U2!T:&4@0V]M<&%N>2!T:')O=6=H('1H92!S86QE(&]F(%-H87)E M2!T:&4@0V]M<&%N>2X\+W`^#0H-"@T*#0H\<"!S='EL93TS1"=M87)G:6XZ M(#!P="<^/"]P/CQS<&%N/CPO7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T* M#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O M;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L M87-S/3-$'0^/'`@6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N M+"!4:6UE'0M86QI9VXZ(&IU6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE M2<^3F]N M(%9O=&EN9R!#;VYV97)T:6)L92!028C,30V.W,@8V]M;6]N('-T;V-K(&%T(&$@8V]N M=F5R2!P6QE/3-$)V9O;G0Z(#$P M<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE2<^)B,Q-C`[/"]P/@T*#0H\<"!S='EL93TS M1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E'0M86QI9VXZ(&IU2!A2!";&]O;6)E'0M86QI9VXZ(&IU6QE/3-$)V9O;G0Z M(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE2<^)B,Q-C`[/"]P/@T*#0H\<"!S='EL M93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E'0M86QI9VXZ(&IU6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@ M3F5W(%)O;6%N+"!4:6UE2<^5&AE(&ES'0O:F%V M87-C3X-"B`@("`\=&%B M;&4@8VQA'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$2`R,2P@,C`Q,BX\ M+V9O;G0^/"]P/@T*#0H-"@T*/'`@'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\ M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$6QE/3-$)V)A8VMG'0M86QI9VXZ(&IU6QE/3-$)V)A8VMG6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W M(%)O;6%N+"!4:6UE2<^/&9O;G0@6QE/3-$)V9O;G0Z(#$P M<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE2<^/&9O;G0@6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE2<^/&9O;G0@ M6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O M;6%N+"!4:6UE2<^/&9O;G0@F5D(&]F(#$P,"PP M,#`@2`R.2P@,C`Q,B`F(S$V,#MA;F0@-"PT M,#`L,#`P(&ES(&%U=&AO6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W M(%)O;6%N+"!4:6UE2<^/&9O;G0@6QE/3-$)V9O;G0Z(#$P M<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE2<^/&9O;G0@2!L:7%U:61A=&EO;BP@9&ES2!D:7-T2!O9B!T:&4@:&]L M9&5R2P@=VAE=&AE'0M86QI9VXZ(&IU6QE/3-$ M)V)A8VMG'0M86QI9VXZ(&IU6QE/3-$)V)A8VMG2!T86ME;B!A="!I=',@9F%IF5D(&]F('=H:6-H(#'0M86QI9VXZ(&IU6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4 M:6UE2<^ M)B,Q-C`[/"]P/@T*#0H\<"!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE M=R!2;VUA;BP@5&EM97,L(%-E'0M86QI9VXZ M(&IU6QE/3-$)V9O;G0Z(#$P M<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE2<^)B,Q-#<[4%))3D-)4$%,($U!4DM%5"8C M,S0[('-H86QL(&UE86X@=&AE#0IP&-H86YG M92!O6QE/3-$)V9O;G0Z(#$P M<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE2<^)B,Q-#<[5%)!1$E.1R!$05DF(S$T.#L@ M0T*;VX@=VAI8V@@=&AE(%!R:6YC:7!A;"!-87)K M970@'0O:F%V87-C M3X-"B`@("`\=&%B;&4@ M8VQA'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@ M("`@/'1R(&-L87-S/3-$'0M86QI9VXZ(&IU'0M86QI9VXZ(&IU6QE/3-$)V)A8VMG M2!I7,@<')I;W(@=&\@=&AE(&-O;G9EF5D('5N9&5R('1H92!);G1E6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4 M:6UE2<^ M/&9O;G0@6QE/3-$)V9O M;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE2<^)B,Q-C`[/"]P/@T*#0H\<"!S M='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E M'0M86QI9VXZ(&IU6QE/3-$)V)A8VMG2!I2!T:6UE(&%F M=&5R(#$X,"!D87ES(&9R;VT@=&AE(&5X96-U=&EO;@T*;V8@=&AE(%1H:7)D M($YO=&4L('1H92!4:&ER9"!.;W1E(&ES(&-O;G9E0T*<&5R:6]D('!R:6]R('1O(&-O;G9EF5D#0IU;F1E6QE/3-$)V9O;G0Z(#$P<'0@ M5&EM97,@3F5W(%)O;6%N+"!4:6UE'0M86QI9VXZ(&IU6QE/3-$)V9O M;G0M28C,30V.W,@8V]M;6]N('-T;V-K+B!4:&4@;F]T92!M87D@8F4@ M8V]N=F5R=&5D(&%T(&$@9FEF='D@='=O('!E2!I2!A('!A>6UE;G0@;V8@)#4W+#8T-RX@/"]F;VYT/CPO<#X- M"@T*/'`@6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W M(%)O;6%N+"!4:6UE6%B;&4@1&5C96UB97(@,S$L(#(P,3(\+V9O;G0^/"]P/@T* M#0H\<"!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM M97,L(%-E'0M86QI9VXZ(&IU M6QE/3-$)V)A8VMG2!P97)I;V0@96YD:6YG(&]N92!4 M2!P2!A(')E M;&EA8FQE(')E<&]R=&EN9R!S97)V:6-E+CPO9F]N=#X\+W`^#0H-"CQP('-T M>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE'0M86QI9VXZ(&IU6QE/3-$)V)A8VMG M2!&96)R M=6%R>2`R.2P@,C`Q,BX@5&AE(&5N=&ER92!P2!P2`R.2P@,C`Q,BX\+V9O;G0^/"]P/@T* M#0H\<"!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM M97,L(%-E'0M86QI9VXZ(&IU'0M86QI9VXZ M(&IU6%B M;&4@=7!O;B!D96UA;F0@;V8@=&AE(&AO;&1E28C,30V.W,@8V]M;6]N('-T M;V-K(&1U7,@:6UM961I871E;'D@<')E M8V5D:6YG(&$@8V]N=F5R2!";&]O M;6)E2!H87,@86=R965D(&]N(&$@;&EM:71A=&EO M;B!O;B!C;VYV97)S:6]N(&5Q=6%L('1O(#DN.3DE#0IO9B!T:&4@0V]M<&%N M>28C,30V.W,@;W5T2!&96)R=6%R>2`R.2P@,C`Q,BX@5&AI'0M86QI9VXZ(&IU2!N;W1E(&EN('1H92!A;6]U M;G0@;V8@)#0R+#4P,"!W:&EC:"!W87,@7,@<')I;W(@=&\@=&AE(&-O;G9EF5D('5N M9&5R('1H92!);G1E6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N M+"!4:6UE2<^/&9O;G0@6QE/3-$)V9O;G0Z(#$P<'0@5&EM M97,@3F5W(%)O;6%N+"!4:6UE2<^/&9O;G0@2!T:&4@2&]L9&5R2!I2!T:6UE(&1U6QE/3-$)V)A8VMGF5D('5N9&5R('1H92!);G1E6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N M+"!4:6UE2<^3VX@075G=7-T(#(Q+"`R,#$R('1H92`\9F]N="!S='EL93TS1"=B86-K M9W)O=6YD+6-O;&]R.B!W:&ET92<^0V]M<&%N>0T*86UE;F1E9"!T:&4@=&5R M;7,@;V8@)#4Y+#`P,"!I;B!E>&ES=&EN9R!P7,@:6UM961I871E;'D@<')E8V5D:6YG(&$@8V]N=F5R2!E>&5C=71E('1R861E2!S:&%L;"!I28C,30V.W,@;W5TF5D("X@/"]F;VYT/CPO<#X-"@T* M#0H-"CQP('-T>6QE/3-$)VUA3X- M"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\R.&$T.3%B.5\S-V$U7S0Q M9C!?839E9%\W9CDR-S-E.&0Q,6$-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z M+R\O0SHO,CAA-#DQ8CE?,S=A-5\T,68P7V$V961?-V8Y,C'0O:'1M M;#L@8VAA'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R M(&-L87-S/3-$6QE/3-$)VUA6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4 M:6UE2<^ M1'5R:6YG('1H92!T=V5L=F4@;6]N=&AS(&5N9&5D($%U9W5S="`S,2P@,C`Q M,@T*=&AE($-O;7!A;GD@:7-S=65D(#$Q,RPV.34L-S`P($-O;6UO;B!3:&%R M97,@:6X@'0M86QI9VXZ(&IU2!I M6QE/3-$ M)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE2<^)B,Q-C`[/"]P/@T*#0H\ M<"!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L M(%-E'0M86QI9VXZ(&IU6QE/3-$)V9O;G0Z(#$P M<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE2<^1'5R:6YG('1H92!T=V5L=F4@;6]N=&AS M(&5N9&5D($%U9W5S="`S,2P@,C`Q,@T*=&AE($-O;7!A;GD@:7-S=65D(#8L M,C6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE M2<^)B,Q M-C`[/"]P/@T*#0H\<"!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2 M;VUA;BP@5&EM97,L(%-E'0M86QI9VXZ(&IU M'0M86QI9VXZ(&IU65E(&]F('1H92!# M;VUP86YY(&-O;G-E;G1E9"!T;R!T:&4@8V%N8V5L;&%T:6]N(&]F(#$U+#`P M,"!C;VUM;VX@'0M M86QI9VXZ(&IU2!T:&4@0V]M<&%N M>2X@3V8@=&AA="!A;6]U;G0@-#`L,#`P('=E'0M86QI9VXZ(&IU6QE/3-$)V)A8VMG'0M M86QI9VXZ(&IU6QE/3-$)V)A8VMG2`S,2P@ M,C`Q,B!A(&1I=FED96YD(&]F(#,L(#(P,2PS.3<@28C M,30V.W,@8V]M;6]N#0IS:&%R96AO;&1E6QE/3-$)V9O M;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE2<^)B,Q-C`[/"]P/@T*#0H\<"!S M='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E M2!I&5C=71I=F4@3V9F:6-E2!N;W0@;V9F97(@=&\@2!O6QE M/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE'0M86QI9VXZ(&IU2!E;7!L;WEE M92!V;VQU;G1A0T*8V5A65D(&%T('1H92!# M;VUP86YY(&]R(&ES('1E6QE/3-$ M)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE'0M86QI9VXZ(&IU3L@;6%R9VEN+7)I9VAT.B`P.R!M87)G M:6XM8F]T=&]M.B`P.R!M87)G:6XM;&5F=#H@,"<^3VX-"D%P2!N;W0@;V9F97(@=&\@2!T:&4@3L@;6%R9VEN+7)I9VAT.B`P.R!M87)G:6XM8F]T=&]M.B`P M.R!M87)G:6XM;&5F=#H@,"<^)B,Q-C`[/"]P/@T*#0H\<"!S='EL93TS1"=F M;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E'0M86QI9VXZ(&IU65E(&]F('1H92!#;VUP86YY#0IC;VYS96YT960@=&\@=&AE M(&-A;F-E;&%T:6]N(&]F(#$U+#`P,"PP,#`@8V]M;6]N('-H87)E7!E.B!T97AT+VAT M;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@ M("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$ M)W1E>'0O:'1M;#L@8VAA'0M M86QI9VXZ(&IU6QE/3-$)V9O;G0Z(#$P<'0@ M5&EM97,@3F5W(%)O;6%N+"!4:6UE'0M86QI9VXZ(&IU'0M86QI9VXZ(&IU2!N:6YE('!E'0M86QI9VXZ(&IUF5D('1O('!A>2`D,30L,S`P(&]F(&1E8G0@ M9'5E('1O(%-O=71H'0M86QI9VXZ(&IU6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N M+"!4:6UE'0M86QI9VXZ(&IU6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N M+"!4:6UE2<^3VX@3V-T;V)E2!I6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N M+"!4:6UE2<^)B,Q-C`[/"]P/@T*#0H\<"!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S M($YE=R!2;VUA;BP@5&EM97,L(%-E2!-8T1O;F%L9"`H)B,S-#M-8T1O;F%L9"8C,S0[ M*2P-"E!E="!0;VEN=&5RF5D(&)Y('1H92!#;VUP86YY(&EN('1H92!O<&5R871I;VX@;V8@=&AE M($UC1&]N86QD($%N:6UA;"!(;W-P:71A;"P@82!F=6QL#0IS97)V:6-E('9E M=&5R:6YA2!T:&4@0V]M M<&%N>2!A;F0@;&]C871E9"!I;B!386YT82!"87)B87)A+"!#86QI9F]R;FEA M("@F(S$T-SM-8T1O;F%L9"!!6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4 M:6UE'0M86QI9VXZ(&IU3L@;6%R9VEN M+7)I9VAT.B`P.R!M87)G:6XM8F]T=&]M.B`P.R!M87)G:6XM;&5F=#H@,"<^ M3VX-"D]C=&]B97(@,3`L(#(P,3(@82!#;VUP;&%I;G0@*"8C,30W.T-O;7!L M86EN="8C,30X.RD@=V%S(&9I;&5D(&EN('1H92!3=7!E2!-8T1O;F%L9"P@82!F;W)M97(@96UP;&]Y M964@;V8@=&AE($-O;7!A;GDL(&%L;&5G:6YG(&)R96%C:"!O9B!C;VYT"!";V%R9"P-"FEN M=&5N=&EO;F%L(&UI2!W86=E6QE M/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE'0M86QI9VXZ(&IU3L@;6%R9VEN+7)I9VAT.B`P.R!M M87)G:6XM8F]T=&]M.B`P.R!M87)G:6XM;&5F=#H@,"<^07,-"F-O;G-I9&5R M871I;VX@=&\@=&AE($-O;7!A;GD@9F]R('1H92!A0T*36-$;VYA;&0@86YD M(%!E="!0;VEN=&5R('=A:79E+"!R96QE87-E(&%N9"!D:7-C:&%R9V4@=&AE M($-O;7!A;GD@86YD('1H96ER(')E6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4 M:6UE'0M86QI9VXZ(&IU3L@;6%R9VEN+7)I9VAT.B`P M.R!M87)G:6XM8F]T=&]M.B`P.R!M87)G:6XM;&5F=#H@,"<^)B,Q-C`[/"]P M/@T*#0H\<"!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@ M5&EM97,L(%-E2!A;F0@2G5D:2!- M87)I;F5L;&D@=VAI8V@@=&AE($-O;7!A;GD@8F5C86UE(&]B;&EG871E9"!T M;R!P87D@;VX@36-$;VYA;&0F(S$T-CMS(&)E:&%L9B!P=7)S=6%N=`T*=&\@ M=&AE(&%S2!A;F0@1W)E9V]R>2!-8T1O;F%L9"!A;F0@4&5T M(%!O:6YT97)S+"!);F,@;VX@2F%N=6%R>2`T+"`R,#$Q+@T*5&AE(&)A;&%N M8V4@9'5E(&]N('1H:7,@;V)L:6=A=&EO;B!A3L@;6%R9VEN+7)I9VAT.B`P.R!M87)G:6XM8F]T=&]M.B`P.R!M M87)G:6XM;&5F=#H@,"<^)B,Q-C`[/"]P/@T*#0H\<"!S='EL93TS1"=F;VYT M.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E2!-8T1O;F%L9"!T;R!T:&4@26YT97)N86P@4F5V96YU92!397)V:6-E('=H M:6-H('1H92!#;VUP86YY(&)E8V%M92!O8FQI9V%T960@=&\@<&%Y(&]N($UC M1&]N86QD)B,Q-#8[3L@ M;6%R9VEN+7)I9VAT.B`P.R!M87)G:6XM8F]T=&]M.B`P.R!M87)G:6XM;&5F M=#H@,"<^)B,Q-C`[/"]P/@T*#0H\<"!S='EL93TS1"=F;VYT.B`Q,'!T(%1I M;65S($YE=R!2;VUA;BP@5&EM97,L(%-E3L@;6%R9VEN M+7)I9VAT.B`P.R!M87)G:6XM8F]T=&]M.B`P.R!M87)G:6XM;&5F=#H@,"<^ M)B,Q-C`[/"]P/@T*#0H\<"!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE M=R!2;VUA;BP@5&EM97,L(%-E2!0;&%N="!A;F0@17%U:7!M96YT(&YE="!O9B!A8V-U;75L871E9"!D97!R M96-I871I;VX-"F%S('=E;&P@87,@86QL(&EN=F5N=&]R>2!H96QD(&%T('1H M92!-8T1O;F%L9"!!;FEM86P@2&]S<&ET86PN)B,Q-C`[/"]P/@T*#0H\<"!S M='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E M6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE M'0M86QI9VXZ(&IU6QE/3-$)V9O;G0Z(#$P<'0@5&EM M97,@3F5W(%)O;6%N+"!4:6UE'0M86QI9VXZ(&IU3L@;6%R9VEN+7)I9VAT.B`P.R!M87)G:6XM8F]T=&]M.B`P.R!M M87)G:6XM;&5F=#H@,"<^*&DI#0I%2!A;&P@:6YT96QL96-T M=6%L('!R;W!EF5D(&EN(&-O;FYE8W1I;VX@=VET:"!T:&4@;W!E3L@;6%R9VEN+7)I9VAT.B`P.R!M87)G:6XM M8F]T=&]M.B`P.R!M87)G:6XM;&5F=#H@,"<^)B,Q-C`[/"]P/@T*#0H\<"!S M='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E M"!N=6UB97)S+"!S97)V:6-E(&UA6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4 M:6UE'0M86QI9VXZ(&IU"!C:&%R9V4@9F]R('1H M92!I;7!A:7)M96YT(&]F(&=O;V1W:6QL(')E8V]R9&5D#0II;B!C;VYN96-T M:6]N('=I=&@@=&AE(&%C<75I2`D-#`U+#`P,"!F;W(@=&AE M('%U87)T97(@96YD960@3F]V96UB97(@,S`L#0HR,#$R+B8C,38P.SPO<#X- M"@T*/'`@3L@;6%R9VEN+7)I9VAT M.B`P.R!M87)G:6XM8F]T=&]M.B`P.R!M87)G:6XM;&5F=#H@,"<^)B,Q-C`[ M/"]P/@T*#0H\<"!S='EL93TS1"=F;VYT.B`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`^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0M86QI9VXZ(&IU6QE/3-$)V)A8VMG6QE/3-$)V9O;G0Z(#$P<'0@ M5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$ M)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE2<^/&9O;G0@'!E;G-E6QE/3-$)V9O;G0Z M(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE2<^/&9O;G0@'0^/'`@6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE'0M86QI9VXZ(&IU6QE/3-$)V)A8VMG M0T*86YD(&5Q=6EP;65N="!A M2!A;F0@97%U:7!M96YT#0IC;VYS:7-T(&]F($]F M9FEC92!%<75I<&UE;G0L(&UE9&EC86P@17%U:7!M96YT(&%N9"!#;VUP=71E M65T M('1O(&)E('!U=`T*:6YT;R!S97)V:6-E+CPO9F]N=#X\+W`^#0H-"CQT86)L M92!C96QL6QE/3-$)V9O M;G0Z(#$R<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)W!A9&1I;F6QE M/3-$)W!A9&1I;F6QE/3-$ M)W!A9&1I;F6QE/3-$)W=I9'1H.B`Q)3L@<&%D9&EN9RUR:6=H=#H@-2XT<'0[('!A M9&1I;F6QE/3-$)W=I9'1H.B`Q,24[('!A9&1I;F6QE/3-$)W9E6QE/3-$)W!A9&1I;F6QE/3-$)W!A9&1I;FF4Z(#$P<'0G/E1O=&%L M/"]T9#X\+W1R/@T*/'1R('-T>6QE/3-$)W9E6QE/3-$ M)W!A9&1I;F6QE/3-$)W!A9&1I;FF4Z(#$P<'0[('1E M>'0M86QI9VXZ(')I9VAT)SXS+#(S-28C,38P.SPO=&0^/"]T6QE/3-$)W!A9&1I M;F6QE/3-$)W!A9&1I;F6QE M/3-$)W9E6QE/3-$)W!A9&1I M;F6QE/3-$)W!A9&1I;FF4Z(#$P<'0[('1E>'0M86QI M9VXZ(')I9VAT)SXR+#$R-B8C,38P.SPO=&0^/"]T6QE/3-$)W!A9&1I;F6QE/3-$)W!A9&1I;F6QE/3-$)W9E6QE/3-$)W!A9&1I;F6QE/3-$)W!A9&1I;F6QE/3-$)W!A9&1I;F6QE/3-$ M)V)A8VMG6QE/3-$)V)A8VMG'0M86QI9VXZ(&IU6QE/3-$)V)A8VMG2!T:&4@2!U'0M86QI9VXZ M(&IU6QE/3-$)V)A8VMG'0M86QI9VXZ(&IU6QE/3-$)V)A8VMG6QE/3-$)V9O;G0Z(#$P M<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE2<^/&9O;G0@6QE M/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE2<^/&9O;G0@6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N M+"!4:6UE2<^/&9O;G0@6QE/3-$)V9O;G0Z(#$P<'0@5&EM M97,@3F5W(%)O;6%N+"!4:6UE2<^/&9O;G0@6%B;&4L("0Q,C$L-#DU(&]F($-O;G9E6%B;&4@*&YE=`T*;V8@9&ES8V]U;G0I+"`D."PP,#`@ M9'5E('1O(%1H97)A0WET92P@26YC+"`D-"PS-#D@;V8@16UP;&]Y964@4F5C M96EV86)L97,@86YD("0S.2PQ-#`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`F(S$V,#M(;W=E=F5R+"!A('9A;'5A=&EO M;B!A;&QO=V%N8V4@;V8@,3`P)2!H87,@8F5E;@T*97-T86)L:7-H960N/"]F M;VYT/CPO<#X-"@T*/'`@F5D(&EN(&%C8V]R9&%N8V4@=VET:"!! M0U,@86-C;W5N=&EN9R!S=&%N9&%R9',@87)E(&-L87-S:69I960@87,@:6YC M;VUE('1A>&5S(&EN(&%C8V]R9&%N8V4-"G=I=&@@05-#(%1O<&EC(#'0^/'`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`Q)3L@<&%D9&EN9RUR:6=H=#H@-2XT<'0[('!A9&1I;F6QE/3-$)W=I9'1H.B`Q M,24[('!A9&1I;F6QE/3-$)W9E6QE M/3-$)W!A9&1I;F6QE/3-$)W!A9&1I;FF4Z(#$P<'0G/E1O=&%L/"]T9#X\+W1R/@T*/'1R M('-T>6QE/3-$)W9E6QE/3-$)W!A9&1I;F6QE/3-$)W!A9&1I;FF4Z(#$P<'0[('1E>'0M86QI9VXZ(')I9VAT M)SXS+#(S-28C,38P.SPO=&0^/"]T6QE/3-$)W!A9&1I;F6QE/3-$)W!A9&1I;F6QE/3-$)W9E6QE/3-$)W!A9&1I;F6QE/3-$)W!A9&1I;FF4Z(#$P<'0[('1E>'0M86QI9VXZ(')I9VAT)SXR+#$R M-B8C,38P.SPO=&0^/"]T6QE/3-$)W!A M9&1I;F6QE/3-$)W!A9&1I M;F6QE/3-$)W9E6QE/3-$)W!A9&1I;F6QE/3-$ M)W!A9&1I;F6QE/3-$)W!A M9&1I;F'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L M87-S/3-$6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@ M3F5W(%)O;6%N+"!4:6UE6QE M/3-$)W=I9'1H.B`W.24[('!A9&1I;F6QE/3-$)V9O;G0Z(#$P<'0@5&EM M97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)W9E6QE/3-$)W!A9&1I;F6QE/3-$)W!A9&1I;F'0M86QI9VXZ(')I9VAT)SXT M,#`P,#PO=&0^/"]T'0M86QI9VXZ M(')I9VAT)SXW.3`P,#PO=&0^/"]T6QE/3-$)W!A9&1I;F6QE M/3-$)W!A9&1I;F6QE/3-$)W9E6QE/3-$)W9E6QE/3-$)W!A9&1I;F6QE/3-$)W!A9&1I;F6QE M/3-$)W!A9&1I;FF4Z(#$R<'0G/B8C,38P.SPO=&0^#0H@("`@/'1D(&YO=W)A M<#TS1&YO=W)A<"!S='EL93TS1"=P861D:6YG+7)I9VAT.B`U+C1P=#L@<&%D M9&EN9RUL969T.B`U+C1P=#L@9F]N="US:7IE.B`Q,G!T)SXF(S$V,#L\+W1D M/CPO='(^#0H\='(@6QE/3-$)W9E'0M86QI9VXZ(')I9VAT)SXS-C0V.3PO=&0^/"]T6QE/3-$)W!A M9&1I;F7!E.B!T M97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE M860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT M96YT/3-$)W1E>'0O:'1M;#L@8VAA"!$:7-C;&]S=7)E(%M!8G-T&5S("T@ M1&5F97)R960@=&%X(&%S'0^/'1A8FQE(&-E;&QS<&%C:6YG/3-$,"!C96QL<&%D9&EN9STS1#`@ MF4Z(#%P="<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$)W9E M'0M86QI9VXZ(')I9VAT)SXF(S$V,#L\+W1D/@T*("`@(#QT M9"!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!B;&%C:R`R+C(U<'0@"!C87)R>2!F;W)W87)D6QE/3-$)W9E6QE/3-$)V)O6QE/3-$)V)O6QE M/3-$)V)O6QE/3-$)V)O6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT)SXF(S$V M,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/CPO='(^#0H\='(@6QE M/3-$)W9E6QE/3-$)W9E7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S M+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE M<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA M'0O:F%V M87-C3X-"B`@("`\=&%B M;&4@8VQA2!0;&%N="!A;F0@17%U:7!M96YT+"!!8W%U M:7-I=&EO;B!#;W-T'0^,S`@;6]N=&AS/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^,S`@;6]N=&AS/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI M(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS M1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA7!E/3-$=&5X="]J879A'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$ M'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T* M("`@("`@/'1R(&-L87-S/3-$2!3;W5T:')I9&=E M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA2!4"D\+W1D/@T*("`@("`@("`\=&0@8VQA2!-8T1O;F%L9"!A;F0@4&5T(%!O:6YT97)S+"!);F,N M("A.;W1E(#$P("D\+W1D/@T*("`@("`@("`\=&0@8VQA3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R M=%\R.&$T.3%B.5\S-V$U7S0Q9C!?839E9%\W9CDR-S-E.&0Q,6$-"D-O;G1E M;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO,CAA-#DQ8CE?,S=A-5\T,68P7V$V M961?-V8Y,C'0O:'1M;#L@8VAA2!B>2!3;W5T:')I9&=E(%!A'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$ M"!3 M8VEE;G1I9FEC($=R;W5P+"!);F,N/"]T9#X-"B`@("`@("`@/'1D(&-L87-S M/3-$=&5X=#X\7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S M8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I M=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA7!E/3-$=&5X="]J879A"!A'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R M/@T*("`@("`@/'1R(&-L87-S/3-$"!C87)R>2!F;W)W M87)D'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA"!A2!F;W)W87)D'!I2!F;W)W87)D'0^,C`@>65A2!F;W)W87)D"!A#PO=&0^#0H@("`@("`@(#QT M9"!C;&%S3X-"CPO:'1M;#X-"@T* M+2TM+2TM/5].97AT4&%R=%\R.&$T.3%B.5\S-V$U7S0Q9C!?839E9%\W9CDR M-S-E.&0Q,6$-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO,CAA-#DQ M8CE?,S=A-5\T,68P7V$V961?-V8Y,C'0O:'1M;#L@8VAA7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C M:&%R2!I3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\R.&$T.3%B M.5\S-V$U7S0Q9C!?839E9%\W9CDR-S-E.&0Q,6$-"D-O;G1E;G0M3&]C871I M;VXZ(&9I;&4Z+R\O0SHO,CAA-#DQ8CE?,S=A-5\T,68P7V$V961?-V8Y,C'0O:'1M;#L@8VAA&EM=6T@ M<&%Y;65N="!T;R!C'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T* M("`@("`@/'1R(&-L87-S/3-$&EM M=6T@<&%Y;65N="!T;R!A9&1I=&EO;F%L(&-R961I=&]R'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\ M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$6UE;G0@=&\@36-$;VYA M;&0\+W1D/@T*("`@("`@("`\=&0@8VQA'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@(#PO=&%B;&4^#0H@ M(#PO8F]D>3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\R.&$T.3%B M.5\S-V$U7S0Q9C!?839E9%\W9CDR-S-E.&0Q,6$-"D-O;G1E;G0M3&]C871I M;VXZ(&9I;&4Z+R\O0SHO,CAA-#DQ8CE?,S=A-5\T,68P7V$V961?-V8Y,C'0O:'1M;#L@8VAA'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T* M("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^-2!Y96%R6UE;G1S('1O(&5X=&EN9W5I'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S6UE;G1S(&1U92!T;R!&2!P87EM96YT'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@ M("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$2!397)V:6-E2!A=V%R9"!S;W5G:'0\+W1D/@T*("`@ M("`@("`\=&0@8VQA'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R M(&-L87-S/3-$'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@(#PO=&%B;&4^#0H@(#PO8F]D>3X- M"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\R.&$T.3%B.5\S-V$U7S0Q M9C!?839E9%\W9CDR-S-E.&0Q,6$-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z M+R\O0SHO,CAA-#DQ8CE?,S=A-5\T,68P7V$V961?-V8Y,C'0O:'1M M;#L@8VAA'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\ M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\R.&$T.3%B.5\S M-V$U7S0Q9C!?839E9%\W9CDR-S-E.&0Q,6$-"D-O;G1E;G0M3&]C871I;VXZ M(&9I;&4Z+R\O0SHO,CAA-#DQ8CE?,S=A-5\T,68P7V$V961?-V8Y,C'0O:'1M;#L@8VAA7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X- M"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP M92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAAF5D/"]T9#X-"B`@("`@("`@ M/'1D(&-L87-S/3-$;G5M<#XQ+#`P,"PP,#`L,#`P/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%SF5D/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XU+#`P M,"PP,#`\F5D/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M M<#XT+#0P,"PP,#`\'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S7!E.B!T97AT+VAT;6P[(&-H87)S970] M(G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T M<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@ M8VAA'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$&ES=&EN9R!P'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R M(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\ M+W1R/@T*("`@(#PO=&%B;&4^#0H@(#PO8F]D>3X-"CPO:'1M;#X-"@T*+2TM M+2TM/5].97AT4&%R=%\R.&$T.3%B.5\S-V$U7S0Q9C!?839E9%\W9CDR-S-E M.&0Q,6$-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO,CAA-#DQ8CE? M,S=A-5\T,68P7V$V961?-V8Y,C'0O:'1M;#L@8VAA7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@ M("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$65E'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S M/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S65E(&%S(%)E'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$2!N;W1E M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\6UE;G0@;V8@9&5B="!T;R!3 M;W5T:')I9&=E/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ-"PS M,#`\'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$F4@8V]M;6]N('-H87)E'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S"!";V%R9"!O;B!-8T1O;F%L9',@8F5H86QF+"!B86QA M;F-E(&1U93PO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R M/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T* M("`@(#PO=&%B;&4^#0H@(#PO8F]D>3X-"CPO:'1M;#X-"@T*+2TM+2TM/5]. M97AT4&%R=%\R.&$T.3%B.5\S-V$U7S0Q9C!?839E9%\W9CDR-S-E.&0Q,6$- M"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO,CAA-#DQ8CE?,S=A-5\T M,68P7V$V961?-V8Y,C&UL M#0I#;VYT96YT+51R86YS9F5R+45N8V]D:6YG.B!Q=6]T960M<')I;G1A8FQE M#0I#;VYT96YT+51Y<&4Z('1E>'0O:'1M;#L@8VAA&UL;G,Z;STS1")U XML 23 R43.htm IDEA: XBRL DOCUMENT v2.4.0.6

STOCK TRANSACTIONS (Details Narrative) (USD $)
3 Months Ended 12 Months Ended

May 31, 2012

Aug. 31, 2012

Aug. 31, 2011

Aug. 02, 2012

Apr. 03, 2012

Dec. 29, 2011

Dec. 26, 2011

Equity [Abstract]

Common Shares issued for Debt, Shares 113,695,700

Common Shares issued for Debt, Amount $ 374,959 $ 341,167

Common Shares issued for services, Shares 3,272,000

Common Shares issued for services, Amount 171,750

Common Shares issued for intangible assets, Shares 2,500,000

Common Shares issued for intangible assets, Amount 700,000

Shares issued pursuant to Contractual Obligations, Shares 6,274,726

Shares issued pursuant to Contractual Obligations, Amount 23,868

Non Voting Convertible Preferred Shares, Shares 75,000

Non Voting Convertible Preferred Shares, Amount $ 75,000

Cancellation of common shares 15,000

Shares returned for cancellation from CFO 75,000

CFO shares subject to forfeiture and are cancelled 40,000

Cancellation of remaining CFO common shares 35,000

Dividend of Series B preferred stock paid 3,201,397

Shares of common stock issued to CEO 50,000,000

Shares of common stock issued to seven employees as restricted stock award 27,000,000

Shares of common stock issued to a consultant as restricted stock award 15,000,000

Cancellation of common shares issued to employee as Restriced Stock Award 15,000,000

X

- Definition

Number of shares under non-option equity instrument agreements that were cancelled.

+ References

No definition available.

+ Details

Name: ENTB_CancellationOfCommonShares

Namespace Prefix: ENTB_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition

Number of shares cancelled during the period related to Restricted Stock Awards, net of any shares forfeited.

+ References

No definition available.

+ Details

Name: ENTB_CancellationOfCommonSharesIssuedToEmployeeAsRestricedStockAward

Namespace Prefix: ENTB_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition

Number of shares under non-option equity instrument agreements that were returned by the former CFO and remain, but will be cancelled.

+ References

No definition available.

+ Details

Name: ENTB_CancellationOfRemainingCfoCommonShares

Namespace Prefix: ENTB_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition

Number of shares under non-option equity instrument agreements that were returned by the former CFO and are scheduled to be cancelled.

+ References

No definition available.

+ Details

Name: ENTB_CfoSharesSubjectToForfeitureAndAreCancelled

Namespace Prefix: ENTB_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition

Distribution of earnings from Series B preferred stock to shareholders either in cash, property, or capital stock.

+ References

No definition available.

+ Details

Name: ENTB_DividendOfSeriesBPreferredStockPaid

Namespace Prefix: ENTB_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition

The fair value of stock issued in noncash financing activities to the Chief Executive Officer.

+ References

No definition available.

+ Details

Name: ENTB_SharesOfCommonStockIssuedToCEO

Namespace Prefix: ENTB_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition

Number of shares issued to a consultant during the period related to Restricted Stock Awards, net of any shares forfeited.

+ References

No definition available.

+ Details

Name: ENTB_SharesOfCommonStockIssuedToConsultantAsRestrictedStockAward

Namespace Prefix: ENTB_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition

Number of shares issued during the period related to Restricted Stock Awards, net of any shares forfeited.

+ References

No definition available.

+ Details

Name: ENTB_SharesOfCommonStockIssuedToSevenEmployeesAsRestrictedStockAward

Namespace Prefix: ENTB_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition

Number of shares under non-option equity instrument agreements that were returned by the former CFO and were then cancelled.

+ References

No definition available.

+ Details

Name: ENTB_SharesReturnedForCancellationFromCfo

Namespace Prefix: ENTB_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition

The value of the financial instrument(s) that the original debt is being converted into in a noncash (or part noncash) transaction. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 50

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=6367179&loc=d3e4304-108586

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 95

-Paragraph 32

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 50

-Paragraph 5

-URI http://asc.fasb.org/extlink&oid=6367179&loc=d3e4332-108586

+ Details

Name: us-gaap_DebtConversionConvertedInstrumentAmount1

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

The number of shares issued in exchange for the original debt being converted in a noncash (or part noncash) transaction. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or payments in the period.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 50

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=6367179&loc=d3e4304-108586

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 95

-Paragraph 32

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 50

-Paragraph 5

-URI http://asc.fasb.org/extlink&oid=6367179&loc=d3e4332-108586

+ Details

Name: us-gaap_DebtConversionConvertedInstrumentSharesIssued1

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition

Equity impact of aggregate cash, stock, and paid-in-kind dividends declared for preferred shareholders during the period.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher AICPA

-Name Statement of Position (SOP)

-Number 01-6

-Paragraph 14

-Subparagraph l

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 04

-Article 3

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.3-04)

-URI http://asc.fasb.org/extlink&oid=6959260&loc=d3e187085-122770

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 942

-SubTopic 405

-Section 45

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6957935&loc=d3e64057-112817

+ Details

Name: us-gaap_DividendsPreferredStock

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Details

Name: us-gaap_EquityAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

Number of shares of common and preferred stock issued as dividends during the period. Excludes stock splits.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21463-112644

+ Details

Name: us-gaap_StockDividendsShares

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition

Number of shares issued for noncash consideration.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 915

-SubTopic 215

-Section 45

-Paragraph 1

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=6472370&loc=d3e38297-110927

+ Details

Name: us-gaap_StockIssuedDuringPeriodSharesIssuedForNoncashConsideration

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition

Number of shares issued in lieu of cash for services contributed to the entity. Number of shares includes, but is not limited to, shares issued for services contributed by vendors and founders.

+ References

No definition available.

+ Details

Name: us-gaap_StockIssuedDuringPeriodSharesIssuedForServices

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition

Number of shares of stock issued during the period as part of a transaction to acquire assets that do not qualify as a business combination.

+ References

No definition available.

+ Details

Name: us-gaap_StockIssuedDuringPeriodSharesPurchaseOfAssets

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition

Value of stock issued for noncash consideration.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 915

-SubTopic 215

-Section 45

-Paragraph 1

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=6472370&loc=d3e38297-110927

+ Details

Name: us-gaap_StockIssuedDuringPeriodValueIssuedForNoncashConsiderations

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

Value of stock issued in lieu of cash for services contributed to the entity. Value of the stock issued includes, but is not limited to, services contributed by vendors and founders.

+ References

No definition available.

+ Details

Name: us-gaap_StockIssuedDuringPeriodValueIssuedForServices

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

Value of shares of stock issued during the period as part of a transaction to acquire assets that do not qualify as a business combination.

+ References

No definition available.

+ Details

Name: us-gaap_StockIssuedDuringPeriodValuePurchaseOfAssets

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

XML 24 R29.htm IDEA: XBRL DOCUMENT v2.4.0.6

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) (USD $)
12 Months Ended

Aug. 31, 2012

Aug. 31, 2011

Accounting Policies [Abstract]

Depreciation expense $ 8,461 $ 5,591

Notes payable 261,831

Convertible notes payable, net of discount 121,495 42,430

Due to TheraCyte, Inc 8,000 8,000

Employee receivables 4,349 4,349

Due from an affiliate $ 39,140 $ 0

Valuation allowance 100.00%

X

- Details

Name: us-gaap_AccountingPoliciesAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

Carrying value as of the balance sheet date of the portion of long-term debt due within one year or the operating cycle if longer identified as Convertible Notes Payable. Convertible Notes Payable is a written promise to pay a note which can be exchanged for a specified amount of another, related security, at the option of the issuer and the holder.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 20

-Article 5

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.20)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_ConvertibleNotesPayableCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition

The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 95

-Paragraph 28

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher AICPA

-Name Accounting Principles Board Opinion (APB)

-Number 12

-Paragraph 5

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3602-108585

+ Details

Name: us-gaap_Depreciation

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition

Amount of receivables due from an entity that is affiliated with the reporting entity by means of direct or indirect ownership, due within 1 year (or 1 business cycle).

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 3

-Subparagraph a

-Article 5

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.4-08.(k)(1))

-URI http://asc.fasb.org/extlink&oid=6881521&loc=d3e23780-122690

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 850

-SubTopic 10

-Section 50

-Paragraph 1

-Subparagraph (d)

-URI http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.3(a)(2))

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 850

-SubTopic 10

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6457730&loc=d3e39599-107864

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 08

-Paragraph k

-Subparagraph 1

-Article 4

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 850

-SubTopic 10

-Section 50

-Paragraph 4

-URI http://asc.fasb.org/extlink&oid=6457730&loc=d3e39622-107864

Reference 8: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 57

-Paragraph 2

-Subparagraph d

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

+ Details

Name: us-gaap_DueFromAffiliateCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition

Amounts due from an Entity employee, not to include stockholders or officers, which are usually due within 1 year (or 1 business cycle).

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 08

-Paragraph k

-Subparagraph 1

-Article 4

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 57

-Paragraph 2

-Subparagraph d

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.3(a)(2))

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 3

-Subparagraph a

-Article 5

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.4-08.(k)(1))

-URI http://asc.fasb.org/extlink&oid=6881521&loc=d3e23780-122690

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 850

-SubTopic 10

-Section 50

-Paragraph 1

-Subparagraph (d)

-URI http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 850

-SubTopic 10

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6457730&loc=d3e39599-107864

+ Details

Name: us-gaap_DueFromEmployeesCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition

Amount of payable due to an entity that is affiliated with the reporting entity by means of direct or indirect ownership. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 57

-Paragraph 2

-Subparagraph d

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.19(a))

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.4-08.(k)(1))

-URI http://asc.fasb.org/extlink&oid=6881521&loc=d3e23780-122690

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 19

-Subparagraph a

-Article 5

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 850

-SubTopic 10

-Section 50

-Paragraph 1

-Subparagraph (d)

-URI http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 08

-Paragraph k

-Subparagraph 1

-Article 4

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 04

-Paragraph 12

-Subparagraph 3

-Article 6

+ Details

Name: us-gaap_DueToAffiliateCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition

The portion of the difference between the effective income tax rate and domestic federal statutory income tax rate attributable to changes in the valuation allowance for deferred tax assets.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 740

-SubTopic 10

-Section 50

-Paragraph 12

-URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32687-109319

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 740

-SubTopic 10

-Section 50

-Paragraph 13

-URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32698-109319

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 740

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SAB TOPIC 6.I)

-URI http://asc.fasb.org/extlink&oid=6889476&loc=d3e330036-122817

+ Details

Name: us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance

Namespace Prefix: us-gaap_

Data Type: num:percentItemType

Balance Type: na

Period Type: duration

X

- Definition

Including the current and noncurrent portions, aggregate carrying amount of all types of notes payable, as of the balance sheet date, with initial maturities beyond one year or beyond the normal operating cycle, if longer.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 03

-Paragraph 13, 16

-Article 9

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 944

-SubTopic 210

-Section S99

-Paragraph 1

-Subparagraph (SX 210.7-03.16)

-URI http://asc.fasb.org/extlink&oid=6879938&loc=d3e572229-122910

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 942

-SubTopic 210

-Section S99

-Paragraph 1

-Subparagraph (SX 210.9-03.16)

-URI http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 19, 20, 22

-Article 5

+ Details

Name: us-gaap_NotesPayable

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

XML 25 R28.htm IDEA: XBRL DOCUMENT v2.4.0.6

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Property Plant and Equipment, Acquisition Costs (Details) (USD $)

Aug. 31, 2012

Estimated useful Life (Months)

Office Equipment 30 months

Medical Equipment 30 months

Computer Equipment 30 months

Acquisition Cost, Total

Office Equipment, Value 3,235

Medical Equipment, Value 17,523

Computer Equipment, Value 2,126

Subtotal 22,884

Less Accumulated Depreciation (14,052)

Total 8,832

X

- Definition

Computer Equipment Estimated Useful Life in Months.

+ References

No definition available.

+ Details

Name: ENTB_ComputerEquipmentUsefulLife

Namespace Prefix: ENTB_

Data Type: xbrli:durationItemType

Balance Type: na

Period Type: instant

X

- Definition

Medical Equipment Estimated Useful Life in Months.

+ References

No definition available.

+ Details

Name: ENTB_MedicalEquipmentUsefulLife

Namespace Prefix: ENTB_

Data Type: xbrli:durationItemType

Balance Type: na

Period Type: instant

X

- Definition

Office Equipment Estimated Useful Life in Months.

+ References

No definition available.

+ Details

Name: ENTB_OfficeEquipmentUsefulLife

Namespace Prefix: ENTB_

Data Type: xbrli:durationItemType

Balance Type: na

Period Type: instant

X

- Definition

The cumulative amount of depreciation, depletion and amortization (related to property, plant and equipment, but not including land) that has been recognized in the income statement.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 14

-Article 5

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher AICPA

-Name Accounting Principles Board Opinion (APB)

-Number 12

-Paragraph 5

-Subparagraph c

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher AICPA

-Name Accounting Principles Board Opinion (APB)

-Number 12

-Paragraph 5

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.14)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 360

-SubTopic 10

-Section 50

-Paragraph 1

-Subparagraph (c)

-URI http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229

+ Details

Name: us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition

Gross amount, at the balance sheet date, of long-lived, depreciable assets commonly used in offices and stores. Examples include desks, chairs, and store fixtures.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher AICPA

-Name Accounting Principles Board Opinion (APB)

-Number 12

-Paragraph 5

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 360

-SubTopic 10

-Section 50

-Paragraph 1

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229

+ Details

Name: us-gaap_FurnitureAndFixturesGross

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition

Gross amount, as of the balance sheet date, of long-lived, depreciable assets used in the production process to produce goods and services.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher AICPA

-Name Accounting Principles Board Opinion (APB)

-Number 12

-Paragraph 5

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 360

-SubTopic 10

-Section 50

-Paragraph 1

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section 45

-Paragraph 4

-Subparagraph (f)

-URI http://asc.fasb.org/extlink&oid=6361293&loc=d3e6812-107765

+ Details

Name: us-gaap_MachineryAndEquipmentGross

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition

Gross amount of long-lived physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher AICPA

-Name Accounting Principles Board Opinion (APB)

-Number 12

-Paragraph 5

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 360

-SubTopic 10

-Section 50

-Paragraph 1

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.13)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_PropertyPlantAndEquipmentGross

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition

This element represents capitalized assets classified as property, plant and equipment not otherwise defined in the taxonomy.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher AICPA

-Name Accounting Principles Board Opinion (APB)

-Number 12

-Paragraph 5

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 360

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229

+ Details

Name: us-gaap_PropertyPlantAndEquipmentOther

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition

The net amount of capitalized assets classified as property, plant and equipment not otherwise defined in the taxonomy.

+ References

No definition available.

+ Details

Name: us-gaap_PropertyPlantAndEquipmentOtherNet

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

XML 26 R44.htm IDEA: XBRL DOCUMENT v2.4.0.6

SUBSEQUENT EVENTS (Details Narrative) (USD $)
0 Months Ended 3 Months Ended

Oct. 02, 2012

Sep. 17, 2012

Nov. 30, 2012

Dec. 05, 2012

Oct. 22, 2012

Oct. 17, 2012

Sep. 21, 2012

Sep. 20, 2012

Subsequent Events [Abstract]

Common shares sold to Southridge 10,837,849 26,802,465

Gross amount of common shares sold to Southridge $ 14,300 $ 50,000

Indebtedness due to Southridge 20,000

Issued a convertible promissory note 63,000

Convertible promissory note interest rate 8.00%

Percentage of discount of possible conversion 39.00%

Payment of debt to Southridge 14,300

Common shares issued for outstanding convertible indebtedness 10,810,811 23,000,000

Value of common shares issued for outstanding convertible indebtedness 8,000 19,320

Certificate of incorporation to authorize common shares 2,000,000,000

Obligation to pay on McDonalds behalf, balance due 55,000

Obligation to pay IRS on McDonalds behalf, balance due 6,369.69

Obligation to pay Franchise Tax Board on McDonalds behalf, balance due 3,474

Assets disposed of pursuant to Agreement 4,897

Impairment of goodwill acquired 405,000

Obligated payment to McDonald Animal Hospital $ 13,000

X

- Definition

Common Shares Issued For Outstanding Convertible Indebtedness.

+ References

No definition available.

+ Details

Name: ENTB_CommonSharesIssuedForOutstandingConvertibleIndebtedness

Namespace Prefix: ENTB_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition

Total current liabilities of the broker-dealer, less certain exceptions as defined due to Southridge.

+ References

No definition available.

+ Details

Name: ENTB_IndebtednessDueToSouthridge

Namespace Prefix: ENTB_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition

The gross value of stock issued during the period upon the conversion of convertible securities.

+ References

No definition available.

+ Details

Name: ENTB_IssuedConvertiblePromissoryNote

Namespace Prefix: ENTB_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition

Minimum amount of other commitment not otherwise specified in the taxonomy. Excludes commitments explicitly modeled in the taxonomy, including but not limited to, long-term and short-term purchase commitments, recorded and unrecorded purchase obligations, supply commitments, registration payment arrangements, leases, debt, product warranties, guarantees, environmental remediation obligations, and pensions. Due to California Franchise Tax Board.

+ References

No definition available.

+ Details

Name: ENTB_OtherCommitmentToFranchiseTaxBoard

Namespace Prefix: ENTB_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition

The discount rate applied to possible conversion in the future.

+ References

No definition available.

+ Details

Name: ENTB_PercentageOfDiscountOfPossibleConversion

Namespace Prefix: ENTB_

Data Type: num:percentItemType

Balance Type: na

Period Type: instant

X

- Definition

The amount of acquisition cost of a business combination allocated to assets to be disposed of by other than sale.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 141

-Paragraph 51

-Subparagraph e

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 141

-Paragraph 37

-Subparagraph d

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

+ Details

Name: us-gaap_BusinessAcquisitionPurchasePriceAllocationCurrentAssetsAssetToBeDisposedOf

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition

Value of all classes of common stock held by shareholders. May be all or portion of the number of common shares authorized. These shares exclude common shares repurchased by the entity and held as treasury shares.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.29)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 30

-Article 5

+ Details

Name: us-gaap_CommonStockValueOutstanding

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition

The effective interest rate at the end of the reporting period.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 835

-SubTopic 30

-Section 45

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6451184&loc=d3e28551-108399

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 22

-Article 5

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.22(a)(1))

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_DebtInstrumentInterestRateAtPeriodEnd

Namespace Prefix: us-gaap_

Data Type: num:percentItemType

Balance Type: na

Period Type: instant

X

- Definition

Total loss recognized during the period from the impairment of goodwill plus the loss recognized in the period resulting from the impairment of the carrying amount of intangible assets, other than goodwill.

+ References

No definition available.

+ Details

Name: us-gaap_GoodwillAndIntangibleAssetImpairment

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition

Minimum amount of other commitment not otherwise specified in the taxonomy. Excludes commitments explicitly modeled in the taxonomy, including but not limited to, long-term and short-term purchase commitments, recorded and unrecorded purchase obligations, supply commitments, registration payment arrangements, leases, debt, product warranties, guarantees, environmental remediation obligations, and pensions.

+ References

No definition available.

+ Details

Name: us-gaap_OtherCommitment

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition

Minimum amount of other commitment maturing in the next fiscal year following the latest fiscal year for commitments not otherwise specified in the taxonomy. Excludes commitments explicitly modeled in this taxonomy, including but not limited to, long-term and short-term purchase commitments, recorded and unrecorded purchase obligations, supply commitments, registration payment arrangements, leases, debt, product warranties, guarantees, environmental remediation obligations, and pensions.

+ References

No definition available.

+ Details

Name: us-gaap_OtherCommitmentDueInNextTwelveMonths

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition

The number of units of other ownership interest authorized to be issued in a limited partnership or master limited partnership. Does not include limited or general partners' ownership interests.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher AICPA

-Name Practice Bulletin (PB)

-Number 14

-Paragraph 10, 15

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section S99

-Paragraph 5

-Subparagraph (SAB TOPIC 4.F)

-URI http://asc.fasb.org/extlink&oid=6959260&loc=d3e187171-122770

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 272

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6373374&loc=d3e70434-108055

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Emerging Issues Task Force (EITF)

-Number 87-21

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

+ Details

Name: us-gaap_OtherOwnershipInterestsUnitsAuthorized

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition

The total of the cash outflow during the period which has been paid to third parties in connection with debt origination, which will be amortized over the remaining maturity period of the associated long-term debt and the cost incurred directly for the issuance of equity securities.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Financing Activities

-URI http://asc.fasb.org/extlink&oid=6513228

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 95

-Paragraph 18, 19, 20

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 15

-URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3291-108585

+ Details

Name: us-gaap_PaymentOfFinancingAndStockIssuanceCosts

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

The cash outflow for securities or other assets acquired, which qualify for treatment as an investing activity and are to be liquidated, if necessary, within the current operating cycle. Includes cash flows from securities classified as trading securities that were acquired for reasons other than sale in the short-term.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 159

-Section Appendix C

-Paragraph 5

-Subparagraph c

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Investing Activities

-URI http://asc.fasb.org/extlink&oid=6516133

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 13

-URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3213-108585

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 95

-Paragraph 15, 17

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

+ Details

Name: us-gaap_PaymentsToAcquireShortTermInvestments

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

Cash received on stock transaction after deduction of issuance costs.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Staff Accounting Bulletin (SAB)

-Number Topic 5

-Section H

+ Details

Name: us-gaap_SaleOfStockConsiderationReceivedOnTransaction

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition

The number of shares issued or sold by the subsidiary or equity method investee per stock transaction.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Staff Accounting Bulletin (SAB)

-Number Topic 5

-Section H

+ Details

Name: us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Details

Name: us-gaap_SubsequentEventsAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 27 R30.htm IDEA: XBRL DOCUMENT v2.4.0.6

GOING CONCERN (Details Narrative) (USD $)
12 Months Ended 48 Months Ended

Aug. 31, 2012

Aug. 31, 2012

Aug. 27, 2012

Jun. 01, 2012

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Net losses $ 3,664,302

Funds raised through the issuance of convertible notes 197,500

Raised from borrowings $ 261,475

Maximum common shares to be purchased by Southridge 10,000,000

Average of two lowest closing prices equal to purchase price of shares 91.00%

Minimum Southridge ownership of common stock 9.99%

Cash placement fee of funds received 5.00%

Shares of common stock registered to Southridge 46,238,705

X

- Definition

Average Of Two Lowest Closing Prices Equal To Purchase Price Of Shares.

+ References

No definition available.

+ Details

Name: ENTB_AverageOfTwoLowestClosingPricesEqualToPurchasePriceOfShares

Namespace Prefix: ENTB_

Data Type: num:percentItemType

Balance Type: na

Period Type: instant

X

- Definition

Description of a cash placement fee percentage associated with the funds received by the Company through the sale of Shares to Southridge as such funds are received by the Company

+ References

No definition available.

+ Details

Name: ENTB_CashPlacementFeeOfFundsReceived

Namespace Prefix: ENTB_

Data Type: num:percentItemType

Balance Type: na

Period Type: instant

X

- Definition

Total number of common shares of an entity that have been registered with the terms of an Equity Purchase Agreement. These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.

+ References

No definition available.

+ Details

Name: ENTB_SharesOfCommonStockRegisteredToSouthridge

Namespace Prefix: ENTB_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition

The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 159

-Paragraph 18

-Subparagraph f

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 323

-SubTopic 10

-Section 50

-Paragraph 3

-Subparagraph (a)(1)

-URI http://asc.fasb.org/extlink&oid=6382943&loc=d3e33918-111571

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher AICPA

-Name Accounting Principles Board Opinion (APB)

-Number 18

-Paragraph 20

-Subparagraph a (1)

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

+ Details

Name: us-gaap_EquityMethodInvestmentOwnershipPercentage

Namespace Prefix: us-gaap_

Data Type: num:percentItemType

Balance Type: na

Period Type: instant

X

- Details

Name: us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

The change in other comprehensive income during the reporting period, net of tax, for an item that is not separately disclosed.

+ References

No definition available.

+ Details

Name: us-gaap_OtherComprehensiveIncomeOtherNetOfTax

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

The cash inflow from the issuance of a long-term debt instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 95

-Paragraph 19

-Subparagraph b

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Financing Activities

-URI http://asc.fasb.org/extlink&oid=6513228

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 95

-Paragraph 18

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 14

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3255-108585

+ Details

Name: us-gaap_ProceedsFromConvertibleDebt

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition

The cash inflow from other borrowing not otherwise defined in the taxonomy.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 95

-Paragraph 19

-Subparagraph b

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Financing Activities

-URI http://asc.fasb.org/extlink&oid=6513228

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 95

-Paragraph 18

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 14

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3255-108585

+ Details

Name: us-gaap_ProceedsFromOtherDebt

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition

The number of shares authorized to be repurchased by an entity's Board of Directors under a stock repurchase plan.

+ References

No definition available.

+ Details

Name: us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

XML 28 R31.htm IDEA: XBRL DOCUMENT v2.4.0.6

NOTES PAYABLE - Notes Payable, Current and Long Term (Details) (USD $)

Aug. 31, 2012

Current:

Bio Technology Partners Business Trust $ 13,500

Venture Bridge Advisors, Inc. 32,508

Southridge Partners II LLP 40,000

Sherman Family Trust 79,000

Officer Loans (Note Six) 30,180

Current portion of amounts to be paid on behalf of Gregory McDonald and Pet Pointers, Inc. (Note 10 ) 30,174

8% Convertible Notes (Note Fourteen) 105,500

10% Convertible Note (Note Fourteen) 59,000

Total: 389,862

Long Term:

Long Term portion of amounts to be paid on behalf of Gregory McDonald and Pet Pointers, Inc. (Note Ten) 36,469

Total: $ 36,469

X

- Definition

Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.19,20)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 20

-Article 5

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 19

-Article 5

+ Details

Name: us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition

Carrying value as of the balance sheet date of obligations incurred and payable to vendors that bear interest at either a stated or an imputed rate. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 835

-SubTopic 30

-Section 45

-Paragraph 1A

-URI http://asc.fasb.org/extlink&oid=6451184&loc=d3e28541-108399

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher AICPA

-Name Accounting Principles Board Opinion (APB)

-Number 21

-Paragraph 16

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.19(a))

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 19

-Subparagraph a

-Article 5

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 835

-SubTopic 30

-Section 45

-Paragraph 4

-URI http://asc.fasb.org/extlink&oid=6451184&loc=d3e28567-108399

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 835

-SubTopic 30

-Section 45

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6451184&loc=d3e28551-108399

+ Details

Name: us-gaap_AccountsPayableInterestBearingCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition

Amount for accounts payable to related parties. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 850

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.4-08.(k)(1))

-URI http://asc.fasb.org/extlink&oid=6881521&loc=d3e23780-122690

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 850

-SubTopic 10

-Section 50

-Paragraph 4

-URI http://asc.fasb.org/extlink&oid=6457730&loc=d3e39622-107864

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 850

-SubTopic 10

-Section 50

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=6457730&loc=d3e39603-107864

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 57

-Paragraph 2

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.19(a))

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 08

-Paragraph k

-Subparagraph 1

-Article 4

Reference 8: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 19

-Subparagraph a

-Article 5

+ Details

Name: us-gaap_AccountsPayableRelatedPartiesCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition

The portion of the carrying value of long-term convertible debt as of the balance sheet date that is scheduled to be repaid within one year or in the normal operating cycle if longer. Convertible debt is a financial instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.20)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 19, 20

-Article 5

+ Details

Name: us-gaap_ConvertibleDebtCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition

Including the current and noncurrent portions, carrying value as of the balance sheet date of a written promise to pay a note, initially due after one year or beyond the operating cycle if longer, which can be exchanged for a specified amount of one or more securities (typically common stock), at the option of the issuer or the holder.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 20, 22

-Article 5

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 942

-SubTopic 210

-Section S99

-Paragraph 1

-Subparagraph (SX 210.9-03.16)

-URI http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 03

-Paragraph 16

-Article 9

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 944

-SubTopic 210

-Section S99

-Paragraph 1

-Subparagraph (SX 210.7-03.16(a))

-URI http://asc.fasb.org/extlink&oid=6879938&loc=d3e572229-122910

+ Details

Name: us-gaap_ConvertibleNotesPayable

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition

Amounts due to recorded owners or owners with a beneficial interest of more than 10 percent of the voting interests or officers of the company. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 57

-Paragraph 2

-Subparagraph d

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.19(a))

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.4-08.(k)(1))

-URI http://asc.fasb.org/extlink&oid=6881521&loc=d3e23780-122690

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 19

-Subparagraph a

-Article 5

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 850

-SubTopic 10

-Section 50

-Paragraph 1

-Subparagraph (d)

-URI http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 08

-Paragraph k

-Subparagraph 1

-Article 4

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 04

-Paragraph 12

-Subparagraph a(1)

-Article 6

+ Details

Name: us-gaap_DueToOfficersOrStockholdersCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition

Carrying amount as of the balance sheet date of obligations due all related parties. For classified balance sheets, represents the current portion of such liabilities (due within one year or within the normal operating cycle if longer).

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 57

-Paragraph 2

-Subparagraph d

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.19(a))

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.4-08.(k)(1))

-URI http://asc.fasb.org/extlink&oid=6881521&loc=d3e23780-122690

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 19

-Subparagraph a

-Article 5

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 850

-SubTopic 10

-Section 50

-Paragraph 1

-Subparagraph (d)

-URI http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 08

-Paragraph k

-Subparagraph 1

-Article 4

+ Details

Name: us-gaap_DueToRelatedPartiesCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition

Portion of the carrying amount as of the balance sheet date of obligations due all related parties that is payable after one year or beyond the normal operating cycle if longer.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 57

-Paragraph 2

-Subparagraph d

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.23)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.4-08.(k)(1))

-URI http://asc.fasb.org/extlink&oid=6881521&loc=d3e23780-122690

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 23

-Article 5

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 850

-SubTopic 10

-Section 50

-Paragraph 1

-Subparagraph (d)

-URI http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 08

-Paragraph k

-Subparagraph 1

-Article 4

+ Details

Name: us-gaap_DueToRelatedPartiesNoncurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition

Carrying value as of the balance sheet date of portion of long-term loans payable due within one year or the operating cycle if longer.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 20

-Article 5

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.20)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_LoansPayableCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Details

Name: us-gaap_LongTermNotesPayableAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

Sum of the carrying values as of the balance sheet date of the portions of all long-term notes and loans payable due within one year or the operating cycle if longer.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.19,20)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 19, 20

-Article 5

+ Details

Name: us-gaap_NotesAndLoansPayableCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Details

Name: us-gaap_NotesPayableCurrentAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

The amount for notes payable (written promise to pay), payable to related parties, which are due after one year (or one business cycle).

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 57

-Paragraph 2

-Subparagraph d

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.23)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.4-08.(k)(1))

-URI http://asc.fasb.org/extlink&oid=6881521&loc=d3e23780-122690

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 23

-Article 5

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 850

-SubTopic 10

-Section 50

-Paragraph 1

-Subparagraph (d)

-URI http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 08

-Paragraph k

-Subparagraph 1

-Article 4

+ Details

Name: us-gaap_NotesPayableRelatedPartiesNoncurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

XML 29 R8.htm IDEA: XBRL DOCUMENT v2.4.0.6

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
12 Months Ended

Aug. 31, 2012

Accounting Policies [Abstract]

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

NOTE 2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

A. BASIS OF ACCOUNTING

The financial statements have been prepared using the basis of accounting generally accepted in the United States of America. Under this basis of accounting, revenues are recorded as earned and expenses are recorded at the time liabilities are incurred. The Company has adopted an August 31 fiscal year-end. The Company recognizes revenue from services and product sales when the following four revenue recognition criteria are met: persuasive evidence of an arrangement exists, delivery has occurred or services have been rendered, the selling price is fixed or determinable, and collectability is reasonably assured. Product sales and service revenues are recorded when the products are delivered and title passes to customers. The customer’s credit card is authorized and charged, or checks/cash are received at the time the services are rendered, thereby providing reasonable assurance of collectability.

B. PRINCIPLES OF CONSOLIDATION

The consolidated financial statements include the accounts of Entest CA, the Company’s wholly owned subsidiary. Significant inter-company transactions have been eliminated.

C. USE OF ESTIMATES

The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.

D. CASH EQUIVALENTS

The Company considers all highly liquid investments with a maturity of three months or less when purchased to be cash equivalents.

E. PROPERTY AND EQUIPMENT

Property and equipment are recorded at cost. Maintenance and repairs are expensed in the year in which they are incurred. Property and equipment consist of Office Equipment, medical Equipment and Computer Equipment. Expenditures that enhance the value of property and equipment are capitalized. All property and equipment is depreciated utilizing the Straight Line Method for a period of thirty months , such period being estimated by the Company to represent the useful life of the assets. For the Fiscal Year ended August 31, 2012 the Company incurred depreciation expense of $8,461 and for the Fiscal Year ended August 31, 2011 the Company incurred depreciation expense of $5,591. No depreciation has been recognized in connection with one piece of computer equipment which has yet to be put into service.

Property Plant and Equipment

Acquisition Cost Estimated useful Life (Months) Total

Office Equipment 30 3,235

Medical Equipment 30 17,523

Computer Equipment 30 2,126

Subtotal 22,884

Less Accumulated Depreciation (14,052)

Total 8,832

F. FAIR VALUE OF FINANCIAL INSTRUMENTS

Fair value is the price that would be received for an asset or the exit price that would be paid to transfer a liability in the principal or most advantageous market in an orderly transaction between market participants on the measurement date. A fair value hierarchy requires an entity to maximize the use of observable inputs, where available. The following summarizes the three levels of inputs required by the standard that the Company uses to measure fair value:

Level 1: Quoted prices in active markets for identical assets or liabilities

Level 2: Observable inputs other than Level 1 prices, such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the related assets or liabilities.

Level 3: Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities.

The Company’s financial instruments as of August 31, 2012 consisted of $261,831, of Notes Payable, $121,495 of Convertible Notes payable (net of discount), $8,000 due to TheraCyte, Inc, $4,349 of Employee Receivables and $39,140 due from an affiliate. The fair value of all of the Company’s financial instruments as of September 30, 2012 were valued according to the Level 3 input. The carrying amount of the financial instruments is equal to the fair value as determined by the Company.

The Company has determined that there are no Level 1 or Level 2 inputs for determining the fair value of the Company’s financial instruments. Fair value was determined by the Company utilizing its own assumptions and estimation. There were no transfers between levels for the period presented.

G. INCOME TAXES

The Company accounts for income taxes using the liability method prescribed by ASC 740, “Income Taxes.” Under this method, deferred tax assets and liabilities are determined based on the difference between the financial reporting and tax bases of assets and liabilities using enacted tax rates that will be in effect in the year in which the differences are expected to reverse. The Company records a valuation allowance to offset deferred tax assets if based on the weight of available evidence, it is more-likely-than-not that some portion, or all, of the deferred tax assets will not be realized. The effect on deferred taxes of a change in tax rates is recognized as income or loss in the period that includes the enactment date.

The Company applied the provisions of ASC 740-10-50, “Accounting For Uncertainty In Income Taxes”, which provides clarification related to the process associated with accounting for uncertain tax positions recognized in our financial statements. Audit periods remain open for review until the statute of limitations has passed. The completion of review or the expiration of the statute of limitations for a given audit period could result in an adjustment to the Company’s liability for income taxes. Any such adjustment could be material to the Company’s results of operations for any given quarterly or annual period based, in part, upon the results of operations for the given period. As of August 31, 2011 and 2010, the Company had no uncertain tax positions, and will continue to evaluate for uncertain positions in the future.

The Company generated a deferred tax credit through net operating loss carry forward. However, a valuation allowance of 100% has been established.

Interest and penalties on tax deficiencies recognized in accordance with ACS accounting standards are classified as income taxes in accordance with ASC Topic 740-10-50-19.

H. BASIC EARNINGS (LOSS) PER SHARE

The Financial Accounting Standards Board (FASB) issued Accounting Standards Codification (ASC) 260, "Earnings Per Share", which specifies the computation, presentation and disclosure requirements for earnings (loss) per share for entities with publicly held common stock. ASC 260 requires the presentation of basic earnings (loss) per share and diluted earnings (loss) per share. The Company has adopted the provisions of ASC 260 effective from inception. Basic net loss per share amounts is computed by dividing the net income by the weighted average number of common shares outstanding. All convertible debt has an anti-dilutive effect on the EPS , therefore Diluted earnings per share are the same as basic earnings per share.

X

- Details

Name: us-gaap_AccountingPoliciesAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

The entire disclosure for all significant accounting policies of the reporting entity.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section 50

-Paragraph 6

-URI http://asc.fasb.org/extlink&oid=6367646&loc=d3e18861-107790

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6367646&loc=d3e18743-107790

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section 50

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=6367646&loc=d3e18780-107790

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section 50

-Paragraph 5

-URI http://asc.fasb.org/extlink&oid=6367646&loc=d3e18854-107790

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6367646&loc=d3e18726-107790

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher AICPA

-Name Accounting Principles Board Opinion (APB)

-Number 22

-Paragraph 8

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

+ Details

Name: us-gaap_SignificantAccountingPoliciesTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 30 R32.htm IDEA: XBRL DOCUMENT v2.4.0.6

NOTES PAYABLE (Details Narrative) (USD $)

Aug. 31, 2012

Debt Disclosure [Abstract]

Lines of credit provided by Bio Technology Partners Business Trust and Venture Bridge Advisors, each $ 200,000

Unpaid principal lines of credit, simple interest rate per annum 10.00%

Loaned to the Company by Southridge Partners II LLP $ 40,000

X

- Definition

Reflects the effective interest rate as of the balance sheet date on interest-bearing trade payables.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 835

-SubTopic 30

-Section 45

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=6451184&loc=d3e28555-108399

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher AICPA

-Name Accounting Principles Board Opinion (APB)

-Number 21

-Paragraph 13, 14, 16

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 835

-SubTopic 30

-Section 45

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6451184&loc=d3e28551-108399

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 835

-SubTopic 30

-Section 25

-Paragraph 13

-URI http://asc.fasb.org/extlink&oid=6451110&loc=d3e27881-108397

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 835

-SubTopic 30

-Section 25

-Paragraph 12

-URI http://asc.fasb.org/extlink&oid=6451110&loc=d3e27862-108397

+ Details

Name: us-gaap_AccountsPayableInterestBearingInterestRate

Namespace Prefix: us-gaap_

Data Type: num:percentItemType

Balance Type: na

Period Type: instant

X

- Details

Name: us-gaap_DebtDisclosureAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

For entities that provide full or partial financing and servicing for customers supplementary to its major operations (such as a manufacturer or a homebuilder providing and servicing loans to buyers), represents the liabilities associated with such activities, including accounts payable and accrued liabilities.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 944

-SubTopic 210

-Section S99

-Paragraph 1

-Subparagraph (SX 210.7-03.15)

-URI http://asc.fasb.org/extlink&oid=6879938&loc=d3e572229-122910

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 942

-SubTopic 210

-Section S99

-Paragraph 1

-Subparagraph (SX 210.9-03.15)

-URI http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878

+ Details

Name: us-gaap_FinancialServicesLiabilities

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition

The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 944

-SubTopic 210

-Section S99

-Paragraph 1

-Subparagraph (SX 210.7-03.16)

-URI http://asc.fasb.org/extlink&oid=6879938&loc=d3e572229-122910

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 942

-SubTopic 210

-Section S99

-Paragraph 1

-Subparagraph (SX 210.9-03.16)

-URI http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 19, 20, 22

-Article 5

+ Details

Name: us-gaap_LineOfCredit

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

XML 31 R40.htm IDEA: XBRL DOCUMENT v2.4.0.6

DIVIDEND OF SERIES B PREFERRED SHARES (Details Narrative)
0 Months Ended

Mar. 06, 2012

Notes to Financial Statements

Dividend paid to common shareholders 201,397

X

- Details

Name: ENTB_NotesToFinancialStatementsAbstract

Namespace Prefix: ENTB_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

Number of shares of preferred stock issued as dividends during the period. Excludes stock splits.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21463-112644

+ Details

Name: us-gaap_PreferredStockDividendsShares

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

XML 32 R2.htm IDEA: XBRL DOCUMENT v2.4.0.6

Consolidated Balance Sheet (USD $)

Aug. 31, 2012

Aug. 31, 2011

Current Assets

Cash $ 42,737 $ 43,901

Trade accounts receivable, less allowance for uncollectible accounts of $0 and $0 at February 29, 2012 and August 31, 2011 respectively 2,268 3,135

Inventory 10,298 7,986

Due from Affiliate 39,140 0

Current Portion of Prepaid Expenses 13,000 62,200

Employee Receivable 4,349 4,349

Total Current Assets 111,792 121,571

Property & Equipment (Net of Accumulated Depreciation) 8,832 17,293

Goodwill 405,000 405,000

Intangible Assets (Net of Accumulated Amortization) 1,052 1,828

Non Current Assets

Non Current Portion of Prepaid Expenses 10,300

Deposits 1,151 0

Total Non Current Assets 1,151 10,300

TOTAL ASSETS 527,827 555,992

Current Liabilities

Accounts Payable 74,574 27,564

Notes Payable 225,362 159,911

Convertible notes payable, net of discount 121,495 42,430

Due to Other 8,000 8,000

Accrued Expenses 119,726 67,206

Total Current Liabilities 549,157 305,111

Non Current Liabilities

Notes Payable - Non Current 36,469 79,143

Total Non Current Liabilities 36,469 79,143

TOTAL LIABILITIES 585,626 384,254

STOCKHOLDERS' EQUITY

Common Stock, $0.001 par value, authorized 1,000,000,000 shares; issued and outstanding 223,492,927 shares as of August 31, 2012 and August 31, 2011 respectively 223,493 20,838

Preferred Stock , $0.001 par value 5,000,000 shares authorized, 0 shares issued and outstanding as of August 31, 2012 and August 31, 2011 0

Series AA Preferred Stock, $0.001 par value 100,000 shares authorized, 5,000 shares issued and outstanding at August 31, 2012 and as of August 31, 2011 5 5

Series B Preferred Stock, $0.001 par value 4,400,000 shares authorized, 3,201,397 and 0 shares issued and outstanding as of August 31, 2012 and as of August 31, 2011 3,201 0

NonVoting Convertible Preferred, $1 par value 200,000 shares authorized, 75,000 and 0 issued and outstanding as of August 31, 2012 and as of August 31, 2011 75,000 0

Additional Paid in Capital 3,030,642 1,619,330

Contributed Capital 274,162 274,162

Accumulated Deficit (3,664,302) (1,742,597)

Total Stockholders' Equity (57,799) 171,738

TOTAL LIABILITIES & STOCKHOLDERS' EQUITY $ 527,827 $ 555,992

X

- Definition

Contributed capital is the total value of stock that shareholders have directly purchased from the issuing company.

+ References

No definition available.

+ Details

Name: ENTB_ContributedCapital

Namespace Prefix: ENTB_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition

Face amount or stated value per share of nonredeemable nonvoting convertible preferred stock (or nonvoting convertible preferred stock redeemable solely at the option of the issuer); generally not indicative of the fair market value per share.

+ References

No definition available.

+ Details

Name: ENTB_NonvotingConvertiblePreferredParValue

Namespace Prefix: ENTB_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition

Face amount or stated value per share of nonredeemable series AA preferred stock (or series AA preferred stock redeemable solely at the option of the issuer); generally not indicative of the fair market value per share.

+ References

No definition available.

+ Details

Name: ENTB_SeriesAaPreferredStockParValue

Namespace Prefix: ENTB_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition

Series B Preferred Stock, $0.001 par value 4,400,000 shares authorized, 3,201,397 and 0 shares issued and outstanding at May 31, 2012 and as of August 31, 2011

+ References

No definition available.

+ Details

Name: ENTB_SeriesBPreferredStock

Namespace Prefix: ENTB_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition

Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.19(a))

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 19

-Subparagraph a

-Article 5

+ Details

Name: us-gaap_AccountsPayableCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition

Amount due from customers or clients, within one year of the balance sheet date (or the normal operating cycle, whichever is longer), for goods or services (including trade receivables) that have been delivered or sold in the normal course of business, reduced to the estimated net realizable fair value by an allowance established by the entity of the amount it deems uncertain of collection.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.3-4)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 3

-Subparagraph a(1)

-Article 5

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 4

-Article 5

+ Details

Name: us-gaap_AccountsReceivableNetCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition

Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 20

-Article 5

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.20)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_AccruedLiabilitiesCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition

Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders. Includes adjustments to additional paid in capital. Some examples of such adjustments include recording the issuance of debt with a beneficial conversion feature and certain tax consequences of equity instruments awarded to employees. Use this element for the aggregate amount of additional paid-in capital associated with common and preferred stock. For additional paid-in capital associated with only common stock, use the element additional paid in capital, common stock. For additional paid-in capital associated with only preferred stock, use the element additional paid in capital, preferred stock.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 31

-Article 5

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.30(a)(1))

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_AdditionalPaidInCapital

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition

Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 03

-Paragraph 12

-Article 7

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Concepts (CON)

-Number 6

-Paragraph 25

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 18

-Article 5

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.18)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_Assets

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition

Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 9

-Article 5

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.9)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section 45

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=6361293&loc=d3e6801-107765

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section 45

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6361293&loc=d3e6676-107765

+ Details

Name: us-gaap_AssetsCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Details

Name: us-gaap_AssetsCurrentAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold or consumed after one year or beyond the normal operating cycle, if longer.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.10-17)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 18

-Article 5

+ Details

Name: us-gaap_AssetsNoncurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Details

Name: us-gaap_AssetsNoncurrentAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Excludes cash and cash equivalents within disposal group and discontinued operation.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 1

-Article 5

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Cash

-URI http://asc.fasb.org/extlink&oid=6506951

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.1)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 95

-Paragraph 7

-Footnote 1

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

+ Details

Name: us-gaap_Cash

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition

Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.29)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 30

-Article 5

+ Details

Name: us-gaap_CommonStockValue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition

Carrying value as of the balance sheet date of the portion of long-term debt due within one year or the operating cycle if longer identified as Convertible Notes Payable. Convertible Notes Payable is a written promise to pay a note which can be exchanged for a specified amount of another, related security, at the option of the issuer and the holder.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 20

-Article 5

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.20)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_ConvertibleNotesPayableCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition

Carrying value of amounts transferred to third parties for security purposes that are expected to be returned or applied towards payment in the future.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.17)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 17

-Article 5

+ Details

Name: us-gaap_DepositsAssets

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition

Amount of receivables due from an entity that is affiliated with the reporting entity by means of direct or indirect ownership, due within 1 year (or 1 business cycle).

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 3

-Subparagraph a

-Article 5

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.4-08.(k)(1))

-URI http://asc.fasb.org/extlink&oid=6881521&loc=d3e23780-122690

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 850

-SubTopic 10

-Section 50

-Paragraph 1

-Subparagraph (d)

-URI http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.3(a)(2))

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 850

-SubTopic 10

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6457730&loc=d3e39599-107864

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 08

-Paragraph k

-Subparagraph 1

-Article 4

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 850

-SubTopic 10

-Section 50

-Paragraph 4

-URI http://asc.fasb.org/extlink&oid=6457730&loc=d3e39622-107864

Reference 8: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 57

-Paragraph 2

-Subparagraph d

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

+ Details

Name: us-gaap_DueFromAffiliateCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition

Amounts due from an Entity employee, not to include stockholders or officers, which are usually due within 1 year (or 1 business cycle).

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 08

-Paragraph k

-Subparagraph 1

-Article 4

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 57

-Paragraph 2

-Subparagraph d

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.3(a)(2))

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 3

-Subparagraph a

-Article 5

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.4-08.(k)(1))

-URI http://asc.fasb.org/extlink&oid=6881521&loc=d3e23780-122690

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 850

-SubTopic 10

-Section 50

-Paragraph 1

-Subparagraph (d)

-URI http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 850

-SubTopic 10

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6457730&loc=d3e39599-107864

+ Details

Name: us-gaap_DueFromEmployeesCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition

Amount of payable due to an entity that is affiliated with the reporting entity by means of direct or indirect ownership. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 57

-Paragraph 2

-Subparagraph d

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.19(a))

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.4-08.(k)(1))

-URI http://asc.fasb.org/extlink&oid=6881521&loc=d3e23780-122690

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 19

-Subparagraph a

-Article 5

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 850

-SubTopic 10

-Section 50

-Paragraph 1

-Subparagraph (d)

-URI http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 08

-Paragraph k

-Subparagraph 1

-Article 4

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 04

-Paragraph 12

-Subparagraph 3

-Article 6

+ Details

Name: us-gaap_DueToAffiliateCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition

Carrying amount as of the balance sheet date, which is the cumulative amount paid and (if applicable) the fair value of any noncontrolling interest in the acquiree, adjusted for any amortization recognized prior to the adoption of any changes in generally accepted accounting principles (as applicable) and for any impairment charges, in excess of the fair value of net assets acquired in one or more business combination transactions.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 142

-Paragraph 45

-Subparagraph e

-Clause 1

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 350

-SubTopic 20

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=14024403&loc=d3e13816-109267

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 350

-SubTopic 20

-Section 45

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6388280&loc=d3e13770-109266

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 141R

-Paragraph 68

-Subparagraph l

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 141R

-Paragraph 34

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 142

-Paragraph 43

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 142

-Paragraph 45

-Subparagraph e

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 8: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 141R

-Paragraph 72

-Subparagraph d

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

+ Details

Name: us-gaap_Goodwill

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition

Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 350

-SubTopic 30

-Section 45

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6388964&loc=d3e16212-109274

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 350

-SubTopic 30

-Section 50

-Paragraph 2

-Subparagraph ((a)(1),(b))

-URI http://asc.fasb.org/extlink&oid=7658586&loc=d3e16323-109275

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 142

-Paragraph 42, 45

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

+ Details

Name: us-gaap_IntangibleAssetsNetExcludingGoodwill

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition

Carrying amount (lower of cost or market) as of the balance sheet date of inventories less all valuation and other allowances. Excludes noncurrent inventory balances (expected to remain on hand past one year or one operating cycle, if longer).

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.6(a))

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 330

-SubTopic 10

-Section 35

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6386567&loc=d3e3927-108312

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section 45

-Paragraph 1

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=6361293&loc=d3e6676-107765

+ Details

Name: us-gaap_InventoryNet

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition

Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.19-26)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_Liabilities

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition

Total of all Liabilities and Stockholders' Equity items (or Partners' Capital, as applicable), including the portion of equity attributable to noncontrolling interests, if any.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.32)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 03

-Paragraph 25

-Article 7

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 32

-Article 5

+ Details

Name: us-gaap_LiabilitiesAndStockholdersEquity

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition

Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.21)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 21

-Article 5

+ Details

Name: us-gaap_LiabilitiesCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Details

Name: us-gaap_LiabilitiesCurrentAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

Total obligations incurred as part of normal operations that is expected to be repaid beyond the following twelve months or one business cycle.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.22-26)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 22, 23, 24, 25, 26, 27

-Article 5

+ Details

Name: us-gaap_LiabilitiesNoncurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Details

Name: us-gaap_LiabilitiesNoncurrentAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

Carrying value as of the balance sheet date of notes payable (with maturities initially due after one year or beyond the operating cycle if longer), excluding current portion.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.22)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 22

-Article 5

+ Details

Name: us-gaap_LongTermNotesPayable

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition

Sum of the carrying values as of the balance sheet date of the portions of long-term notes payable due within one year or the operating cycle if longer.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.19,20)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 19, 20

-Article 5

+ Details

Name: us-gaap_NotesPayableCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition

Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 29

-Article 5

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.28)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher AICPA

-Name Accounting Principles Board Opinion (APB)

-Number 12

-Paragraph 10

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 129

-Paragraph 2, 3, 4, 5, 6, 7, 8

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 04

-Article 3

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.3-04)

-URI http://asc.fasb.org/extlink&oid=6959260&loc=d3e187085-122770

+ Details

Name: us-gaap_PreferredStockValue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition

Sum of the amounts paid in advance for capitalized costs that will be expensed with the passage of time or the occurrence of a triggering event, and will be charged against earnings within one year or the normal operating cycle, if longer.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section 45

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6361293&loc=d3e6787-107765

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 340

-SubTopic 10

-Section 05

-Paragraph 5

-URI http://asc.fasb.org/extlink&oid=6386993&loc=d3e5879-108316

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher AICPA

-Name Accounting Research Bulletin (ARB)

-Number 43

-Section A

-Paragraph 4

-Chapter 3

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Current Assets

-URI http://asc.fasb.org/extlink&oid=6509628

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section 45

-Paragraph 1

-Subparagraph (g)

-URI http://asc.fasb.org/extlink&oid=6361293&loc=d3e6676-107765

+ Details

Name: us-gaap_PrepaidExpenseCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition

Sum of the carrying amounts as of the balance sheet date of amounts paid in advance for expenses which will be charged against earnings in periods after one year or beyond the operating cycle, if longer.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.17)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 17

-Article 5

+ Details

Name: us-gaap_PrepaidExpenseNoncurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition

Amount, net of accumulated depreciation, depletion and amortization, of long-lived physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 03

-Paragraph 8

-Article 7

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 12

-Paragraph 5

-Subparagraph b, c

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 360

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.13)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 13

-Subparagraph a

-Article 5

+ Details

Name: us-gaap_PropertyPlantAndEquipmentNet

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition

The cumulative amount of the reporting entity's undistributed earnings or deficit.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.31(a)(3))

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher AICPA

-Name Accounting Principles Board Opinion (APB)

-Number 12

-Paragraph 10

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 31

-Article 5

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 04

-Article 3

+ Details

Name: us-gaap_RetainedEarningsAccumulatedDeficit

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition

Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.29-31)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 29, 30, 31

-Article 5

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher AICPA

-Name Accounting Research Bulletin (ARB)

-Number 51

-Paragraph A3

-Appendix A

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 310

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SAB TOPIC 4.E)

-URI http://asc.fasb.org/extlink&oid=6228006&loc=d3e74512-122707

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Staff Accounting Bulletin (SAB)

-Number Topic 4

-Section E

+ Details

Name: us-gaap_StockholdersEquity

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Details

Name: us-gaap_StockholdersEquityAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 33 R6.htm IDEA: XBRL DOCUMENT v2.4.0.6

Consolidated Statement of Cash Flows (USD $)
12 Months Ended

Aug. 31, 2012

Aug. 31, 2011

OPERATING ACTIVITIES

Net (loss) $ (1,889,563) $ (951,783)

Adjustments to reconcile net loss to net cash used by operating activities:

Depreciation Expense 8,461 5,591

Amortization Expense 776 505

Stock issued as Compensation to Employees 48,681 55,399

Stock issued as Compensation to Consultants 181,540 122,007

Change in operating assets and liabilities:

(Increase) Decrease in Trade Accounts Receivable 867 (3,135)

(Increase) Decrease in Inventory (2,312) (7,986)

(Increase) Decrease in Employee Receivable (2,953)

Increase (Decrease) in Accounts Payable 47,010 6,222

(Increase) Decrease in Prepaid Expenses 59,500 10,100

(Increase) Decrease in Due from Affiliate (39,140)

(Increase) Decrease in Deposits (1,151) 1,059

Increase (Decrease) in amortization of intangibles 16,667

Increase (Decrease) in Accrued Expenses 52,520 (60,889)

(Increase) Decrease on gain realized on cancellation of stock (94,937)

Increase (Decrease) in Loss on Impairment of Intangible Assets 683,333

Net Cash Provided Used in Operating Activities (927,748) (825,863)

INVESTING ACTIVITIES

Purchase/Sale of Equipment 0 (22,884)

Net cash Provided by (Used in) Investing Activities 0 (22,884)

FINANCING ACTIVITIES

(Increase) Decrease in Goodwill from acquisition (195,000)

Stock issued in Payment of Debt 374,959 341,167

Increase (Decrease) in Common stock issued for cash 217,600

(Increase) Decrease in Intangible Assets (net) (2,299)

Increase (Decrease) in Common stock issued for expenses 104,768

Increase (Decrease) in Due to Affiliate 8,000

Increase (Decrease) in Notes Payable 470,901 516,085

Increase (Decrease) in Contributed Capital 259,058

Increase (Decrease) in Additional paid in Capital 350,915 88,998

Net Cash Provided by Financing Activities 926,584 892,442

Net Increase in Cash (1,164) 43,695

Cash at Beginning of Period 43,901 206

Cash at End of Period 42,737 43,901

Supplemental Disclosure of Noncash investing and financing activities:

Stock issued in payment of Debt 369,059 391,167

Stock issued in Acquisition of McDonald Animal Hospital 210,000

Stock issued pursuant to Titterington Agreement $ 700,000

X

- Definition

Increase (Decrease) in Additional paid in Capital

+ References

No definition available.

+ Details

Name: ENTB_IncreaseDecreaseInAdditionalPaidInCapital

Namespace Prefix: ENTB_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

Increase (Decrease) in Common stock issued for cash

+ References

No definition available.

+ Details

Name: ENTB_IncreaseDecreaseInCommonStockIssuedForCash

Namespace Prefix: ENTB_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

Increase (Decrease) in Common stock issued for expenses

+ References

No definition available.

+ Details

Name: ENTB_IncreaseDecreaseInCommonStockIssuedForExpenses

Namespace Prefix: ENTB_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

Increase (Decrease) in Contributed Capital

+ References

No definition available.

+ Details

Name: ENTB_IncreaseDecreaseInContributedCapital

Namespace Prefix: ENTB_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

Increase (Decrease) in Loss on Impairment of Intangible Assets

+ References

No definition available.

+ Details

Name: ENTB_IncreaseDecreaseInLossOnImpairmentOfIntangibleAssets

Namespace Prefix: ENTB_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

(Increase) Decrease on gain realized on cancellation of stock

+ References

No definition available.

+ Details

Name: ENTB_IncreaseDecreaseOnGainRealizedOnCancellationOfStock

Namespace Prefix: ENTB_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

The aggregate amount of recurring noncash expense charged against earnings in the period to allocate the cost of assets over their estimated remaining economic lives.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3602-108585

+ Details

Name: us-gaap_AdjustmentForAmortization

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Details

Name: us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section 45

-Paragraph 1

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=6361293&loc=d3e6676-107765

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Cash Equivalents

-URI http://asc.fasb.org/extlink&oid=6507016

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 95

-Paragraph 8, 9

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 95

-Paragraph 7, 26

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Cash

-URI http://asc.fasb.org/extlink&oid=6506951

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 4

-URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3044-108585

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 95

-Paragraph 7

-Footnote 1

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 8: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.1)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 9: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 1

-Article 5

+ Details

Name: us-gaap_CashAndCashEquivalentsAtCarryingValue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition

Amount of increase (decrease) in cash. Cash is the amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Excludes cash and cash equivalents within disposal group and discontinued operation.

+ References

No definition available.

+ Details

Name: us-gaap_CashPeriodIncreaseDecrease

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition

The value of the financial instrument(s) that the original debt is being converted into in a noncash (or part noncash) transaction. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 50

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=6367179&loc=d3e4304-108586

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 95

-Paragraph 32

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 50

-Paragraph 5

-URI http://asc.fasb.org/extlink&oid=6367179&loc=d3e4332-108586

+ Details

Name: us-gaap_DebtConversionConvertedInstrumentAmount1

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 95

-Paragraph 28

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher AICPA

-Name Accounting Principles Board Opinion (APB)

-Number 12

-Paragraph 5

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3602-108585

+ Details

Name: us-gaap_Depreciation

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition

Costs and payments related to employee benefits and equity-based compensation, such as pension expense and contributions, other postretirement benefits expense and payments, stock or unit options expense, and amortization of restricted stock or unit.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 95

-Paragraph 28

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3602-108585

+ Details

Name: us-gaap_EmployeeBenefitsAndShareBasedCompensation

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition

Change in the carrying value of goodwill. The change could be the result of new goodwill acquired, goodwill impairment, if any, goodwill written off related to the sale of a business or other adjustments to goodwill.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 350

-SubTopic 20

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=14024403&loc=d3e13816-109267

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 142

-Paragraph 45

-Subparagraph e

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 141R

-Paragraph 72

-Subparagraph d

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

+ Details

Name: us-gaap_GoodwillPeriodIncreaseDecrease

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: na

Period Type: duration

X

- Definition

The increase (decrease) during the reporting period in receivables to be collected from an entity that is controlling, under the control of, or within the same control group as the reporting entity by means of direct or indirect ownership.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 95

-Paragraph 28

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3602-108585

+ Details

Name: us-gaap_IncreaseDecreaseDueFromAffiliates

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 95

-Paragraph 28

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3602-108585

+ Details

Name: us-gaap_IncreaseDecreaseInAccountsPayable

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition

The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 95

-Paragraph 28

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3602-108585

+ Details

Name: us-gaap_IncreaseDecreaseInAccountsReceivable

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 95

-Paragraph 28

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3602-108585

+ Details

Name: us-gaap_IncreaseDecreaseInAccruedLiabilities

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition

The net cash inflow or outflow for the increase (decrease) in the beginning and end of period deposits balances.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 942

-SubTopic 230

-Section 45

-Paragraph 1

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=6477933&loc=d3e60009-112784

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 8

-URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3095-108585

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher AICPA

-Name Audit and Accounting Guide (AAG)

-Number AAG-DEP

-IssueDate 2006-05-01

-Chapter 13

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

+ Details

Name: us-gaap_IncreaseDecreaseInDeposits

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition

The increase (decrease) during the reporting period in the amount due within one year (or one business cycle) from employees for floats, allowances and loans (generally evidenced by promissory notes).

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 95

-Paragraph 28

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3602-108585

+ Details

Name: us-gaap_IncreaseDecreaseInDueFromEmployeeCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

The increase (decrease) in obligations owed to an entity that is controlling, under the control of, or within the same control group as the reporting entity by means of direct or indirect ownership.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 95

-Paragraph 28

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3602-108585

+ Details

Name: us-gaap_IncreaseDecreaseInDueToAffiliates

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition

The increase (decrease) during the reporting period in intangible assets (for example patents and licenses).

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 95

-Paragraph 28

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3602-108585

+ Details

Name: us-gaap_IncreaseDecreaseInIntangibleAssetsCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 95

-Paragraph 28

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3602-108585

+ Details

Name: us-gaap_IncreaseDecreaseInInventories

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

The increase (decrease) during the reporting period in current portion (due within one year or one business cycle) of obligations evidenced by formal promissory notes.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 95

-Paragraph 28

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3602-108585

+ Details

Name: us-gaap_IncreaseDecreaseInNotesPayableCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Details

Name: us-gaap_IncreaseDecreaseInOperatingCapitalAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

The increase (decrease) during the reporting period in other noncurrent operating assets not separately disclosed in the statement of cash flows.

+ References

No definition available.

+ Details

Name: us-gaap_IncreaseDecreaseInOtherNoncurrentAssets

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

The increase (decrease) during the reporting period in the amount of outstanding money paid in advance for goods or services that bring economic benefits for future periods.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 95

-Paragraph 28

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3602-108585

+ Details

Name: us-gaap_IncreaseDecreaseInPrepaidExpense

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

The net cash inflow or outflow from financing activity for the period.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 24

-URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3521-108585

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 26

-URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3574-108585

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 95

-Paragraph 26

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

+ Details

Name: us-gaap_NetCashProvidedByUsedInFinancingActivities

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Details

Name: us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

The net cash inflow or outflow from investing activity.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 24

-URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3521-108585

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 26

-URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3574-108585

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 95

-Paragraph 26

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

+ Details

Name: us-gaap_NetCashProvidedByUsedInInvestingActivities

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Details

Name: us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

The net cash from (used in) all of the entity's operating activities, including those of discontinued operations, of the reporting entity. Operating activities generally involve producing and delivering goods and providing services. Operating activity cash flows include transactions, adjustments, and changes in value that are not defined as investing or financing activities. While for technical reasons this element has no balance attribute, the default assumption is a debit balance consistent with its label.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 95

-Paragraph 26

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 25

-URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3536-108585

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3602-108585

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 95

-Paragraph 28

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 24

-URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3521-108585

+ Details

Name: us-gaap_NetCashProvidedByUsedInOperatingActivities

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: na

Period Type: duration

X

- Details

Name: us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher AICPA

-Name Accounting Research Bulletin (ARB)

-Number 51

-Paragraph A1, A4, A5

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 810

-SubTopic 10

-Section 45

-Paragraph 19

-URI http://asc.fasb.org/extlink&oid=7656940&loc=SL4569616-111683

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher AICPA

-Name Accounting Research Bulletin (ARB)

-Number 51

-Paragraph 29

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher AICPA

-Name Accounting Research Bulletin (ARB)

-Number 51

-Paragraph 5

-Subparagraph b

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 810

-SubTopic 10

-Section 55

-Paragraph 4K

-URI http://asc.fasb.org/extlink&oid=18733213&loc=SL4591552-111686

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 810

-SubTopic 10

-Section 50

-Paragraph 1A

-Subparagraph (a),(c)

-URI http://asc.fasb.org/extlink&oid=18733093&loc=SL4573702-111684

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher AICPA

-Name Accounting Research Bulletin (ARB)

-Number 51

-Paragraph 38

-Subparagraph c(1)

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 8: http://www.xbrl.org/2003/role/presentationRef

-Publisher AICPA

-Name Accounting Research Bulletin (ARB)

-Number 51

-Paragraph 38

-Subparagraph a

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 9: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 810

-SubTopic 10

-Section 55

-Paragraph 4J

-URI http://asc.fasb.org/extlink&oid=18733213&loc=SL4591551-111686

+ Details

Name: us-gaap_ProfitLoss

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

Property, plant and equipment additions minus disposals plus or minus transfers and other changes equals the increase or decrease in property, plant and equipment for the period.

+ References

No definition available.

+ Details

Name: us-gaap_PropertyPlantAndEquipmentGrossPeriodIncreaseDecrease

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: na

Period Type: duration

X

- Definition

The amount by which the statement of cash flows was affected by a transaction in which equity securities were issued to pay for goods or nonemployee services.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 123R

-Paragraph 65

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 1

-Subparagraph (d)

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5047-113901

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 50

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=6367179&loc=d3e4304-108586

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 123R

-Paragraph 64

-Subparagraph d

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 95

-Paragraph 32

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 50

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6406099&loc=d3e25284-112666

+ Details

Name: us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionCashFlowEffects

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition

The fair value of stock issued in noncash financing activities.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 50

-Paragraph 5

-URI http://asc.fasb.org/extlink&oid=6367179&loc=d3e4332-108586

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 50

-Paragraph 4

-URI http://asc.fasb.org/extlink&oid=6367179&loc=d3e4313-108586

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 50

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=6367179&loc=d3e4304-108586

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 95

-Paragraph 32

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

+ Details

Name: us-gaap_StockIssued1

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

Value of stock issued pursuant to acquisitions during the period.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.3-04)

-URI http://asc.fasb.org/extlink&oid=6959260&loc=d3e187085-122770

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.29-31)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher AICPA

-Name Accounting Principles Board Opinion (APB)

-Number 12

-Paragraph 10

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 29, 30, 31

-Article 5

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 04

-Article 3

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21463-112644

+ Details

Name: us-gaap_StockIssuedDuringPeriodValueAcquisitions

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

Value of shares of stock issued during the period that is attributable to transactions involving issuance of stock not separately disclosed.

+ References

No definition available.

+ Details

Name: us-gaap_StockIssuedDuringPeriodValueOther

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Details

Name: us-gaap_SupplementalCashFlowInformationAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 34 R35.htm IDEA: XBRL DOCUMENT v2.4.0.6

INCOME TAXES (Details Narrative) (USD $)
12 Months Ended

Aug. 31, 2012

Income Tax Disclosure [Abstract]

Deferred tax asset $ 1,250,503

Net operating loss carry forwards 3,677,949

Expiration of net operating loss carry forwards 20 years

Net operating loss carry forwards acquired in the reverse acquisition of Entest BioMedical, Inc. 13,647

Net operating loss carry forwards attributable to Entest BioMedical, Inc. 3,664,302

Deferred tax assets, net valuation allowance $ 0

Federal Corporate Rate income tax 34.00%

X

- Definition

The expiration date (in number of years) of the operating loss carryforward included in total operating loss carryforwards.

+ References

No definition available.

+ Details

Name: ENTB_ExpirationOfNetOperatingLossCarryForwards

Namespace Prefix: ENTB_

Data Type: xbrli:durationItemType

Balance Type: na

Period Type: instant

X

- Definition

Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards expected to be realized or consumed within one year or operating cycle, if longer.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 740

-SubTopic 10

-Section 50

-Paragraph 2

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32537-109319

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 740

-SubTopic 10

-Section 45

-Paragraph 5

-URI http://asc.fasb.org/extlink&oid=21917399&loc=d3e31928-109318

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 740

-SubTopic 10

-Section 45

-Paragraph 4

-URI http://asc.fasb.org/extlink&oid=21917399&loc=d3e31917-109318

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 740

-SubTopic 10

-Section 45

-Paragraph 9

-URI http://asc.fasb.org/extlink&oid=21917399&loc=d3e31958-109318

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 740

-SubTopic 10

-Section 45

-Paragraph 6

-URI http://asc.fasb.org/extlink&oid=21917399&loc=d3e31931-109318

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 109

-Paragraph 41, 42, 43

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

+ Details

Name: us-gaap_DeferredTaxAssetsNetCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition

Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 740

-SubTopic 10

-Section 25

-Paragraph 20

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=6969291&loc=d3e28680-109314

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 740

-SubTopic 10

-Section 50

-Paragraph 6

-URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32621-109319

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 109

-Paragraph 43, 289

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 740

-SubTopic 10

-Section 50

-Paragraph 8

-URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32632-109319

+ Details

Name: us-gaap_DeferredTaxAssetsOperatingLossCarryforwards

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition

The amount as of the balance sheet date of the estimated future tax effects attributable to policy acquisition costs being expensed for tax purposes but capitalized in conformity with generally accepted accounting principles, which will reverse in future periods when amortization of such capitalized costs cannot be deducted for tax purposes.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 740

-SubTopic 10

-Section 50

-Paragraph 8

-URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32632-109319

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 109

-Paragraph 11

-Subparagraph d

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 740

-SubTopic 10

-Section 50

-Paragraph 6

-URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32621-109319

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 740

-SubTopic 10

-Section 25

-Paragraph 20

-URI http://asc.fasb.org/extlink&oid=6969291&loc=d3e28680-109314

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 109

-Paragraph 43

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

+ Details

Name: us-gaap_DeferredTaxLiabilitiesDeferredExpenseDeferredPolicyAcquisitionCost

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition

The domestic federal statutory tax rate applicable under enacted tax laws to the Company's pretax income from continuing operations for the period. The "statutory" tax rate is the regular tax rate if there are alternative tax systems.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 109

-Paragraph 47

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 740

-SubTopic 10

-Section 50

-Paragraph 12

-URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32687-109319

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 740

-SubTopic 10

-Section 50

-Paragraph 13

-URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32698-109319

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 740

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SAB TOPIC 6.I)

-URI http://asc.fasb.org/extlink&oid=6889476&loc=d3e330036-122817

+ Details

Name: us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate

Namespace Prefix: us-gaap_

Data Type: num:percentItemType

Balance Type: na

Period Type: duration

X

- Details

Name: us-gaap_IncomeTaxDisclosureAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

The sum of domestic, foreign and state and local operating loss carryforwards, before tax effects, available to reduce future taxable income under enacted tax laws.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 740

-SubTopic 10

-Section 50

-Paragraph 3

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32559-109319

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 109

-Paragraph 48

-Subparagraph a

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

+ Details

Name: us-gaap_OperatingLossCarryforwards

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition

The cumulative amount of future tax effects arising from the unused tax credit carryforward attributable to some other tax carryforward (not otherwise stated) that cannot be utilized on the tax return during the period and that may be carried forward and are expected to more likely than not be used to reduce taxable income or taxes payable in future periods.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 109

-Paragraph 43

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 109

-Paragraph 48

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 109

-Paragraph 17

-Subparagraph d

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

+ Details

Name: us-gaap_OtherTaxCarryforwardDeferredTaxAsset

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

XML 35 R22.htm IDEA: XBRL DOCUMENT v2.4.0.6

SUBSEQUENT EVENTS
12 Months Ended

Aug. 31, 2012

Subsequent Events [Abstract]

SUBSEQUENT EVENTS

NOTE 17. SUBSEQUENT EVENTS

Between September 4, 2012 and September 17, 2012 the Company sold 26,802,465 common shares to Southridge for the gross amount of $50,000 pursuant to the June Purchase Agreement.

On September 21 , 2012 the Company paid $20,000 of indebtedness due to Southridge.

On September 20, 2012 the Company issued a convertible promissory note in the amount of $63,000 cash from which was received September 27, 2012. The note bears an interest rate of eight percent (8%), matures on June 25, 2013. and may be converted after 180 days from execution of this note for shares of the Company’s common stock. The note may be converted at a thirty nine percent (39%) discount to the average of the lowest 3 closing bid prices of the common stock during the 10 trading days prior to the conversion date.

On October 2 , 2012 the Company sold 10,837,849 common shares to Southridge for the gross amount of $14,300 pursuant to the June Purchase Agreement. Total gross proceeds of $14,300 were utilized to pay $14,300 of debt due to Southridge by the Company.

On October 17, 2012 the Company issued 23,000,000 common shares in satisfaction of $19,320 of outstanding convertible indebtedness.

On October 17, 2012 the Company amended its certificate of incorporation in order to authorize 2,000,000,000 shares of Common Stock

On October 22, 2012 the Company issued 10,810,811 common shares in satisfaction of $8,000 of outstanding convertible indebtedness.

On November 28, 2012 the “Company executed an agreement (“Agreement”) with Gregory McDonald ("McDonald"), Pet Pointers, Inc. ("Pet Pointer") whereby Mc Donald and Pet Pointer would acquire from the Company all assets ( with the exception of cash and accounts receivable) utilized by the Company in the operation of the McDonald Animal Hospital, a full service veterinary clinic owned and operated by the Company and located in Santa Barbara, California (“McDonald Asset Sale”).

On October 10, 2012 a Complaint (“Complaint”) was filed in the Superior Court of the State of California against the Company and David Koos by McDonald, a former employee of the Company, alleging breach of contract and breach of the covenant of good faith and dealing in connection with the assumption of lease obligations by the Company in connection with the acquisition of the assets of Pet Pointers, Inc breach of contract and breach of the covenant of good faith and dealing in connection with an employment agreement enters into with McDonald inc connection with the Acquisition, breach of contract in connection with the Acquisition purchase agreement, breach of the covenant of good faith and dealing in connection with the Acquisition purchase agreement, implied indemnity in connection to amounts owed by McDonald to Anthony and Judi Marinelli, the Internal Revenue Service, and the California Franchise Tax Board, intentional misrepresentation, negligent misrepresentation , failure to pay wages and violations of Sections 2802, 203, and 2806 of the California Labor Code. The Complaint sought judgment for nominal damages, actual damages, compensatory damages, lost wages, compensation, expenses wage benefits and penalties pursuant to California Labor Code Sections 203 et al, 2802 and 2806, indemnification, accrued interest, punitive damages, costs of suit and attorney’s fees.

As consideration to the Company for the assets acquired, McDonald and Pet Pointers provided to the Company a General release whereby McDonald and Pet Pointer waive, release and discharge the Company and their respective assignees, officers, directors, shareholders, boards, owners, employees, attorneys, agents, trustors, trustees, beneficiaries, heirs, successors, and representatives from all known and unknown claims, demands, causes of action, attorney's fees, costs, or expenses including:

(1) All claims relating to the Complaint.

(2) Those owed by McDonald to Anthony and Judi Marinelli which the Company became obligated to pay on McDonald’s behalf pursuant to the asset purchase agreement entered into between the Company and Gregory McDonald and Pet Pointers, Inc on January 4, 2011. The balance due on this obligation as of December 5, 2012 was $55,000.

(3) Those amounts owed by McDonald to the Internal Revenue Service which the Company became obligated to pay on McDonald’s behalf pursuant to the asset purchase agreement entered into between the Company and Gregory McDonald and Pet Pointers, Inc on January 4, 2011. The balance due on this obligation as of December 5, 2012 was $6,369.69.

(4) Those amounts owed by McDonald to the California Franchise Tax Board which the Company became obligated to pay on McDonald’s behalf pursuant to the asset purchase agreement entered into between the Company and Gregory McDonald and Pet Pointers, Inc on January 4, 2011. The balance due on this obligation as of December 5, 2012 was $3,474.

Assets disposed of pursuant to the Agreement include approximately $4,897 of Property Plant and Equipment net of accumulated depreciation as well as all inventory held at the McDonald Animal Hospital.

Assets disposed of pursuant to the Agreement also include

(i) Essentially all intellectual property, including computer software, utilized in connection with the operation of the McDonald Animal Hospital.

(ii) All telephone numbers, fax numbers, service marks, trademarks, trade names, fictitious business names, websites, business email addresses, vendor lists, promotional materials, vendor records and any and all business records including, but not limited to, such items stored in computer memories, microfiche, paper record or by any other means relevant to the operation of the McDonald Animal Hospital.

(iii) All customer lists, customer contacts, and any and all customer records that are related to the McDonald Animal Hospital.

As a result of the agreement, the Company anticipates recording a non-cash pre-tax charge for the impairment of goodwill recorded in connection with the acquisition of the McDonald Animal Hospital of approximately $405,000 for the quarter ended November 30, 2012.

Pursuant to the Agreement, the Company is obligated to make payment of $13,000 within five days of the Closing of the Agreement as such term is defined in the Agreement.

Pursuant to the Agreement, the Company agrees to waive, release and discharge McDonald and Pet Pointer from all known and unknown claims, demands, causes of action, attorney's fees, costs, or expenses.

X

- Details

Name: us-gaap_SubsequentEventsAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.

+ References

No definition available.

+ Details

Name: us-gaap_SubsequentEventsTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 36 R36.htm IDEA: XBRL DOCUMENT v2.4.0.6

ACQUISITION OF ENTEST CA (Details Narrative)

Jul. 10, 2009

Business Combinations [Abstract]

Acquisition of Entest CA 100.00%

Newly issued common shares of Entest 10,000,000

Cancellation of shares of common stock 10,000,000

X

- Definition

The return by Mr. Rick Plote of shares of Entest’s common stock previously issued to him by Entest for cancellation.

+ References

No definition available.

+ Details

Name: ENTB_CancellationOfSharesOfCommonStock

Namespace Prefix: ENTB_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Details

Name: us-gaap_BusinessCombinationsAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

In a business combination achieved in stages, this element represents the acquisition-date percentage of equity in the acquiree held by the acquirer immediately before the acquisition date.

+ References

No definition available.

+ Details

Name: us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage

Namespace Prefix: us-gaap_

Data Type: num:percentItemType

Balance Type: na

Period Type: instant

X

- Definition

Number of shares of stock issued as of the balance sheet date, including shares that had been issued and were previously outstanding but which are now held in the treasury.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21463-112644

+ Details

Name: us-gaap_SharesIssued

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

XML 37 R24.htm IDEA: XBRL DOCUMENT v2.4.0.6

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)
12 Months Ended

Aug. 31, 2012

Accounting Policies [Abstract]

Property Plant and Equipment, Acquisition Costs

Property Plant and Equipment

Acquisition Cost Estimated useful Life (Months) Total

Office Equipment 30 3,235

Medical Equipment 30 17,523

Computer Equipment 30 2,126

Subtotal 22,884

Less Accumulated Depreciation (14,052)

Total 8,832

X

- Details

Name: us-gaap_AccountingPoliciesAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

Tabular disclosure of all information related to any significant acquisition and disposal. Disclosure may include methodology and assumptions, type of asset, asset classification, useful life, useful purpose, acquisition cost, method of acquisition or disposal, depreciation method, gain (loss) on disposal pretax and net of tax, date of acquisition or disposal and restrictions on amount of proceeds from donated assets.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 205

-SubTopic 20

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6360339&loc=d3e1361-107760

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 144

-Paragraph 47

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

+ Details

Name: us-gaap_PropertyPlantAndEquipmentScheduleOfSignificantAcquisitionsAndDisposalsTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 38 Show.js IDEA: XBRL DOCUMENT /** * Rivet Software Inc. * * @copyright Copyright (c) 2006-2011 Rivet Software, Inc. All rights reserved. * Version 2.1.0.1 * */ var moreDialog = null; var Show = { Default:'raw', more:function( obj ){ var bClosed = false; if( moreDialog != null ) { try { bClosed = moreDialog.closed; } catch(e) { //Per article at http://support.microsoft.com/kb/244375 there is a problem with the WebBrowser control // that somtimes causes it to throw when checking the closed property on a child window that has been //closed. So if the exception occurs we assume the window is closed and move on from there. bClosed = true; } if( !bClosed ){ moreDialog.close(); } } obj = obj.parentNode.getElementsByTagName( 'pre' )[0]; var hasHtmlTag = false; var objHtml = ''; var raw = ''; //Check for raw HTML var nodes = obj.getElementsByTagName( '*' ); if( nodes.length ){ objHtml = obj.innerHTML; }else{ if( obj.innerText ){ raw = obj.innerText; }else{ raw = obj.textContent; } var matches = raw.match( /<\/?[a-zA-Z]{1}\w*[^>]*>/g ); if( matches && matches.length ){ objHtml = raw; //If there is an html node it will be 1st or 2nd, // but we can check a little further. var n = Math.min( 5, matches.length ); for( var i = 0; i < n; i++ ){ var el = matches[ i ].toString().toLowerCase(); if( el.indexOf( '= 0 ){ hasHtmlTag = true; break; } } } } if( objHtml.length ){ var html = ''; if( hasHtmlTag ){ html = objHtml; }else{ html = ''+ "\n"+''+ "\n"+' Report Preview Details'+ "\n"+' '+ "\n"+''+ "\n"+''+ objHtml + "\n"+''+ "\n"+''; } moreDialog = window.open("","More","width=700,height=650,status=0,resizable=yes,menubar=no,toolbar=no,scrollbars=yes"); moreDialog.document.write( html ); moreDialog.document.close(); if( !hasHtmlTag ){ moreDialog.document.body.style.margin = '0.5em'; } } else { //default view logic var lines = raw.split( "\n" ); var longest = 0; if( lines.length > 0 ){ for( var p = 0; p < lines.length; p++ ){ longest = Math.max( longest, lines[p].length ); } } //Decide on the default view this.Default = longest < 120 ? 'raw' : 'formatted'; //Build formatted view var text = raw.split( "\n\n" ) >= raw.split( "\r\n\r\n" ) ? raw.split( "\n\n" ) : raw.split( "\r\n\r\n" ) ; var formatted = ''; if( text.length > 0 ){ if( text.length == 1 ){ text = raw.split( "\n" ) >= raw.split( "\r\n" ) ? raw.split( "\n" ) : raw.split( "\r\n" ) ; formatted = "
"+ text.join( "

\n" ) +"
"; }else{ for( var p = 0; p < text.length; p++ ){ formatted += "
" + text[p] + "
\n"; } } }else{ formatted = '
' + raw + '
'; } html = ''+ "\n"+''+ "\n"+' Report Preview Details'+ "\n"+' '+ "\n"+''+ "\n"+''+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+'
'+ "\n"+' formatted: '+ ( this.Default == 'raw' ? 'as Filed' : 'with Text Wrapped' ) +''+ "\n"+'
'+ "\n"+'
'+formatted+'
'+ "\n"+'
'+ "\n"+'
'+raw+'
'+ "\n"+'
'+ "\n"+''+ "\n"+''; moreDialog = window.open("","More","width=700,height=650,status=0,resizable=yes,menubar=no,toolbar=no,scrollbars=yes"); moreDialog.document.write(html); moreDialog.document.close(); this.toggle( moreDialog ); } moreDialog.document.title = 'Report Preview Details'; }, toggle:function( win, domLink ){ var domId = this.Default; var doc = win.document; var domEl = doc.getElementById( domId ); domEl.style.display = 'block'; this.Default = domId == 'raw' ? 'formatted' : 'raw'; if( domLink ){ domLink.innerHTML = this.Default == 'raw' ? 'with Text Wrapped' : 'as Filed'; } var domElOpposite = doc.getElementById( this.Default ); domElOpposite.style.display = 'none'; }, LastAR : null, showAR : function ( link, id, win ){ if( Show.LastAR ){ Show.hideAR(); } var ref = link; do { ref = ref.nextSibling; } while (ref && ref.nodeName != 'TABLE'); if (!ref || ref.nodeName != 'TABLE') { var tmp = win ? win.document.getElementById(id) : document.getElementById(id); if( tmp ){ ref = tmp.cloneNode(true); ref.id = ''; link.parentNode.appendChild(ref); } } if( ref ){ ref.style.display = 'block'; Show.LastAR = ref; } }, toggleNext : function( link ){ var ref = link; do{ ref = ref.nextSibling; }while( ref.nodeName != 'DIV' ); if( ref.style && ref.style.display && ref.style.display == 'none' ){ ref.style.display = 'block'; if( link.textContent ){ link.textContent = link.textContent.replace( '+', '-' ); }else{ link.innerText = link.innerText.replace( '+', '-' ); } }else{ ref.style.display = 'none'; if( link.textContent ){ link.textContent = link.textContent.replace( '-', '+' ); }else{ link.innerText = link.innerText.replace( '-', '+' ); } } }, hideAR : function(){ Show.LastAR.style.display = 'none'; } } XML 39 R7.htm IDEA: XBRL DOCUMENT v2.4.0.6

ORGANIZATION AND DESCRIPTION OF BUSINESS
12 Months Ended

Aug. 31, 2012

Accounting Policies [Abstract]

ORGANIZATION AND DESCRIPTION OF BUSINESS

NOTE 1. ORGANIZATION AND DESCRIPTION OF BUSINESS

Entest BioMedical Inc. (the “Company”) was incorporated in the State of Nevada on September 24, 2008 as JB Clothing Corporation. Until July 10, 2009, the Company’s principal business objective was the offering of active/leisure fashion design clothing.

On July 10, 2009 the Company abandoned its efforts in the field of active/leisure fashion design clothing when it acquired 100% of the share capital of Entest BioMedical, Inc., a California corporation, (“Entest CA”).

The Company’s current business consists of the development and commercialization of immunotherapeutic therapies for the veterinary market as well as the acquisition and operation of veterinary hospitals.

X

- Details

Name: us-gaap_AccountingPoliciesAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

The entire disclosure for the business description and basis of presentation concepts. Business description describes the nature and type of organization including but not limited to organizational structure as may be applicable to holding companies, parent and subsidiary relationships, business divisions, business units, business segments, affiliates and information about significant ownership of the reporting entity. Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).

+ References

No definition available.

+ Details

Name: us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 40 R3.htm IDEA: XBRL DOCUMENT v2.4.0.6

Consolidated Balance Sheet (Parenthetical) (USD $)

Aug. 31, 2012

Aug. 31, 2011

Statement of Financial Position [Abstract]

Uncollectible accounts $ 0 $ 0

Common stock, par value $ 0.001 $ 0.001

Common stock, shares authorized 1,000,000,000 1,000,000,000

Common stock, shares issued 223,492,927 223,492,927

Common stock, shares outstanding 223,492,927 223,492,927

Preferred stock, par value $ 0.001 $ 0.001

Preferred stock, shares authorized 5,000,000 5,000,000

Preferred stock, shares issued 0 0

Preferred stock, shares outstanding 0 0

Series AA Preferred shares, par value $ 0.001 $ 0.001

Series AA Preferred shares, shares authorized 100,000 100,000

Series AA Preferred shares, shares issued 5,000

Series AA Preferred shares, shares outstanding 5,000

Series B Preferred shares, par value $ 0.001 $ 0.001

Series B Preferred shares, shares authorized 4,400,000 4,400,000

Series B Preferred shares, shares issued 3,201,397 3,201,397

Series B Preferred shares, shares outstanding 0 0

NonVoting Convertible Preferred shares, par value $ 1.00 $ 1

NonVoting Convertible Preferred shares, shares authorized 200,000 200,000

NonVoting Convertible Preferred shares, shares issued 75,000 75,000

NonVoting Convertible Preferred shares, shares outstanding 0 0

X

- Definition

Face amount or stated value per share of nonredeemable nonvoting convertible preferred stock (or nonvoting convertible preferred stock redeemable solely at the option of the issuer); generally not indicative of the fair market value per share.

+ References

No definition available.

+ Details

Name: ENTB_NonvotingConvertiblePreferredSharesParValue

Namespace Prefix: ENTB_

Data Type: num:perShareItemType

Balance Type: na

Period Type: instant

X

- Definition

The maximum number of nonvoting convertible preferred shares permitted to be issued by an entity's charter and bylaws.

+ References

No definition available.

+ Details

Name: ENTB_NonvotingConvertiblePreferredSharesSharesAuthorized

Namespace Prefix: ENTB_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition

Total number of nonredeemable nonvoting convertible preferred shares (or nonvoting convertible preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related nonvoting convertible preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of nonvoting convertible preferred shares authorized. Excludes nonvoting convertible preferred shares that are classified as debt.

+ References

No definition available.

+ Details

Name: ENTB_NonvotingConvertiblePreferredSharesSharesIssued

Namespace Prefix: ENTB_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition

Aggregate share number for all nonredeemable nonvoting convertible preferred stock (or nonvoting convertible preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include nonvoting convertible preferred shares that have been repurchased.

+ References

No definition available.

+ Details

Name: ENTB_NonvotingConvertiblePreferredSharesSharesOutstanding

Namespace Prefix: ENTB_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition

Face amount or stated value per share of nonredeemable series AA preferred stock (or series AA preferred stock redeemable solely at the option of the issuer); generally not indicative of the fair market value per share.

+ References

No definition available.

+ Details

Name: ENTB_SeriesAaPreferredSharesParValue

Namespace Prefix: ENTB_

Data Type: num:perShareItemType

Balance Type: na

Period Type: instant

X

- Definition

The maximum number of series AA preferred shares permitted to be issued by an entity's charter and bylaws.

+ References

No definition available.

+ Details

Name: ENTB_SeriesAaPreferredSharesSharesAuthorized

Namespace Prefix: ENTB_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition

Total number of nonredeemable series AA preferred shares (or series AA preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related series AA preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of series AA preferred shares authorized. Excludes series AA preferred shares that are classified as debt.

+ References

No definition available.

+ Details

Name: ENTB_SeriesAaPreferredSharesSharesIssued

Namespace Prefix: ENTB_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition

Aggregate share number for all nonredeemable series AA preferred stock (or series AA preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include series AA preferred shares that have been repurchased.

+ References

No definition available.

+ Details

Name: ENTB_SeriesAaPreferredSharesSharesOutstanding

Namespace Prefix: ENTB_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition

Face amount or stated value per share of nonredeemable series B preferred stock (or series B preferred stock redeemable solely at the option of the issuer); generally not indicative of the fair market value per share.

+ References

No definition available.

+ Details

Name: ENTB_SeriesBPreferredSharesParValue

Namespace Prefix: ENTB_

Data Type: num:perShareItemType

Balance Type: na

Period Type: instant

X

- Definition

The maximum number of series B preferred shares permitted to be issued by an entity's charter and bylaws.

+ References

No definition available.

+ Details

Name: ENTB_SeriesBPreferredSharesSharesAuthorized

Namespace Prefix: ENTB_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition

Total number of nonredeemable series B preferred shares (or series B preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related series B preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of series B preferred shares authorized. Excludes series B preferred shares that are classified as debt.

+ References

No definition available.

+ Details

Name: ENTB_SeriesBPreferredSharesSharesIssued

Namespace Prefix: ENTB_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition

Aggregate share number for all nonredeemable series B preferred stock (or series B preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include series B preferred shares that have been repurchased.

+ References

No definition available.

+ Details

Name: ENTB_SeriesBPreferredSharesSharesOutstanding

Namespace Prefix: ENTB_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition

For an unclassified balance sheet, a valuation allowance for receivables due a company that are expected to be uncollectible.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 310

-SubTopic 10

-Section 50

-Paragraph 4

-URI http://asc.fasb.org/extlink&oid=7512638&loc=d3e5074-111524

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 4

-Article 5

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 942

-SubTopic 210

-Section S99

-Paragraph 1

-Subparagraph (SX 210.9-03.10)

-URI http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878

+ Details

Name: us-gaap_AllowanceForDoubtfulAccountsReceivable

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition

Face amount or stated value of common stock per share; generally not indicative of the fair market value per share.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 129

-Paragraph 4

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.29)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 30

-Article 5

+ Details

Name: us-gaap_CommonStockParOrStatedValuePerShare

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: instant

X

- Definition

The maximum number of common shares permitted to be issued by an entity's charter and bylaws.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.29)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 30

-Article 5

+ Details

Name: us-gaap_CommonStockSharesAuthorized

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition

Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.29)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 30

-Article 5

+ Details

Name: us-gaap_CommonStockSharesIssued

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition

Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.3-04)

-URI http://asc.fasb.org/extlink&oid=6959260&loc=d3e187085-122770

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.29)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher AICPA

-Name Accounting Principles Board Opinion (APB)

-Number 12

-Paragraph 10

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 30

-Article 5

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 04

-Article 3

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21463-112644

+ Details

Name: us-gaap_CommonStockSharesOutstanding

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition

Face amount or stated value per share of nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer); generally not indicative of the fair market value per share.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 129

-Paragraph 2, 3, 4, 5, 6, 7, 8

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher AICPA

-Name Accounting Principles Board Opinion (APB)

-Number 12

-Paragraph 10

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 29

-Article 5

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.28)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_PreferredStockParOrStatedValuePerShare

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: instant

X

- Definition

The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 29

-Article 5

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.28)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 129

-Paragraph 2, 3, 4, 5, 6, 7, 8

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

+ Details

Name: us-gaap_PreferredStockSharesAuthorized

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition

Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 29

-Article 5

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.28)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_PreferredStockSharesIssued

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition

Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 29

-Article 5

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.28)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_PreferredStockSharesOutstanding

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Details

Name: us-gaap_StatementOfFinancialPositionAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 41 R17.htm IDEA: XBRL DOCUMENT v2.4.0.6

NON VOTING CONVERTIBLE PREFERRED STOCK
12 Months Ended

Aug. 31, 2012

Equity [Abstract]

NON VOTING CONVERTIBLE PREFERRED STOCK

NOTE 11. NON VOTING CONVERTIBLE PREFERRED STOCK

On March 27, 2012 the company issued to Southridge 75,000 shares of its nonvoting convertible preferred stock to Southridge in accordance with the terms of an Equity Purchase Agreement entered into by and between the Company and Southridge which was terminated at the Company’s option on June 1, 2012 (“February Purchase Agreement”).

Non Voting Convertible Preferred Stock is convertible at the option of the holder into shares of the Company’s common stock at a conversion price equal to seventy percent (70%) of the lowest Closing Price for the five (5) trading days immediately preceding written receipt by the Company of the holder’s intent to convert.

“CLOSING PRICE" shall mean the closing bid price for the Company’s common stock on the Principal Market on a Trading Day as reported by Bloomberg Finance L.P.

“PRINCIPAL MARKET" shall mean the principal trading exchange or market for the Company’s common stock.

“TRADING DAY” shall mean a day on which the Principal Market shall be open for business.

The issuance of 75,000 shares of the Company’s nonvoting convertible preferred stock to Southridge resulted in recognition of a beneficial conversion feature in the amount of $32,142. Accordingly, the Company recorded a deemed dividend on the 75,000 shares of the Company’s nonvoting convertible preferred stock of $32,142.

X

- Details

Name: us-gaap_EquityAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

The entire disclosure for terms, amounts, nature of changes, rights and privileges, dividends, and other matters related to preferred stock.

+ References

No definition available.

+ Details

Name: us-gaap_PreferredStockTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 42 R1.htm IDEA: XBRL DOCUMENT v2.4.0.6

Document and Entity Information (USD $)
12 Months Ended

Aug. 31, 2012

Mar. 30, 2012

Jan. 25, 2013

Common shares outstanding

Jan. 25, 2013

Series B preferred shares outstanding

Jan. 25, 2013

Series AA preferred shares outstanding

Jan. 25, 2013

Non voting convertible preferred shares outstanding

Entity Registrant Name ENTEST BIOMEDICAL, INC.

Entity Central Index Key 0001449447

Document Type 10-K

Document Period End Date Aug. 31, 2012

Amendment Flag false

Current Fiscal Year End Date --08-31

Is Entity a Well-known Seasoned Issuer? No

Is Entity a Voluntary Filer? No

Is Entity's Reporting Status Current? Yes

Entity Filer Category Smaller Reporting Company

Entity Public Float $ 528,715

Entity Common Stock, Shares Outstanding 446,519,900 3,201,397 5,000 75,000

Document Fiscal Period Focus FY

Document Fiscal Year Focus 2011

X

- Definition

If the value is true, then the document is an amendment to previously-filed/accepted document.

+ References

No definition available.

+ Details

Name: dei_AmendmentFlag

Namespace Prefix: dei_

Data Type: xbrli:booleanItemType

Balance Type: na

Period Type: duration

X

- Definition

End date of current fiscal year in the format --MM-DD.

+ References

No definition available.

+ Details

Name: dei_CurrentFiscalYearEndDate

Namespace Prefix: dei_

Data Type: xbrli:gMonthDayItemType

Balance Type: na

Period Type: duration

X

- Definition

This is focus fiscal period of the document report. For a first quarter 2006 quarterly report, which may also provide financial information from prior periods, the first fiscal quarter should be given as the fiscal period focus. Values: FY, Q1, Q2, Q3, Q4, H1, H2, M9, T1, T2, T3, M8, CY.

+ References

No definition available.

+ Details

Name: dei_DocumentFiscalPeriodFocus

Namespace Prefix: dei_

Data Type: dei:fiscalPeriodItemType

Balance Type: na

Period Type: duration

X

- Definition

This is focus fiscal year of the document report in CCYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.

+ References

No definition available.

+ Details

Name: dei_DocumentFiscalYearFocus

Namespace Prefix: dei_

Data Type: xbrli:gYearItemType

Balance Type: na

Period Type: duration

X

- Definition

The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented. If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.

+ References

No definition available.

+ Details

Name: dei_DocumentPeriodEndDate

Namespace Prefix: dei_

Data Type: xbrli:dateItemType

Balance Type: na

Period Type: duration

X

- Definition

The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word "Other".

+ References

No definition available.

+ Details

Name: dei_DocumentType

Namespace Prefix: dei_

Data Type: dei:submissionTypeItemType

Balance Type: na

Period Type: duration

X

- Definition

A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation 12B

-Number 240

-Section 12b

-Subsection 1

+ Details

Name: dei_EntityCentralIndexKey

Namespace Prefix: dei_

Data Type: dei:centralIndexKeyItemType

Balance Type: na

Period Type: duration

X

- Definition

Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.

+ References

No definition available.

+ Details

Name: dei_EntityCommonStockSharesOutstanding

Namespace Prefix: dei_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition

Indicate "Yes" or "No" whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.

+ References

No definition available.

+ Details

Name: dei_EntityCurrentReportingStatus

Namespace Prefix: dei_

Data Type: dei:yesNoItemType

Balance Type: na

Period Type: duration

X

- Definition

Indicate whether the registrant is one of the following: (1) Large Accelerated Filer, (2) Accelerated Filer, (3) Non-accelerated Filer, (4) Smaller Reporting Company (Non-accelerated) or (5) Smaller Reporting Accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.

+ References

No definition available.

+ Details

Name: dei_EntityFilerCategory

Namespace Prefix: dei_

Data Type: dei:filerCategoryItemType

Balance Type: na

Period Type: duration

X

- Definition

State aggregate market value of voting and non-voting common equity held by non-affiliates computed by reference to price at which the common equity was last sold, or average bid and asked price of such common equity, as of the last business day of registrant's most recently completed second fiscal quarter. The public float should be reported on the cover page of the registrants form 10K.

+ References

No definition available.

+ Details

Name: dei_EntityPublicFloat

Namespace Prefix: dei_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition

The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation 12B

-Number 240

-Section 12b

-Subsection 1

+ Details

Name: dei_EntityRegistrantName

Namespace Prefix: dei_

Data Type: xbrli:normalizedStringItemType

Balance Type: na

Period Type: duration

X

- Definition

Indicate "Yes" or "No" if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.

+ References

No definition available.

+ Details

Name: dei_EntityVoluntaryFilers

Namespace Prefix: dei_

Data Type: dei:yesNoItemType

Balance Type: na

Period Type: duration

X

- Definition

Indicate "Yes" or "No" if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.

+ References

No definition available.

+ Details

Name: dei_EntityWellKnownSeasonedIssuer

Namespace Prefix: dei_

Data Type: dei:yesNoItemType

Balance Type: na

Period Type: duration

XML 43 R18.htm IDEA: XBRL DOCUMENT v2.4.0.6

DIVIDEND OF SERIES B PREFERRED SHARES
12 Months Ended

Aug. 31, 2012

Notes to Financial Statements

DIVIDEND OF SERIES B PREFERRED SHARES

NOTE 12. DIVIDEND OF SERIES B PREFERRED SHARES

On March 6, 2012 a dividend of 3, 201,397 shares of Series B Preferred Stock was paid to the Company’s common shareholders of record as of February 21, 2012.

X

- Definition

Disclosure of policy for declaring and paying dividends of Series B Preferred shares to policyholders.

+ References

No definition available.

+ Details

Name: ENTB_DividendOfSeriesBPreferredSharesTextBlock

Namespace Prefix: ENTB_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Details

Name: ENTB_NotesToFinancialStatementsAbstract

Namespace Prefix: ENTB_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 44 R4.htm IDEA: XBRL DOCUMENT v2.4.0.6

Consolidated Statement of Operations (USD $)
12 Months Ended

Aug. 31, 2012

Aug. 31, 2011

REVENUES

Revenues from Veterinary Services $ 419,336 $ 349,141

Online Revenues 6,916

TOTAL REVENUE 426,252 349,141

Cost of Revenue 119,299 89,405

GROSS PROFIT 306,953 259,736

COSTS AND EXPENSES

Research and Development 5,798 109,063

Rent Costs 126,812 108,596

General and Administrative 562,424 793,609

Incorporation Costs

Consultant's Expenses 428,040 159,518

Miscellaneous Expenses

Total Costs and Expenses 1,123,074 1,170,786

OPERATING LOSS (816,121) (911,050)

OTHER INCOME AND EXPENSE

Other Income 94,949 99

Loss on Early Extinguishment of Debt (18,647)

Income generated from Revenue Share Agreement 187,699

Expenses incurred from Revenue Share Agreement (145,362)

Loss on Impairment of intangible assets (683,333)

Interest Expense (29,400) (24,404)

Interest Expense attributable to amortization of discount (380,480) (16,428)

Expenses attributable to issuance of shares pursuant to contractual obligation (23,868)

Expenses attributable to issuance of Non Voting Convertible Preferred Shares in connection with Stock Purchase Agreement (75,000)

TOTAL OTHER INCOME AND EXPENSE (1,073,442) (40,733)

LOSS BEFORE INCOME TAXES (1,889,563) (951,783)

Income Taxes 0 0

NET LOSS (1,889,563) (951,783)

Beneficial conversion feature attributable to issuance of NonVoting Preferred Stock (32,142)

NET LOSS available to common shareholders $ (1,921,705) $ (951,783)

BASIC AND DILUTED LOSS PER SHARE $ (0.02) $ (0.05)

WEIGHTED AVERAGE NUMBER OF COMMON SHARES OUTSTANDING 94,990,042 19,895,368

X

- Definition

Expenses attributable to issuance of Non Voting Convertible Preferred Shares in connection with Stock Purchase Agreement

+ References

No definition available.

+ Details

Name: ENTB_ExpensesAttributableToIssuanceOfNonVotingConvertiblePreferredSharesInConnectionWithStockPurchaseAgreement

Namespace Prefix: ENTB_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

Expenses incurred from Revenue Share Agreement

+ References

No definition available.

+ Details

Name: ENTB_ExpensesIncurredFromRevenueShareAgreement

Namespace Prefix: ENTB_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition

Income generated from Revenue Share Agreement

+ References

No definition available.

+ Details

Name: ENTB_IncomeGeneratedFromRevenueShareAgreement

Namespace Prefix: ENTB_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

Amount of noncash expense included in interest expense to amortize debt discount and premium associated with the related debt instruments. Excludes amortization of financing costs. Alternate captions include noncash interest expense.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.8)

-URI http://asc.fasb.org/extlink&oid=6880815&loc=d3e20235-122688

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 03

-Paragraph 8

-Article 5

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 835

-SubTopic 30

-Section 45

-Paragraph 1A

-URI http://asc.fasb.org/extlink&oid=6451184&loc=d3e28541-108399

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher AICPA

-Name Accounting Principles Board Opinion (APB)

-Number 21

-Paragraph 16

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3602-108585

+ Details

Name: us-gaap_AmortizationOfDebtDiscountPremium

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition

The aggregate cost of goods produced and sold and services rendered during the reporting period.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.2)

-URI http://asc.fasb.org/extlink&oid=6880815&loc=d3e20235-122688

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 03

-Paragraph 2

-Article 5

+ Details

Name: us-gaap_CostOfRevenue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition

Total costs of sales and operating expenses for the period.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03)

-URI http://asc.fasb.org/extlink&oid=6880815&loc=d3e20235-122688

+ Details

Name: us-gaap_CostsAndExpenses

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Details

Name: us-gaap_CostsAndExpensesAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

Amount of a favorable spread to a debt holder between the amount of debt being converted and the value of the securities received upon conversion. This is an embedded conversion feature of convertible debt issued that is in-the-money at the commitment date.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Emerging Issues Task Force (EITF)

-Number 98-5

-Paragraph 7

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Emerging Issues Task Force (EITF)

-Number 00-27

-Paragraph 56

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Beneficial Conversion Feature

-URI http://asc.fasb.org/extlink&oid=6505963

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 129

-Paragraph 4

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section 50

-Paragraph 8

-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21538-112644

+ Details

Name: us-gaap_DebtInstrumentConvertibleBeneficialConversionFeature

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

The amount of net income or loss for the period per each share in instances when basic and diluted earnings per share are the same amount and reported as a single line item on the face of the financial statements. Basic earnings per share is the amount of net income or loss for the period per each share of common stock or unit outstanding during the reporting period. Diluted earnings per share includes the amount of net income or loss for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.

+ References

No definition available.

+ Details

Name: us-gaap_EarningsPerShareBasicAndDiluted

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: duration

X

- Definition

Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher AICPA

-Name Accounting Principles Board Opinion (APB)

-Number 26

-Paragraph 20, 21

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3602-108585

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 470

-SubTopic 50

-Section 40

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6850294&loc=d3e12317-112629

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 470

-SubTopic 50

-Section 40

-Paragraph 4

-URI http://asc.fasb.org/extlink&oid=6850294&loc=d3e12355-112629

+ Details

Name: us-gaap_GainsLossesOnExtinguishmentOfDebt

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.4)

-URI http://asc.fasb.org/extlink&oid=6880815&loc=d3e20235-122688

+ Details

Name: us-gaap_GeneralAndAdministrativeExpense

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition

Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.1,2)

-URI http://asc.fasb.org/extlink&oid=6880815&loc=d3e20235-122688

+ Details

Name: us-gaap_GrossProfit

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

The amount of impairment loss recognized in the period resulting from the write-down of the carrying amount of a finite-lived intangible asset to fair value.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 350

-SubTopic 30

-Section 50

-Paragraph 3

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=7658586&loc=d3e16373-109275

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 142

-Paragraph 46

-Subparagraph b

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

+ Details

Name: us-gaap_ImpairmentOfIntangibleAssetsFinitelived

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition

The portion of earnings or loss from continuing operations before income taxes that is attributable to domestic operations.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.4-08.(h)(1)(i))

-URI http://asc.fasb.org/extlink&oid=6881521&loc=d3e23780-122690

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 08

-Paragraph h

-Subparagraph 1(i)

-Article 4

+ Details

Name: us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

The sum of the current income tax expense or benefit and the deferred income tax expense or benefit pertaining to continuing operations.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 740

-SubTopic 10

-Section 50

-Paragraph 9

-Subparagraph (a),(b)

-URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32639-109319

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 109

-Paragraph 45

-Subparagraph a, b

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.4-08.(h))

-URI http://asc.fasb.org/extlink&oid=6881521&loc=d3e23780-122690

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 08

-Paragraph h

-Article 4

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Income Tax Expense (or Benefit)

-URI http://asc.fasb.org/extlink&oid=6515339

+ Details

Name: us-gaap_IncomeTaxExpenseBenefit

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition

The cost of borrowed funds accounted for as interest that was charged against earnings during the period.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 04

-Paragraph 9

-Article 9

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher OTS

-Name Federal Regulation (FR)

-Number Title 12

-Section 563c.102

-Paragraph 9

-Chapter V

-Subsection II

-LegacyDoc This is a non-GAAP reference that was included in the 2009 taxonomy. It will be removed from future versions of this taxonomy.

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 34

-Paragraph 21

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 835

-SubTopic 20

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 942

-SubTopic 225

-Section S99

-Paragraph 1

-Subparagraph (SX 210.9-04.9)

-URI http://asc.fasb.org/extlink&oid=6879574&loc=d3e536633-122882

+ Details

Name: us-gaap_InterestExpense

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition

Rental expense incurred for leased assets including furniture and equipment which has not been recognized in costs and expenses applicable to sales and revenues; for example, cost of goods sold or other operating costs and expenses.

+ References

No definition available.

+ Details

Name: us-gaap_LeaseAndRentalExpense

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition

The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 03

-Paragraph 19

-Article 5

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 260

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 944

-SubTopic 225

-Section S99

-Paragraph 1

-Subparagraph (SX 210.7-04.22)

-URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Other Comprehensive Income

-URI http://asc.fasb.org/extlink&oid=6519514

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.18)

-URI http://asc.fasb.org/extlink&oid=6880815&loc=d3e20235-122688

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 130

-Paragraph 10, 15

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 04

-Paragraph 20

-Article 9

Reference 8: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Net Income

-URI http://asc.fasb.org/extlink&oid=6518256

Reference 9: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Emerging Issues Task Force (EITF)

-Number 87-21

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 10: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 95

-Paragraph 28, 29, 30

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 11: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3602-108585

Reference 12: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 944

-SubTopic 225

-Section S99

-Paragraph 1

-Subparagraph (SX 210.7-04.19)

-URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913

Reference 13: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 220

-SubTopic 10

-Section 45

-Paragraph 6

-URI http://asc.fasb.org/extlink&oid=20435746&loc=d3e565-108580

Reference 14: http://www.xbrl.org/2003/role/presentationRef

-Publisher AICPA

-Name Accounting Research Bulletin (ARB)

-Number 51

-Paragraph A7

-Appendix A

Reference 15: http://www.xbrl.org/2003/role/presentationRef

-Publisher AICPA

-Name Accounting Research Bulletin (ARB)

-Number 51

-Paragraph 38

-Subparagraph a

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 16: http://www.xbrl.org/2003/role/presentationRef

-Publisher AICPA

-Name Accounting Research Bulletin (ARB)

-Number 51

-Paragraph 38

-Subparagraph d

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

+ Details

Name: us-gaap_NetIncomeLoss

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

Net income after adjustments for dividends on preferred stock (declared in the period) and/or cumulative preferred stock (accumulated for the period).

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 260

-SubTopic 10

-Section 45

-Paragraph 11

-URI http://asc.fasb.org/extlink&oid=7655603&loc=d3e1377-109256

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 128

-Paragraph 9

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

+ Details

Name: us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

The net result for the period of deducting operating expenses from operating revenues.

+ References

No definition available.

+ Details

Name: us-gaap_OperatingIncomeLoss

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

This element represents a sum total of expenses not separately reflected on the income statement for the period.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.4,6)

-URI http://asc.fasb.org/extlink&oid=6880815&loc=d3e20235-122688

+ Details

Name: us-gaap_OtherExpenses

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition

The sum of expenses not otherwise specified in the taxonomy for managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.4)

-URI http://asc.fasb.org/extlink&oid=6880815&loc=d3e20235-122688

+ Details

Name: us-gaap_OtherGeneralAndAdministrativeExpense

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition

Reflects the sum of all other revenue and income recognized by the entity in the period not otherwise specified in the income statement.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 944

-SubTopic 225

-Section S99

-Paragraph 1

-Subparagraph (SX 210.7-04.4)

-URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 04

-Paragraph 4

-Article 7

+ Details

Name: us-gaap_OtherIncome

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Details

Name: us-gaap_OtherIncomeAndExpensesAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

The net amount of other income and expense amounts, the components of which are not separately disclosed on the income statement, resulting from ancillary business-related activities (that is, excluding major activities considered part of the normal operations of the business) also known as other nonoperating income (expense) recognized for the period. Such amounts may include: (a) dividends, (b) interest on securities, (c) net gains or losses on securities, (d) unusual costs, (e) gains or losses on foreign exchange transactions, and (f) miscellaneous other income and expense items.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 03

-Paragraph 9

-Article 5

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.9)

-URI http://asc.fasb.org/extlink&oid=6880815&loc=d3e20235-122688

+ Details

Name: us-gaap_OtherNonoperatingIncomeExpense

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

Revenues from the sale of other goods or rendering of other services, not elsewhere specified in the taxonomy; net of (reduced by) sales adjustments, returns, allowances, and discounts.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.1(a),(d))

-URI http://asc.fasb.org/extlink&oid=6880815&loc=d3e20235-122688

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 03

-Paragraph 1

-Article 5

+ Details

Name: us-gaap_OtherSalesRevenueNet

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

Professional and contract service expense includes cost reimbursements for support services related to contracted projects, outsourced management, technical and staff support.

+ References

No definition available.

+ Details

Name: us-gaap_ProfessionalAndContractServicesExpense

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition

The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 141

-Paragraph 51

-Subparagraph g

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 86

-Paragraph 11, 12

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 985

-SubTopic 20

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 730

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6420194&loc=d3e21568-108373

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 2

-Paragraph 12, 13

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

+ Details

Name: us-gaap_ResearchAndDevelopmentExpense

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition

Aggregate revenue recognized during the period (derived from goods sold, services rendered, insurance premiums, or other activities that constitute an entity's earning process). For financial services companies, also includes investment and interest income, and sales and trading gains.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.1)

-URI http://asc.fasb.org/extlink&oid=6880815&loc=d3e20235-122688

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 03

-Paragraph 1

-Article 5

+ Details

Name: us-gaap_Revenues

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Details

Name: us-gaap_RevenuesAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

Total revenue from sale of goods and services rendered during the reporting period, in the normal course of business, reduced by sales returns and allowances, and sales discounts.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.1)

-URI http://asc.fasb.org/extlink&oid=6880815&loc=d3e20235-122688

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 03

-Paragraph 1

-Article 5

+ Details

Name: us-gaap_SalesRevenueNet

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

The amount of expense reported during the period resulting from the transaction in which equity securities were issued to pay for goods or nonemployee services.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 2

-Subparagraph (h)(1)(i)

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 50

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6406099&loc=d3e25284-112666

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 123R

-Paragraph 65

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

+ Details

Name: us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionExpense

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition

Average number of shares or units issued and outstanding that are used in calculating basic and diluted earnings per share (EPS).

+ References

No definition available.

+ Details

Name: us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

XML 45 R12.htm IDEA: XBRL DOCUMENT v2.4.0.6

RELATED PARTY TRANSACTIONS
12 Months Ended

Aug. 31, 2012

Related Party Transactions [Abstract]

RELATED PARTY TRANSACTIONS

NOTE 6. RELATED PARTY TRANSACTIONS

During the quarter ended November 30, 2011 David Koos made loans to the Company totaling $8,400. These loans are due and payable at the demand of David Koos and bear simple interest at a rate of 15% per annum.

During the quarter ended February 29, 2012 David Koos made loans to the Company totaling $7,550. These loans are due and payable at the demand of David Koos and bear simple interest at a rate of 15% per annum.

During the quarter ended February 29, 2012 David Koos granted to the Sherman Family Trust, an irrevocable trust for the benefit of Blossom Sherman, all rights to and interest in $25,956 in unpaid indebtedness owed by the Company (bearing simple interest at a rate of 15% per annum and due and payable at the demand of the holder) as well as $3,051 in unpaid interest owed by the Company.

During the quarter ended May 31, 2012 David Koos made loans to the Company in the amount of $13,625. These loans are due and payable at the demand of David Koos and bear simple interest at a rate of 15% per annum

As of August 31, 2012 the Company remains indebted to David R. Koos in the principal amount of $30,180 due and payable at the demand of David Koos and bearing simple interest at a rate of 15% per annum

As of August 31 , 2012 Bio-Matrix Scientific Group, Inc. (“BMSN”) , a major shareholder of the Company, is indebted to the Company in the amount of $39,140. This amount is non interest bearing and is due at the demand of the Company.

X

- Details

Name: us-gaap_RelatedPartyTransactionsAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 850

-SubTopic 10

-Section 50

-Paragraph 6

-URI http://asc.fasb.org/extlink&oid=6457730&loc=d3e39691-107864

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 850

-SubTopic 10

-Section 50

-Paragraph 4

-URI http://asc.fasb.org/extlink&oid=6457730&loc=d3e39622-107864

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 850

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 57

-Paragraph 1-4

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 850

-SubTopic 10

-Section 50

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=6457730&loc=d3e39603-107864

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 850

-SubTopic 10

-Section 50

-Paragraph 5

-URI http://asc.fasb.org/extlink&oid=6457730&loc=d3e39678-107864

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.4-08.(k))

-URI http://asc.fasb.org/extlink&oid=6881521&loc=d3e23780-122690

Reference 8: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 04

-Paragraph b

-Article 3A

Reference 9: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 08

-Paragraph k

-Article 4

+ Details

Name: us-gaap_RelatedPartyTransactionsDisclosureTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 46 R11.htm IDEA: XBRL DOCUMENT v2.4.0.6

NOTES PAYABLE
12 Months Ended

Aug. 31, 2012

Debt Disclosure [Abstract]

NOTES PAYABLE

NOTE 5. NOTES PAYABLE

As of August 31, 2012

Current :

Bio Technology Partners Business Trust 13500

Venture Bridge Advisors, Inc. 32508

Southridge Partners II LLP 40000

Sherman Family Trust 79000

Officer Loans (Note 6) 30,180

Current portion of amounts to be paid on

behalf of Gregory McDonald and Pet Pointers, Inc. (Note 10 ) 30174

8% Convertible Notes (Note14 ) 105,500

10% Convertible Note (Note 14) 59000

Total: 389862

Long Term:

Long Term portion of amounts to be paid on

behalf of Gregory McDonald and

Pet Pointers, Inc. (Note 10 ) 36469

Total: 36469

Both of Bio Technology Partners Business Trust and Venture Bridge Advisors have provided lines of credit to the Company in the amount of $200,000 each or so much thereof as may be disbursed to, or for the benefit of the Company by Lender in Lender's sole and absolute discretion. The unpaid principal of these lines of credit bear simple interest at the rate of ten percent per annum. Interest is calculated based on the principal balance as may be adjusted from time to time to reflect additional advances or payments made hereunder. Principal balance and accrued interest shall become due and payable in whole or in part at the demand of the Lender. The Sherman Family Trust has provided a line of credit to the Company in the amount of $____ or so much thereof as may be disbursed to, or for the benefit of the Company by Lender in Lender's sole and absolute discretion. The unpaid principal of this line of credit bears simple interest at the rate of ten percent per annum. Interest is calculated based on the principal balance as may be adjusted from time to time to reflect additional advances or payments made hereunder. Principal balance and accrued interest shall become due and payable in whole or in part at the demand of the Lender. $40,000 loaned to the Company by Southridge Partners II LLP bears no stated interest rate and is payable at the demand of Southridge Partners II LLP.

X

- Details

Name: us-gaap_DebtDisclosureAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.19,20,22)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section 50

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21475-112644

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 19, 20, 22

-Article 5

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 129

-Paragraph 2, 4

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

+ Details

Name: us-gaap_DebtDisclosureTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 47 R23.htm IDEA: XBRL DOCUMENT v2.4.0.6

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)
12 Months Ended

Aug. 31, 2012

Accounting Policies [Abstract]

BASIS OF ACCOUNTING
A. BASIS OF ACCOUNTING

The financial statements have been prepared using the basis of accounting generally accepted in the United States of America. Under this basis of accounting, revenues are recorded as earned and expenses are recorded at the time liabilities are incurred. The Company has adopted an August 31 fiscal year-end. The Company recognizes revenue from services and product sales when the following four revenue recognition criteria are met: persuasive evidence of an arrangement exists, delivery has occurred or services have been rendered, the selling price is fixed or determinable, and collectability is reasonably assured. Product sales and service revenues are recorded when the products are delivered and title passes to customers. The customer’s credit card is authorized and charged, or checks/cash are received at the time the services are rendered, thereby providing reasonable assurance of collectability.

PRINCIPLES OF CONSOLIDATION
B. PRINCIPLES OF CONSOLIDATION

The consolidated financial statements include the accounts of Entest CA, the Company’s wholly owned subsidiary. Significant inter-company transactions have been eliminated.

USE OF ESTIMATES
C. USE OF ESTIMATES

The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.

CASH EQUIVALENTS
D. CASH EQUIVALENTS

The Company considers all highly liquid investments with a maturity of three months or less when purchased to be cash equivalents.

PROPERTY AND EQUIPMENT
E. PROPERTY AND EQUIPMENT

Property and equipment are recorded at cost. Maintenance and repairs are expensed in the year in which they are incurred. Property and equipment consist of Office Equipment, medical Equipment and Computer Equipment. Expenditures that enhance the value of property and equipment are capitalized. All property and equipment is depreciated utilizing the Straight Line Method for a period of thirty months , such period being estimated by the Company to represent the useful life of the assets. For the Fiscal Year ended August 31, 2012 the Company incurred depreciation expense of $8,461 and for the Fiscal Year ended August 31, 2011 the Company incurred depreciation expense of $5,591. No depreciation has been recognized in connection with one piece of computer equipment which has yet to be put into service.

Property Plant and Equipment

Acquisition Cost Estimated useful Life (Months) Total

Office Equipment 30 3,235

Medical Equipment 30 17,523

Computer Equipment 30 2,126

Subtotal 22,884

Less Accumulated Depreciation (14,052)

Total 8,832

FAIR VALUE OF FINANCIAL INSTRUMENTS
F. FAIR VALUE OF FINANCIAL INSTRUMENTS

Fair value is the price that would be received for an asset or the exit price that would be paid to transfer a liability in the principal or most advantageous market in an orderly transaction between market participants on the measurement date. A fair value hierarchy requires an entity to maximize the use of observable inputs, where available. The following summarizes the three levels of inputs required by the standard that the Company uses to measure fair value:

Level 1: Quoted prices in active markets for identical assets or liabilities

Level 2: Observable inputs other than Level 1 prices, such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the related assets or liabilities.

Level 3: Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities.

The Company’s financial instruments as of August 31, 2012 consisted of $261,831, of Notes Payable, $121,495 of Convertible Notes payable (net of discount), $8,000 due to TheraCyte, Inc, $4,349 of Employee Receivables and $39,140 due from an affiliate. The fair value of all of the Company’s financial instruments as of September 30, 2012 were valued according to the Level 3 input. The carrying amount of the financial instruments is equal to the fair value as determined by the Company.

The Company has determined that there are no Level 1 or Level 2 inputs for determining the fair value of the Company’s financial instruments. Fair value was determined by the Company utilizing its own assumptions and estimation. There were no transfers between levels for the period presented.

INCOME TAXES
G. INCOME TAXES

The Company accounts for income taxes using the liability method prescribed by ASC 740, “Income Taxes.” Under this method, deferred tax assets and liabilities are determined based on the difference between the financial reporting and tax bases of assets and liabilities using enacted tax rates that will be in effect in the year in which the differences are expected to reverse. The Company records a valuation allowance to offset deferred tax assets if based on the weight of available evidence, it is more-likely-than-not that some portion, or all, of the deferred tax assets will not be realized. The effect on deferred taxes of a change in tax rates is recognized as income or loss in the period that includes the enactment date.

The Company applied the provisions of ASC 740-10-50, “Accounting For Uncertainty In Income Taxes”, which provides clarification related to the process associated with accounting for uncertain tax positions recognized in our financial statements. Audit periods remain open for review until the statute of limitations has passed. The completion of review or the expiration of the statute of limitations for a given audit period could result in an adjustment to the Company’s liability for income taxes. Any such adjustment could be material to the Company’s results of operations for any given quarterly or annual period based, in part, upon the results of operations for the given period. As of August 31, 2011 and 2010, the Company had no uncertain tax positions, and will continue to evaluate for uncertain positions in the future.

The Company generated a deferred tax credit through net operating loss carry forward. However, a valuation allowance of 100% has been established.

Interest and penalties on tax deficiencies recognized in accordance with ACS accounting standards are classified as income taxes in accordance with ASC Topic 740-10-50-19.

BASIC EARNINGS (LOSS) PER SHARE
H. BASIC EARNINGS (LOSS) PER SHARE

The Financial Accounting Standards Board (FASB) issued Accounting Standards Codification (ASC) 260, "Earnings Per Share", which specifies the computation, presentation and disclosure requirements for earnings (loss) per share for entities with publicly held common stock. ASC 260 requires the presentation of basic earnings (loss) per share and diluted earnings (loss) per share. The Company has adopted the provisions of ASC 260 effective from inception. Basic net loss per share amounts is computed by dividing the net income by the weighted average number of common shares outstanding. All convertible debt has an anti-dilutive effect on the EPS , therefore Diluted earnings per share are the same as basic earnings per share.

X

- Details

Name: us-gaap_AccountingPoliciesAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).

+ References

No definition available.

+ Details

Name: us-gaap_BasisOfAccountingPolicyPolicyTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition

Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Financial Reporting Release (FRR)

-Number 203

-Paragraph 02-03

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Cash

-URI http://asc.fasb.org/extlink&oid=6506951

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Cash Equivalents

-URI http://asc.fasb.org/extlink&oid=6507016

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 95

-Paragraph 7, 8, 9, 10

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section 50

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=6367646&loc=d3e18780-107790

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher AICPA

-Name Technical Practice Aid (TPA)

-Number 2110

-Paragraph 6

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 1

-Article 5

Reference 8: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6367179&loc=d3e4273-108586

Reference 9: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 305

-SubTopic 10

-URI http://asc.fasb.org/subtopic&trid=2122427

+ Details

Name: us-gaap_CashAndCashEquivalentsPolicyTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition

Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 810

-SubTopic 10

-URI http://asc.fasb.org/subtopic&trid=2197480

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 325

-SubTopic 20

-URI http://asc.fasb.org/subtopic&trid=2197087

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher AICPA

-Name Accounting Principles Board Opinion (APB)

-Number 18

-Paragraph 20

-Subparagraph a(2)

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher AICPA

-Name Accounting Research Bulletin (ARB)

-Number 51

-Paragraph 2-6

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 323

-SubTopic 10

-URI http://asc.fasb.org/subtopic&trid=2196966

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 860

-SubTopic 40

-Section 45

-URI http://asc.fasb.org/section&trid=2197723

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher AICPA

-Name Accounting Principles Board Opinion (APB)

-Number 18

-Paragraph 5, 6, 16-19

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 8: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name FASB Interpretation (FIN)

-Number 46R

-Paragraph 4

-Subparagraph c

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 9: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph k

-Article 1

Reference 10: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 810

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=18733093&loc=d3e5614-111684

Reference 11: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 323

-SubTopic 10

-Section 45

-Paragraph 4

-URI http://asc.fasb.org/extlink&oid=16385135&loc=d3e33801-111570

Reference 12: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name FASB Interpretation (FIN)

-Number 46R

-Paragraph 14, 15

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 13: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name FASB Interpretation (FIN)

-Number 46R

-Paragraph 4

-Subparagraph d

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 14: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 140

-Paragraph 46

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 15: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 810

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.3A-02)

-URI http://asc.fasb.org/extlink&oid=6959686&loc=d3e355033-122828

Reference 16: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Emerging Issues Task Force (EITF)

-Number 96-16

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 17: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section 50

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=6367646&loc=d3e18780-107790

Reference 18: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02, 03

-Article 3A

Reference 19: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Emerging Issues Task Force (EITF)

-Number 97-2

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

+ Details

Name: us-gaap_ConsolidationPolicyTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition

Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 128

-Paragraph 40

-Subparagraph a

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 260

-SubTopic 10

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3630-109257

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section 50

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=6367646&loc=d3e18780-107790

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 128

-Paragraph 6, 8-16, 60

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 260

-SubTopic 10

-Section 50

-Paragraph 1

-Subparagraph (c)

-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 260

-SubTopic 10

-URI http://asc.fasb.org/subtopic&trid=2144384

+ Details

Name: us-gaap_EarningsPerSharePolicyTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition

Disclosure of accounting policy for determining the fair value of financial instruments.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section 50

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=6367646&loc=d3e18780-107790

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 820

-SubTopic 10

-URI http://asc.fasb.org/subtopic&trid=2155942

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 107

-Paragraph 8, 10, 12, 13, 14

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

+ Details

Name: us-gaap_FairValueOfFinancialInstrumentsPolicy

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition

Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 740

-SubTopic 10

-Section 50

-Paragraph 17

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32809-109319

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name FASB Interpretation (FIN)

-Number 48

-Paragraph 20

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 740

-SubTopic 10

-Section 45

-Paragraph 25

-URI http://asc.fasb.org/extlink&oid=21917399&loc=d3e32247-109318

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher AICPA

-Name Accounting Principles Board Opinion (APB)

-Number 4

-Paragraph 11

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 740

-SubTopic 10

-Section 50

-Paragraph 19

-URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32840-109319

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 109

-Paragraph 6-34, 43, 47, 49

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section 50

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=6367646&loc=d3e18780-107790

Reference 8: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 740

-SubTopic 10

-Section 45

-Paragraph 28

-URI http://asc.fasb.org/extlink&oid=21917399&loc=d3e32280-109318

Reference 9: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 954

-SubTopic 740

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6491622&loc=d3e9504-115650

Reference 10: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 740

-SubTopic 30

-URI http://asc.fasb.org/subtopic&trid=2144749

Reference 11: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 740

-SubTopic 10

-URI http://asc.fasb.org/subtopic&trid=2144681

+ Details

Name: us-gaap_IncomeTaxPolicyTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition

Disclosure of accounting policy for property, plant and equipment which may include the basis of such assets, depreciation methods used and estimated useful lives, the entity's capitalization policy, including its accounting treatment for costs incurred for repairs and maintenance activities, whether such asset balances include capitalized interest and the method by which such is calculated, how disposals of such assets are accounted for and how impairment of such assets is assessed and recognized.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.13(a))

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 360

-SubTopic 10

-URI http://asc.fasb.org/subtopic&trid=2155824

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher AICPA

-Name Accounting Principles Board Opinion (APB)

-Number 22

-Paragraph 12, 13

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 34

-Paragraph 8, 9

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section 50

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=6367646&loc=d3e18780-107790

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 13

-Subparagraph a

-Article 5

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher AICPA

-Name Accounting Principles Board Opinion (APB)

-Number 12

-Paragraph 5

-Subparagraph d

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 8: http://www.xbrl.org/2003/role/presentationRef

-Publisher AICPA

-Name Accounting Research Bulletin (ARB)

-Number 43

-Section C

-Paragraph 5

-Chapter 9

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 9: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 144

-Paragraph 7

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

+ Details

Name: us-gaap_PropertyPlantAndEquipmentPolicyTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition

Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher AICPA

-Name Statement of Position (SOP)

-Number 94-6

-Paragraph 11, 14

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 275

-SubTopic 10

-Section 50

-Paragraph 9

-URI http://asc.fasb.org/extlink&oid=6927468&loc=d3e6143-108592

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 275

-SubTopic 10

-Section 50

-Paragraph 8

-URI http://asc.fasb.org/extlink&oid=6927468&loc=d3e6132-108592

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 275

-SubTopic 10

-Section 50

-Paragraph 4

-URI http://asc.fasb.org/extlink&oid=6927468&loc=d3e6061-108592

+ Details

Name: us-gaap_UseOfEstimates

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 48 R19.htm IDEA: XBRL DOCUMENT v2.4.0.6

STOCKHOLDERS EQUITY
12 Months Ended

Aug. 31, 2012

Equity [Abstract]

STOCKHOLDERS EQUITY

NOTE 13. STOCKHOLDERS EQUITY

The stockholders' equity section of the Company contains the following classes of capital stock as of August 31, 2012:

Common Stock:

$0.001 par value, 1,000,000,000 shares authorized 222,791,778 shares issued and outstanding as of August 31, 2012.

Preferred Stock:

$0.001 par value 5,000,000 shares authorized of 100,000 shares authorized is authorized as Series AA Preferred Stock , $001 par value of which 5,000 shares are issued and outstanding as of February 29, 2012 and 4,400,000 is authorized as Series B Preferred Stock of which 3, 201,397 shares are issued and outstanding as of August 31, 2012.

Upon any liquidation, dissolution, or winding up of the Company, whether voluntary or involuntary (collectively, a “Liquidation”), before any distribution or payment shall be made to any of the holders of Common Stock or any other series of preferred stock, the holders of Series B Preferred Stock shall be entitled to receive out of the assets of the Company, whether such assets are capital, surplus or earnings, an amount equal to $0.10 per share of Series B Preferred Stock (the “Liquidation Amount”) plus all declared and unpaid dividends thereon, for each share of Series B Preferred Stock held by them.

If, upon any Liquidation, the assets of the Company shall be insufficient to pay the Liquidation Amount, together with declared and unpaid dividends thereon, in full to all holders of Series B Preferred Stock, then the entire net assets of the Company shall be distributed among the holders of the Series B Preferred Stock, ratably in proportion to the full amounts to which they would otherwise be respectively entitled and such distributions may be made in cash or in property taken at its fair value (as determined in good faith by the Board), or both, at the election of the Board..

Non Voting Convertible Preferred Stock having a $1.00 par value:

200,000 shares authorized of which 75, 000 shares are issued and outstanding as of August 31, 2102.

Non Voting Convertible Preferred Stock shall convert at the option of the holder into shares of the corporation’s common stock at a conversion price equal to seventy percent (70%) of the lowest Closing Price for the five (5) trading days immediately preceding written receipt by the corporation of the holder’s intent to convert.

“CLOSING PRICE" shall mean the closing bid price for the corporation’s common stock on the Principal Market on a Trading Day as reported by Bloomberg Finance L.P.

“PRINCIPAL MARKET" shall mean the principal trading exchange or market for the corporation’s common stock.

“TRADING DAY” shall mean a day on which the Principal Market shall be open for business.

X

- Details

Name: us-gaap_EquityAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

The entire disclosure for shareholders' equity, comprised of portions attributable to the parent entity and noncontrolling interest, if any, including other comprehensive income (as applicable). Including, but not limited to: (1) balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings; (2) accumulated balance for each classification of other comprehensive income and total amount of comprehensive income; (3) amount and nature of changes in separate accounts, including the number of shares authorized and outstanding, number of shares issued upon exercise and conversion, and for other comprehensive income, the adjustments for reclassifications to net income; (4) rights and privileges of each class of stock authorized; (5) basis of treasury stock, if other than cost, and amounts paid and accounting treatment for treasury stock purchased significantly in excess of market; (6) dividends paid or payable per share and in the aggregate for each class of stock for each period presented; (7) dividend restrictions and accumulated preferred dividends in arrears (in aggregate and per share amount); (8) retained earnings appropriations or restrictions, such as dividend restrictions; (9) impact of change in accounting principle, initial adoption of new accounting principle and correction of an error in previously issued financial statements; (10) shares held in trust for Employee Stock Ownership Plan (ESOP); (11) deferred compensation related to issuance of capital stock; (12) note received for issuance of stock; (13) unamortized discount on shares; (14) description, terms, and number of warrants or rights outstanding; (15) shares under subscription and subscription receivables, effective date of new retained earnings after quasi-reorganization and deficit eliminated by quasi-reorganization and, for a period of at least ten years after the effective date, the point in time from which the new retained dates; and (16) retroactive effective of subsequent change in capital structure.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 04

-Article 3

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section 50

-Paragraph 5

-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21488-112644

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 29, 30, 31

-Article 5

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Staff Accounting Bulletin (SAB)

-Number Topic 4

-Section E

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Preferred Stock

-URI http://asc.fasb.org/extlink&oid=6521494

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section 50

-Paragraph 11

-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21564-112644

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section S99

-Paragraph 4

-Subparagraph (SAB TOPIC 4.C)

-URI http://asc.fasb.org/extlink&oid=6959260&loc=d3e187143-122770

Reference 8: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section 50

-Paragraph 4

-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21484-112644

Reference 9: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section 50

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21475-112644

Reference 10: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section 50

-Paragraph 6

-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21506-112644

Reference 11: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 30

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6405834&loc=d3e23285-112656

Reference 12: http://www.xbrl.org/2003/role/presentationRef

-Publisher AICPA

-Name Accounting Research Bulletin (ARB)

-Number 43

-Section B

-Paragraph 7, 11A

-Chapter 1

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 13: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Staff Accounting Bulletin (SAB)

-Number Topic 4

-Section C

Reference 14: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21463-112644

Reference 15: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 08

-Paragraph d

-Article 4

Reference 16: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.29-31)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 17: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 310

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SAB TOPIC 4.E)

-URI http://asc.fasb.org/extlink&oid=6228006&loc=d3e74512-122707

Reference 18: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 5

-Paragraph 15

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 19: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.3-04)

-URI http://asc.fasb.org/extlink&oid=6959260&loc=d3e187085-122770

Reference 20: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 129

-Paragraph 2, 3, 4, 5, 6, 7, 8

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 21: http://www.xbrl.org/2003/role/presentationRef

-Publisher AICPA

-Name Accounting Principles Board Opinion (APB)

-Number 12

-Paragraph 10

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 22: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.4-08.(d),(e))

-URI http://asc.fasb.org/extlink&oid=6881521&loc=d3e23780-122690

Reference 23: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 08

-Article 4

+ Details

Name: us-gaap_StockholdersEquityNoteDisclosureTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 49 R15.htm IDEA: XBRL DOCUMENT v2.4.0.6

ACQUISITION OF THE ASSETS OF PET POINTERS, INC.
12 Months Ended

Aug. 31, 2012

Business Combinations [Abstract]

ACQUISITION OF THE ASSETS OF PET POINTERS, INC.

NOTE 9. ACQUISITION OF THE ASSETS OF PET POINTERS, INC.

On January 4, 2011Entest CA acquired from Pet Pointers, Inc., a California corporation doing business as McDonald Animal Hospital (“Seller”), and Dr. Gregory McDonald DVM (“McDonald”) all the goodwill from McDonald and assets of Seller except cash and accounts receivables used in connection with the operation of a veterinary medical clinic located at 225 S. Milpas Street, Santa Barbara, CA 93103 (the "Business").

Consideration for the acquisition consisted of:

 I. $70,000 in cash

 II. $210,000 of the Company’s common shares valued at the closing price per share as of January 4, 2011

 III. Payment of no more than $78,000 to a creditor of the Seller to be paid in monthly installments of $1,500 per month

 IV. Payment of no more than $25,000 to additional creditors of the Seller to be paid in monthly installments of $825 per month

 V. Payment of $50,000 to McDonald on the first business day of the fourth month following the closing of the acquisition (“Closing”)

X

- Definition

The entire description for costs incurred to effect a business combination that have been expensed during the period. Such costs could include business integration costs, systems integration and conversion costs, and severance and other employee-related costs.

+ References

No definition available.

+ Details

Name: us-gaap_BusinessAcquisitionIntegrationRestructuringAndOtherRelatedCostsTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Details

Name: us-gaap_BusinessCombinationsAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 50 R13.htm IDEA: XBRL DOCUMENT v2.4.0.6

INCOME TAXES
12 Months Ended

Aug. 31, 2012

Income Tax Disclosure [Abstract]

INCOME TAXES

NOTE 7. INCOME TAXES

As of August 31, 2012

Deferred tax assets:

Net operating tax carry forwards $ 1,250,503

Other -0-

Gross deferred tax assets 1,250,503

Valuation allowance (1,250,503)

Net deferred tax assets $ -0-

As of August 31 ,2012 the Company has a Deferred Tax Asset of $1,250,503 completely attributable to net operating loss carry forwards of approximately $3,677,949 (which expire 20 years from the date the loss was incurred) consisting of:

(a) $ 13,647 of Net Operating Loss carry forwards acquired in the reverse acquisition of Entest BioMedical, Inc., a California corporation, and

(b) $ 3,664,302 of Net Operating Loss carry forwards attributable to Entest BioMedical, Inc.

Realization of deferred tax assets is dependent upon sufficient future taxable income during the period that deductible temporary differences and carry forwards are expected to be available to reduce taxable income. A valuation allowance is recorded when it is “more likely-than-not” that a deferred tax asset will not be realized. In addition, the reverse acquisition in which Entest BioMedical, Inc. was involved in 2009 has resulted in a change of control. Internal Revenue Code Sec 382 limits the amount of income that may be offset by net operating loss (NOL) carryovers after an ownership change. As a result, the Company has recorded a valuation allowance reducing all deferred tax assets to $ -0-.

Income tax is calculated at the 34% Federal Corporate Rate.

X

- Details

Name: us-gaap_IncomeTaxDisclosureAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 109

-Paragraph 136, 172

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.4-08.(h))

-URI http://asc.fasb.org/extlink&oid=6881521&loc=d3e23780-122690

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 08

-Paragraph h

-Article 4

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 740

-SubTopic 10

-Section 50

-Paragraph 15

-URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32718-109319

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 109

-Paragraph 43, 44, 45, 46, 47, 48, 49

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 740

-SubTopic 10

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32537-109319

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 740

-SubTopic 10

-Section 50

-Paragraph 9

-URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32639-109319

Reference 8: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 740

-SubTopic 10

-Section 50

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32559-109319

+ Details

Name: us-gaap_IncomeTaxDisclosureTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 51 R14.htm IDEA: XBRL DOCUMENT v2.4.0.6

ACQUISITION OF ENTEST CA
12 Months Ended

Aug. 31, 2012

Business Combinations [Abstract]

ACQUISITION OF ENTEST CA

NOTE 8. ACQUISITION OF ENTEST CA

On July 10, 2009 the Company acquired 100% of Entest CA, a California corporation and wholly owned subsidiary of the Company, from BMSN for consideration consisting of (a) the issuance to BMSN of 10,000,000 newly issued common shares of Entest and (b) the return by Mr. Rick Plote of 10,000,000 shares of Entest’s common stock previously issued to him by Entest for cancellation.

X

- Definition

The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable).

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 805

-SubTopic 10

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=7659399&loc=d3e1392-128463

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 805

-SubTopic 20

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6910749&loc=d3e4845-128472

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 805

-SubTopic 20

-Section 50

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=6910749&loc=d3e4926-128472

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 805

-SubTopic 10

-Section 50

-Paragraph 4

-URI http://asc.fasb.org/extlink&oid=7659399&loc=d3e1490-128463

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 805

-SubTopic 30

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=7488404&loc=d3e6927-128479

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 805

-SubTopic 30

-Section 50

-Paragraph 4

-URI http://asc.fasb.org/extlink&oid=7488404&loc=d3e7008-128479

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 805

-SubTopic 30

-Section 50

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=7488404&loc=d3e7000-128479

Reference 8: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 805

-SubTopic 10

-Section 50

-Paragraph 7

-URI http://asc.fasb.org/extlink&oid=7659399&loc=d3e1524-128463

Reference 9: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 805

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=7659399&loc=d3e1383-128463

Reference 10: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 805

-SubTopic 10

-Section 50

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=7659399&loc=d3e1486-128463

Reference 11: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 805

-SubTopic 10

-Section 50

-Paragraph 6

-URI http://asc.fasb.org/extlink&oid=7659399&loc=d3e1500-128463

Reference 12: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 141R

-Paragraph 67-73

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 13: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 805

-SubTopic 20

-Section 50

-Paragraph 4

-URI http://asc.fasb.org/extlink&oid=6910749&loc=d3e4934-128472

Reference 14: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 141R

-Paragraph F4

-Subparagraph e

-Appendix F

Reference 15: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 805

-SubTopic 10

-Section 50

-Paragraph 5

-URI http://asc.fasb.org/extlink&oid=7659399&loc=d3e1497-128463

Reference 16: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 805

-SubTopic 20

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6910749&loc=d3e4922-128472

Reference 17: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Emerging Issues Task Force (EITF)

-Number 88-16

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 18: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 141

-Paragraph 51, 52

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 19: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 805

-SubTopic 30

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=7488404&loc=d3e6996-128479

+ Details

Name: us-gaap_BusinessCombinationDisclosureTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Details

Name: us-gaap_BusinessCombinationsAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 52 R16.htm IDEA: XBRL DOCUMENT v2.4.0.6

COMMITMENTS AND CONTINGECIES
12 Months Ended

Aug. 31, 2012

Commitments and Contingencies Disclosure [Abstract]

COMMITMENTS AND CONTINGECIES

NOTE 10. COMMITMENTS AND CONTINGECIES

On November 1, 2011, the Company entered into an agreement to lease approximately 2,320 square feet of office space beginning December 1, 2011 for a period of five years.

Rent to be charged to the Company pursuant to the lease is as follows:

$2,996 per month for the period beginning December 1, 2011 and ending November 30, 2012

$3,116 per month for the period beginning December 1, 2012 and ending November 30, 2013

$3,241 per month for the period beginning December 1, 2013 and ending November 30, 2014

$3,371 per month for the period beginning December 1, 2014 and ending November 30, 2015

$3,506 per month for the period beginning December 1, 2015 and ending November 30, 2016

This property is utilized as office space. The Company believes that the foregoing property is adequate to meet its current needs. While it is anticipated that the Company will require access to laboratory facilities in the future, the Company believes that access to such facilities are available from a variety of sources.

On January 4, 2011, as part of the asset purchase agreement with the Company and Gregory McDonald and Pet Pointers, Inc., the Company pays on behalf of Gregory McDonald and Pet Pointers monthly rent of $7,526 to Anthony Marinelli for the terms indicated in the Gregory McDonald / Pet Pointers lease. These payments are not obligations of the Company but, are payments the Company agreed to make on behalf of Gregory McDonald and Pet Pointers as part of the Asset Purchase Agreement.

On January 4, 2011, as part of the asset purchase agreement with the Company and Gregory McDonald on behalf of Pet Pointers, Inc., the Company pays on behalf of Gregory McDonald and Pet Pointers monthly payments of $1,500 to Anthony and Judi Marinelli towards the extinguishment of a total note of $78,000. These payments are payments the Company agreed to make on behalf of Gregory McDonald and Pet Pointers.

On January 4, 2011, as part of the asset purchase agreement with the Company and Gregory McDonald on behalf of Pet Pointers, Inc., the Company pays on behalf of Gregory McDonald and Pet Pointers an installment agreement due to the Franchise Tax Board in the amount of $11,405 with monthly payments of $400. These payments are payments the Company agreed to make on behalf of Gregory McDonald and Pet Pointers.

On January 4, 2011, as part of the asset purchase agreement with the Company and Gregory McDonald on behalf of Pet Pointers, Inc., the Company pays on behalf of Gregory McDonald and Pet Pointers an installment agreement due to the Internal Revenue Service in the amount of $13,595 with monthly payments of $425. These payments are payments the Company agreed to make on behalf of Gregory McDonald and Pet Pointers.

On February 3, 2011, a Complaint (“Complaint”) was filed in the U.S. District Court Middle District of the State of Pennsylvania against the Company, the Company’s Chairman and BMSN. by 18KT.TV LLC (“Plaintiffs”) seeking to recover general damages from the Company. in excess of $125,000. The Complaint alleges breach of contract and unjust enrichment relating to an investor relations contract executed by the Company and Craig Fischer (on behalf of 18KT.TV LLC). The Complaint also seeks similar damages from BMSN. The Company believes that the allegations in the complaint are without merit and intends to vigorously defend its interests in this matter. At this time, it is not possible to predict the ultimate outcome of these matters.

On May 24, 2012, a Complaint (“Complaint”) was filed in the U.S. Bankruptcy Court for the District of Oregon against the Company by Titterington Veterinary Services Inc. (“TVS”). The Complaint is an adversary proceeding filed by TVS arising from TVS’s bankruptcy case currently pending in U.S. Bankruptcy Court for the District of Oregon. The Complaint alleges Breach of Contract resulting from the Company’s alleged failure to pay certain expenses the Company was required to pay pursuant to an agreement with TVS, Dr. Ronald Titterington, DVM and Dr. Kathy Snell, DVM (“TVS Agreement”). TVS is seeking a judgment and money award against the Company in an amount to be proven at trial which TVS estimates in the Complaint to be up to $50,000. TVS is also seeking a judgment and order against the Company to provide an accounting of all revenues received by the Company pursuant to the TVS Agreement, all expenses paid, unpaid, and due and owing pursuant to the TVS Agreement as well as a revenue share which TVS claims is due them pursuant to the TVS Agreement. TVS is also seeking a judgment requiring the Company to turn over a sum of money equal to expenses the Company was obligated to pay pursuant to the TVS Agreement. TVS is also seeking attorney’s fees and expenses. The Company believes that the allegations in the complaint are without merit and intends to vigorously defend its interests in this matter. At this time, it is not possible to predict the ultimate outcome of these matters and an outcome unfavorable to the Company may have a material adverse effect on the Company. On September 19, 2012 the Plaintiff’s Claim for Relief for turnover and an accounting under 11 U.S.C. § 542 and the Plaintiff's Claim for Relief for attorney fees were dismissed with prejudice and , as per the claim of breach of contract, the proceeding was transferred to the United States Bankruptcy Court for the District of Southern California for all further proceedings.

On October 10, 2012 a Complaint(“Complaint”) was filed in the Superior Court of the State of California against the Company and David Koos by Dr. Gregory McDonald, a former employee of the Company, alleging breach of contract and breach of the covenant of good faith and dealing in connection with the assumption of lease obligations by the Company in connection with the acquisition of the assets of Pet Pointers, Inc (“Acquisition”) (Note 9) breach of contract and breach of the covenant of good faith and dealing in connection with an employment agreement enters into with Dr. McDonald inc connection with the Acquisition, breach of contract in connection with the Acquisition purchase agreement, breach of the covenant of good faith and dealing in connection with the Acquisition purchase agreement, implied indemnity in connection to amounts owed by Dr. McDonald to Anthony and Judi Marinelli, the Internal Revenue Service, and the California Franchise Tax Board, intentional misrepresentation, negligent misrepresentation , failure to pay wages and violations of Sections 2802, 203, and 2806 of the California Labor Code. The Complaint seeks judgment for nominal damages, actual damages, compensatory damages, lost wages, compensation, expenses wage benefits and penalties pursuant to California Labor Code Sections 203 et al, 2802 and 2806, indemnification, accrued interest, punitive damages, costs of suit and attorney’s fees.

There were no other legal proceedings against the Company with respect to matters arising in the ordinary course of business. The Company is not involved in any other litigation either as plaintiffs or defendants, and has no knowledge of any threatened or pending litigation against the Company.

On June 1, 2012 the Company entered into an Equity Purchase Agreement (the "June Purchase Agreement") with Southridge Partners II, LP, a Delaware limited partnership ("Southridge").

Under the terms of the June Purchase Agreement, Southridge will purchase, at the Company's election, up to $10,000,000 of the Company's registered common stock (the "Shares"). During the term of the Purchase Agreement, the Company may at any time deliver a "put notice" to Southridge thereby requiring Southridge to purchase a certain dollar amount of the Shares. Simultaneous with the delivery of such Shares, Southridge shall deliver payment for the Shares. Subject to certain restrictions, the purchase price for the Shares shall be equal to 91% of the average of the two lowest Closing Prices during the Valuation Period as such capitalized terms are defined in the Agreement.

The number of Shares sold to Southridge shall not exceed the number of such shares that, when aggregated with all other shares of common stock of the Company then beneficially owned by Southridge, would result in Southridge owning more than 9.99% of all of the Company's common stock then outstanding. Additionally, Southridge may not execute any short sales of the Company's common stock.

Any sale of Shares pursuant to the June Agreement is subject to a Registration Statement filed under the Securities Act of 1933 remaining effective for the sale by Southridge of those Shares.

June Agreement shall terminate (i) on the date on which Southridge shall have purchased Shares pursuant to this Agreement for an aggregate Purchase Price of $10,000,000, or (ii) on the date occurring 24 months from the date on which the June Agreement was executed and delivered by the Company and Southridge.

The Company has also agreed to pay the following to Capital Path Securities LLC for acting as the Company’s exclusive advisor and placement agent in connection with the June Purchase Agreement a cash placement fee of 5% of funds received by the Company through the sale of Shares to Southridge as such funds are received by the Company.

X

- Details

Name: us-gaap_CommitmentsAndContingenciesDisclosureAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

The entire disclosure for commitments and contingencies.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 460

-SubTopic 10

-Section 50

-Paragraph 8

-URI http://asc.fasb.org/extlink&oid=6398077&loc=d3e12565-110249

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 450

-SubTopic 20

-Section 50

-Paragraph 4

-URI http://asc.fasb.org/extlink&oid=6952336&loc=d3e14435-108349

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name FASB Interpretation (FIN)

-Number 14

-Paragraph 3

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 440

-SubTopic 10

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6394976&loc=d3e25287-109308

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.25)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 825

-SubTopic 20

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6449706&loc=d3e16207-108621

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 5

-Paragraph 9, 10, 11, 12

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

+ Details

Name: us-gaap_CommitmentsAndContingenciesDisclosureTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 53 R34.htm IDEA: XBRL DOCUMENT v2.4.0.6

INCOME TAXES - Income Taxes - Deferred tax assets (Details) (USD $)

Aug. 31, 2012

Income Tax Disclosure [Abstract]

Net operating tax carry forwards $ 1,250,503

Other 0

Gross deferred tax assets 1,250,503

Valuation allowance (1,250,503)

Net deferred tax assets $ 0

X

- Definition

Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 109

-Paragraph 43, 289

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 740

-SubTopic 10

-Section 50

-Paragraph 2

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32537-109319

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Deferred Tax Asset

-URI http://asc.fasb.org/extlink&oid=6510090

+ Details

Name: us-gaap_DeferredTaxAssetsGross

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition

Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 740

-SubTopic 10

-Section 50

-Paragraph 2

-Subparagraph (b),(c)

-URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32537-109319

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 109

-Paragraph 43

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

+ Details

Name: us-gaap_DeferredTaxAssetsNet

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition

Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 740

-SubTopic 10

-Section 25

-Paragraph 20

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=6969291&loc=d3e28680-109314

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 740

-SubTopic 10

-Section 50

-Paragraph 6

-URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32621-109319

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 109

-Paragraph 43, 289

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 740

-SubTopic 10

-Section 50

-Paragraph 8

-URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32632-109319

+ Details

Name: us-gaap_DeferredTaxAssetsOperatingLossCarryforwards

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition

Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences not separately disclosed.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 740

-SubTopic 10

-Section 50

-Paragraph 8

-URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32632-109319

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 740

-SubTopic 10

-Section 50

-Paragraph 6

-URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32621-109319

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 740

-SubTopic 10

-Section 25

-Paragraph 20

-URI http://asc.fasb.org/extlink&oid=6969291&loc=d3e28680-109314

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 109

-Paragraph 43

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

+ Details

Name: us-gaap_DeferredTaxAssetsOther

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition

Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 740

-SubTopic 10

-Section 50

-Paragraph 2

-Subparagraph (c)

-URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32537-109319

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 109

-Paragraph 43-49

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 109

-Paragraph 17

-Subparagraph e

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

+ Details

Name: us-gaap_DeferredTaxAssetsValuationAllowance

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Details

Name: us-gaap_IncomeTaxDisclosureAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 54 R21.htm IDEA: XBRL DOCUMENT v2.4.0.6

STOCK TRANSACTIONS
12 Months Ended

Aug. 31, 2012

Equity [Abstract]

STOCK TRANSACTIONS

NOTE 16. STOCK TRANSACTIONS

During the twelve months ended August 31, 2012 the Company issued 113,695,700 Common Shares in satisfaction of $374,959 in debt and accrued interest.

During the twelve months ended August 31, 2012 the Company issued 3,272,000 Common Shares for services rendered valued at $171,750.

During the twelve months ended August 31, 2012 the Company issued 2,500,000 Common shares for acquisition of intangible assets valued at $700,000.

During the twelve months ended August 31, 2012 the Company issued 6,274,726 Common Shares valued at $23,868 pursuant to contractual obligations contained in certain convertible notes outstanding.

During the twelve months ended August 31, 2012 the Company issued 75,000 shares of its Non Voting Convertible Preferred Stock for services rendered valued at $75,000.

On December 26, 2011 an employee of the Company consented to the cancellation of 15,000 common shares previously issued as compensation.

On December 29, 2011 75,000 common shares previously issued to the company’s former Chief Financial Officer were returned for cancellation by the Company. Of that amount 40,000 were subject to forfeiture and are cancelled pursuant to those forfeiture provisions at the company’s option and the company’s former Chief Financial Officer has consented to cancellation of the remaining 35,000 common shares.

During the Quarter ended May 31, 2012 a dividend of 3, 201,397 shares of Series B Preferred Stock was paid to the Company’s common shareholders of record as of February 21, 2012.

On April 3, 2012 the Company issued 50,000,000 shares of common stock to David R. Koos, the Company’s Chief Executive Officer, as a restricted stock award (“Bonus Shares”).David Koos may not offer to sell, sell, transfer, pledge or otherwise dispose of the Bonus Shares prior to April 2, 2017 (“Restricted Period”). In the event that, prior to the expiration of the Restricted Period, David Koos voluntarily ceases to be employed at the Company or is terminated for cause the Shares shall be forfeited.

On April 3, 2012 the Company issued 27,000,000 shares of common stock to seven employees as a restricted stock award (“Bonus Shares”).No employee may offer to sell, sell, transfer, pledge or otherwise dispose of the Bonus Shares prior to April 2, 2017 (“Restricted Period”).In the event that, prior to the expiration of the Restricted Period, any employee voluntarily ceases to be employed at the Company or is terminated for cause his or her Shares shall be forfeited.

On April 3, 2012 the Company issued 15,000,000 shares of common stock to a consultant as a restricted stock award (“Bonus Shares”).The recipient may not offer to sell, sell, transfer, pledge or otherwise dispose of the Shares prior to April 2, 2017 (“Restricted Period”). In the event that, prior to the expiration of the Restricted Period, the recipient declines to provide if requested to provide, or is unable to provide if requested to provide, consulting services to the Company of a nature that have been customarily provided by the recipient to the Company the Shares shall be forfeited.

On August 2, 2012 an employee of the Company consented to the cancelation of 15,000,000 common shares issued to her as a Restricted Stock Award.

X

- Details

Name: us-gaap_EquityAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

The entire disclosure for accounts comprising shareholders' equity, comprised of portions attributable to the parent entity and noncontrolling interest, if any, including other comprehensive income (as applicable). Also includes disclosure of compensation-related costs for equity-based compensation which may include disclosure of policies, compensation plan details, allocation of equity compensation, incentive distributions, equity-based arrangements to obtain goods and services, deferred compensation arrangements, employee stock ownership plan details, and employee stock purchase plan details.

+ References

No definition available.

+ Details

Name: us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 55 R26.htm IDEA: XBRL DOCUMENT v2.4.0.6

INCOME TAXES (Tables)
12 Months Ended

Aug. 31, 2012

Income Tax Disclosure [Abstract]

Income Taxes - Deferred tax assets

As of August 31, 2012

Deferred tax assets:

Net operating tax carry forwards $ 1,250,503

Other -0-

Gross deferred tax assets 1,250,503

Valuation allowance (1,250,503)

Net deferred tax assets $ -0-

X

- Details

Name: us-gaap_IncomeTaxDisclosureAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 740

-SubTopic 10

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32537-109319

+ Details

Name: us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 56 R41.htm IDEA: XBRL DOCUMENT v2.4.0.6

STOCKHOLDERS EQUITY (Details Narrative) (USD $)

Aug. 31, 2012

Mar. 27, 2012

Feb. 29, 2012

Aug. 31, 2011

Equity [Abstract]

Common stock, par value $ 0.001 $ 0.001

Common stock, shares authorized 1,000,000,000 1,000,000,000

Common stock, shares issued 223,492,927 223,492,927

Common stock, shares outstanding 223,492,927 223,492,927

Preferred stock, par value $ 0.001 $ 0.001

Preferred stock, shares authorized 5,000,000 5,000,000

Series AA Preferred shares, shares authorized 100,000 100,000

Series AA Preferred shares, par value $ 0.001 $ 0.001 $ 0.001

Series AA Preferred shares, shares issued 5,000 5,000

Series AA Preferred shares, shares outstanding 5,000 5,000

Series B Preferred shares, shares authorized 4,400,000 4,400,000

Series B Preferred shares, shares issued 3,201,397 3,201,397

NonVoting Convertible Preferred shares, par value $ 1.00 $ 1

NonVoting Convertible Preferred shares, shares authorized 200,000 200,000

NonVoting Convertible Preferred shares, shares issued 75,000 75,000

Non Voting Convertible Preferred Stock conversion price percentage 70.00% 70.00%

X

- Definition

Face amount or stated value per share of nonredeemable nonvoting convertible preferred stock (or nonvoting convertible preferred stock redeemable solely at the option of the issuer); generally not indicative of the fair market value per share.

+ References

No definition available.

+ Details

Name: ENTB_NonvotingConvertiblePreferredSharesParValue

Namespace Prefix: ENTB_

Data Type: num:perShareItemType

Balance Type: na

Period Type: instant

X

- Definition

The maximum number of nonvoting convertible preferred shares permitted to be issued by an entity's charter and bylaws.

+ References

No definition available.

+ Details

Name: ENTB_NonvotingConvertiblePreferredSharesSharesAuthorized

Namespace Prefix: ENTB_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition

Total number of nonredeemable nonvoting convertible preferred shares (or nonvoting convertible preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related nonvoting convertible preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of nonvoting convertible preferred shares authorized. Excludes nonvoting convertible preferred shares that are classified as debt.

+ References

No definition available.

+ Details

Name: ENTB_NonvotingConvertiblePreferredSharesSharesIssued

Namespace Prefix: ENTB_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition

The price percentage per share of the conversion feature embedded in the debt instrument.

+ References

No definition available.

+ Details

Name: ENTB_NonVotingConvertiblePreferredStockConversionPricePercentage

Namespace Prefix: ENTB_

Data Type: num:percentItemType

Balance Type: na

Period Type: instant

X

- Definition

Face amount or stated value per share of nonredeemable series AA preferred stock (or series AA preferred stock redeemable solely at the option of the issuer); generally not indicative of the fair market value per share.

+ References

No definition available.

+ Details

Name: ENTB_SeriesAaPreferredSharesParValue

Namespace Prefix: ENTB_

Data Type: num:perShareItemType

Balance Type: na

Period Type: instant

X

- Definition

The maximum number of series AA preferred shares permitted to be issued by an entity's charter and bylaws.

+ References

No definition available.

+ Details

Name: ENTB_SeriesAaPreferredSharesSharesAuthorized

Namespace Prefix: ENTB_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition

Total number of nonredeemable series AA preferred shares (or series AA preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related series AA preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of series AA preferred shares authorized. Excludes series AA preferred shares that are classified as debt.

+ References

No definition available.

+ Details

Name: ENTB_SeriesAaPreferredSharesSharesIssued

Namespace Prefix: ENTB_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition

Aggregate share number for all nonredeemable series AA preferred stock (or series AA preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include series AA preferred shares that have been repurchased.

+ References

No definition available.

+ Details

Name: ENTB_SeriesAaPreferredSharesSharesOutstanding

Namespace Prefix: ENTB_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition

The maximum number of series B preferred shares permitted to be issued by an entity's charter and bylaws.

+ References

No definition available.

+ Details

Name: ENTB_SeriesBPreferredSharesSharesAuthorized

Namespace Prefix: ENTB_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition

Total number of nonredeemable series B preferred shares (or series B preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related series B preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of series B preferred shares authorized. Excludes series B preferred shares that are classified as debt.

+ References

No definition available.

+ Details

Name: ENTB_SeriesBPreferredSharesSharesIssued

Namespace Prefix: ENTB_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition

Face amount or stated value of common stock per share; generally not indicative of the fair market value per share.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 129

-Paragraph 4

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.29)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 30

-Article 5

+ Details

Name: us-gaap_CommonStockParOrStatedValuePerShare

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: instant

X

- Definition

The maximum number of common shares permitted to be issued by an entity's charter and bylaws.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.29)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 30

-Article 5

+ Details

Name: us-gaap_CommonStockSharesAuthorized

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition

Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.29)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 30

-Article 5

+ Details

Name: us-gaap_CommonStockSharesIssued

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition

Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.3-04)

-URI http://asc.fasb.org/extlink&oid=6959260&loc=d3e187085-122770

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.29)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher AICPA

-Name Accounting Principles Board Opinion (APB)

-Number 12

-Paragraph 10

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 30

-Article 5

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 04

-Article 3

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21463-112644

+ Details

Name: us-gaap_CommonStockSharesOutstanding

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Details

Name: us-gaap_EquityAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

Face amount or stated value per share of nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer); generally not indicative of the fair market value per share.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 129

-Paragraph 2, 3, 4, 5, 6, 7, 8

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher AICPA

-Name Accounting Principles Board Opinion (APB)

-Number 12

-Paragraph 10

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 29

-Article 5

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.28)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_PreferredStockParOrStatedValuePerShare

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: instant

X

- Definition

The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 29

-Article 5

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.28)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 129

-Paragraph 2, 3, 4, 5, 6, 7, 8

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

+ Details

Name: us-gaap_PreferredStockSharesAuthorized

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

XML 57 R5.htm IDEA: XBRL DOCUMENT v2.4.0.6

Consolidated Statement of Stockholders' Equity (USD $)

Common shares outstanding

Series AA preferred shares outstanding

Series B preferred shares outstanding

Non Voting Convertible Preferred

Additional Paid-in Capital

Contributed Capital

Accumulated Deficit during the Development Stage

Total

Beginning balance, Amount at Aug. 31, 2010 $ 17,553 $ 537,415 $ 15,104 $ (790,814) $ (220,742)

Beginning balance, Shares at Aug. 31, 2010 17,553,040

Common Shares issued for Cash, Shares 2,217,600

Common Shares issued for Cash, Amount 2,217 215,383 217,600

Common Shares issued for Debt, Shares 781,712

Common Shares issued for Debt, Amount 780 340,387 341,167

Common Shares issued to Consultants, Shares 74,383

Common Shares issued to Consultants, Amount 74 121,967 122,041

Common Stock issued to employees, Shares 163,766

Common Stock issued to employees, Amount 164 303,235 303,399

Restricted Stock Awards issued to employee, Shares 50,000

Restricted Stock Awards issued to employee, Amount 50 (50)

Expense Recognized 10,000 10,000

Discount on Convertible Debt recognized 88,998 88,998

Increases in Contributed capital 259,058 259,058

Preferred Stock issued for Accrued compensation, Shares 5,000

Preferred Stock issued for Accrued compensation, Amount 5 1,995 2,000

Net Loss for the Year (951,783) (951,783)

Ending balance, Amount at Aug. 31, 2011 20,838 5 1,619,330 274,162 (1,742,597) 171,738

Ending balance, Shares at Aug. 31, 2011 20,840,501 5,000

Common Shares issued for Debt, Shares 113,695,700 113,695,700

Common Shares issued for Debt, Amount 113,695 261,264 374,959

Restricted Stock Awards issued to employee, Shares 77,000,000

Restricted Stock Awards issued to employee, Amount 77,000 (77,000) 0

Common Shares issued for services, Shares 3,272,000 3,272,000

Common Shares issued for services, Amount 3,269 168,481 171,750

Common Shares issued for intangible assets, Shares 2,500,000 2,500,000

Common Shares issued for intangible assets, Amount 2,500 697,500 700,000

Cancellation of Common Shares Issued, Shares (90,000)

Cancellation of Common Shares Issued, Amount (83) (86,687) (86,687)

Restricted Stock Awards to consultant, Shares 15,000,000

Restricted Stock Awards to consultant, Amount 15,000 (15,000) 0

Expense Recognized 58,491 58,491

Discount on Convertible Debt recognized 350,915 350,915

Series B Preferred Dividend paid, Shares 3,201,397

Series B Preferred Dividend paid, Amount 3,201 (3,201) 0

Preferred Shares, Shares 75,000 75,000

Preferred Shares, Amount 75,000 75,000

Recognition of Beneficial Conversion Feature 32,142 32,142

Shares issued pursuant to Contractual Obligations, Shares 6,274,726 6,274,726

Shares issued pursuant to Contractual Obligations, Amount 6,274 17,594 23,868

Cancellation of Restricted Stock Award to Employee, Shares (15,000,000)

Cancellation of Restricted Stock Award to Employee, Shares (15,000) 6,813 (8,187)

Net Loss for the Year (1,889,563) (1,889,563)

Beneficial Conversion Feature Deemed Dividend (32,142) (32,142)

Ending balance, Amount at Aug. 31, 2012 $ 223,493 $ 5 $ 3,201 $ 75,000 $ 3,030,642 $ 274,162 $ (3,664,302) $ (57,799)

Ending balance, Shares at Aug. 31, 2012 223,492,927 5,000 3,201,397 75,000

X

- Definition

The amount of convertible debt discount that was originally recognized at the issuance of the instrument that has yet to be amortized.

+ References

No definition available.

+ Details

Name: ENTB_DiscountOnConvertibleDebtRecognized

Namespace Prefix: ENTB_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

Adjustment to Additional Paid in Capital resulting from the recognition of deferred taxes for the temporary difference of the convertible debt with a beneficial conversion feature. A beneficial conversion feature is a nondetachable conversion feature that is in-the-money.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Beneficial Conversion Feature

-URI http://asc.fasb.org/extlink&oid=6505963

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Emerging Issues Task Force (EITF)

-Number 05-8

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21463-112644

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.3-04)

-URI http://asc.fasb.org/extlink&oid=6959260&loc=d3e187085-122770

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 740

-SubTopic 10

-Section 55

-Paragraph 51

-URI http://asc.fasb.org/extlink&oid=21917533&loc=d3e34017-109320

+ Details

Name: us-gaap_AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

Represents increases or decreases in additional paid in capital not separately disclosed.

+ References

No definition available.

+ Details

Name: us-gaap_AdjustmentsToAdditionalPaidInCapitalOther

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

The value of the financial instrument(s) that the original debt is being converted into in a noncash (or part noncash) transaction. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 50

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=6367179&loc=d3e4304-108586

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 95

-Paragraph 32

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 50

-Paragraph 5

-URI http://asc.fasb.org/extlink&oid=6367179&loc=d3e4332-108586

+ Details

Name: us-gaap_DebtConversionConvertedInstrumentAmount1

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

The number of shares issued in exchange for the original debt being converted in a noncash (or part noncash) transaction. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or payments in the period.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 50

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=6367179&loc=d3e4304-108586

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 95

-Paragraph 32

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 50

-Paragraph 5

-URI http://asc.fasb.org/extlink&oid=6367179&loc=d3e4332-108586

+ Details

Name: us-gaap_DebtConversionConvertedInstrumentSharesIssued1

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition

Equity impact of aggregate cash, stock, and paid-in-kind dividends declared for all securities (common shares, preferred shares, etc.) during the period.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher AICPA

-Name Statement of Position (SOP)

-Number 01-6

-Paragraph 14

-Subparagraph l

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 04

-Article 3

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.3-04)

-URI http://asc.fasb.org/extlink&oid=6959260&loc=d3e187085-122770

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 942

-SubTopic 405

-Section 45

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6957935&loc=d3e64057-112817

+ Details

Name: us-gaap_Dividends

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition

Equity impact of aggregate cash, stock, and paid-in-kind dividends declared for preferred shareholders during the period.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher AICPA

-Name Statement of Position (SOP)

-Number 01-6

-Paragraph 14

-Subparagraph l

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 04

-Article 3

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.3-04)

-URI http://asc.fasb.org/extlink&oid=6959260&loc=d3e187085-122770

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 942

-SubTopic 405

-Section 45

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6957935&loc=d3e64057-112817

+ Details

Name: us-gaap_DividendsPreferredStock

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition

Equity impact of stock dividends for preferred shareholders declared by an entity during the period. This element includes paid and unpaid dividends declared during the period.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher AICPA

-Name Statement of Position (SOP)

-Number 01-6

-Paragraph 14

-Subparagraph l

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 04

-Article 3

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.3-04)

-URI http://asc.fasb.org/extlink&oid=6959260&loc=d3e187085-122770

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 942

-SubTopic 405

-Section 45

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6957935&loc=d3e64057-112817

+ Details

Name: us-gaap_DividendsPreferredStockStock

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition

The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 03

-Paragraph 19

-Article 5

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 260

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 944

-SubTopic 225

-Section S99

-Paragraph 1

-Subparagraph (SX 210.7-04.22)

-URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Other Comprehensive Income

-URI http://asc.fasb.org/extlink&oid=6519514

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.18)

-URI http://asc.fasb.org/extlink&oid=6880815&loc=d3e20235-122688

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 130

-Paragraph 10, 15

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 04

-Paragraph 20

-Article 9

Reference 8: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Net Income

-URI http://asc.fasb.org/extlink&oid=6518256

Reference 9: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Emerging Issues Task Force (EITF)

-Number 87-21

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 10: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 95

-Paragraph 28, 29, 30

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 11: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3602-108585

Reference 12: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 944

-SubTopic 225

-Section S99

-Paragraph 1

-Subparagraph (SX 210.7-04.19)

-URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913

Reference 13: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 220

-SubTopic 10

-Section 45

-Paragraph 6

-URI http://asc.fasb.org/extlink&oid=20435746&loc=d3e565-108580

Reference 14: http://www.xbrl.org/2003/role/presentationRef

-Publisher AICPA

-Name Accounting Research Bulletin (ARB)

-Number 51

-Paragraph A7

-Appendix A

Reference 15: http://www.xbrl.org/2003/role/presentationRef

-Publisher AICPA

-Name Accounting Research Bulletin (ARB)

-Number 51

-Paragraph 38

-Subparagraph a

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 16: http://www.xbrl.org/2003/role/presentationRef

-Publisher AICPA

-Name Accounting Research Bulletin (ARB)

-Number 51

-Paragraph 38

-Subparagraph d

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

+ Details

Name: us-gaap_NetIncomeLoss

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

Amount of general expenses not normally included in Other Operating Costs and Expenses.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.6)

-URI http://asc.fasb.org/extlink&oid=6880815&loc=d3e20235-122688

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 03

-Paragraph 6

-Article 5

+ Details

Name: us-gaap_OtherGeneralExpense

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition

Number of shares of preferred stock issued as dividends during the period. Excludes stock splits.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21463-112644

+ Details

Name: us-gaap_PreferredStockDividendsShares

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition

Proceeds from issuance of capital stock which provides for a specific dividend that is paid to the shareholders before any dividends to common stockholders and which takes precedence over common stockholders in the event of liquidation.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 95

-Paragraph 19

-Subparagraph a

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Financing Activities

-URI http://asc.fasb.org/extlink&oid=6513228

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 95

-Paragraph 18

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 14

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3255-108585

+ Details

Name: us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition

The number of restricted shares issued as compensation, net of shares for the payment of withholding taxes. This element is to be used only if shares are used in lieu of cash to satisfy all or a portion of withholding taxes.

+ References

No definition available.

+ Details

Name: us-gaap_RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition

The value of restricted shares issued as compensation, net of the value of shares for the payment of withholding taxes. This element is to be used only if shares are used in lieu of cash to satisfy all or a portion of withholding taxes.

+ References

No definition available.

+ Details

Name: us-gaap_RestrictedStockValueSharesIssuedNetOfTaxWithholdings

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

Number of shares issued and outstanding as of the balance sheet date.

+ References

No definition available.

+ Details

Name: us-gaap_SharesOutstanding

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition

Number of shares of common and preferred stock issued as dividends during the period. Excludes stock splits.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21463-112644

+ Details

Name: us-gaap_StockDividendsShares

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition

Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.29-31)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 29, 30, 31

-Article 5

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher AICPA

-Name Accounting Research Bulletin (ARB)

-Number 51

-Paragraph A3

-Appendix A

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 310

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SAB TOPIC 4.E)

-URI http://asc.fasb.org/extlink&oid=6228006&loc=d3e74512-122707

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Staff Accounting Bulletin (SAB)

-Number Topic 4

-Section E

+ Details

Name: us-gaap_StockholdersEquity

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition

Number of shares issued during the period from a dividend reinvestment plan (DRIP). A dividend reinvestment plan allows the shareholders to reinvest dividends paid to them by the entity on new issues of stock by the entity.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21463-112644

+ Details

Name: us-gaap_StockIssuedDuringPeriodSharesDividendReinvestmentPlan

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition

Number of shares issued during the period to an employee benefit plan, such as a defined contribution or defined benefit plan.

+ References

No definition available.

+ Details

Name: us-gaap_StockIssuedDuringPeriodSharesEmployeeBenefitPlan

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition

Number of shares issued as consideration for cash.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 915

-SubTopic 215

-Section 45

-Paragraph 1

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=6472370&loc=d3e38297-110927

+ Details

Name: us-gaap_StockIssuedDuringPeriodSharesIssuedForCash

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition

Number of shares issued for noncash consideration.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 915

-SubTopic 215

-Section 45

-Paragraph 1

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=6472370&loc=d3e38297-110927

+ Details

Name: us-gaap_StockIssuedDuringPeriodSharesIssuedForNoncashConsideration

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition

Number of shares issued in lieu of cash for services contributed to the entity. Number of shares includes, but is not limited to, shares issued for services contributed by vendors and founders.

+ References

No definition available.

+ Details

Name: us-gaap_StockIssuedDuringPeriodSharesIssuedForServices

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition

Number of shares of stock issued during the period as part of a transaction to acquire assets that do not qualify as a business combination.

+ References

No definition available.

+ Details

Name: us-gaap_StockIssuedDuringPeriodSharesPurchaseOfAssets

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition

Total number of shares issued during the period, including shares forfeited, as a result of Restricted Stock Awards.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 129

-Paragraph 4, 5

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher AICPA

-Name Accounting Principles Board Opinion (APB)

-Number 12

-Paragraph 10

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21463-112644

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.3-04)

-URI http://asc.fasb.org/extlink&oid=6959260&loc=d3e187085-122770

+ Details

Name: us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition

Number of shares (or other type of equity) issued during the period as a result of any equity-based compensation plan other than an employee stock ownership plan (ESOP), net of any shares forfeited. Shares issued could result from the issuance of restricted stock, the exercise of stock options, stock issued under employee stock purchase plans, and/or other employee benefit plans.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.3-04)

-URI http://asc.fasb.org/extlink&oid=6959260&loc=d3e187085-122770

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 129

-Paragraph 5

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher AICPA

-Name Accounting Principles Board Opinion (APB)

-Number 12

-Paragraph 10

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 29, 30

-Article 5

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 04

-Article 3

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21463-112644

+ Details

Name: us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition

Value of shares issued during the period to an employee benefit plan, such as a defined contribution or defined benefit plan.

+ References

No definition available.

+ Details

Name: us-gaap_StockIssuedDuringPeriodValueEmployeeBenefitPlan

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

Value of stock issued as consideration for cash.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 915

-SubTopic 215

-Section 45

-Paragraph 1

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=6472370&loc=d3e38297-110927

+ Details

Name: us-gaap_StockIssuedDuringPeriodValueIssuedForCash

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

Value of stock issued for noncash consideration.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 915

-SubTopic 215

-Section 45

-Paragraph 1

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=6472370&loc=d3e38297-110927

+ Details

Name: us-gaap_StockIssuedDuringPeriodValueIssuedForNoncashConsiderations

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

Value of stock issued in lieu of cash for services contributed to the entity. Value of the stock issued includes, but is not limited to, services contributed by vendors and founders.

+ References

No definition available.

+ Details

Name: us-gaap_StockIssuedDuringPeriodValueIssuedForServices

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

Value of shares of stock issued during the period as part of a transaction to acquire assets that do not qualify as a business combination.

+ References

No definition available.

+ Details

Name: us-gaap_StockIssuedDuringPeriodValuePurchaseOfAssets

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

Aggregate value of stock related to Restricted Stock Awards issued during the period.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.3-04)

-URI http://asc.fasb.org/extlink&oid=6959260&loc=d3e187085-122770

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 29, 30, 31

-Article 5

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher AICPA

-Name Accounting Principles Board Opinion (APB)

-Number 12

-Paragraph 10

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 04

-Article 3

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21463-112644

+ Details

Name: us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

Value of stock (or other type of equity) issued during the period as a result of any equity-based compensation plan other than an employee stock ownership plan (ESOP), net of stock value of such awards forfeited. Stock issued could result from the issuance of restricted stock, the exercise of stock options, stock issued under employee stock purchase plans, and/or other employee benefit plans.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 123R

-Paragraph 64

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 2

-Subparagraph (d)(1)

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher AICPA

-Name Accounting Principles Board Opinion (APB)

-Number 12

-Paragraph 10

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 1

-Subparagraph (c)

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5047-113901

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 04

-Article 3

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.3-04)

-URI http://asc.fasb.org/extlink&oid=6959260&loc=d3e187085-122770

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 29, 30, 31

-Article 5

+ Details

Name: us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

Number of shares that have been repurchased and retired during the period.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 29, 30

-Article 5

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher AICPA

-Name Accounting Principles Board Opinion (APB)

-Number 12

-Paragraph 10

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 04

-Article 3

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21463-112644

+ Details

Name: us-gaap_StockRepurchasedAndRetiredDuringPeriodShares

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition

Equity impact of the value of stock that has been repurchased and retired during the period. The excess of the purchase price over par value can be charged against retained earnings (once the excess is fully allocated to additional paid in capital).

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 29, 30, 31

-Article 5

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher AICPA

-Name Accounting Principles Board Opinion (APB)

-Number 12

-Paragraph 10

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 04

-Article 3

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21463-112644

+ Details

Name: us-gaap_StockRepurchasedAndRetiredDuringPeriodValue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition

Number of shares that have been repurchased during the period and have not been retired and are not held in treasury. Some state laws may govern the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher AICPA

-Name Accounting Research Bulletin (ARB)

-Number 43

-Section B

-Paragraph 11A

-Chapter 1

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 29, 30

-Article 5

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher AICPA

-Name Accounting Principles Board Opinion (APB)

-Number 12

-Paragraph 10

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 04

-Article 3

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21463-112644

+ Details

Name: us-gaap_StockRepurchasedDuringPeriodShares

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition

Equity impact of the value of stock that has been repurchased during the period and has not been retired and is not held in treasury. Some state laws may mandate the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher AICPA

-Name Accounting Research Bulletin (ARB)

-Number 43

-Section B

-Paragraph 11A

-Chapter 1

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 29, 30, 31

-Article 5

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher AICPA

-Name Accounting Principles Board Opinion (APB)

-Number 12

-Paragraph 10

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 04

-Article 3

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21463-112644

+ Details

Name: us-gaap_StockRepurchasedDuringPeriodValue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

XML 58 R10.htm IDEA: XBRL DOCUMENT v2.4.0.6

GOING CONCERN
12 Months Ended

Aug. 31, 2012

Organization, Consolidation and Presentation of Financial Statements [Abstract]

GOING CONCERN

NOTE 4. GOING CONCERN

The accompanying financial statements have been prepared assuming that the Company will continue as a going concern. The Company generated net losses of $3,664,302 during the period from August 22, 2008 (inception) through August 31, 2012. This condition raises substantial doubt about the Company's ability to continue as a going concern. The Company's continuation as a going concern is dependent on its ability to meet its obligations, to obtain additional financing as may be required and ultimately to attain profitability. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.

Management plans to raise additional funds primarily by offering securities for cash. Management has raised $197,500 net of legal expenses in the twelve months ended August 31, 2012 through the issuance of convertible notes. The Company has also raised $261,475 from other borrowings during the twelve month ended August 31, 2012.

On June 1, 2012 the Company entered into an Equity Purchase Agreement (the "June Purchase Agreement") with Southridge Partners II, LP, a Delaware limited partnership ("Southridge").

Under the terms of the June Purchase Agreement, Southridge will purchase, at the Company's election, up to $10,000,000 of the Company's registered common stock (the "Shares"). During the term of the Purchase Agreement, the Company may at any time deliver a "put notice" to Southridge thereby requiring Southridge to purchase a certain dollar amount of the Shares. Simultaneous with the delivery of such Shares, Southridge shall deliver payment for the Shares. Subject to certain restrictions, the purchase price for the Shares shall be equal to 91% of the average of the two lowest Closing Prices during the Valuation Period as such capitalized terms are defined in the Agreement.

The number of Shares sold to Southridge shall not exceed the number of such shares that, when aggregated with all other shares of common stock of the Company then beneficially owned by Southridge, would result in Southridge owning more than 9.99% of all of the Company's common stock then outstanding. Additionally, Southridge may not execute any short sales of the Company's common stock.

Any sale of Shares pursuant to the June Agreement is subject to a Registration Statement filed under the Securities Act of 1933 remaining effective for the sale by Southridge of those Shares.

June Agreement shall terminate (i) on the date on which Southridge shall have purchased Shares pursuant to this Agreement for an aggregate Purchase Price of $10,000,000, or (ii) on the date occurring 24 months from the date on which the June Agreement was executed and delivered by the Company and Southridge.

The Company has also agreed to pay the following to Capital Path Securities LLC for acting as the Company’s exclusive advisor and placement agent in connection with the June Purchase Agreement a cash placement fee of 5% of funds received by the Company through the sale of Shares to Southridge as such funds are received by the Company.

On June 12, 2012 a registration statement on form S-1 was filed with the United States Securities and Exchange Commission registering 46,238,705 shares of the Company’s common stock that will be put to Southridge pursuant to the June Agreement which was declared effective by the United States Securities and Exchange Commission on August 27, 2012.

There is no guarantee that the Company will be able to raise additional capital through offerings.

X

- Definition

Disclosure of accounting policy for reporting when there is a substantial doubt about an entity's ability to continue as a going concern for a reasonable period of time (generally a year from the balance sheet date). Disclose: (a) pertinent conditions and events giving rise to the assessment of substantial doubt about the entity's ability to continue as a going concern for a reasonable period of time, (b) the possible effects of such conditions and events, (c) management's evaluation of the significance of those conditions and events and any mitigating factors, (d) possible discontinuance of operations, (e) management's plans (including relevant prospective financial information), and (f) information about the recoverability or classification of recorded asset amounts or the amounts or classification of liabilities. If management's plans alleviate the substantial doubt about the entity's ability to continue as a going concern, disclosure of the principal conditions and events that initially raised the substantial doubt about the entity's ability to continue as a going concern would be expected to be considered. Disclose whether operations for the current or prior years generated sufficient cash to cover current obligations, whether waivers were obtained from creditors relating to the company's default under the provisions of debt agreements and possible effects of such conditions and events, such as: whether there is a possible need to obtain additional financing (debt or equity) or to liquidate certain holdings to offset future cash flow deficiencies. Disclose appropriate parent company information when parent is dependent upon remittances from subsidiaries to satisfy its obligations.

+ References

No definition available.

+ Details

Name: us-gaap_LiquidityDisclosureTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Details

Name: us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 59 R27.htm IDEA: XBRL DOCUMENT v2.4.0.6

ORGANIZATION AND DESCRIPTION OF BUSINESS (Details Narrative)

Jul. 10, 2009

Accounting Policies [Abstract]

Acquisition of share capital of Entest BioMedical, Inc. (“Entest CA") 100.00%

X

- Details

Name: us-gaap_AccountingPoliciesAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

In a business combination achieved in stages, this element represents the acquisition-date percentage of equity in the acquiree held by the acquirer immediately before the acquisition date.

+ References

No definition available.

+ Details

Name: us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage

Namespace Prefix: us-gaap_

Data Type: num:percentItemType

Balance Type: na

Period Type: instant

XML 60 FilingSummary.xml IDEA: XBRL DOCUMENT 2.4.0.6 Html 81 310 1 false 13 0 false 6 false false R1.htm 0001 - Document - Document and Entity Information Sheet http://entb.net/role/DocumentAndEntityInformation Document and Entity Information true false R2.htm 0002 - Statement - Consolidated Balance Sheet Sheet http://entb.net/role/ConsolidatedBalanceSheet Consolidated Balance Sheet false false R3.htm 0003 - Statement - Consolidated Balance Sheet (Parenthetical) Sheet http://entb.net/role/ConsolidatedBalanceSheetParenthetical Consolidated Balance Sheet (Parenthetical) false false R4.htm 0004 - Statement - Consolidated Statement of Operations Sheet http://entb.net/role/ConsolidatedStatementOfOperations Consolidated Statement of Operations false false R5.htm 0005 - Statement - Consolidated Statement of Stockholders' Equity Sheet http://entb.net/role/ConsolidatedStatementOfStockholdersEquity Consolidated Statement of Stockholders' Equity false false R6.htm 0006 - Statement - Consolidated Statement of Cash Flows Sheet http://entb.net/role/ConsolidatedStatementOfCashFlows Consolidated Statement of Cash Flows false false R7.htm 0007 - Disclosure - ORGANIZATION AND DESCRIPTION OF BUSINESS Sheet http://entb.net/role/OrganizationAndDescriptionOfBusiness ORGANIZATION AND DESCRIPTION OF BUSINESS false false R8.htm 0008 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Sheet http://entb.net/role/SummaryOfSignificantAccountingPolicies SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES false false R9.htm 0009 - Disclosure - RECENT ACCOUNTING PRONOUNCEMENTS Sheet http://entb.net/role/RecentAccountingPronouncements RECENT ACCOUNTING PRONOUNCEMENTS false false R10.htm 0010 - Disclosure - GOING CONCERN Sheet http://entb.net/role/GoingConcern GOING CONCERN false false R11.htm 0011 - Disclosure - NOTES PAYABLE Notes http://entb.net/role/NotesPayable NOTES PAYABLE false false R12.htm 0012 - Disclosure - RELATED PARTY TRANSACTIONS Sheet http://entb.net/role/RelatedPartyTransactions RELATED PARTY TRANSACTIONS false false R13.htm 0013 - Disclosure - INCOME TAXES Sheet http://entb.net/role/IncomeTaxes INCOME TAXES false false R14.htm 0014 - Disclosure - ACQUISITION OF ENTEST CA Sheet http://entb.net/role/AcquisitionOfEntestCa ACQUISITION OF ENTEST CA false false R15.htm 0015 - Disclosure - ACQUISITION OF THE ASSETS OF PET POINTERS, INC. Sheet http://entb.net/role/AcquisitionOfAssetsOfPetPointersInc. ACQUISITION OF THE ASSETS OF PET POINTERS, INC. false false R16.htm 0016 - Disclosure - COMMITMENTS AND CONTINGECIES Sheet http://entb.net/role/CommitmentsAndContingecies COMMITMENTS AND CONTINGECIES false false R17.htm 0017 - Disclosure - NON VOTING CONVERTIBLE PREFERRED STOCK Sheet http://entb.net/role/NonVotingConvertiblePreferredStock NON VOTING CONVERTIBLE PREFERRED STOCK false false R18.htm 0018 - Disclosure - DIVIDEND OF SERIES B PREFERRED SHARES Sheet http://entb.net/role/DividendOfSeriesBPreferredShares DIVIDEND OF SERIES B PREFERRED SHARES false false R19.htm 0019 - Disclosure - STOCKHOLDERS EQUITY Sheet http://entb.net/role/StockholdersEquity STOCKHOLDERS EQUITY false false R20.htm 0020 - Disclosure - CONVERTIBLE DEBENTURES Sheet http://entb.net/role/ConvertibleDebentures CONVERTIBLE DEBENTURES false false R21.htm 0021 - Disclosure - STOCK TRANSACTIONS Sheet http://entb.net/role/StockTransactions STOCK TRANSACTIONS false false R22.htm 0022 - Disclosure - SUBSEQUENT EVENTS Sheet http://entb.net/role/SubsequentEvents SUBSEQUENT EVENTS false false R23.htm 0023 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) Sheet http://entb.net/role/SummaryOfSignificantAccountingPoliciesPolicies SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) false false R24.htm 0024 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables) Sheet http://entb.net/role/SummaryOfSignificantAccountingPoliciesTables SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables) false false R25.htm 0025 - Disclosure - NOTES PAYABLE (Tables) Notes http://entb.net/role/NotesPayableTables NOTES PAYABLE (Tables) false false R26.htm 0026 - Disclosure - INCOME TAXES (Tables) Sheet http://entb.net/role/IncomeTaxesTables INCOME TAXES (Tables) false false R27.htm 0027 - Disclosure - ORGANIZATION AND DESCRIPTION OF BUSINESS (Details Narrative) Sheet http://entb.net/role/OrganizationAndDescriptionOfBusinessDetailsNarrative ORGANIZATION AND DESCRIPTION OF BUSINESS (Details Narrative) false false R28.htm 0028 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Property Plant and Equipment, Acquisition Costs (Details) Sheet http://entb.net/role/SummaryOfSignificantAccountingPolicies-PropertyPlantAndEquipmentAcquisitionCostsDetails SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Property Plant and Equipment, Acquisition Costs (Details) false false R29.htm 0029 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) Sheet http://entb.net/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) false false R30.htm 0030 - Disclosure - GOING CONCERN (Details Narrative) Sheet http://entb.net/role/GoingConcernDetailsNarrative GOING CONCERN (Details Narrative) false false R31.htm 0031 - Disclosure - NOTES PAYABLE - Notes Payable, Current and Long Term (Details) Notes http://entb.net/role/NotesPayable-NotesPayableCurrentAndLongTermDetails NOTES PAYABLE - Notes Payable, Current and Long Term (Details) false false R32.htm 0032 - Disclosure - NOTES PAYABLE (Details Narrative) Notes http://entb.net/role/NotesPayableDetailsNarrative NOTES PAYABLE (Details Narrative) false false R33.htm 0033 - Disclosure - RELATED PARTY TRANSACTIONS (Details Narrative) Sheet http://entb.net/role/RelatedPartyTransactionsDetailsNarrative RELATED PARTY TRANSACTIONS (Details Narrative) false false R34.htm 0034 - Disclosure - INCOME TAXES - Income Taxes - Deferred tax assets (Details) Sheet http://entb.net/role/IncomeTaxes-IncomeTaxes-DeferredTaxAssetsDetails INCOME TAXES - Income Taxes - Deferred tax assets (Details) false false R35.htm 0035 - Disclosure - INCOME TAXES (Details Narrative) Sheet http://entb.net/role/IncomeTaxesDetailsNarrative INCOME TAXES (Details Narrative) false false R36.htm 0036 - Disclosure - ACQUISITION OF ENTEST CA (Details Narrative) Sheet http://entb.net/role/AcquisitionOfEntestCaDetailsNarrative ACQUISITION OF ENTEST CA (Details Narrative) false false R37.htm 0037 - Disclosure - ACQUISITION OF THE ASSETS OF PET POINTERS, INC. (Details Narrative) Sheet http://entb.net/role/AcquisitionOfAssetsOfPetPointersInc.DetailsNarrative ACQUISITION OF THE ASSETS OF PET POINTERS, INC. (Details Narrative) false false R38.htm 0038 - Disclosure - COMMITMENTS AND CONTINGECIES (Details Narrative) Sheet http://entb.net/role/CommitmentsAndContingeciesDetailsNarrative COMMITMENTS AND CONTINGECIES (Details Narrative) false false R39.htm 0039 - Disclosure - NON VOTING CONVERTIBLE PREFERRED STOCK (Details Narrative) Sheet http://entb.net/role/NonVotingConvertiblePreferredStockDetailsNarrative NON VOTING CONVERTIBLE PREFERRED STOCK (Details Narrative) false false R40.htm 0040 - Disclosure - DIVIDEND OF SERIES B PREFERRED SHARES (Details Narrative) Sheet http://entb.net/role/DividendOfSeriesBPreferredSharesDetailsNarrative DIVIDEND OF SERIES B PREFERRED SHARES (Details Narrative) false false R41.htm 0041 - Disclosure - STOCKHOLDERS EQUITY (Details Narrative) Sheet http://entb.net/role/StockholdersEquityDetailsNarrative STOCKHOLDERS EQUITY (Details Narrative) false false R42.htm 0042 - Disclosure - CONVERTIBLE DEBENTURES (Details Narrative) Sheet http://entb.net/role/ConvertibleDebenturesDetailsNarrative CONVERTIBLE DEBENTURES (Details Narrative) false false R43.htm 0043 - Disclosure - STOCK TRANSACTIONS (Details Narrative) Sheet http://entb.net/role/StockTransactionsDetailsNarrative STOCK TRANSACTIONS (Details Narrative) false false R44.htm 0044 - Disclosure - SUBSEQUENT EVENTS (Details Narrative) Sheet http://entb.net/role/SubsequentEventsDetailsNarrative SUBSEQUENT EVENTS (Details Narrative) false false All Reports Book All Reports Process Flow-Through: 0002 - Statement - Consolidated Balance Sheet Process Flow-Through: Removing column 'Aug. 31, 2010' Process Flow-Through: 0003 - Statement - Consolidated Balance Sheet (Parenthetical) Process Flow-Through: Removing column 'Feb. 29, 2012' Process Flow-Through: 0004 - Statement - Consolidated Statement of Operations Process Flow-Through: 0006 - Statement - Consolidated Statement of Cash Flows entb-20120831.xml entb-20120831.xsd entb-20120831_cal.xml entb-20120831_def.xml entb-20120831_lab.xml entb-20120831_pre.xml true true XML 61 R38.htm IDEA: XBRL DOCUMENT v2.4.0.6

COMMITMENTS AND CONTINGECIES (Details Narrative) (USD $)
12 Months Ended 20 Months Ended

Nov. 30, 2016

Nov. 30, 2015

Nov. 30, 2014

Nov. 30, 2013

Nov. 30, 2012

Aug. 31, 2012

Jun. 01, 2012

May 24, 2012

Nov. 01, 2011

Feb. 03, 2011

Jan. 04, 2011

Commitments and Contingencies Disclosure [Abstract]

Lease terms 5 years

Rent to be charged per month $ 3,506 $ 3,371 $ 3,241 $ 3,116 $ 2,996

Acquired monthly rent, as part of asset purchase agreement 7,526

Acquired monthly payments to extinguish note 1,500

Acquired note, as part of asset purchase agreement 78,000

Due to Franchise Tax Board, as part of asset purchase agreement 11,405

Monthly payments due to Franchise Tax Board 400

Due to the Internal Revenue Service, as part of the asset purchase agreement 13,595

Monthly payments due to the Internal Revenue Service 425

General damages sought 125,000

Titterington Veterinary Services money award sought $ 50,000

Maximum common shares to be purchased by Southridge 10,000,000

Average of two lowest closing prices equal to purchase price of shares 91.00%

Minimum Southridge ownership of common stock 9.99%

Cash placement fee of funds received 5.00%

X

- Definition

Average Of Two Lowest Closing Prices Equal To Purchase Price Of Shares.

+ References

No definition available.

+ Details

Name: ENTB_AverageOfTwoLowestClosingPricesEqualToPurchasePriceOfShares

Namespace Prefix: ENTB_

Data Type: num:percentItemType

Balance Type: na

Period Type: instant

X

- Definition

Description of a cash placement fee percentage associated with the funds received by the Company through the sale of Shares to Southridge as such funds are received by the Company

+ References

No definition available.

+ Details

Name: ENTB_CashPlacementFeeOfFundsReceived

Namespace Prefix: ENTB_

Data Type: num:percentItemType

Balance Type: na

Period Type: instant

X

- Definition

Description of a fee associated with the debt instrument, including a commitment fee on unborrowed portions of a lender's total contractual commitment.

+ References

No definition available.

+ Details

Name: ENTB_MonthlyPaymentsDueToInternalRevenueService

Namespace Prefix: ENTB_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition

Agreement of lease entered into, period of years.

+ References

No definition available.

+ Details

Name: ENTB_PeriodOfLease

Namespace Prefix: ENTB_

Data Type: xbrli:durationItemType

Balance Type: na

Period Type: instant

X

- Definition

Amount of bankruptcy claim filed with bankruptcy court that are likely to be denied.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher AICPA

-Name Statement of Position (SOP)

-Number 90-7

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

+ Details

Name: us-gaap_BankruptcyClaimsAmountOfFiledClaimsLikelyToBeDenied

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition

The amount of acquisition cost of a business combination allocated to the current portion of long-term debt of the acquired entity.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 141

-Paragraph 51

-Subparagraph e

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

+ Details

Name: us-gaap_BusinessAcquisitionPurchasePriceAllocationCurrentLiabilitiesLongTermDebt

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition

The amount of acquisition cost of a business combination allocated to other current liabilities of the acquired entity. Does not include amounts allocated to the current portion of long-term debt, accounts payable and accrued expenses.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 141

-Paragraph 51

-Subparagraph e

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

+ Details

Name: us-gaap_BusinessAcquisitionPurchasePriceAllocationCurrentLiabilitiesOtherLiabilities

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition

The amount of acquisition cost of a business combination allocated to notes payables and long-term debt assumed from the acquired entity.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 141

-Paragraph 51

-Subparagraph e

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Emerging Issues Task Force (EITF)

-Number 98-1

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 141

-Paragraph 37

-Subparagraph g

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

+ Details

Name: us-gaap_BusinessAcquisitionPurchasePriceAllocationNotesPayableAndLongTermDebt

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Details

Name: us-gaap_CommitmentsAndContingenciesDisclosureAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 159

-Paragraph 18

-Subparagraph f

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 323

-SubTopic 10

-Section 50

-Paragraph 3

-Subparagraph (a)(1)

-URI http://asc.fasb.org/extlink&oid=6382943&loc=d3e33918-111571

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher AICPA

-Name Accounting Principles Board Opinion (APB)

-Number 18

-Paragraph 20

-Subparagraph a (1)

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

+ Details

Name: us-gaap_EquityMethodInvestmentOwnershipPercentage

Namespace Prefix: us-gaap_

Data Type: num:percentItemType

Balance Type: na

Period Type: instant

X

- Definition

Gross amount of debt extinguished.

+ References

No definition available.

+ Details

Name: us-gaap_ExtinguishmentOfDebtAmount

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition

This element represents the amount of value allocated by a lessor (acquirer) to lease agreements which exist at acquisition of a leased property. Such amount may include the value assigned to existing tenant relationships and excludes the market adjustment component of the value assigned for above or below-market leases acquired.

+ References

No definition available.

+ Details

Name: us-gaap_FiniteLivedIntangibleAssetAcquiredInPlaceLeases

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition

Rental expense for the reporting period incurred under operating leases, including minimum and any contingent rent expense, net of related sublease income.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 840

-SubTopic 20

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6453985&loc=d3e41499-112717

+ Details

Name: us-gaap_OperatingLeasesRentExpenseNet

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition

The amount of any current tax-related balances due to affiliates as of the date of each statement of financial position presented.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 740

-SubTopic 10

-Section 50

-Paragraph 17

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32809-109319

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 109

-Paragraph 49

-Subparagraph a

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

+ Details

Name: us-gaap_RelatedPartyTaxExpenseDueToAffiliatesCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition

The estimated amount as of the balance sheet date to be received by an insurer from the sale of property (usually damaged) on which the insurer has paid a total claim to the insured and has obtained title to the property and the right of an insurer to pursue any course of recovery of damages, in its name or in the name of the policyholder, against a third party who is liable for costs relating to an insured event that have been paid by the insurer. Estimated salvage and subrogation is generally deducted from the liability for unpaid claims.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher AICPA

-Name Audit and Accounting Guide (AAG)

-Number AAG-PLI

-Paragraph 32

-IssueDate 2006-09-01

-Chapter 4

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 944

-SubTopic 40

-Section 30

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6482241&loc=d3e13779-158432

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 944

-SubTopic 40

-Section 30

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=6482241&loc=d3e13783-158432

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 60

-Paragraph 18

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

+ Details

Name: us-gaap_SalvageAndSubrogationRecoveriesValue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition

The number of shares authorized to be repurchased by an entity's Board of Directors under a stock repurchase plan.

+ References

No definition available.

+ Details

Name: us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

XML 62 R20.htm IDEA: XBRL DOCUMENT v2.4.0.6

CONVERTIBLE DEBENTURES
12 Months Ended

Aug. 31, 2012

Debt Disclosure [Abstract]

CONVERTIBLE DEBENTURES

NOTE 14. CONVERTIBLE DEBENTURES

On May 20, 2011, the Company issued a convertible promissory note in the amount of $42,500 which was received May 26, 2011. The note bears an interest rate of eight percent (8%), matures on February 23, 2012 and may be converted after 180 days from execution of this note for shares of the Company’s common stock. The note may be converted at a forty two percent (42%) discount to the average of the lowest 3 closing bid prices of the common stock during the 10 trading days prior to the conversion date. The issuance of the note amounted in a beneficial conversion feature of $16,398 which has been amortized under the Interest Method. $42,500 of the principal amount due and $1700 in accrued interest has been converted into 1,012,425 shares of the common stock of the Company.

On July 5, 2011, the Company issued a convertible promissory note (the “Second Note”) in the principal amount of $37,500. The Second Note, which matures April 11, 2012, bears interest at the rate of 8% per annum. At any time after 180 days from the execution of the Second Note, the Second Note is convertible into shares of the Company’s common stock at the election of Asher at a conversion price equal to a 45% discount to the average of the 3 closing bid prices of the common stock during the 10 trading day period prior to conversion. The issuance of the note amounted in a beneficial conversion feature of $37,500 which is amortized under the Interest Method. $37,500 of the principal amount due and $1500 in accrued interest has been converted into 6,193,242 shares of the common stock of the Company.

On August 29, 2011, the Company issued a convertible promissory note (the “Third Note”) in the principal amount of $35,000. The Third Note, which matures May 25, 2012, bears interest at the rate of 8% per annum. At any time after 180 days from the execution of the Third Note, the Third Note is convertible into shares of the Company’s common stock at the election of Asher at a conversion price equal to a 45% discount to the average of the 3 closing bid prices of the common stock during the 10 trading day period prior to conversion. The issuance of the note amounted in a beneficial conversion feature of $35,000 which is amortized under the Interest Method. . $35,000 of the principal amount due and $1400 in accrued interest has been converted into 21,708,333 shares of the common stock of the Company.

On October 25, 2011, the Company issued a convertible promissory note in the amount of $32,500. The note bears an interest rate of eight percent (8%), matures on July 27, 2012 and may be converted after 180 days from execution of this note for shares of the Company’s common stock. The note may be converted at a fifty two percent (52%) discount to the average of the lowest 3 closing bid prices of the common stock during the 10 trading days prior to the conversion date. The issuance of the note amounted in a beneficial conversion feature of $7,634 which is amortized under the Interest Method. $32,500 of the principal amount due and $1300 in accrued interest has been converted into 24,635,165 shares of the common stock of the Company.

On December 19, 2011, the Company issued a convertible promissory note in the amount of $37,500. The note bears an interest rate of eight percent (8%), matures on September 21, 2012 and may be converted after 180 days from execution of this note for shares of the Company’s common stock. The note may be converted at a fifty two percent (52%) discount to the average of the lowest 3 closing bid prices of the common stock during the 10 trading days prior to the conversion date. The issuance of the note amounted in a beneficial conversion feature of $37,500 which is amortized under the Interest Method. The principal balance and $1,500 in accrued interest was satisfied by a payment of $57,647.

On December 20, 2011 the Company amended the terms of $30,000 in existing debt as follows:

(a) Due and payable December 31, 2012

(b) Simple interest of 10% from December 20, 2011 to the date the debt is fully converted or paid in full

(c) Convertible into the common stock of the Company at the option of the holder at a 50% discount from the average of the lowest three Trading Prices for the common stock during the 10 trading day period ending one Trading Day prior to the date the conversion notice is sent by the holder. "Trading Price" means the closing bid price on the applicable trading market as reported by a reliable reporting service.

The amendment of the note amounted in a beneficial conversion feature of $16,153 which was fully amortized by February 29, 2012. The entire principal balance of the convertible note was converted into 1,249,975 shares of the common stock of the Company prior to February 29, 2012.

On February 28, 2012 the Company amended the terms of $85,500 in existing principal indebtedness as well as 3,710 of interest accrued but unpaid to be as follows:

The aggregate indebtedness of $89,210 shall bear simple interest, be payable upon demand of the holder, and be convertible into the common shares of the company at a conversion price per share equal to 60% (the “Discount”) of the lowest closing bid price for the Company’s common stock during the 5 trading days immediately preceding a conversion date, as reported by Bloomberg. provided that if the closing bid price for the common stock on the date in which the conversion shares are deposited into Holder’s brokerage account and confirmation has been received that Holder may execute trades of the conversion shares ( Clearing Date) is lower than the Closing Bid Price, then the purchase price for the conversion shares shall be adjusted such that the Discount shall be taken from the closing bid price on the Clearing Date, and the Company shall issue additional shares to Purchaser to reflect such adjusted Purchase Price (“Bonus Shares”). The company has agreed on a limitation on conversion equal to 9.99% of the Company’s outstanding common stock. The amendment of the note amounted in a beneficial conversion feature of $59,473 which was fully amortized by February 29, 2012. This aggregate indebtedness was converted into 21,307,702 of the company’s common shares.

On April 16, 2012 the Company issued a convertible promissory note in the amount of $42,500 which was received April 21, 2012. The note bears an interest rate of eight percent (8%), matures on January 18, 2013. and may be converted after 180 days from execution of this note for shares of the Company’s common stock. The note may be converted at a fifty two percent (52%) discount to the average of the lowest 3 closing bid prices of the common stock during the 10 trading days prior to the conversion date. The issuance of the note amounted in a beneficial conversion feature of $11,805 which is amortized under the Interest Method.

On June 15, 2012 the Company amended the terms of $102,349 in existing principal indebtedness as follows:

The Aggregate Indebtedness of $102,349 is convertible at Holder’s option at a conversion price per share equal to 60% (the “Discount”) of the lowest closing bid price for the Company’s common stock during the 5 trading days immediately preceding a conversion date, as reported by Bloomberg (the “Closing Bid Price”); provided that if the closing bid price for the common stock on the date in which the conversion shares are deposited into Holder’s brokerage account and confirmation has been received that Holder may execute trades of the conversion shares ( Clearing Date) is lower than the Closing Bid Price, then the purchase price for the conversion shares shall be adjusted such that the Discount shall be taken from the closing bid price on the Clearing Date, and the Company shall issue additional shares to Purchaser to reflect such adjusted Purchase Price (“Bonus Shares”). The company has agreed on a limitation on conversion equal to 9.99% of the Company’s outstanding common stock. The issuance of the note amounted in a beneficial conversion feature of $102,349 which is immediately amortized . This aggregate indebtedness was converted by the Holders into 36,838,692 shares of the Company’s common stock.

On July 26, 2012, the Company issued a convertible note in the principal amount of $63,000 to Asher Enterprises, Inc. The Note bears interest at the rate of 8% per annum and matures on April 30, 2013. The Note is convertible any time during the period beginning on the date which is one hundred eighty (180) days following the date of the Note into common stock of the Company, at Asher’s option, at a 39% discount to the average of the three lowest closing bid prices of the common stock during the 10 Trading Day period prior to conversion as Trading Day is defined in the Note. The issuance of the note amounted in a beneficial conversion feature of $63,000 which is amortized under the Interest Method.

On August 21, 2012 the Company amended the terms of $59,000 in existing principal indebtedness as follows:

The Aggregate Indebtedness of $59,000 is convertible at Holder’s option at a conversion price per share equal to 60% (the “Discount”) of the lowest closing bid price for the Company’s common stock during the 10 trading days immediately preceding a conversion date, as reported by Bloomberg (the “Closing Bid Price”); provided that if the closing bid price for the common stock on the date in which the conversion shares are deposited into Holder’s brokerage account and confirmation has been received that Holder may execute trades of the conversion shares ( Clearing Date) is lower than the Closing Bid Price, then the purchase price for the conversion shares shall be adjusted such that the Discount shall be taken from the closing bid price on the Clearing Date, and the Company shall issue additional shares to Purchaser to reflect such adjusted Purchase Price (“Bonus Shares”). The company has agreed on a limitation on conversion equal to 9.99% of the Company’s outstanding common stock. The issuance of the note amounted in a beneficial conversion feature of $53,000 which was immediately amortized .

X

- Definition

The entire disclosure for debt and capital lease obligations can be reported. Information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants. Also includes descriptions and amounts of capital leasing arrangements that consist of direct financing, sales type and leveraged leases. Disclosure may include the effect on the balance sheet and the income statement resulting from a change in lease classification for leases that at inception would have been classified differently had guidance been in effect at the inception of the original lease.

+ References

No definition available.

+ Details

Name: us-gaap_DebtAndCapitalLeasesDisclosuresTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Details

Name: us-gaap_DebtDisclosureAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

RELATED PARTY TRANSACTIONS (Details Narrative) (USD $)	3 Months Ended
RELATED PARTY TRANSACTIONS (Details Narrative) (USD $)	May 31, 2012	Feb. 29, 2012	Nov. 30, 2011	Aug. 31, 2012
Related Party Transactions [Abstract]
Loans made to Company by David Koos	$ 13,625	$ 7,550	$ 8,400
Loan simple interest rate per annum	15.00%	15.00%	15.00%
Unpaid indebtedness		25,956
Unpaid indebtedness interest rate per annum		15.00%
Unpaid interest		3,051
Indebted to David Koos, principal				30,180
Indebted to David Koos, interest rate per annum				15.00%
Indebted to Bio-Matrix Scientific Group, Inc.				$ 39,140

CONVERTIBLE DEBENTURES (Details Narrative) (USD $)	Aug. 21, 2012	Jul. 26, 2012	Jun. 15, 2012	Apr. 16, 2012	Feb. 28, 2012	Dec. 20, 2011	Dec. 19, 2011	Oct. 25, 2011	Aug. 29, 2011	Jul. 05, 2011	May 20, 2011
Debt Disclosure [Abstract]
Convertible promissory note issued		$ 63,000		$ 42,500			$ 37,500	$ 32,500	$ 35,000	$ 37,500	$ 42,500
Note interest rate per annum		8.00%		8.00%			8.00%	8.00%	8.00%	8.00%	8.00%
Note conversion, discount rate		39.00%		52.00%		50.00%	52.00%	52.00%	45.00%	45.00%	42.00%
Beneficial conversion feature		63,000		11,805		16,153	37,500	7,634	35,000	37,500	16,398
Principal amount due							57,647	32,500	35,000	37,500	42,500
Accrued interest on note							1,500	1,300	1,400	1,500	1,700
Shares of common stock converted from accrued interest								24,635,165	21,708,333	6,193,242	1,012,425
Amended existing debt						30,000
Simple interest rate of existing debt						10.00%
Shares of common stock converted from principal balance of convertible note						1,249,975
Amended existing principal indebtedness	59,000		102,349		85,500
Amended interest accrued but unpaid					3,710
Aggregate indebtedness	59,000		102,349		89,210
Conversion price per share percentage	60.00%		60.00%		60.00%
Limitation on conversion percentage	9.99%		9.99%		9.99%
Amendment of the note beneficial conversion feature	$ 53,000		$ 102,349		$ 59,473
Common shares converted from aggregate indebtedness			36,838,692		21,307,702

ACQUISITION OF THE ASSETS OF PET POINTERS, INC. (Details Narrative) (USD $)	20 Months Ended
	Aug. 31, 2012	Jan. 04, 2011
Business Combinations [Abstract]
Acquisition of cash	$ 70,000
Acquisition of common shares		210,000
Maximum payment to creditor	78,000
Monthly installments to creditor	1,500
Maximum payment to additional creditors	25,000
Monthly installments to additional creditors	825
Monthly payment to McDonald	$ 50,000

STOCK TRANSACTIONS (Details Narrative) (USD $)	3 Months Ended	12 Months Ended
STOCK TRANSACTIONS (Details Narrative) (USD $)	May 31, 2012	Aug. 31, 2012	Aug. 31, 2011	Aug. 02, 2012	Apr. 03, 2012	Dec. 29, 2011	Dec. 26, 2011
Equity [Abstract]
Common Shares issued for Debt, Shares		113,695,700
Common Shares issued for Debt, Amount		$ 374,959	$ 341,167
Common Shares issued for services, Shares		3,272,000
Common Shares issued for services, Amount		171,750
Common Shares issued for intangible assets, Shares		2,500,000
Common Shares issued for intangible assets, Amount		700,000
Shares issued pursuant to Contractual Obligations, Shares		6,274,726
Shares issued pursuant to Contractual Obligations, Amount		23,868
Non Voting Convertible Preferred Shares, Shares		75,000
Non Voting Convertible Preferred Shares, Amount		$ 75,000
Cancellation of common shares							15,000
Shares returned for cancellation from CFO						75,000
CFO shares subject to forfeiture and are cancelled						40,000
Cancellation of remaining CFO common shares						35,000
Dividend of Series B preferred stock paid	3,201,397
Shares of common stock issued to CEO					50,000,000
Shares of common stock issued to seven employees as restricted stock award					27,000,000
Shares of common stock issued to a consultant as restricted stock award					15,000,000
Cancellation of common shares issued to employee as Restriced Stock Award				15,000,000

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) (USD $)	12 Months Ended
	Aug. 31, 2012	Aug. 31, 2011
Accounting Policies [Abstract]
Depreciation expense	$ 8,461	$ 5,591
Notes payable	261,831
Convertible notes payable, net of discount	121,495	42,430
Due to TheraCyte, Inc	8,000	8,000
Employee receivables	4,349	4,349
Due from an affiliate	$ 39,140	$ 0
Valuation allowance	100.00%

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Property Plant and Equipment, Acquisition Costs (Details) (USD $)	Aug. 31, 2012
Estimated useful Life (Months)
Office Equipment	30 months
Medical Equipment	30 months
Computer Equipment	30 months
Acquisition Cost, Total
Office Equipment, Value	3,235
Medical Equipment, Value	17,523
Computer Equipment, Value	2,126
Subtotal	22,884
Less Accumulated Depreciation	(14,052)
Total	8,832

SUBSEQUENT EVENTS (Details Narrative) (USD $)	0 Months Ended		3 Months Ended
SUBSEQUENT EVENTS (Details Narrative) (USD $)	Oct. 02, 2012	Sep. 17, 2012	Nov. 30, 2012	Dec. 05, 2012	Oct. 22, 2012	Oct. 17, 2012	Sep. 21, 2012	Sep. 20, 2012
Subsequent Events [Abstract]
Common shares sold to Southridge	10,837,849	26,802,465
Gross amount of common shares sold to Southridge	$ 14,300	$ 50,000
Indebtedness due to Southridge							20,000
Issued a convertible promissory note								63,000
Convertible promissory note interest rate								8.00%
Percentage of discount of possible conversion								39.00%
Payment of debt to Southridge	14,300
Common shares issued for outstanding convertible indebtedness					10,810,811	23,000,000
Value of common shares issued for outstanding convertible indebtedness					8,000	19,320
Certificate of incorporation to authorize common shares						2,000,000,000
Obligation to pay on McDonalds behalf, balance due				55,000
Obligation to pay IRS on McDonalds behalf, balance due				6,369.69
Obligation to pay Franchise Tax Board on McDonalds behalf, balance due				3,474
Assets disposed of pursuant to Agreement				4,897
Impairment of goodwill acquired			405,000
Obligated payment to McDonald Animal Hospital			$ 13,000

GOING CONCERN (Details Narrative) (USD $)	12 Months Ended	48 Months Ended
GOING CONCERN (Details Narrative) (USD $)	Aug. 31, 2012	Aug. 31, 2012	Aug. 27, 2012	Jun. 01, 2012
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Net losses		$ 3,664,302
Funds raised through the issuance of convertible notes	197,500
Raised from borrowings	$ 261,475
Maximum common shares to be purchased by Southridge				10,000,000
Average of two lowest closing prices equal to purchase price of shares				91.00%
Minimum Southridge ownership of common stock				9.99%
Cash placement fee of funds received				5.00%
Shares of common stock registered to Southridge			46,238,705

NOTES PAYABLE - Notes Payable, Current and Long Term (Details) (USD $)	Aug. 31, 2012
Current:
Bio Technology Partners Business Trust	$ 13,500
Venture Bridge Advisors, Inc.	32,508
Southridge Partners II LLP	40,000
Sherman Family Trust	79,000
Officer Loans (Note Six)	30,180
Current portion of amounts to be paid on behalf of Gregory McDonald and Pet Pointers, Inc. (Note 10 )	30,174
8% Convertible Notes (Note Fourteen)	105,500
10% Convertible Note (Note Fourteen)	59,000
Total:	389,862
Long Term:
Long Term portion of amounts to be paid on behalf of Gregory McDonald and Pet Pointers, Inc. (Note Ten)	36,469
Total:	$ 36,469

NOTES PAYABLE (Details Narrative) (USD $)	Aug. 31, 2012
Debt Disclosure [Abstract]
Lines of credit provided by Bio Technology Partners Business Trust and Venture Bridge Advisors, each	$ 200,000
Unpaid principal lines of credit, simple interest rate per annum	10.00%
Loaned to the Company by Southridge Partners II LLP	$ 40,000

DIVIDEND OF SERIES B PREFERRED SHARES (Details Narrative)	0 Months Ended
	Mar. 06, 2012
Notes to Financial Statements
Dividend paid to common shareholders	201,397

Consolidated Balance Sheet (USD $)	Aug. 31, 2012	Aug. 31, 2011
Current Assets
Cash	$ 42,737	$ 43,901
Trade accounts receivable, less allowance for uncollectible accounts of $0 and $0 at February 29, 2012 and August 31, 2011 respectively	2,268	3,135
Inventory	10,298	7,986
Due from Affiliate	39,140	0
Current Portion of Prepaid Expenses	13,000	62,200
Employee Receivable	4,349	4,349
Total Current Assets	111,792	121,571
Property & Equipment (Net of Accumulated Depreciation)	8,832	17,293
Goodwill	405,000	405,000
Intangible Assets (Net of Accumulated Amortization)	1,052	1,828
Non Current Assets
Non Current Portion of Prepaid Expenses		10,300
Deposits	1,151	0
Total Non Current Assets	1,151	10,300
TOTAL ASSETS	527,827	555,992
Current Liabilities
Accounts Payable	74,574	27,564
Notes Payable	225,362	159,911
Convertible notes payable, net of discount	121,495	42,430
Due to Other	8,000	8,000
Accrued Expenses	119,726	67,206
Total Current Liabilities	549,157	305,111
Non Current Liabilities
Notes Payable - Non Current	36,469	79,143
Total Non Current Liabilities	36,469	79,143
TOTAL LIABILITIES	585,626	384,254
STOCKHOLDERS' EQUITY
Common Stock, $0.001 par value, authorized 1,000,000,000 shares; issued and outstanding 223,492,927 shares as of August 31, 2012 and August 31, 2011 respectively	223,493	20,838
Preferred Stock , $0.001 par value 5,000,000 shares authorized, 0 shares issued and outstanding as of August 31, 2012 and August 31, 2011		0
Series AA Preferred Stock, $0.001 par value 100,000 shares authorized, 5,000 shares issued and outstanding at August 31, 2012 and as of August 31, 2011	5	5
Series B Preferred Stock, $0.001 par value 4,400,000 shares authorized, 3,201,397 and 0 shares issued and outstanding as of August 31, 2012 and as of August 31, 2011	3,201	0
NonVoting Convertible Preferred, $1 par value 200,000 shares authorized, 75,000 and 0 issued and outstanding as of August 31, 2012 and as of August 31, 2011	75,000	0
Additional Paid in Capital	3,030,642	1,619,330
Contributed Capital	274,162	274,162
Accumulated Deficit	(3,664,302)	(1,742,597)
Total Stockholders' Equity	(57,799)	171,738
TOTAL LIABILITIES & STOCKHOLDERS' EQUITY	$ 527,827	$ 555,992

Consolidated Statement of Cash Flows (USD $)	12 Months Ended
Consolidated Statement of Cash Flows (USD $)	Aug. 31, 2012	Aug. 31, 2011
OPERATING ACTIVITIES
Net (loss)	$ (1,889,563)	$ (951,783)
Adjustments to reconcile net loss to net cash used by operating activities:
Depreciation Expense	8,461	5,591
Amortization Expense	776	505
Stock issued as Compensation to Employees	48,681	55,399
Stock issued as Compensation to Consultants	181,540	122,007
Change in operating assets and liabilities:
(Increase) Decrease in Trade Accounts Receivable	867	(3,135)
(Increase) Decrease in Inventory	(2,312)	(7,986)
(Increase) Decrease in Employee Receivable		(2,953)
Increase (Decrease) in Accounts Payable	47,010	6,222
(Increase) Decrease in Prepaid Expenses	59,500	10,100
(Increase) Decrease in Due from Affiliate	(39,140)
(Increase) Decrease in Deposits	(1,151)	1,059
Increase (Decrease) in amortization of intangibles	16,667
Increase (Decrease) in Accrued Expenses	52,520	(60,889)
(Increase) Decrease on gain realized on cancellation of stock	(94,937)
Increase (Decrease) in Loss on Impairment of Intangible Assets	683,333
Net Cash Provided Used in Operating Activities	(927,748)	(825,863)
INVESTING ACTIVITIES
Purchase/Sale of Equipment	0	(22,884)
Net cash Provided by (Used in) Investing Activities	0	(22,884)
FINANCING ACTIVITIES
(Increase) Decrease in Goodwill from acquisition		(195,000)
Stock issued in Payment of Debt	374,959	341,167
Increase (Decrease) in Common stock issued for cash		217,600
(Increase) Decrease in Intangible Assets (net)		(2,299)
Increase (Decrease) in Common stock issued for expenses	104,768
Increase (Decrease) in Due to Affiliate		8,000
Increase (Decrease) in Notes Payable	470,901	516,085
Increase (Decrease) in Contributed Capital		259,058
Increase (Decrease) in Additional paid in Capital	350,915	88,998
Net Cash Provided by Financing Activities	926,584	892,442
Net Increase in Cash	(1,164)	43,695
Cash at Beginning of Period	43,901	206
Cash at End of Period	42,737	43,901
Supplemental Disclosure of Noncash investing and financing activities:
Stock issued in payment of Debt	369,059	391,167
Stock issued in Acquisition of McDonald Animal Hospital		210,000
Stock issued pursuant to Titterington Agreement	$ 700,000

INCOME TAXES (Details Narrative) (USD $)	12 Months Ended
INCOME TAXES (Details Narrative) (USD $)	Aug. 31, 2012
Income Tax Disclosure [Abstract]
Deferred tax asset	$ 1,250,503
Net operating loss carry forwards	3,677,949
Expiration of net operating loss carry forwards	20 years
Net operating loss carry forwards acquired in the reverse acquisition of Entest BioMedical, Inc.	13,647
Net operating loss carry forwards attributable to Entest BioMedical, Inc.	3,664,302
Deferred tax assets, net valuation allowance	$ 0
Federal Corporate Rate income tax	34.00%

ACQUISITION OF ENTEST CA (Details Narrative)	Jul. 10, 2009
Business Combinations [Abstract]
Acquisition of Entest CA	100.00%
Newly issued common shares of Entest	10,000,000
Cancellation of shares of common stock	10,000,000

Consolidated Balance Sheet (Parenthetical) (USD $)	Aug. 31, 2012	Aug. 31, 2011
Statement of Financial Position [Abstract]
Uncollectible accounts	$ 0	$ 0
Common stock, par value	$ 0.001	$ 0.001
Common stock, shares authorized	1,000,000,000	1,000,000,000
Common stock, shares issued	223,492,927	223,492,927
Common stock, shares outstanding	223,492,927	223,492,927
Preferred stock, par value	$ 0.001	$ 0.001
Preferred stock, shares authorized	5,000,000	5,000,000
Preferred stock, shares issued	0	0
Preferred stock, shares outstanding	0	0
Series AA Preferred shares, par value	$ 0.001	$ 0.001
Series AA Preferred shares, shares authorized	100,000	100,000
Series AA Preferred shares, shares issued		5,000
Series AA Preferred shares, shares outstanding		5,000
Series B Preferred shares, par value	$ 0.001	$ 0.001
Series B Preferred shares, shares authorized	4,400,000	4,400,000
Series B Preferred shares, shares issued	3,201,397	3,201,397
Series B Preferred shares, shares outstanding	0	0
NonVoting Convertible Preferred shares, par value	$ 1.00	$ 1
NonVoting Convertible Preferred shares, shares authorized	200,000	200,000
NonVoting Convertible Preferred shares, shares issued	75,000	75,000
NonVoting Convertible Preferred shares, shares outstanding	0	0

Document and Entity Information (USD $)	12 Months Ended
Document and Entity Information (USD $)	Aug. 31, 2012	Mar. 30, 2012	Jan. 25, 2013 Common shares outstanding	Jan. 25, 2013 Series B preferred shares outstanding	Jan. 25, 2013 Series AA preferred shares outstanding	Jan. 25, 2013 Non voting convertible preferred shares outstanding
Entity Registrant Name	ENTEST BIOMEDICAL, INC.
Entity Central Index Key	0001449447
Document Type	10-K
Document Period End Date	Aug. 31, 2012
Amendment Flag	false
Current Fiscal Year End Date	--08-31
Is Entity a Well-known Seasoned Issuer?	No
Is Entity a Voluntary Filer?	No
Is Entity's Reporting Status Current?	Yes
Entity Filer Category	Smaller Reporting Company
Entity Public Float		$ 528,715
Entity Common Stock, Shares Outstanding			446,519,900	3,201,397	5,000	75,000
Document Fiscal Period Focus	FY
Document Fiscal Year Focus	2011

Consolidated Statement of Operations (USD $)	12 Months Ended
Consolidated Statement of Operations (USD $)	Aug. 31, 2012	Aug. 31, 2011
REVENUES
Revenues from Veterinary Services	$ 419,336	$ 349,141
Online Revenues	6,916
TOTAL REVENUE	426,252	349,141
Cost of Revenue	119,299	89,405
GROSS PROFIT	306,953	259,736
COSTS AND EXPENSES
Research and Development	5,798	109,063
Rent Costs	126,812	108,596
General and Administrative	562,424	793,609
Incorporation Costs
Consultant's Expenses	428,040	159,518
Miscellaneous Expenses
Total Costs and Expenses	1,123,074	1,170,786
OPERATING LOSS	(816,121)	(911,050)
OTHER INCOME AND EXPENSE
Other Income	94,949	99
Loss on Early Extinguishment of Debt	(18,647)
Income generated from Revenue Share Agreement	187,699
Expenses incurred from Revenue Share Agreement	(145,362)
Loss on Impairment of intangible assets	(683,333)
Interest Expense	(29,400)	(24,404)
Interest Expense attributable to amortization of discount	(380,480)	(16,428)
Expenses attributable to issuance of shares pursuant to contractual obligation	(23,868)
Expenses attributable to issuance of Non Voting Convertible Preferred Shares in connection with Stock Purchase Agreement	(75,000)
TOTAL OTHER INCOME AND EXPENSE	(1,073,442)	(40,733)
LOSS BEFORE INCOME TAXES	(1,889,563)	(951,783)
Income Taxes	0	0
NET LOSS	(1,889,563)	(951,783)
Beneficial conversion feature attributable to issuance of NonVoting Preferred Stock	(32,142)
NET LOSS available to common shareholders	$ (1,921,705)	$ (951,783)
BASIC AND DILUTED LOSS PER SHARE	$ (0.02)	$ (0.05)
WEIGHTED AVERAGE NUMBER OF COMMON SHARES OUTSTANDING	94,990,042	19,895,368

Consolidated Statement of Stockholders' Equity (USD $)	Common shares outstanding	Series AA preferred shares outstanding	Series B preferred shares outstanding	Non Voting Convertible Preferred	Additional Paid-in Capital	Contributed Capital	Accumulated Deficit during the Development Stage	Total
Beginning balance, Amount at Aug. 31, 2010	$ 17,553				$ 537,415	$ 15,104	$ (790,814)	$ (220,742)
Beginning balance, Shares at Aug. 31, 2010	17,553,040
Common Shares issued for Cash, Shares	2,217,600
Common Shares issued for Cash, Amount	2,217				215,383			217,600
Common Shares issued for Debt, Shares	781,712
Common Shares issued for Debt, Amount	780				340,387			341,167
Common Shares issued to Consultants, Shares	74,383
Common Shares issued to Consultants, Amount	74				121,967			122,041
Common Stock issued to employees, Shares	163,766
Common Stock issued to employees, Amount	164				303,235			303,399
Restricted Stock Awards issued to employee, Shares	50,000
Restricted Stock Awards issued to employee, Amount	50				(50)
Expense Recognized					10,000			10,000
Discount on Convertible Debt recognized					88,998			88,998
Increases in Contributed capital						259,058		259,058
Preferred Stock issued for Accrued compensation, Shares		5,000
Preferred Stock issued for Accrued compensation, Amount		5			1,995			2,000
Net Loss for the Year							(951,783)	(951,783)
Ending balance, Amount at Aug. 31, 2011	20,838	5			1,619,330	274,162	(1,742,597)	171,738
Ending balance, Shares at Aug. 31, 2011	20,840,501	5,000
Common Shares issued for Debt, Shares	113,695,700							113,695,700
Common Shares issued for Debt, Amount	113,695				261,264			374,959
Restricted Stock Awards issued to employee, Shares	77,000,000
Restricted Stock Awards issued to employee, Amount	77,000				(77,000)			0
Common Shares issued for services, Shares	3,272,000							3,272,000
Common Shares issued for services, Amount	3,269				168,481			171,750
Common Shares issued for intangible assets, Shares	2,500,000							2,500,000
Common Shares issued for intangible assets, Amount	2,500				697,500			700,000
Cancellation of Common Shares Issued, Shares	(90,000)
Cancellation of Common Shares Issued, Amount	(83)				(86,687)			(86,687)
Restricted Stock Awards to consultant, Shares	15,000,000
Restricted Stock Awards to consultant, Amount	15,000				(15,000)			0
Expense Recognized					58,491			58,491
Discount on Convertible Debt recognized					350,915			350,915
Series B Preferred Dividend paid, Shares			3,201,397
Series B Preferred Dividend paid, Amount			3,201		(3,201)			0
Preferred Shares, Shares				75,000				75,000
Preferred Shares, Amount				75,000				75,000
Recognition of Beneficial Conversion Feature					32,142			32,142
Shares issued pursuant to Contractual Obligations, Shares	6,274,726							6,274,726
Shares issued pursuant to Contractual Obligations, Amount	6,274				17,594			23,868
Cancellation of Restricted Stock Award to Employee, Shares	(15,000,000)
Cancellation of Restricted Stock Award to Employee, Shares	(15,000)				6,813			(8,187)
Net Loss for the Year							(1,889,563)	(1,889,563)
Beneficial Conversion Feature Deemed Dividend							(32,142)	(32,142)
Ending balance, Amount at Aug. 31, 2012	$ 223,493	$ 5	$ 3,201	$ 75,000	$ 3,030,642	$ 274,162	$ (3,664,302)	$ (57,799)
Ending balance, Shares at Aug. 31, 2012	223,492,927	5,000	3,201,397	75,000

ORGANIZATION AND DESCRIPTION OF BUSINESS (Details Narrative)	Jul. 10, 2009
Accounting Policies [Abstract]
Acquisition of share capital of Entest BioMedical, Inc. (“Entest CA")	100.00%

COMMITMENTS AND CONTINGECIES (Details Narrative) (USD $)	12 Months Ended					20 Months Ended
	Nov. 30, 2016	Nov. 30, 2015	Nov. 30, 2014	Nov. 30, 2013	Nov. 30, 2012	Aug. 31, 2012	Jun. 01, 2012	May 24, 2012	Nov. 01, 2011	Feb. 03, 2011	Jan. 04, 2011
Commitments and Contingencies Disclosure [Abstract]
Lease terms									5 years
Rent to be charged per month	$ 3,506	$ 3,371	$ 3,241	$ 3,116	$ 2,996
Acquired monthly rent, as part of asset purchase agreement											7,526
Acquired monthly payments to extinguish note						1,500
Acquired note, as part of asset purchase agreement											78,000
Due to Franchise Tax Board, as part of asset purchase agreement											11,405
Monthly payments due to Franchise Tax Board						400
Due to the Internal Revenue Service, as part of the asset purchase agreement											13,595
Monthly payments due to the Internal Revenue Service						425
General damages sought										125,000
Titterington Veterinary Services money award sought								$ 50,000
Maximum common shares to be purchased by Southridge							10,000,000
Average of two lowest closing prices equal to purchase price of shares							91.00%
Minimum Southridge ownership of common stock							9.99%
Cash placement fee of funds received							5.00%

Title of Class

Name and Address of Beneficial Owner

Amount and Nature

of Beneficial Owner

Percent of Class

NonVoting Convertible Preferred Shares

Southridge Partners II LLP(1)

90 Grove Street

Ridgefield CT

All Officers and Directors

As a Group

(1) Stephen Hicks possesses voting power and investment power over 75,000 NonVoting Convertible Preferred Shares held by Southridge.